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Abstract 
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Abstract 
 
This thesis describes the development of new methods for the asymmetric synthesis of 
α-alkoxy and α-amino organometallic reagents.  Two approaches were taken: (i) 
sulfoxide → magnesium exchange; (ii) asymmetric lithiation-trapping using chiral 
bases. A review of this area is provided in Chapter One.  
 
Chapter Two details the synthesis of α-alkoxy sulfoxides A in 99:1 er by asymmetric 
lithiation using s-BuLi and chiral diamines and trapping with Andersen’s sulfinate.  In 
addition, an investigation into the lack of stereospecificity at sulfur during the trapping 
process is presented.  Finally, a sulfoxide → magnesium exchange was used to convert 
the α-alkoxy sulfoxides into α-alkoxy Grignard reagents B and subsequent trapping 
allows access to a range of products as single enantiomers. The remarkable 
configurational stability of α-alkoxy Grignard reagents when compared to their 
organolithium counterparts is of particular note.  
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Attempts to use a similar method to synthesise α-amino sulfoxides in 99:1 er is 
described in Chapter Three.  Furthermore, insights are given into the surprising 
instability of unsubstituted α-amino sulfoxides.   Novel α-amino sulfoxides C were 
designed to prohibit sulfoxide elimination.  From the isolatable α-amino sulfoxides, the 
synthesis and reactions of α-amino Grignard reagents D in 99:1 er via sulfoxide → 
magnesium exchange is reported.   
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In Chapter Four, an investigation into the mechanism of the asymmetric lithiation-
trapping of N-thiopivaloyl azetidine E using s-BuLi and chiral diamines is presented.  
The configurational stability of the organolithium intermediate F was determined at −78 
°C and the scope of electrophilic trapping was investigated. 
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Chapter One: Introduction 
 
Nature shows an astonishing ability to distinguish between the enantiomers of chiral 
molecules.  Indeed, the mirror image arrangements of a molecule can elicit contrasting 
responses in a whole host of biological receptors.
1
  Therefore, the continued 
development of novel synthetic approaches towards diverse three-dimensional 
molecules remains of utmost importance to modern society.   
 
Organometallic chemistry offers an attractive technique for the introduction of new 
stereogenic centres within complex molecules and has thus become a key part of the 
modern synthetic chemist’s armoury.  New methods for the synthesis of α-
functionalised organolithium
2,3
 and organomagnesium reagents are of particular 
interest.
4,5
  In addition to their use in the synthesis of pharmaceutical products,
6-8
 α-
functionalised organometallics have been used in the stereo-inducing step in a number 
of natural product total syntheses, with some recent examples including (−)-kainic acid,9 
(−)-swainsonine10 and (−)-decarestrictine D11 (Figure 1.1).  
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Figure 1.1 
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1.1 Asymmetric Synthesis of α-Functionalised Organolithium Reagents 
Organolithium reagents were discovered by Wilhelm Schlenk in 1917.
12
  The first 
synthetic route was an exchange reaction from the mercury derivative forming mercury 
amalgam (Scheme 1.1).  Schlenk gave vivid descriptions of the organolithium reagents 
that were formed, with methyllithium being said to form a “brilliant red flame with a 
shower of golden sparks” when exposed to air.13 
 
Et2Hg 2EtLi Li(Hg)
3Li
+  
Scheme 1.1 
 
Fortunately, the synthesis of organolithium reagents has been significantly improved 
over the past century.  A contemporary organic chemist would typically synthesise an 
organolithium reagent via one of three general methods; transmetallation or halogen-
metal exchange, reductive lithiation of alkyl halides with lithium metal, or 
deprotonation/lithiation (Scheme 1.2). 
 
Transmetallation or 
Halogen-Metal Exchange 
Reductive Lithiation Deprotonation/Lithiation 
R1X R1Li
R2Li R2X
X = Sn(R3)3, SR
4, Br, I  
R1X R1Li
2Li LiX
X = Br, I
 
R1H R1Li
R2Li R2H
 
Scheme 1.2 
 
For the synthesis of organolithium reagents in an asymmetric fashion, deprotonation 
using strong organolithium bases in the presence of chiral ligands is the premier 
approach.  Significantly, asymmetric deprotonation avoids some mechanistic limitations 
of the alternative methods such as difficulties in synthesising secondary organolithium 
reagents
14
 or planar radical intermediates.
15
  Tin → lithium exchange offers the only 
real alternative for the synthesis of chiral organolithium reagents.  This methodology 
was exemplified by Still and co-workers in 1980.
16
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By far the most important ligand used in asymmetric lithiation is (−)-sparteine, a 
naturally occurring chiral diamine (Figure 1.2).  It was first used in as a bidentate ligand 
in organometallic chemistry in 1968
17
 and since then, it has consistently outperformed 
other diamine ligands in terms of yield and enantioselectivity.
18
  (−)-Sparteine is 
extracted from Scotch Broom and is commercially available but more recently, supplies 
have been variable.  Its enantiomer, (+)-sparteine, is not commerically available.  In 
2002, our group reported the first readily accessible (+)-sparteine surrogate 1 which 
provides enantiocomplementary reactions to (−)-sparteine.19  A review of the chemistry 
of the (+)-sparteine surrogate 1 was published in 2008.
20
 
 
N
N
H
H
N
N
H
(_)-Sparteine (+)-Sparteine
Surrogate 1
N
N
H
H
(+)-Sparteine
 
Figure 1.2 
 
There are three possible mechanistic pathways that can lead to enantioenriched products 
by a lithiation-substitution process.  The mechanisms are dictated by the configurational 
stability of the organolithium reagent and the relative rates of trapping with 
electrophiles.  If the organolithium reagent is configurationally stable, then the reaction 
will proceed via an enantioselective deprotonation pathway.  In contrast, if the 
organolithium reagent is configurationally unstable, then the reaction can proceed either 
by a dynamic thermodynamic resolution or a dynamic kinetic resolution. 
 
1.1.1 Enantioselective Deprotonation as a Route to Organolithium Reagents 
 
Clayden describes enantioselective deprotonation as ‘conceptually the simplest sort 
of asymmetric organolithium reaction’.18  A general enantioselective deprotonation is 
depicted in Scheme 1.3.  The complex of an organolithium reagent (RLi) and a chiral 
ligand (L
*
) performs an enantioselective deprotonation of substrate 2 to form chiral 
organolithium reagent 3.  This is the stereo-inducing step and it is essential for the 
intermediate organolithium 3 to be configurationally stable under the reaction 
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conditions (typically −78 °C).  Organolithium reagent 3 is then trapped by electrophiles 
to give enantioenriched products of type 4. 
 
X Y
H H
X Y
H Li.L*
X Y
H ERLi.L* E
+
2 3 4
L* = Chiral Ligand
_78 °C
 
Scheme 1.3 
 
The first enantioselective deprotonation was reported in 1990 by Hoppe et al.
21
 O-Alkyl 
carbamate 5 was treated with s-BuLi/(−)-sparteine in Et2O at −78 °C for 5 hours to give 
lithiated intermediate (S)-6 which was then trapped with carbon dioxide or 
trimethylsilyl chloride in good yields and enantiomeric ratio (Scheme 1.4).  At the time, 
Hoppe postulated that activation of carbamate 5 occurred due to chelation and dipole 
stabilisation, a phenomenon which was later christened the ‘Complex Induced 
Proximity Effect’ (CIPE).22  
s-BuLi, (_)-sparteine
Et2O,
_78 °C, 5 hO
O
ON O
O
ONMe
H Li
NN
O
O
ONMe
E
Electrophile
(R)-7, E = CO2H,
75%, >98:2 er
(S)-8, E = SnMe3,
76%, >98:2 erNN = (
_)-sparteine
5 (S)-6
N
N
H
H
 
Scheme 1.4 
 
The absolute configuration of (R)-7 was determined by comparison to a known lactic 
acid derivative.  Crucially, organolithium reagent (S)-6 was configurationally stable 
under the reaction conditions
16
 and trapping proceeded with retention of configuration 
at carbon. 
 
In contrast, Hoppe and co-workers reported that the lithiation-trapping of benzylic 
carbamate (R)-9 proceeded with either retention or inversion of configuration, 
depending on the electrophile employed.
23
 In this work, (R)-9 (98.5:1.5 er) was treated 
with s-BuLi/TMEDA to give organolithium (R)-10.  The lithiated intermediate was then 
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either reprotonated or trapped with electrophiles (Schemes 1.5 and 1.6).  Reprotonation 
by methanol or acetic acid proceeded with retention of configuration to give (R)-9 in 
90:10 er.   Interestingly, reprotonation by acetic acid was originally reported to proceed 
with inversion of configuration however, this has since been corrected.
24,25
 
 
Ph Li
Me OCb
Ph H
Me OCb
Ph H
Me OCbs-BuLi, TMEDA
Hexane, _78 °C, 30 min
AcOH
MeOH
(R)-9
98.5:1.5 er
(R)-9, 75%
90:10 er
(R)-9, 80%
90:10 er
Cb = CONiPr2
(R)-10
N
N
TMEDA Ph H
Me OCb
 
Scheme 1.5 
 
Furthermore, alkylation of (R)-10 with n-propyl bromide or dimethyl carbonate gave 
(S)-12 (77%, 92.5:7.5 er) or (R)-13 (85%, 95:5 er) respectively with retention of 
configuration.  However, the trapping reaction with methyl chloroformate proceeded 
with inversion of configuration to give methyl ester (S)-13 in 90% yield and 92.5:7.5 er. 
'r etent ion'
'inversion'
Ph Li
Me OCb
Ph CO2Me
Me OCb
Ph H
Me OCb
Ph CO2Me
Me OCbs-BuLi, TMEDA
Hexane, _78 °C, 30 min
MeOCOCl
(MeO)2CO
(R)-9
98.5:1.5 er
(S)-13, 90%
92.5:7.5 er
(R)-13, 85%
95:5 er
Cb = CONiPr2
(R)-10
Ph
Me OCb
(S)-12, 77%
92.5:7.5 er
n-PrBr
'r etent ion'
 
Scheme 1.6 
 
For the case of α-oxybenzyl organolithium reagents, Hoppe suggested that the 
propensity for the trapping to occur with either retention or inversion of configuration is 
due to the close-lying activation energies for front-side and back-side attack. This was 
supported by theoretical calculations by Schleyer et al.
26
 Therefore, the steric demand of 
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the electrophile and the interaction of the leaving group with the lithium ultimately 
determine the reaction pathway. 
 
Our group has contributed to the O-alkyl carbamate deprotonation methodology by the 
introduction of a catalytic asymmetric variant.
27
 It was reported that treatment of O-
alkyl carbamate 14 with 2.8 equivalents of s-BuLi in the presence of just 0.2 equivalents 
of (−)-sparteine and 1.2 equivalents of achiral diamine 16 and trapping with tributyltin 
chloride gave stannane (S)-15 in 60% yield and 97:3 er (Scheme 1.7).  The opposite 
enantiomeric series was also accessible through the use of the (+)-sparteine surrogate 1, 
giving stannane (R)-15 in 86% yield and 96:4 er.  The role of achiral diamine 16 is to 
displace the chiral ligand from the lithiated intermediate.  Thus, the s-BuLi/chiral ligand 
complex is then available to deprotonate more O-alkyl carbamate 14.  Diamine 16 was a 
suitable ligand as its complex with s-BuLi has been shown to be a slow lithiator when 
compared to the s-BuLi complexes of (−)-sparteine and (+)-sparteine surrogate 1.28 
 
1. 2.8 eq. s-BuLi, 0.2 eq. (_)-sparteine
1.2 eq. diamine 16, Et2O,
_78 °C
2. Bu3SnCl
14
Ph OCb
Cb=CONiPr2
Ph SnBu3
1. 2.8 eq. s-BuLi, 0.2 eq. (+)-sp. surr. 1
1.2 eq. diamine 16, Et2O,
_78 °C
2. Bu3SnCl
14
Ph OCb
Cb=CONiPr2
Ph SnBu3
(S)-15, 60%
97:3 e.r
(R)-15, 86%
96:4 e.r
N
N
16
N
N
H
(+)-Sparteine
Surrogate 1
OCbH
CbO H
Scheme 1.7 
 
The lithiation-trapping of O-alkyl carbamates is a useful method for synthesising α-
substituted protected alcohols in good yield and high enantiomeric ratio.  Furthermore, 
due to the introduction of the (+)-sparteine surrogate 1, both enantiomers of the 
products are accessible.
19
  In order to access the synthetically desirable secondary 
alcohols, removal of the carbamate group would be necessary.  This typically proceeds 
under harsh reductive conditions (LiAlH4, THF, reflux).
29
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Hoppe developed an alternative approach to secondary alcohols that avoided the need to 
use harsh reductive conditions (Scheme 1.8).
30
   Indeed, lithiation of O-alkyl carbamate 
14 and trapping with boronates followed by treatment with Grignard reagents effected 
1,2-metallate rearrangement with expulsion of the carbamate moiety.  Finally, oxidation 
gave chiral alcohols in good yield and high enantiomeric ratio.  An example (14 → (S)-
17 → (R)-18) is shown in Scheme 1.8.  However, until 2007, there was only one 
example of trapping of a lithiated carbamate with a borate ester to give in situ access to 
a chiral alcohol in 98:2 er.
31
  
1. s-BuLi, (_)-sparteine
Et2O,
_78 °C, 3 h
2. B(Oi -Pr)3
3. pinacol, p-TsOH,
MgSO4, CH2Cl2
14
Ph OCb
Cb=CONiPr2
Ph OCb
(S)-17
90%, 98:2 er
O
B
O
Ph
OH
(R)-18
70%, 98:2 er
1. C6H11MgBr
Et2O,
_78 °C, 1h
2. H2O2, NaOH
Ph OCb
O B
O
Ph
O
B
O
v ia
Scheme 1.8 
 
In 2007, Aggarwal and co-workers reported a general procedure for the trapping of 
Hoppe-type lithiated O-alkyl carbamates with boranes and borates and subsequent 
conversion into chiral alcohols.
32
  First, carbamates 14, 19 and 20 were treated with s-
BuLi/(−)-sparteine in Et2O at −78 °C to give the lithiated intermediates. Subsequent 
addition of boranes or boronic esters to the lithiated carbamates gave ate-complexes 
which furnished secondary alcohols 21-25 via a 1,2-metallate rearrangement and 
subsequent oxidation (Scheme 1.9).  Selected results are summarised in Table 1.1.  
Aggarwal et al. were able to conclude that the reaction of the lithiated carbamates with 
both boranes and boronic esters and subsequent 1,2 metallate rearrangement proceeded 
with retention of configuration.  This supports what was previously reported in the 
literature.
27,30,33
  The configurations of alcohols 21-25 were determined by comparison 
to known compounds.  Furthermore, the sense of induction in the lithiation of O-alkyl 
carbamates using s-BuLi/(−)-sparteine is well established from Hoppe’s work.21 
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s-BuLi, (_)-sparteine
Et2O,
_78 °C, 5 h
14, R1 = Ph(CH2)2
19, R1 = Me2C=CH(CH2)
20, R1 = TBSO(CH2)C(Me)2CH2
14, 19 or 20
R1 OCb
Cb=CONiPr2
HH
R1 OCb
Li.(_)-sp.H R2B(R3)2
OCb
B(R3)2
H
R1
R2
B(R3)2
R2
H
R1
OH
R2
H
R1
(Lewis
Acid)
NaOH/H2O2
21-25
 
Scheme 1.9 
Table 1.1: Lithiation-Boronate rearrangement of O-Alkyl Carbamates 
Entry SM R
2
 (R
3
)2 Lewis Acid Product Yield  / % er 
1 14 Et Et - 21 91 98:2 
2 14 Ph 9-BBN - 22 85 88:12 
3 14 Ph 9-BBN MgBr2 22 94 97:3 
4 19 Et Et - 23 90 97:3 
5 19 Et pinacol MgBr2 23 75 97:3 
6 20 Et Et - 24 67 95:5 
7 20 Ph pinacol MgBr2 25 64 98:2 
 
The methodology was shown to tolerate a number of boranes and boronates.  Use of 
triethyl borane gave good to excellent yields and excellent enantiomeric ratios in all 
cases (entries 1, 4 and 6).  Interestingly, in the case of B-Ph-9-BBN, higher er was 
obtained in the presence of MgBr2 (entry 3 vs. entry 2), but this was not found to be 
necessary in the case of aliphatic groups where high enantioselectivity was observed 
without addition of a Lewis acid (entry 1).  It was postulated that the addition of MgBr2 
sequesters either (−)-sparteine or the carbamate leaving group, thus preventing it from 
binding to the borane which would cause homolysis of the benzylic carbon-boron bond.  
This would result in a lower enantiomeric ratio of the final alcohol.  In addition, this 
was the first example of a clean migration of the boron substituent when the leaving 
group is not a halide.  Finally, pinacol boronates were shown to give good yields (64-
75%) and excellent enantioselectivity (97:3-98:2 er) (entries 5 and 7). 
Chapter One: Introduction 
 
9 
 
 
Extension of the methodology to include an iterative process with boronic esters 
allowed access to scaffolds bearing multiple adjacent stereocentres (Scheme 1.10).  
Lithiation of O-alkyl carbamate 14 with s-BuLi/(−)-sparteine gave lithiated intermediate 
(S)-26, trapping with ethyl pinacol boronate ester and subsequent 1,2-metallate 
rearrangement gave boronic ester (R)-27. A second homologation with lithiated 
carbamate (S)-28 gave alcohol (1R,2R)-29 in 82% yield, >98:2 er and 96:4 dr.  Alcohol 
(1S,2R)-29 was synthesised from boronic ester (R)-27 and lithiated intermediate (R)-28 
in good yield (63%) and excellent stereoselectivity (>98:2 er and 96:4 dr).  The 
enantiocomplementary alcohols (1R,2S)-29 and (1S,2S)-29 were accessed in good yields 
and stereoselectivity via lithiation of carbamate 14 with s-BuLi/(+)-sparteine surrogate 
1 and electrophilic trapping with ethyl pinacol boronic acid to give boronate (S)-27 and 
subsequent homologation with either (S)-28 or (R)-28. 
HO
Ph
HO
Ph
HO
Ph
HO
Ph
Ph OCb
Ph OCb
Ph
Ph
B
B
Li
OCb
Li
OCb
Li
OCb
Li
OCb
EtB(pin)
EtB(pin)
Ph OCb
Li
Li
s-BuLi,
(_)-sparteine
s-BuLi,
(+)-sparteine
surrogate 1
(1R,2R)-29, 82%
>98:2 er, 96:4 dr
(1S,2R)-29, 63%
>98:2 er, 96:4 dr
(1R,2S)-29, 64%
>98:2 er, 96:4 dr
(1S,2S)-29, 63%
>98:2 er, 90:10 dr
(S)-26
14
(R)-26
(R)-27
78%, 98:2 er
(S)-27
75%, 97:3 er
(R)-28
(R)-28
(S)-28
(S)-28
OO
OO
Scheme 1.10 
 
In 2008, Aggarwal and co-workers used the 1,2-metallate rearrangement of boronate 
complexes to convert chiral secondary alcohols into tertiary alcohols.
34
  To prove the 
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concept, carbamate (S)-8 (99:1 er) was deprotonated with s-BuLi in Et2O.  Subsequent 
addition of the borane or boronic ester followed by oxidation gave the tertiary alcohols 
(S)-30 or (R)-30 in excellent yield and enantioselectivity.  Two examples are shown in 
Scheme 1.11. 
Ph
CbO
Ph
Et OH
Ph
CbO
Ph
Et OH
1. s-BuLi, Et2O,
_78 °C, 20 min
1. s-BuLi, Et2O,
_78 °C, 20 min
2. BEt3, 
3. H2O2, NaOH
2. EtB(pin), 
3. H2O2, NaOH
(S)-30
91%, 99:1 er
(S)-8
99:1 e.r
(S)-8
99:1 e.r
(R)-30
95%, 99:1 er
H
H
 
Scheme 1.11 
 
Interestingly, when using boranes the reactions occurred with inversion of 
configuration, but the use of boronic esters caused the reaction to proceed with retention 
of configuration.  Consequently, either enantiomeric series of alcohols can be accessed 
starting from (S)-8.  Aggarwal suggested that for the case of boronic esters, coordination 
between the oxygen of the ester and the lithium of the metalated carbamate causes 
delivery on the same face as the metal.  As boranes are unable to form the same 
complex, reaction occurred on the opposite face to the metal where there is significant 
electron density due to a partial-flattening of the carbanion because of its benzylic 
nature. This is in contrast to lithiated alkyl carbamates where both boranes and boronic 
esters react with retention of configuration due to a sp
3
-hybridised carbanion which has 
very little electron density opposite the metal.  
 
In summary, the lithiation of O-alkyl carbamates, trapping with boranes or boronic 
esters and subsequent 1,2-metallate rearrangement, affords chiral secondary and tertiary 
alcohols in good yield and excellent enantiomeric ratio.  The expediency of the 
methodology is highlighted in a number of total syntheses.
11,35,36
 For example, the 
stereo-determining step in the synthesis of (−)-decarestrictine D is shown in Scheme 
1.12.  Lithiation of O-alkyl carbamate 31 using s-BuLi/(+)-sparteine surrogate 1 and 
trapping with tributyltin chloride gave stannane 32 in 72% yield and 97:3 dr.  Tin → 
lithium exchange of stannane 32 and trapping with silyl vinyl borane 33 gave adduct 34 
which underwent 1,2-metallate rearrangement to give 35.  Subsequent addition of 
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aldehyde 36 gave cis-alkene 38.  This reaction proceeds via the six-membered transition 
state 37 in which the alkyl group has to occupy the axial position due to steric 
interaction with the boron ligand, thereby giving the Z-double bond.  Intermediate 38 
was then converted into (−)-decarestrictine D in six steps.11,37 
 
O
O
HO
OH
OH
(_)-Decarestrictine D
CO2Me
OBn
OHOSEM
OCb
SnBu3
OCb
OSEM
1. s-BuLi, (+)-sp. surr. 1
Et2O,
_78 °C, 1 h
2. Bu3SnCl
SEMO
31 32
72%, 97:3 dr
OCb
SiMe3
BSEMOBSEMO
SiMe3
B O
R
SiMe3
1. n-BuLi,
Et2O,
_78 °C, 5 min
2.
SiMe3
B
35 34
OHC
OBn
CO2Me
33
36
Me3Si
38
37
H
SEMO
 
Scheme 1.12 
 
Enantioselective deprotonation has also been exemplified on a wide array of nitrogen 
heterocycles.  In 1991, Beak and Kerrick reported the asymmetric lithiation-trapping of 
N-Boc pyrrolidine 39 and it has since become the most extensively studied nitrogen 
heterocycle.
38
  Lithiation of N-Boc pyrrolidine 39 using s-BuLi/(−)-sparteine gave chiral 
organolithium reagent (S)-40.  Subsequent trapping with electrophiles generated α-
substituted pyrrolidines in good yield (55-76%) and high enantioselectivity (≥94:6 er).  
For example, silylated pyrrolidine (S)-41 was formed in 71% yield and 97:3 er (Scheme 
1.13).   
N
Boc
39
N
Li
s-BuLi
(_)-sparteine
Et2O,
_78 °C, 4-6 h
N
Boc
SiMe3
tBuO O
N
N
H
H
= (_)-sparteine
Me3SiCl
H
(S)-40 (S)-41
71%, 97:3 er
H
H H
N
N
N
N  
Scheme 1.13 
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Alternative diamine ligands have also been used to mediate the deprotonation of N-Boc 
pyrrolidine 39.  For example, lithiation using s-BuLi/diamine (R,R)-42 and trapping 
with trimethylsilyl chloride gave (S)-41 in 72% yield and 95:5 er (Scheme 1.14).
29
  In 
addition, the opposite enantiomeric series is also readily available through the use of s-
BuLi/(+)-sparteine surrogate 1.
19
  Indeed, lithiation of N-Boc pyrrolidine 39 using (+)-
sparteine surrogate 1 as the ligand gave (R)-41 in 84% yield and 95:5 er. 
 
N
Boc
SiMe3
H
(S)-41
72%, 95:5 er
N
Boc
1. s-BuLi, (R,R)-42
Et2O,
_78 °C, 3 h
2. Me3SiCl N
Me
Me
N
tBu
tBu
(R,R)-4239
N
Boc
SiMe3
H
(R)-41
84%, 95:5 er
N
Boc
1. s-BuLi, (+)-sp. surr. 1
Et2O,
_78 °C, 3 h
2. Me3SiCl N
N
H
(+)-Sparteine
Surrogate 1
39
 
Scheme 1.14 
  
Lithiation of an N-Boc pyrrolidine using s-BuLi/(+)-sparteine surrogate 1 was also used 
as a key step in the total synthesis of (−)-kainic acid (Scheme 1.15).9  Treatment of 
subsituted pyrrolidine 43 with s-BuLi/(+)-sparteine surrogate 1 and subsequent trapping 
with carbon dioxide gave an 81:19 mixture of regioisomeric acids 44 and 45 in 71% 
total yield.  Elaboration of acid 44 gave (−)-kainic acid in eight steps. 
 
N
Boc
H H
H O
OH
N
Boc
H H
N
H
H H
H O
OH
O
OH
(_)-Kainic Acid
43
1. s-BuLi, (+)-sp. surr. 1
THF, _78 °C, 3 h
2. CO2
OMOM OMOM
+
N
Boc
H H
OMOM
H
HO
O
4544 71%
81:19 mixture
of regioisomers
N
N
H
(+)-Sparteine
Surrogate 1
 
Scheme 1.15 
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In 2006, Campos and co-workers reported the synthesis of chiral α-arylated N-Boc 
pyrrolidines (Scheme 1.16).
39
 First, enantioselective deprotonation of N-Boc pyrrolidine 
39 using s-BuLi and (−)-sparteine and subsequent transmetallation with zinc chloride 
gave organozinc reagent (S)-46.  Then, palladium-catalysed Negishi coupling of 
organozinc reagent (S)-46 with bromobenzene gave phenyl pyrrolidine (S)-47 in 80% 
yield and 96:4 er.    
 
N
Boc
1. s-BuLi, (_)-sparteine,
MTBE, _78 °C, 1 h
2. ZnCl2,
_78 °C, 30 min N
Boc
ZnCl
H
Pd(OAc)2, t -Bu3PHBF4
rt, 16 h
PhBr
N
Boc
Ph
H
39 (S)-46 (S)-47
80%, 96:4 er  
Scheme 1.16 
 
The wide scope of the transmetallation-Negishi methodology has been demonstrated by 
O’Brien, Campos et al. and the mechanism was probed by in-situ ReactIR® 
spectroscopic monitoring.
40
  In addition, this type of enantioselective arylation has been 
scaled up to produce ~0.6 kg of a glucose kinase inhibitor.
6
 
 
The enantioselective deprotonation of N-Boc piperidine 48 has also been explored.  In 
2002, Beak and co-workers reported that lithiation mediated by s-BuLi/(−)-sparteine 
and trapping with trimethylsilyl chloride gave α-substituted piperidine (S)-49 in 87:13 
er but only 8% yield (Scheme 1.17).
41
  In addition, enamine 50 was formed as the major 
product (43% yield).  It was suggested that, due to the very slow rate of deprotonation, 
enamine 50 is formed as the product of addition of s-BuLi to the carbonyl of the Boc 
group.  
 
N
Boc
48
N
Boc
1. s-BuLi, (_)-sparteine
Et2O,
_78 °C, 16 h
2. Me3SiCl
SiMe3 N
N
H
H
(_)-sparteine
N
50, 43%
H
(S)-49
8%, 87:13 er  
Scheme 1.17 
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In an attempt to solve this problem, a collaboration between the O’Brien and Coldham 
groups led to the screening of fourteen chiral ligands for the asymmetric deprotonation 
of N-Boc piperidine 48.
42
  It was shown that increasing the steric bulk of the ligand 
dramatically reduced the yield of the lithiation-trapping. However, less sterically 
hindered ligands led to reduced enantioselectivity.  The highest enantioselectivity was 
achieved by using s-BuLi/(R,R)-42 to lithiated N-Boc piperidine 48 and trapping with 
trimethylsilyl chloride (Scheme 1.18).  From this reaction, silylated piperidine (S)-49 
was isolated in 90:10 er but only 13% yield. 
N
Me
Me
N
tBu
tBu
(R,R)-42
N
Boc
48
N
Boc
1. s-BuLi, (R,R)-42
Et2O,
_78 °C, 6 h
2. Me3SiCl
SiMe3
H
(S)-49
13%, 90:10 er  
Scheme 1.18 
 
More recently, the first example of a high yielding asymmetric deprotonation of N-Boc 
piperidine 48 was reported by our group.
43
 This lithiation was effected by s-BuLi/(+)-
sparteine surrogate 1. Trapping with trimethylsilyl chloride gave α-substituted 
piperidine (R)-49 in 73% yield and 86:14 er (Scheme 1.19).   
 
N
Boc
48
N
Boc
(R)-49, 73%
1. s-BuLi, (+)-sp. surr. 1
Et2O,
_78 °C, 6 h
2. Me3SiCl
SiMe3
86:14 er
N
N
Me H
(+)-sparteine
surrogate 1
H
 
Scheme 1.19 
 
This methodology was then applied to a wide range of electrophiles.  However, lower 
enantioselectivity was noted in trappings with phenyldimethylsilyl chloride, methyl 
iodide and dimethyl sulfate.  It was speculated that, due to the steric bulk of the lithium-
diamine complex, trapping with these electrophiles only occurred at temperatures where 
the organolithium was configurationally unstable.
44
  
 
Enantioselective deprotonation offers an expedient method for the synthesis of α-
functionalised organolithium reagents.  Of particular note is the extensive studies of the 
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lithiation-trapping of O-alkyl carbamates and N-Boc heterocycles but enantioselective 
deprotonation has also been conducted on phosphine boranes,
45
 phosphine sulfides
46
 
and ferrocenes.
47
 
 
 
1.1.2 Dynamic Kinetic Resolution of Organolithium Reagents 
 
An alternative method for synthesising chiral organolithium reagents is by a dynamic 
kinetic resolution process.  If the intermediate α-functionalised organolithium reagent is 
configurationally unstable in the presence of a chiral ligand on the timescale of reaction 
with the electrophile then the enantiomeric ratio of the products will reflect the rate of 
reaction not the ratio of the diastereomeric organolithium complexes.  This process is 
known as a dynamic kinetic resolution and a general reaction pathway is depicted in 
Scheme 1.20.
18
  The reaction begins by deprotonation of substrate 2 by the complex of 
an organolithium reagent (RLi) and a chiral ligand (L
*
) which leads to the formation of 
diastereomeric organolithium reagents (S)-3 and (R)-3.  These organolithium reagents 
are able to interconvert under the reaction conditions at rate kinv.  On addition of an 
electrophile (E
+
), each organolithium reagent will react with a different rate (kS or kR) to 
give products (S)-4 and (R)-4. In a dynamic kinetic resolution process, the degree 
enantioselectivity is controlled by the difference in energy between the energies of the 
transition states of the electrophilic trap, ΔΔG‡.   
 
X Y
H H
X Y
H Li.L*
X Y
H E
RLi.L*
E+
2
(S)-3
X Y
H Li.L*
X Y
H E
E+
k inv
kS
kR
(R)-3
(S)-4
(R)-4
k inv > kS , kR
L* = Chiral
Ligand
    
Scheme 1.20 
 
In 1994, Beak and co-workers reported the dynamic kinetic resolution of benzylic 
organolithium 52 (Scheme 1.21).
48
 Lithiation of amide 51 by s-BuLi/(
_
)-sparteine gave 
(R)-3 
(R)-4 
(S)-3 
(S)-4 
ΔΔG‡ 
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diastereomeric organolithium reagents (S)-52 and (R)-52 which were shown to be 
configurationally unstable at −78 °C.  Upon addition of allyl chloride, trapping occurred 
to give (R)-53 in 89% yield and 96:4 er. 
 
O(i -Pr)2N
O(i -Pr)2N
O(i -Pr)2N
kinv
51
Li.(_)-sp
Li.(_)-sp
H
H
O(i -Pr)2N
H
s-BuLi, (_)-sparteine
pentane, _78 °C
(R)-52
Fast
Slow
O(i -Pr)2N
H
(S)-52 (R)-53
(S)-53
89%, 96:4 er
Cl
Cl
 
Scheme 1.21 
 
Organolithium reagent 52 was shown to be configurationally unstable by a tin → 
lithium exchange reaction from enantioenriched stannane (R)-54 (Scheme 1.22). 
Treatment of stannane (R)-54 (94:6 er) with s-BuLi in pentane at −78 °C gave 
organolithium 52 and trapping with allyl chloride generated (S)-53 in only 52:48 er.  
Similarly, in the presence of TMEDA, (S)-53 was isolated in 51:49 er.  This reaction 
proved that the organolithium reagent was configurationally unstable and the 
enantioselectivity could not be attributed to an enantioselective deprotonation event. 
 
O(i -Pr)2N
SnBu3H
(R)-54, 94:6 er
s-BuLi, Ligand
pentane, _78 °C
O(i -Pr)2N
Li
O(i -Pr)2N
H
Cl
Ligand
(S)-53
Ligand .
none - 52:48 er
TMEDA - 51:49 er
52
 
Scheme 1.22 
 
In addition, the configurational stability was also evaluated using the Hoffmann test.
49-51
  
The Hoffmann test determines the configurational stability of organolithium reagents on 
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the timescale of reaction with electrophiles.  Racemic lithiation of amide 51 (s-BuLi, 
pentane, −78 °C) gave racemic organolithium reagent 52.  Trapping with racemic amide 
rac-55 gave ketone 56 as a 1:1.6 mixture of diastereoisomers.  In addition, trapping with 
enantioenriched amide (S)-55 also gave ketone 56 in 1:1.6 dr (Scheme 1.23).   
 
O(i -Pr)2N
51
pentane, _78 °C
O(i -Pr)2N
52
Li
N
O
MeO NBn2
N
O
MeO NBn2
s-BuLi
O(i -Pr)2N
NBn2
O(i -Pr)2N
O
NBn2
O
56, 1:1.6 dr
56, 1:1.6 dr
rac-55
(S)-55
 
Scheme 1.23 
 
Due to the diastereoselectivity of the reactions with racemic and enantioenriched amide 
56 being the same, it was concluded that organolithium reagent 52 was 
configurationally unstable on the timescale of reactions with the amide electrophile.  
Thus, a dynamic kinetic resolution process was occurring.  If the diastereoselectivity 
had been different then the organolithium reagent would have been configurationally 
stable on the timescale of reaction with the amide and a dynamic thermodynamic 
resolution process would have been occurring (see Chapter 1.1.3). 
 
Interestingly, the leaving group in the electrophile was revealed to have a dramatic 
effect on the enantioselectivity of the lithiation-trapping of 51.  Indeed, trapping with 
allyl tosylate gave (S)-53 in 94:6 er (Scheme 1.24).  This is the opposite enantiomer to 
that formed when allyl chloride was used.  Beak suggests that this is due to electrophilic 
trapping of (S)-52 occurring with inversion due to the change of the leaving group. 
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O(i-Pr)2N
O(i-Pr)2N
O(i-Pr)2N
kinv
51
Li.(_)-sp
Li.(_)-sp
H
H O(i-Pr)2N
H
s-BuLi, (_)-sparteine
pentane, _78 °C
(R)-52
Fast
Slow
O(i-Pr)2N
H
(S)-52
(R)-53
(S)-53
46%, 96:4 er
OTs
OTs
Inversion
 
Scheme 1.24 
 
A dynamic kinetic resolution of N-Boc 2-lithiopiperidine 59 has also been reported by 
Coldham et al.
52
  This is significant due to low yields for the enantioselective 
deprotonation of N-Boc piperidine 48 using s-BuLi/(−)-sparteine and other chiral 
diamines (see Scheme 1.17).  The resolution protocol began with a tin → lithium 
exchange on stannane rac-57 in the presence of chiral ligand 58 at −78 °C.  Warming 
the reaction mixture to −20 °C and slow addition of trimethylsilyl chloride over 50 
minutes gave (S)-49 in 71% yield and 94:6 er (Scheme 1.25). 
N
Boc
SnBu3
N
Boc
Li.58
2. _20 °C, 2 min
1. n-BuLi, 58
Et2O,
_78 °C, 10 min
N
Boc
Li.58
N
Me
N
OLi
58
Fast
Slow
Me3SiCl
Me3SiCl
N
Boc
SiMe3
N
Boc
SiMe3
(S)-59
(R)-59 (R)-49
(S)-49
71%, 94:6 er
rac-57
H H
H H
 
Scheme 1.25 
 
A dynamic kinetic resolution process can also be carried out directly from N-Boc 
piperidine 48 (Scheme 1.26).  Racemic lithiation of N-Boc piperidine 48 (s-BuLi, 
TMEDA, Et2O, −78 °C, 3 hours) followed by addition of chiral ligand 58 at −20 °C and 
Chapter One: Introduction 
 
19 
 
slow addition of trimethylsilyl chloride over 50 minutes gave silylated piperidine (S)-49 
in 60% yield and 95:5 er. 
N
Boc
N
Boc
Li.58
2. 58, _20 °C, 2 min
1. s-BuLi, TMEDA
Et2O,
_78 °C, 10 min
N
Boc
Li.58
N
Me
N
OLi
58
Fast
Slow
Me3SiCl
Me3SiCl
N
Boc
SiMe3
N
Boc
SiMe3
(S)-59
(R)-59 (R)-49
(S)-49
60%, 95:5 er
48
H H
H H
 
Scheme 1.26 
 
Extensive work by Coldham et al. established that this was a dynamic kinetic resolution 
process.  Unfortunately, high enantiomeric ratios were only achievable with slow 
reacting electrophiles.  For example, use of tributyltin chloride, DMF or dimethyl 
sulfate gave products with little or no enantioselectivity.  It was suggested that more 
reactive electrophiles are less able to discriminate between the diastereomeric 
organolithium reagents. 
 
 
1.1.3 Dynamic Thermodynamic Resolution of Organolithium Reagents 
 
Another approach to synthesising organolithium reagents in high enantiomeric ratio is 
dynamic thermodynamic resolution.  If the intermediate organolithium reagent is 
configurationally unstable in the presence of a chiral ligand but interconversion of the 
diastereomeric complexes does not occur on the timescale of reaction with the 
electrophile then the enantiomeric ratio of the products will reflect the ratio of the 
diastereomeric organolithium reagents.  This process is known as a dynamic 
thermodynamic resolution and the organolithium reagents are said to have microscopic 
configurational stability (Scheme 1.27).
18
 The process begins with the complex of an 
organolithium reagent (RLi) and a chiral ligand (L
*
) deprotonating substrate 2 to give 
diastereomeric organolithium reagents (S)-3 and (R)-3.  These organolithium reagents 
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are able to interconvert under the reaction conditions at rate kinv to give a 
thermodynamic ratio of diastereoisomers.  When an electrophile (E
+
) is added, each 
organolithium reagent will react with a different rate (kS or kR) to give products (S)-4 
and (R)-4.  However, because kS and kR are greater than the rate of interconversion of 
the diastereomeric organolithium reagents (kinv) the thermodynamic ratio will be 
trapped. The enantioselectivity of a dynamic thermodynamic resolution is determined 
by the difference in energy between the two diastereomeric lithiated intermediates (ΔG) 
and in the presence of an excess of electrophile the enantiomeric ratio of (S)-4 and (R)-4 
will directly reflect the diastereomeric ratio of the organolithium intermediates. 
 
X Y
H H
X Y
H Li.L*
X Y
H E
RLi.L*
E+
2
(S)-3
X Y
H Li.L*
X Y
H E
E+
k inv
kS
kR
(R)-3
(S)-4
(R)-4
kS , kR > k inv
L* = Ligand
Chiral
     
Scheme 1.27 
 
An example of this process is shown in Scheme 1.28.
53
  Lithiation of N-pivaloyl-o-
ethylaniline 60 by s-BuLi in MTBE at −25 °C gave racemic organolithium reagent rac-
61.  Cooling the reaction to −78 °C followed by the addition of (−)-sparteine and 
trapping with trimethylsilyl chloride gave silylated product (R)-62 in only 56:44 er.  
However, if (−)-sparteine was added at −25 °C, incubated at that temperature for 45 
minutes and then cooled to −78 °C before trapping with trimethylsilyl chloride, then 
silylated product (R)-62 was isolated in a dramatically improved 92:8 er.  
 
(R)-3 
(R)-4 
(S)-3 
(S)-3 
ΔG ΔG‡ 
ΔG‡ 
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NH
O
NLi
O
Li NH
O
MTBE
_25 °C
1. (_)-sparteine
_78 °C, 15 min
2. 2.3 eq. Me3SiCl
(R)-62, 56:44 er
NH
O
NLi
O
Li NH
O
2. _78 °C, 15 min
3. 2.3 eq. Me3SiCl
(R)-62, 92:8 er
1. (_)-sparteine
_25 °C, 45 min
rac-61
rac-61
60
60
2 eq. s-BuLi
MTBE
_25 °C
2 eq. s-BuLi
H
H
SiMe3
SiMe3
 
Scheme 1.28 
 
The necessity for a warm-cool cycle to achieve high enantioselectivity indicates that the 
diastereomeric lithiated intermediates are interconverting at −25 °C but are not at −78 
°C.  This is shown schematically in Scheme 1.29.  Initially, enantiomeric organolithium 
reagents (R)-61 and (S)-61 were present in a 50:50 ratio.  Then, (−)-sparteine was added 
at −25 °C and diastereomeric organolithium reagents (R)-61.(−)-sp and (S)-61.(−)-sp are 
formed.  The organolithium reagents then equilibrate to a 92:8 diastereomeric ratio.  
This ratio then remained on cooling to −78 °C, a temperature at which the 
organolithium reagents are configurationally stable.  Addition of an excess of 
trimethylsilyl chloride traps the 92:8 mixture of diastereomeric organolithium reagents 
and this is reflected in the enantiomeric ratio of the product. 
NLi
O
Li NH
O
NLi
O
Li NH
O
_25 °C, 45 min
(R)-61
(S)-61
NLi
O
Li.(_)-sp
NLi
O
Li.(_)-sp
(R)-61.(_)-sp
(S)-61.(_)-sp
NLi
O
Li.(_)-sp
NLi
O
Li.(_)-sp
(R)-61.(_)-sp
(S)-61.(_)-sp
(_)-sparteine _78 °C
Me3SiCl
Me3SiCl
(S)-62
50
:
50
(R)-62
92
:
8
92
:
8
92
:
8
H
SiMe3H
SiMe3
 
Scheme 1.29 
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Finally, Beak and co-workers also showed that it was possible to improve the 
enantiomeric ratio of the product be using a deficiency of the electrophile.  Thus, 
addition of just 0.1 eq. of trimethylsilyl chloride gave silylated product (R)-62 in 99:1 er 
but the yield is limited to 10% based on 60 (Scheme 1.30).  Such a high 
enantioselectivity is a result of a kinetic resolution with organolithium (R)-61.(−)-sp 
reacting faster with the electrophile than organolithium (S)-61.(−)-sp, leading to a high 
enantioselectivity of the product (R)-62. 
MTBE
_25 °C
2 eq. s-BuLi
NH
O
NLi
O
Li NH
O
2. _78 °C, 15 min
3. 0.1 eq. Me3SiCl
(R)-62, 99:1 er
1. (_)-sparteine
_25 °C, 45 min
6160
H SiMe3
 
Scheme 1.30 
 
The dynamic thermodynamic resolution of N-alkyl and N-allyl-2-lithiopyrrolidines was 
reported by Coldham et al. in 2006.
52,54
 Stannane rac-63 was treated with n-
BuLi/TMEDA in Et2O followed by n-BuLi/64 at −5 °C (Scheme 1.31).  After stirring at 
−5 °C for 90 minutes, the reaction was cooled to −78 °C and phenylisocyanate was 
added.  After chromatography, amide (S)-66 was isolated in 56% yield and 96:4 er. 
Organolithium reagents (R)-65 and (S)-65 were shown to be configurationally labile at 
−5 °C but configurationally stable at −78 °C. 
 
N SnBu3
N Li.64
N
NHPh
O
(S)-66
56%, 96:4 er
1. n-BuLi, TMEDA
Et2O,
_5 °C
2. n-BuLi, 64
_5 °C, 90 min
N
OLi
MeN
64
N Li.64
(R)-65
(S)-65
N Li.64
N Li.64
(R)-65
(S)-65
PhNCO_78 °C
rac-63
H H
H
H H
 
Scheme 1.31 
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The resolution of lithiated pyrrolidine 65 was later expanded by Gawley and co-workers 
to include a catalytic dynamic resolution process in the presence of just 0.15 equivalents 
of chiral ligand 64.
55
 
 
In 2008, Coldham reported the dynamic thermodynamic resolution of N-Boc 2-
lithiopiperidine 68.
56
  Racemic lithiation of N-Boc piperidine 48 using s-BuLi/TMEDA 
in Et2O at −78 °C was followed by addition of chiral ligand 67 at −20 °C (Scheme 
1.32).  The reaction was then incubated at −20 °C for 90 minutes to allow the 
equilibration of the diastereomeric lithiated intermediates (S)-68 and (R)-68. Cooling to 
−78 °C prevented further interconversion and trapping with trimethylsilyl chloride, 
tributyltin chloride or DMF gave silylated piperidine (S)-49 (79:21 er), stannane (S)-57 
(80:20 er) or aldehyde (R)-70 (77:23 er) respectively.  In contrast to a dynamic kinetic 
resolution, a wide range of electrophiles gave similar enantiomeric ratio in the dynamic 
thermodynamic resolution process. 
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Scheme 1.32 
 
In more recent work, Gawley has reported a catalytic variant of the dynamic 
thermodynamic resolution of N-Boc 2-lithiopiperidine 68.
57,58
 Lithiation of N-Boc 
piperidine 48 (s-BuLi/TMEDA, −78 °C, 3 hours) followed by addition of 10 mol% of 
chiral ligand 67 at −45 °C presumably gave 10 mol% diastereomeric lithiated 
intermediates (S)-68.67 and (R)-68.67 which were able to interconvert (Scheme 1.33).  
In order to achieve high enantioselectivity, TMEDA must be able to displace chiral 
ligand 67 from the lithiated intermediates without perturbing the thermodynamic ratio 
and therefore (R)-68.TMEDA and (S)-68.TMEDA must be configurationally stable at 
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−45 °C.  Chiral ligand 67 will then displace TMEDA from the lithiated intermediate 
allowing further equilibration of the organolithium reagents. Finally, cooling the 
reaction to −78 °C and addition of trimethylsilyl chloride gave silylated piperidine (S)-
49 in 74% yield and 96:4 er.  This reaction has been further expanded to include 
examples of transmetallation-Negishi coupling.
59
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Scheme 1.33 
 
To conclude, dynamic thermodynamic resolution can be used to synthesise chiral 
organolithium reagents which are than reacted with electrophiles to give substituted 
products.  The enantiomeric ratio of the products is dependent upon the thermodynamic 
ratio of diastereomeric organolithium reagents.  Unlike a dynamic kinetic resolution 
process, the enantioselectivity does not vary significantly between electrophiles 
allowing for a wide scope of products to be formed. 
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1.2 Asymmetric Synthesis of α-Functionalised Organomagnesium 
Reagents 
 
Since their preparation by Victor Grignard in 1900,
60,61
 organomagnesium reagents have 
become ubiquitous within organic chemistry.  The classic preparation of Grignard 
reagents – as they would later become known – is the oxidative insertion of magnesium 
into carbon-halogen bonds (Scheme 1.34).  It is generally accepted that this reaction 
proceeds via a radical pathway.
62,63
   
 
R X R MgX
Mg
THF or Et2O  
Scheme 1.34 
 
The induction period for the insertion is typically dependent on the amount of moisture 
present and the nature of the surface of the magnesium turnings.  Therefore, a number 
of chemical activation procedures have been developed, such as the addition of iodine,
64
 
1,2-dibromoethane
65
 and diisobutylaluminum hydride.
66
  In addition, physical activation 
procedures have also been utilised (e.g. dry stirring magnesium turnings under an inert 
atmosphere
67
 and removal of metal oxides from the surface of magnesium turnings
68
).  
 
In 1929, Schlenk described the chemical equilibrium taking place within ethereal 
solutions of Grignard reagents (Scheme 1.35).
69
 The equilibrium exists between 2 eq. of 
the alkyl or aryl magnesium halide and 1 eq. the dialkyl or diaryl magnesium species 
and the magnesium halide salt.  The position of the equilibrium can be dependent upon 
temperature, solvents and additives such as [15]-crown-5 or 1,4-dioxane.
70,71
  
 
RMgX R2Mg + MgX22  
Scheme 1.35 
 
Knochel and co-workers have also reported the syntheses of the more reactive dialkyl or 
diaryl magnesium species without the need for manipulation of the Schlenk equilibrium 
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(Scheme 1.36).
71
  Addition of an alkyllithium reagent to an alkyl magnesium halide 
gives the dialkylmagnesium lithium halide complex by a transmetallation process. 
 
RMgCl + RLi R2Mg
.LiCl 
Scheme 1.36 
 
Despite the common use of Grignard reagents in organic synthesis, there are very few 
methods for synthesising enantioenriched α-functionalised Grignard reagents reported 
in the literature.  Two such methods are transmetallation of chiral organolithium 
reagents and sulfoxide → magnesium exchange of enantioenriched sulfoxides. 
 
 
1.2.1 Asymmetric Synthesis of Grignard Reagents by Lithium → Magnesium 
Transmetallation 
 
Chiral Grignard reagents can be synthesised by transmetallation of enantioenriched 
organolithium reagents.  In 2001, Nakai and co-workers described the transmetallation 
of lithiated O-alkyl carbamates using MgBr2 (freshly prepared from 1,2-dibromoethane 
and magnesium metal) to give enantioenriched Grignard reagents.
72
  Treatment of 
organolithium (S)-26 (formed by tin → lithium exchange) with MgBr2 gave Grignard 
reagent (S)-70 (Scheme 1.37).  Subsequently, the reaction was warmed to room 
temperature for 1 hour and then cyclohexenone was added.  From the reaction, alcohols 
(R)-71 were isolated in 44% yield as a 79:21 mixture of diastereoisomers.  
Hydrogenation of (R)-71 established the absolute configuration and enantiomeric ratio 
(95:5 er) by comparison with a known compound.  The transmetallation and trapping 
was shown to proceed with retention of configuration from organolithium (S)-26.  When 
compared to organolithium (S)-26, Grignard reagent (S)-70 shows remarkable 
configurational and chemical stability up to room temperature.  In contrast, (S)-26 
undergoes 1,2-carbamoyl migration at −20 °C.73 
 
Li
CbO
Ph MgBr
CbO
Ph
CbO
Ph
HO
(R)-71, 44%
95:5 er, 79:21 dr
O2.
1. rt, 1 hMgBr2
(S)-26, 95:5 er (S)-70, 95:5 er
THF
_78 °C, 1 h
H H H
 
Scheme 1.37 
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A similar approach was used in our group to synthesise chiral α-amino Grignard 
reagents.
74
  Transmetallation of organolithium reagent (S)-40 (formed by 
enantioselective deprotonation of N-Boc pyrrolidine 39 using s-BuLi/(−)-sparteine) with 
MgBr2 gave Grignard reagent (S)-72 (Scheme 1.38).  The reaction was then warmed to 
0 °C for 30 minutes and addition of benzaldehyde gave a 70:30 mixture of 
diastereomeric alcohols anti-(S,R)-73 and syn-(R,R)-73 in 96:4 and 97:3 er respectively. 
Interestingly, when the organolithium reagent was trapped with benzaldehyde, syn-
(R,R)-73 was formed as the major diastereoisomer (75:25 dr). 
 
N
Boc
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OH
H
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Boc
Ph
OH
H
N
Boc
Li
H
N
Boc
MgBr
H 1. 0 °C, 30 min
2. PhCHO
anti-(S,R)-73
56%, 96:4 er
syn-(R,R)-73
17%, 97:3 er
MgBr2
Et2O,
_78 °C
30 min
(S)-40 (S)-72
 
Scheme 1.38 
 
The configurational stability of Grignard reagent (S)-72 was remarkable when compared 
to organolithium reagent (S)-40.  The Grignard reagent was shown to be 
configurationally stable at 0 °C for at least 30 minutes, whereas the organolithium 
reagent is known to be configurationally labile at temperatures above −40 °C.75,76  
 
The limitation of synthesising Grignard reagents by transmetallation of organolithium 
reagents is that the enantiomeric ratio of the products is dependent upon the 
enantioselectivity of the formation of the organolithium.  Therefore, it may not be 
possible to access an array of α-alkoxy and α-amino Grignard reagents in ≥99:1 er using 
this method.  Of significant note, however, α-alkoxy and α-amino Grignard reagents 
show increased configurational stability when compared to their organolithium 
counterparts. 
 
 
1.2.2 Asymmetric Synthesis of Grignard Reagents by Sulfoxide → Magnesium 
Exchange 
 
Since its discovery in 1962,
77
 the sulfoxide → magnesium exchange reaction has been 
widely applied to the synthesis of enantiomerically pure sulfoxides.  However, its use to 
form Grignard reagents has been given significantly less attention.
4
  To this end, the 
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groups of Satoh, Knochel and Hoffmann have been the pioneers of sulfoxide → metal 
exchange reactions over the past two decades.  Initially, much effort was given to the 
investigation of sulfoxide → lithium exchange as a method to synthesise chiral N-aryl 
aziridines, epoxides, allylic alcohols and α-amino carbonyls.78,79  However, in 1988, 
Satoh reported the use of sulfoxide → magnesium exchange chemistry to synthesise N-
aryl aziridines.
78,80
  A general reaction between an alkyl aryl sulfoxide 74 and a 
Grignard reagent to give either an alkyl Grignard reagent 75 or an aryl Grignard reagent 
76 is shown in Scheme 1.39.  The structure of sulfoxide 74 and relative stabilities of the 
Grignard reagents 75 and 76 determine which of these routes is preferred.
81
 
Ar
S
R
O
Ar
S
R'
O
R'
S
R
O
RMgX
ArMgX
R'MgX
74
75
76  
Scheme 1.39 
 
Sulfoxide → magnesium exchange has been proved to be an expedient method for 
synthesising sp
2 
hybridised Grignard reagents.
82
 Selected examples of efficient 
sulfoxide → magnesium exchange include 1-halovinyl sulfoxides,81,83 pyridyl and 
quinolyl sulfoxides,
84
 meta- and para-difunctionalisation of arenes
85,86
 and 2,3-
funtionalisation of furans, benzofurans and thiophenes.
87
  
 
Sulfoxide → magnesium exchange reactions that yield chiral Grignard reagents are of 
most relevance to the work described in this thesis. Indeed, there are limited alternatives 
to synthesise sp
3
 hybridised Grignard reagents. One example of note is alkoxide 
directed iodine → magnesium exchange.88 
 
In 1989, Satoh and co-workers reported the synthesis of chiral N-aryl aziridines via 
sulfoxide → magnesium exchange (Scheme 1.40).80 Treatment of sulfoxide (R,R,RS)-77 
with EtMgBr gave chiral Grignard reagent (S,R)-78 which was trapped with EtOH to 
give aziridine (S,R)-79 in 95% yield.  The reaction proceeds by attack of EtMgBr on the 
sulfoxide with displacement of the most stable anion, metalated aziridine (S,R)-78 in 
this case.  The authors report no observable loss of enantiomeric ratio under the reaction 
conditions, as determined by optical rotation. 
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Scheme 1.40 
 
The synthesis of chiral Grignard reagents was further developed by Hoffmann and co-
workers during the 1990s.
89,90
  In 1999, Hoffmann and Neil reported the synthesis of α-
chloro alkyl organomagnesium reagents in >95:5 er via sulfoxide → magnesium 
exchange (Scheme 1.41).
90
 α-Chloro sulfoxide (R,RS)-80 (98.5:1.5 er) was treated with 
EtMgBr at −78 °C to give α-chloro Grignard reagent (R)-81.  Grignard reagent (R)-81 
was then trapped with α-aminomethyl benzotriazole 82 to give chloro amine (R)-83 in 
50% yield and 96.5:3.5 er.  The full versatility of this methodology was exemplified in 
2000.
91
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N
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Ph
(R,RS)-80, 98.5:1.5 er (R)-81 (R)-83
50%, 96.5:3.5 er
82
 
Scheme 1.41 
 
In addition, Blakemore and co-workers have utilised the sulfoxide → magnesium 
exchange reaction to conduct a stereospecific reagent-controlled homologation starting 
from α-chloro sulfoxides (Scheme 1.42).92  Trapping of Grignard reagent (S)-81 
(generated by sulfoxide → magnesium exchange from (R,RS)-80) with Ph(CH2)2B-
dioxaborinane followed by metallate rearrangement and oxidation (H2O2, NaOH) gave 
alcohol (S)-84 in 49% yield and 91:9 er.  The authors noted that the disappointing 
stereochemical control in the reaction could be improved by using organolithium 
reagents.  
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Scheme 1.42 
 
In more recent work from the Satoh group, chiral α-chloro sulfoxides have also been 
used to synthesise cyclic α-amino acid derivatives via sulfoxide → magnesium 
exchange.
93
  t-BuMgCl was added to sulfoxide (S,RS)-85 in order to deprotonate the 
aniline moiety and then addition of i-PrMgCl facilitated a sulfoxide → magnesium 
exchange to give adduct 86 (Scheme 1.43).  Subsequent cyclisation to give Grignard 
reagent (S)-87 and trapping with ethyl chloroformate gave (R)-88 in 66% yield and 99:1 
er. 
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(S,RS)-85, 99:1 er
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MgCl
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N
Me
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(S)-87  
Scheme 1.43 
 
In 1999, Knochel et al. reported the synthesis and trapping of α-alkoxy Grignard reagent 
90 from sulfoxide 89 (Scheme 1.44).
94
  Sulfoxide → magnesium exchange mediated by 
i-PrMgBr (THF, −78 °C, 15 minutes) gave Grignard reagent 90 and trapping with 
benzaldehyde gave alcohol anti-91 in 61% yield and 93:7 dr. 
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Scheme 1.44 
 
Palladium-catalysed cross coupling of Grignard reagents formed by sulfoxide → 
magnesium exchange has also been reported.  In 2003, Hoffmann and Hӧlzer reported 
the Kumada-Corriu
95,96
 coupling of Grignard reagents derived from a sulfoxide → 
magnesium exchange (Scheme 1.45).
97
 α-Chloro sulfoxide (S,RS)-80 was treated with 5 
eq. of EtMgCl at −78 °C to give Grignard reagent (S)-92 (which had previously been 
shown to be configurationally stable at −78 °C).  Subsequent Kumada-type coupling 
with vinyl bromide gave the coupled product (S)-93 in an optimised 60% yield and 94:6 
er.  This represents essentially full retention of configuration from Grignard reagent (S)-
92. 
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THF, _78 °C, 5 d
(S,RS)-80, 95:5 er (S)-92, 95:5 er (S)-93
60%, 94:6 er
Br
 
Scheme 1.45 
 
The major limitation of the Kumada-Corriu coupling as reported by Hoffmann is the 
need for extremely long reaction times (5 days) at −78 °C. One way to circumvent this 
problem is to conduct a transmetallation-Negishi coupling of the Grignard reagent.  
Indeed, Bull et al. reported the palladium-catalysed cross-coupling of aziridinylmetal 
species generated from sulfoxide → magnesium exchange in 2013 (Scheme 1.46).98  
Treatment of sulfoxide 94 (synthesised in three steps from ethyl p-tolyl sulfoxide
99
) 
with i-PrMgCl in THF at −78 °C gave Grignard reagent 95.  Subsequent in situ 
transmetallation of 95 with zinc chloride and Negishi coupling gave phenyl aziridine 96 
in 80% yield. 
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Scheme 1.46 
 
To conclude, sulfoxide → magnesium exchange provides an expedient method for 
synthesising chiral Grignard reagents.  However, only two examples of sulfoxide → 
magnesium exchange giving α-amino Grignard reagents in high enantiomeric ratio have 
been reported.   Much attention has been focused on the synthesis of α-chloro Grignard 
reagents and their application in synthesis.  Currently, there have been no examples 
reported of sulfoxide → magnesium exchange reactions being conducted at 
temperatures higher than −40 °C. 
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1.3 Project Outline 
The aim of the research described in this thesis is to develop novel methods for 
synthesising chiral α-alkoxy and α-amino organometallic reagents.  Two approaches 
will be taken; (i) synthesis of α-alkoxy and α-amino Grignard reagents by sulfoxide → 
magnesium exchange (Chapters Two and Three) and (ii) asymmetric lithiation of N-
thiopivaloyl azetidine and pyrrolidine (Chapter Four). 
 
Asymmetric lithiation of O-alkyl carbamates and N-Boc heterocycles using s-
BuLi/chiral ligands is typically performed at low temperatures (−78 °C) for long 
reaction times (1-6 hours).  In addition, products are typically formed in ≤99:1 er.  To 
address these limitations, we propose that enantiopure sulfoxides can be used as 
precursors for chiral Grignard reagents (Scheme 1.47).  The Grignard reagents will be 
formed via sulfoxide → magnesium exchange, which will ideally take place at 
temperatures of 0 °C or above making it amenable to industrial-scale synthesis.  
Furthermore, we will particularly focus on substrates where asymmetric deprotonation 
chemistry cannot access organolithium reagents in ≥99:1 er. The results of this project 
are presented in Chapter Two (α-alkoxy Grignard reagents) and Chapter Three (α-amino 
Grignard reagents). 
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Scheme 1.47 
 
We believe that this methodology will provide significant benefits over asymmetric 
lithiation chemistry not least because the availability of (−)-sparteine has been variable 
during the course of the research described in this thesis.  This is of much concern as 
(−)-sparteine generally gives the highest enantioselectivity over a wide range of reaction 
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types.  The plan was that the enantiopure sulfoxides would be synthesised by lithiation 
of the corresponding O-alkyl carbamates or N-Boc heterocycles and trapping with 
Andersen’s sulfinate (SS)-97 (Scheme 1.48).  Subsequent sulfoxide → magnesium 
exchange would give access to the corresponding Grignard reagents.  This would mean 
that one lithiation-trapping reaction would give access to an array of products in ≥99:1 
er. 
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O
(SS)-97
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Scheme 1.48 
 
One example of the use of sulfoxides as chiral auxiliaries in this way is shown in 
Scheme 1.49.  In 2001, Johannsen and co-workers reported the use of a sulfoxide → 
lithium exchange as a route to optically pure azaferrocenyls.
100
  Ortho-lithiation of 
azaferrocene 98 by n-BuLi followed by addition of Andersen’s sulfinate (SS)-97 gave 
diastereomeric sulfoxides (SS,SP)-99 and (SS,RP)-99 in 29% yield and 33% yield 
respectively, both in ≥99:1 er.  These are essentially enantiomeric ferrocenyl anion 
equivalents. 
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N
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1. 1.1 eq. n-BuLi, THF, 0 °C
2. 1.2 eq. N
Fe
N
Fe
S S
pTolpTol
O O
(Ss,Sp)-99
29%, 99:1 er
(Ss,Rp)-99
33%, 99:1 er
98
 
Scheme 1.49 
 
The authors then treated sulfoxide (SS,SP)-99 with t-BuLi in THF at −78 °C to achieve a 
sulfoxide → lithium exchange.  Subsequent trapping of the lithiated intermediate with 
iodine gave iodide (SP)-100 in 52% yield and ≥99:1 er (Scheme 1.50).  In addition, 
enantiomeric iodide (RP)-100 was synthesised in similar fashion from sulfoxide (SS,RP)-
99 in 68% yield and ≥99:1 er. 
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Scheme 1.50 
 
We propose that the use of sulfoxide → magnesium exchange would provide significant 
benefits.  Not only does the use of Grignard reagents deliver a safety benefit 
(particularly if this chemistry is to become available to the industrial chemist), but chiral 
α-substituted Grignard reagents have been shown to have a higher degree of 
configurational stability than their organolithium counterparts.
72,74
  This should allow 
our proposed methodology to be conducted at ambient temperatures. 
 
In Chapter Four, an investigation into the asymmetric lithiation-trapping of N-
thiopivaloyl azetidine 101 is presented.  Despite their importance as bioactive 
compounds, novel methods for synthesising substituted chiral azetidines have received 
limited attention from the academic community.
101
  One approach is the lithiation of N-
thiopivaloyl azetidine 101 using s-BuLi and chiral diamines although only one example 
has been reported in the literature (Scheme 1.51).
102
 Lithiation of 101 using s-
BuLi/(R,R)-42 and trapping with methyl iodide gave methylated azetidine (R)-102 in 
96% yield and 80:20 er 
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Scheme 1.51 
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To our surprise, lithiation of N-thiopivaloyl azetidine 101 proceeded with the opposite 
sense of induction to that observed for the asymmetric lithiation of N-Boc pyrrolidine 
39
38
 and N-Boc piperidine 48
41
.  The authors offered no explanation for the differing 
enantio-induction between these examples but suggested that a directed enantioselective 
deprotonation may take place. 
 
Our aim was to identify the mechanism by which asymmetric lithiation-substitution 
occurs.  Therefore, a detailed mechanistic study of this reaction was undertaken and is 
described in Chapter Four. 
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Chapter Two: Synthesis and Reactions of α-Alkoxy 
Grignard Reagents 
 
Our goal was to synthesise enantiopure α-alkoxy Grignard reagents and exemplify their 
reaction profile.  The plan was twofold.  First, the intention was to synthesise 
diastereomeric sulfoxides anti-(S,SS)-103 and syn-(R,SS)-103 in ≥99:1 er (Scheme 2.1).  
It was envisaged that an expedient route would be via lithiation-trapping of O-alkyl 
carbamate 14, with the α-alkoxy stereocentre being controlled by a chiral base and the 
sulfoxide stereocentre arising from Andersen’s sulfinate (SS)-97. 
 
SPh
O
SPh
CbO H
O
CbO H
ant i-(S,Ss)-103 syn-(R,Ss)-103
Ph OCb S
O
O
(SS)-9714
Cb = CONiPr2  
Scheme 2.1 
 
Second, a sulfoxide → magnesium exchange procedure would then be developed to 
allow access to either enantiomer of Grignard reagent 104 in ≥99:1 er, hopefully under 
ambient conditions (Scheme 2.2).  Subsequent electrophilic trapping would generate α-
substituted products in ≥99:1 er.  Our efforts towards these aims are described in this 
chapter.  
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Scheme 2.2 
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2.1 Previous Syntheses of α-Alkoxy Sulfoxides 
Three different approaches for the synthesis of α-alkoxy sulfoxides have been reported 
in the literature.  Each method requires a late-stage sulfide oxidation to yield the target 
molecule.  First, Nozaki and co-workers reported the synthesis of sulfoxides anti-107 
and syn-107 en route to isomeric alkenes cis-108 and trans-108 (Scheme 2.3).
103
  This 
strategy began with the lithiation-trapping of sulfide 105 and subsequent acetylation to 
give sulfides anti-106 and syn-106.  Subsequent m-CPBA oxidation of anti-106 
furnished sulfoxide anti-107 which was isolated before elimination at high temperature 
to give alkene cis-108 in 50% yield over two steps.  A similar procedure was used to 
convert sulfide syn-106 into alkene trans-108. 
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Scheme 2.3 
 
In 1999, Knochel et al. reported the synthesis of α-alkoxy sulfoxide 89.94  The strategy 
began with chlorination of ethyl sulfide 109 using N-chlorosuccinimide.  This gave 
chlorosulfide 110 in 86% yield.  Nucleophilic addition of pivalic acid to chlorosulfide 
110 followed by oxidation using mCPBA gave sulfoxide 89 in 62% yield over two steps 
(Scheme 2.4). 
S Cl S
MeMe
O S
Me
O
CH2Cl2, rt, 2 h
NCS
DBU, PhMe, 10 h
2. mCPBA, CH2Cl2
_30 °C, 30 min
109 110, 86% 89, 62%
OOH
O
1.
 
Scheme 2.4 
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Finally, Yoshimura et al. have reported the synthesis of α-alkoxy sulfoxides via a 
Pummerer rearrangement and subsequent oxidation (Scheme 2.5).
104
  Refluxing ethyl 
phenyl sulfoxide 111 in acetic anhydride gave sulfide 112 in poor yield (8%).  mCPBA 
oxidation of sulfide 112 gave sulfoxide 113 although the yield for this step was not 
reported.  
S
O
S
OAc
S
OAc
O
Ac2O
reflux, 3 h
m-CPBA
CH2Cl2, 0 °C 2 h
112, 8% 113
yield not reported
111
 
Scheme 2.5 
 
None of the reported approaches to α-alkoxy sulfoxides control the sulfoxide 
configuration.  Indeed, the use of oxidation chemistry to access sulfoxides provides a 
limitation when extending the methodology to encompass the synthesis of 
enantiomerically pure sulfoxides.   Typically, asymmetric oxidation of sulfides gives 
products with varying enantioselectivity. The most useful protocol was published by 
Kagan et al. in 1984 and involved use of a modified Sharpless reagent which proceeds 
in 85:15-95:5 er (Scheme 2.6).
105
 For example, when methyl p-tolylsulfide 114 was 
treated with Ti(Oi-Pr)4, (R,R)-diethyl tartrate, water and t-BuOOH, sulfoxide (R)-115 
was formed in 90% yield and 95:5 er.  In limited examples, recrystallisation can afford 
sulfoxides in 99:1 er.
106
 
 
OH
HO
O
EtO
O
OEt
(R,R)-DET
S
O
S
114
Ti(Oi-Pr)4, (R,R)-DET
H2O, t-BuOOH
CH2Cl2,
_20 °C, 4 h
(R)-115
90%, 95:5 er  
Scheme 2.6 
 
Other reported methods for asymmetric sulfide oxidation include the use of chiral 
peracids and oxaziridines (<60:40 er),
107
 electrochemical oxidation (78:22 er)
108
  and 
oxidation using micro-organisms (<99:1 er).
109
 However, none of these methods 
provides an improvement on the Kagan protocol. 
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An alternative approach to synthesise enantiopure sulfoxides is the use of sulfinyl 
transfer reagents.  In 1962, Andersen reported the first synthesis of an enantiomerically 
pure sulfoxide from an enantiomerically pure sulfinate by addition of a Grignard reagent 
(Scheme 2.7).
110
  Sulfinate (SS)-97 was first synthesised by Phillips et al. in 1926 from 
(−)-menthol and p-toluenesulfinyl chloride in 44% yield after two recrystallisations.111  
Andersen treated sulfinate (SS)-97 with EtMgBr to give ethyl p-tolylsulfoxide (R)-116 
in 64% yield. 
HO O
S
O
(SS)-97, 44%
S
O
(R)-116, 64%
EtMgBr
Et2O, 0 °C
pTolS(O)Cl
pyridine
 
Scheme 2.7 
 
Later, Andersen used this method to synthesise a number of enantiomerically pure 
sulfoxides.
77,112
  Detailed mechanistic studies have also shown that the nucleophilic 
addition to sulfinates and sulfoxides occurs with inversion of configuration at 
sulfur.
113,114
   
 
Whilst Andersen’s sulfinate (SS)-97 remains the archetypal precursor for the synthesis 
of chiral sulfoxides, other sulfinyl transfer reagents have been reported in the literature 
(Figure 2.1).  In 1992, Alcudia and co-workers reported the synthesis of the sulfinate 
ester of diacetone-D-glucose (SS)-117.
115
  Addition of Grignard reagents to sulfinate 
(SS)-117 furnished an array of sulfoxides as single enantiomers.   
 
ON O
S
TsN
Ph Ph
O
S
O O
(SS)-118 (SS)-119
O
O
O
O
O
O
S
O
Me
(SS)-117  
Figure 2.1 
 
In the same year, Evans et al. reported the synthesis and reactions of N-sulfinyl 
oxazolidinone (SS)-118 to form chiral sulfoxides.
116
  More recently, Stockman and co-
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workers described the synthesis of oxathiazolidine oxide (SS)-119 from L-phenylalanine 
and thionyl chloride.
117,118
  Oxathiazolidine oxide (SS)-119 has been used to form single 
enantiomers of sulfoxides, sulfonamides and sulfinimines. 
 
To conclude, none of the reported methods offer a convenient approach to the synthesis 
of α-alkoxy sulfoxides as single enantiomers.  However, modifications could be made to 
include an asymmetric sulfide oxidation of which the Kagan protocol would offer the 
best method.  An alternative route to chiral sulfoxides would be the addition of 
organometallic reagents to sulfinyl transfer reagents although, prior to the work 
described in this thesis, this chemistry has not yet been applied to α-alkoxy sulfoxides. 
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2.2 Synthesis of α-Alkoxy Sulfoxides 
We envisaged that sulfoxides anti-(S,SS)-103 and syn-(R,SS)-103 would be synthesised 
by lithiation chemistry from O-alkyl carbamate 14 and Andersen’s sulfinate (SS)-97 as 
outlined in Scheme 2.8.  Lithiation of O-alkyl carbamate 14 mediated by s-BuLi and a 
diamine and then trapping with inversion of configuration at sulfur with Andersen’s 
sulfinate (SS)-97 would allow rapid access to the desired sulfoxides without the need to 
use asymmetric oxidation chemistry.  It was hoped that use of a chiral diamine would 
allow access to the major diastereoisomer in high yield. 
 
OCbPh
1. s-BuLi, diamine
Et2O,
_78 °C
2.
anti-(S,Ss)-103 syn-(R,Ss)-10314
SPh
CbO H
O
S
O
O
(Ss)-97
Cb = CONiPr2
SPh
CbO H
O
 
Scheme 2.8 
 
 
2.2.1 s-BuLi/TMEDA-Mediated Lithiation of O-Alkyl Carbamates and Trapping 
with Andersen’s Sulfinate 
  
First, the racemic synthesis of sulfoxides anti-rac-103 and syn-rac-103 was required in 
order to provide standards for CSP-HPLC analysis.  Therefore, O-alkyl carbamate 14 
was synthesised using a method previously reported by our group.
29
  3-Phenyl propanol 
was deprotonated using sodium hydride and diisopropylcarbamoyl chloride was added 
to give the desired carbamate 14 in 88% yield (Scheme 2.9). 
 
OPh
14, 88%
OHPh
1. NaH, Et2O, rt, 5 min
N
O
2. i-Pr2NCOCl, rt, 16 h
 
Scheme 2.9 
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In addition,  methyl p-tolyl sulfinate 121 was synthesised in 88% yield by oxidation of 
p-tolyl disulfide 120 with bromine in methanol (Scheme 2.10).
119
  This would be used 
as the electrophile in the lithiation-trapping of O-alkyl carbamate 14 before 
investigating the trapping with Andersen’s sulfinate (SS)-97. 
 
S
S
S
OMe
O
Br2, Na2CO3
MeOH, rt, 3 h
121, 88%120  
Scheme 2.10 
 
Lithiation of O-alkyl carbamate 14 with 1.2 eq. of s-BuLi/TMEDA at −78 °C and 
trapping with methyl p-tolyl sulfinate 121 gave sulfoxides anti-rac-103 and syn-rac-103 
in 25% and 32% yield respectively (Scheme 2.11).  Importantly, the two 
diastereoisomers were readily separable by column chromatography and had distinctive 
1
H and 
13
C NMR spectra.  The OCH signals for sulfoxide anti-rac-103 were δH 5.45 
(doublet of doublets, J = 10.0, 3.0 Hz) and δC 91.7 and for sulfoxide syn-rac-103 were 
δH 5.72 (doublet of doublets, J = 9.5, 4.0 Hz) and δC 86.8.  Each diastereoisomer was 
shown to be separable into a 50:50 mixture of enantiomers by CSP-HPLC.  Assignment 
of the relative stereochemistry is provided later (see Scheme 2.24). 
 
OCbPh
1. s-BuLi, TMEDA
Et2O,
_78 °C, 1 h
2.
anti-rac-103, 25% syn-rac-103, 32%14
Cb = CONiPr2
S
OMe
O
121
SPh
CbO H
O
SPh
CbO H
O
 
Scheme 2.11 
 
Next, the use of Andersen’s sulfinate (SS)-97 as the electrophile was explored.  
Andersen’s sulfinate (SS)-97 was synthesised using a modified Solladié procedure.
120
  
First, sodium p-toluene sulfinate was treated with thionyl chloride to give sulfinyl 
chloride 122 (Scheme 2.12).  Then, after removal of excess thionyl chloride by 
distillation, (−)-menthol was added to give a single diastereoisomer of Andersen’s 
sulfinate (SS)-97 in 50% yield after recrystallisation. 
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S
O
O
(SS)-97, 50%
S
ONa
O
S
Cl
O
122
SOCl2
PhMe, rt, 2 h
1. (_)-menthol, pyridine
Et2O, rt, 16 h
2. Recrystallisation
 
Scheme 2.12 
 
Due to extensive literature precedence,
110,112,113,121,122
 it was anticipated that addition of 
the lithiated intermediate to Andersen’s sulfinate (SS)-97 would proceed with complete 
inversion of configuration at sulfur, leading to the isolation of two enantiopure 
diastereomeric sulfoxides.  However, this was not the case.  Lithiation of O-alkyl 
carbamate 14 with s-BuLi/TMEDA and trapping with Andersen’s sulfinate (SS)-97 gave 
diastereomeric sulfoxides anti-(S,Ss)-103 (25%) and syn-(R,Ss)-103 (21%) in 87:13 er 
and 85:15 er respectively (Scheme 2.13).  The enantiomeric ratios were determined by 
CSP-HPLC and were much lower than expected. 
 
OCbPh
1. s-BuLi, TMEDA,
Et2O,
_78 °C, 1 h
2.
14
S
O
O
(SS)-97
ant i-(S,Ss)-103
25%, 87:13 er
syn-(R,Ss)-103
21%, 85:15 erCb = CONiPr2
SPh
CbO H
O
SPh
CbO H
O
 
Scheme 2.13 
 
It was postulated that the lack of stereospecificity in the trapping reaction could be due 
to the electrophilicity of the sulfoxide products that are formed.  This could cause a 
sulfoxide → lithium exchange to occur during the trapping procedure.   Our proposed 
mechanistic scenario is shown in Scheme 2.14.  The reaction begins with a racemic 
lithiation of carbamate 14 to give a 50:50 ratio of enantiomeric lithiated adducts (S)-26 
and (R)-26. Subsequent trapping with Andersen’s sulfinate (SS)-97 would then give 
sulfoxides anti-(S,SS)-103 and syn-(R,SS)-103.  The trapping process is presumed to 
occur with inversion of configuration at sulfur in line with the literature precedent.
113
 
However, due to the stability of (S)-26 and (R)-26, it is possible for a nucleophilic 
addition to the sulfoxide products to occur.  This would expel organolithium reagents 
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(S)-26 or (R)-26 as a leaving group.  In a similar fashion, the addition to the sulfoxide is 
presumed to occur with inversion of configuration at sulfur resulting in sulfoxides syn-
(S,RS)-103 and anti-(R,RS)-103 being formed.  These sulfoxides are the enantiomers of 
those formed in the initial trapping reaction.  This mechanism would explain the 
reduction in enantiomeric ratio observed in the major products anti-(S,SS)-103 and syn-
(R,SS)-103.  
OCbPh
s-BuLi, TMEDA
SPh
O
SPh
OCb
O
14
S
O
O
(SS)-97
OCb
anti-(S,Ss)-103 syn-(R,Ss)-103
LiPh
(S)-26
LiPh
(R)-26
OCb OCb
SPh
O
SPh
OCb
O
OCb
LiPh LiPh
OCb OCb
syn-(S,Rs)-103 ant i-(R,Rs)-103
Et2O,
_78 °C, 3 h
(S)-26 (R)-26
Cb = CONiPr2
(SS)-97 (SS)-97
50:50
 
Scheme 2.14 
 
To probe this mechanism, a crossover experiment was designed.  This experiment 
would introduce an alternative lithiated O-alkyl carbamate into the presence of the 
sulfoxide products formed by lithiation-trapping of O-alkyl carbamate 14.  Our choice 
was to add lithiated O-ethyl carbamate 28 to sulfoxide anti-rac-103 at −78 °C (Scheme 
2.15).  If ethyl sulfoxides anti-rac-123 and syn-rac-123 were isolated from this reaction 
then it would prove that a sulfoxide → lithium exchange reaction occurs between 
lithiated O-alkyl carbamates and the sulfoxide formed during the lithiation-trapping 
reaction. 
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Li
28
Cb = CONiPr2
ant i-rac-123 syn-rac-123
S
CbO H
O
ant i-rac-103
SPh
CbO H
O
S
CbO H
O
_78 °C, 1 h
OCb
 
Scheme 2.15 
 
Before carrying out the crossover experiment, ethyl sulfoxides anti-rac-123 and syn-
rac-123 were independently synthesised by lithiation of O-ethyl carbamate 124 
(synthesised from ethyl chloroformate and diisopropyl amine as reported in the 
literature)
123
 using s-BuLi/TMEDA at −78 °C for 1 hour and trapping with methyl p-
toluene sulfinate 121 (Scheme 2.16).  Sulfoxides anti-rac-123 and syn-rac-123 were 
isolated in 29% and 22% yield respectively.  The OCH signals provided key diagnostic 
information for sulfoxide anti-rac-123 (δH 5.52, quartet, J = 6.5 Hz and δC 89.3) and for 
sulfoxide syn-rac-123 (δH 5.80, quartet, J = 6.5 Hz and δC 84.0).  Assignment of the 
relative stereochemistry is provided later (see Scheme 2.25). 
 
OCb
1. s-BuLi, TMEDA
Et2O,
_78 °C, 1 h
2.
124
Cb = CONiPr2
ant i-rac-123, 29% syn-rac-123, 22%
S
CbO H
O
S
CbO H
O
S
O
OMe
121  
Scheme 2.16 
 
For the crossover experiment, O-ethyl carbamate 124 was lithiated by s-BuLi/TMEDA 
and then sulfoxide anti-rac-103 was added. After stirring the reaction for 1 hour at −78 
°C, the reaction was quenched with methanol.  Purification by flash column 
chromatography gave a mixture of four inseparable sulfoxides.  Analysis of the 
1
H 
NMR spectrum of the sulfoxide mixture allowed the determination of yield based on 
sulfoxide anti-rac-103.  Recovered anti-rac-103 was isolated in 66% yield and its 
epimer, sulfoxide syn-rac-103, was formed in 5% yield.  It is postulated that syn-rac-
103 could be formed by either a double substitution event or α-deprotonation of anti-
rac-103. Crucially, ethyl carbamate sulfoxides anti-rac-123 and syn-rac-123 were 
formed in 13% and 12% yield respectively (Scheme 2.17). 
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OCb
1. s-BuLi, TMEDA
Et2O,
_78 °C, 1 h
2.
ant i-rac-103, 66% syn-rac-103, 5%124
Cb = CONiPr2
ant i-rac-123, 13% syn-rac-123, 12%
S
CbO H
O
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SPh
CbO H
O
SPh
CbO H
O
SPh
CbO H
O
S
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Scheme 2.17 
 
This experiment shows that during the lithiation-trapping reaction, it is possible for 
excess lithiated intermediate to attack the forming sulfoxides.  This would cause a 
second inversion of configuration at sulfur to take place.  Hence, sulfoxides anti-(S,SS)-
103 and syn-(R,SS)-103 could be formed in reduced enantiomeric ratio. 
 
Closer inspection of the literature revealed a number of isolated examples of low 
stereochemical fidelity during the reaction of organolithium reagents with enantiopure 
sulfinates.
124-126
  One example is shown in Scheme 2.18.  Kagan and co-workers 
reported that the lithiation of ferrocene and trapping with Andersen’s sulfinate (SS)-97 
gave sulfoxide (SS)-125 in 69% yield but only 91:9 er. 
Fe
3.
Fe
(SS)-125
69%, 91:9 er
S
pTol
O
S
O
O
(SS)-97
1. t-BuOK, THF, _78 °C, 30 min
2. t-BuLi, _78 to _25 °C , 30 min
 
Scheme 2.18 
 
We suggest that the loss of enantiomeric ratio of sulfoxide (SS)-125 could be explained 
using the mechanism outlined in Scheme 2.14.  In this case, lithiated ferrocene would 
attack sulfoxide (SS)-125 as it forms, with inversion of configuration at sulfur giving 
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some of the enantiomeric sulfoxide (RS)-125.  The key to the lack of stereospecificity is 
having a moderately stabilised organolithium that can act as a leaving group. 
 
With the mechanism for loss of enantiomeric ratio identified, a series of experiments 
were carried out in order to improve the enantioselectivity of the lithiation-trapping.  
The results are shown in Scheme 2.19 and Table 2.1 and the initial result from Scheme 
2.13 is shown in entry 1.  First, we hypothesised that the process of warming the 
reaction from −78 °C to room temperature over 16 hours was the cause of the lower 
enantiomeric ratio.  Since we had already shown that sulfoxide → lithium exchange 
took place within 1 hour at −78 °C, we chose to quench the reaction 5 minutes after 
Andersen’s sulfinate (SS)-97 was added.  This allowed us to isolate sulfoxides anti-
(S,SS)-103 and syn-(R,SS)-103 in a significantly improved 88:12 er and 91:9 er 
respectively (entry 2).   
 
The mechanism we proposed for the loss of enantiomeric ratio requires a second 
addition of nucleophile to the sulfoxide products in order to invert the configuration at 
sulfur.  Therefore, when there is an excess of lithiated intermediates (R)-26 and (S)-26, 
this inversion event is favoured.  We postulated that by using a reverse addition 
protocol, whereby the lithiated intermediates are added to Andersen’s sulfinate (SS)-97 
via cannula transfer, there would never be an excess of nucleophile present within the 
reaction mixture.  Using the reverse addition protocol did not significantly enhance the 
enantioselectivity as sulfoxides anti-(S,SS)-103 and syn-(R,SS)-103  were isolated in 
87:13 er and 90:10 er respectively (entry 3). 
 
OCbPh
1. s-BuLi, TMEDA,
Et2O,
_78 °C, 1 h
2. X eq. Andersen's
Sulfinate (Ss)-97
SPh
O
SPh
CbO H
O
14
S
O
O
(Ss)-97
H OCb
ant i-(S,Ss)-103 syn-(R,Ss)-103
Cb = CONiPr2
 
Scheme 2.19 
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Table 2.1: Optimisation of the Racemic Lithiation of O-Alkyl Carbamate 14 and 
Trapping with Andersen’s sulfinate (SS)-97 
Entry X  
Reverse 
Addition 
Trap Length 
 / min 
anti-(S,Ss)-103 syn-(R,Ss)-103 
Yield / % er
a
 Yield / % er
a
 
1 1.3 No 16 h 
b
 25 83:17 21 85:15 
2 1.3 No 5 23 88:12 32 91:9 
3 1.3 Yes 5 25 87:13 29 90:10 
4 2.0 Yes 5 21 92:8 24 95:5 
5 3.0 Yes 5 26 90:10 31 93:7 
6
c
 1.3 No 30 8 92:8 8 87:13 
a
er determined by CSP-HPLC,
 b
 Warmed from −78 °C to room temperature, c 
Transmetallation with MgBr2 before addition of Andersen’s sulfinate (SS)-97 
 
The enantioselectivity was further improved by using 2.0 eq. of Andersen’s sulfinate 
(SS)-97 (entry 4) whereas use of 3.0 eq. of Andersen’s sulfinate (SS)-97 did not lead to 
further improvement (entry 5).  Finally, we attempted to transmetalate the lithiated 
intermediates by treatment with MgBr2 (entry 6).
74
  It was hypothesised that the 
nucleophilicity of the organometallic reagent could be influenced leading to a reduced 
propensity for addition to the sulfoxide product.  Unfortunately, this led to a poor 
overall yield (16%) but there was a modest improvement in the enantioselectivity in 
both diastereomeric sulfoxides anti-(S,SS)-103 (92:8 er) and syn-(R,SS)-103 (87:13 er) 
compared to an analogous organolithium reaction (entry 1). 
 
To conclude, our optimised conditions for the trapping of lithiated O-alkyl carbamates 
was using 2.0 eq. Andersen’s sulfinate (SS)-97 and a reverse addition protocol (addition 
of lithiated carbamate to Andersen’s sulfinate (SS)-97).  This gave sulfoxides anti-
(S,SS)-103 and syn-(R,SS)-103  in 92:8 er and 95:5 er respectively.  However, we were 
unable to generate products in ≥99:1 er using the racemic lithiation method. 
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2.2.2 s-BuLi/Chiral Ligand-mediated Lithiation of O-Alkyl Carbamates and 
Trapping with Andersen’s Sulfinate 
 
To overcome our inability to isolate the α-alkoxy sulfoxides in ≥99:1 er, our thoughts 
then turned to a chiral amplification strategy.  It was postulated that an asymmetric 
lithiation of O-alkyl carbamate 14 mediated by s-BuLi/chiral diamine and subsequent 
trapping with Andersen’s sulfinate (SS)-97 would lead to an increase in 
enantioselectivity in the major sulfoxide diastereoisomer (and a simultaneous loss of 
enantiomeric ratio in the minor diastereoisomer) due to two chiral partners reacting with 
one another.  Furthermore, we would expect the enantiomeric ratio for the major 
diastereoisomer to be (v × y):(w × z), where v:w is the enantiomeric ratio of the first 
enantioselective reaction and y:z is the enantiomeric ratio of the second.
32
   
 
As an example, s-BuLi/(+)-sparteine surrogate 1 is reported in the literature to give 93:7 
er
127
 in the asymmetric lithiation of O-alkyl carbamate 14 and we have shown that, 
using the reverse addition protocol, Andersen’s sulfinate (SS)-97  traps with ca. 90:10 
er.  Therefore, the enantiomeric ratio of the major diastereoisomer, sulfoxide syn-(R,SS)-
103, should be (93×90):(7×10) = (8370):(70) = >99:1 er (Scheme 2.20).  The increase in 
the enantiomeric ratio observed in the major diastereoisomer will be at the expense of 
the enantiomeric ratio of the minor diastereoisomer which will be reduced. 
 
OCbPh
s-BuLi, (+)-sp. surr. 1
Andersen's
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CbO H
O
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anti-(S,Ss)-103syn-(R,Ss)-103
Ph Ph
CbO HCbO H
Li
(R)-26
Li
(S)-26
Et2O,
_78 °C, 3 h
ca. 93:7
ca. 90:10ca.90:10
(93 x 90):(7 x 10)
= 8370:70 = 99:1 er
(93 x 10):(90 x 7)
= 930:630 = 60:40 er
N
N
H
(+)-Sparteine
Surrogate 1
 
Scheme 2.20 
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With this in mind, it is essential to first know the enantioselectivity obtained with 
different ligands in the lithiation-trapping of O-alkyl carbamate 14.  The investigation 
would involve the use of (−)-sparteine, (+)-sparteine surrogate 1 and diamine (S,S)-42.  
Previously, our group has reported that lithiation of O-alkyl carbamate 14 with s-
BuLi/(−)-sparteine and trapping with methyl chloroformate gave ester (R)-126 in 84% 
yield and 97:3 er.  In addition, lithiation with s-BuLi/(+)-sparteine surrogate 1 gave 
ester (S)-126 in 67% yield and 93:7 er (Scheme 2.21).  It is also worth noting that 
lithiation of O-alkyl carbamate 14 with s-BuLi/(−)-sparteine has been reported to give 
trapped products in 99:1 er in some cases.
128
 
 
OCbPh
1. s-BuLi, Ligand
Et2O,
_78 °C, 1 h
2. MeOCOCl
Ph
14
H OCb
O
OMe
(R)-126
N
N
H
H N
N
H
(_)-Sparteine (+)-Sparteine
Surrogate 1Cb = CONiPr2
84%, 97:3 er 67%, 7:93 er  
Scheme 2.21 
 
Alexakis introduced diamine 42 as a ligand to direct organolithium addition to 
imines.
129
  It is readily available as either enantiomer and has been used in our group as 
a (+)-sparteine surrogate.
29
  It is of particular interest due to the current global shortage 
of (−)-sparteine and only one enantiomer of (+)-sparteine surrogate 1 being readily 
available. In our hands, lithiation of O-alkyl carbamate 14 mediated by s-BuLi/(S,S)-42 
and trapping with cyclohexanone gave alcohol (R)-127 in 72% yield and 82:18 er 
(Scheme 2.22).   
N
Me
Me
N
tBu
tBu
(S,S)-42
OCbPh
1. s-BuLi, (S,S)-42
Et2O,
_78 °C, 1 h
2. Cyclohexanone
Ph
14
CbO H
Cb = CONiPr2
HO
(R)-127
72%, 82:18 er
 
Scheme 2.22 
 
With knowledge of the inherent enantioselectivity of the different chiral diamines, we 
were now in a position to undertake the asymmetric lithiation of O-alkyl carbamate 14 
and trapping with Andersen’s sulfinate (SS)-97.  To our delight, lithiation mediated by s-
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BuLi/(−)-sparteine gave anti-(S,SS)-103 in 53% yield and 99:1 er (Scheme 2.23, Table 
2.2, entry 1).  Diastereomeric sulfoxide syn-(R,SS)-103 was isolated in only 0.2% yield 
(enantiomeric ratio not determined).  The opposite diastereoisomer was also synthesised 
as the major product by changing the ligand to the (+)-sparteine surrogate 1.  Lithiation 
of O-alkyl carbamate 14 with s-BuLi/(+)-sparteine surrogate 1 and trapping with 
Andersen’s sulfinate (SS)-97 gave sulfoxide anti-(S,SS)-103 in 7% yield and 87:13 er 
and sulfoxide syn-(R,SS)-103 in 54% yield and 99:1 er (entry 2).  Thus, either 
diastereoisomer of α-alkoxy sulfoxides was accessible in 99:1 er. 
 
OCbPh
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_78 °C, 3 h
2.
14 S
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O
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Scheme 2.23 
 
Table 2.2: Asymmetric Lithiation of O-Alkyl Carbamate 14 and trapping with 
Andersen’s Sulfinate (SS)-97 
Entry Ligand 
anti-(S,SS)-103 syn-(R,SS)-103 
Yield / % er
a
 Yield / % er
a
 
1 (−)-sparteine 53 99:1 0.2 nd 
2 (+)-sparteine surrogate 1 7 87:13 45 99:1 
3 (S,S)-42 17 95:5 54 99:1 
4 (R,R)-42 56 99:1 14 93:7 
a
er determined by CSP-HPLC, nd = not determined 
 
Furthermore, the lithiation using diamine (S,S)-42 as the ligand gave sulfoxide anti-
(S,SS)-42 in 17% yield and 95:5 er and sulfoxide syn-(R,SS)-103 in good yield (54%) 
and excellent enantiomeric ratio (99:1 er) (entry 3). Finally, lithiation mediated by s-
BuLi/diamine (R,R)-42 gave sulfoxide anti-(S,SS)-103 in 56% yield and 99:1 er and 
sulfoxide syn-(R,SS)-103 in 14% yield and 93:7 er (entry 4).  Crucially, we can 
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synthesise either diastereoisomer in 99:1 er without the need to use (−)-sparteine or (+)-
sparteine surrogate 1. 
 
The successful asymmetric lithiation protocols also allowed us to assign the 
stereochemistry of the diastereomeric sulfoxides (Scheme 2.24).   It is well established 
that the lithiation of O-alkyl carbamate 14 with s-BuLi/(−)-sparteine gives lithiated 
intermediate (S)-26 in high enantiomeric ratio (ca. 97:3 er).
21
 Trapping of (S)-26 with 
Andersen’s sulfinate (SS)-97 occurs with inversion of configuration at sulfur.
113
  
Therefore, it was expected that sulfoxide anti-(S,SS)-103 would be the major 
diastereomer in this case.  On the other hand, lithiation of O-alkyl carbamate 14 
mediated by s-BuLi/(+)-sparteine surrogate 1 is known to give (R)-26 in 93:7 er.
127
  
Subsequent trapping of the lithiated intermediate with Andersen’s sulfinate (SS)-97 
would lead to the formation of syn-(R,SS)-103 as the major diastereoisomer.  
 
OCbPh
s-BuLi, (_)-sparteine
Andersen's
Sulfinate (SS)-97
SPh
O
SPh
CbO H
O
14
S
O
O
(SS)-97
H OCb
ant i-(S,Ss)-103 syn-(R,Ss)-103
Ph Ph
CbO HH OCb
Li
(S)-26
Li
(R)-26
OCbPh
s-BuLi, (+)-sp. surr. 1
14
Ph Ph
CbO HH OCb
Li
(S)-26
Li
(R)-26
Et2O,
_78 °C, 3 h
Et2O,
_78 °C, 3 h
ca. 97:3
ca. 7:93
Andersen's
Sulfinate (SS)-97
'major '
'major ''minor'
'minor'
 
Scheme 2.24 
 
In a similar fashion, the relative stereochemistry of the O-ethyl sulfoxides was assigned.  
Lithiation of O-ethyl carbamate 124 mediated by s-BuLi/(S,S)-42 and trapping with 
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Andersen’s sulfinate (SS)-97 gave sulfoxides anti-(S,Ss)-123 and syn-(R,Ss)-123 in 4% 
and 9% yield respectively (Scheme 2.25).  We were unable to determine the 
enantiomeric ratios by CSP-HPLC.  Importantly, the relative stereochemistry can be 
assigned from the known
29,32
 induction of diamine (S,S)-42 and trapping of Andersen’s 
sulfinate with inversion of configuration at sulfur to give syn-(R,SS)-123 as the major 
diastereomeric sulfoxide. 
OCb
1. s-BuLi, (S,S)-42
Et2O,
_78 °C, 1 h
2.
124
Cb = CONiPr2
anti-(S,SS)-123, 4% syn-(R,SS)-123, 9%
S
CbO H
O
S
CbO H
O
S
O
O
(SS)-97  
Scheme 2.25 
 
To conclude, by combining highly enantioselective lithiation reactions and trapping 
with Andersen’s sulfinate (SS)-97, it is possible to synthesis either diastereoisomer of 
sulfoxides anti-(S,SS)-103 and syn-(R,SS)-103 in 45-54% yield and 99:1 er. 
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2.3 Sulfoxide → Magnesium Exchange of α-Alkoxy Sulfoxides 
With a robust method for the synthesis of sulfoxides anti-(S,SS)-103 and syn-(R,SS)-103 
in hand, we set about using them to create α-alkoxy Grignard reagents in 99:1 er.  The 
method of choice was sulfoxide → magnesium exchange, due to significant precedent 
for high stereochemical fidelity during the reaction (see Scheme 1.41).
90,91
  In addition, 
we were expecting that the α-alkoxy Grignard reagents would have a higher degree of 
configurational stability when compared to their organolithium counterparts.
72
  
However, there is no precedent for carrying out sulfoxide magnesium → exchange 
reactions at higher temperatures, such as 0 °C or above.  This was one of our key aims.   
 
 
2.3.1 Optimising the Sulfoxide → Magnesium Exchange Reaction 
 
It was hypothesised that the sulfoxide → magnesium exchange reaction would occur 
very quickly at temperatures ≥0 °C.  Therefore, racemic sulfoxide anti-rac-103 was 
treated with 1.1 eq. of i-PrMgCl in THF at 0 °C, and methyl chloroformate was added 
after just 10 seconds (Scheme 2.26, Table 2.3).  This led to ester rac-126 being isolated 
in 49% yield (entry 1).  In addition, sulfoxide rac-128 (formed as a by-product of the 
sulfoxide → magnesium exchange product whereby i-PrMgCl attacks at the sulfur 
atom) was isolated in 54% yield and starting sulfoxide anti-rac-103 was recovered in 
20% yield.  With a significant amount of starting material being recovered, the number 
of equivalents of Grignard reagent and the reaction time were increased.  Treatment of 
sulfoxide anti-rac-103 with 1.3 eq. i-PrMgCl for 1 minute at 0 °C and trapping with 
methyl chloroformate gave ester rac-126 in an improved 58% yield and a reduction in 
recovered sulfoxide anti-rac-103 (3%) (entry 2).  However, sulfoxide rac-128 was 
isolated in 74% yield, indicating that the exchange reaction had occurred to a much 
larger degree than previously.  Furthermore, carbamate 14 was isolated in 3% yield.  
Carbamate 14 was presumably formed by the Grignard reagent from the initial 
exchange reaction being quenched with a proton which could come from the α-proton in 
sulfoxide rac-128 which is formed as the by-product from the sulfoxide → magnesium 
exchange reaction.   
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1. n eq. i-PrMgCl, THF
Temp., Time
2. n eq. MeOCOCl
SPh
O
CbO H
anti-rac-103
Ph
OMe
O
rac-126
Ph OCb
14
S
pTol
O
rac-128
OCb
Cb = CONiPr2
Scheme 2.26 
Table 2.3: Optimisation of the Sulfoxide → Magnesium Exchange of anti-rac-103 
Entry n 
Temp. 
/ °C 
Time  
/ min 
Yield rac-
126 / % 
Yield 14  
/ % 
Yield rac-
128 / % 
Recovered 
anti-103 / % 
1 1.1 0 10 s 49 - 54 20 
2 1.3 0 1 58 3 74 3 
3 1.3 rt 20 s 56 1 71 5 
4 1.3 rt 1 65 6 73 8 
5 1.3 rt 5 48 14 81 4 
6 1.5 rt 1 67 9 84 0 
7 1.5 rt 5 42 17 82 0 
8 2.5 rt 1 75 5 84 0 
 
The yield of ester rac-126 was further improved to 65% by carrying out the reaction at 
room temperature for 1 minute using 1.3 eq. of i-PrMgCl but the yield of carbamate 14 
was also increased (6%) (entry 4).  Repeating the reaction under the same conditions but 
reducing the time to 20 seconds led to ester rac-126 being isolated in a reduced 56% 
yield (entry 3).  Extension of the reaction time to 5 minutes gave ester rac-126 in a poor 
48% yield but sulfoxide rac-128 was isolated in an improved 81% yield (entry 5).  This 
suggests that the initial exchange reaction is high yielding but the intermediate Grignard 
reagent has more time to be protonated.  An increased yield of carbamate 14 also 
supports this notion.  Under each of these reaction conditions there was still a small 
amount of starting sulfoxide anti-rac-103 recovered (4-8%). 
 
Therefore, we decided to increase the number of equivalents of i-PrMgCl.  Addition of 
1.5 eq. of i-PrMgCl to sulfoxide anti-rac-103 at room temperature for 1 minute gave 
ester rac-126 in 67% yield and sulfoxide rac-128 in 84% (entry 6).  In addition, 
carbamate 14 was isolated in 9% yield indicating a small amount of protonation 
occurred under the reaction conditions.  Extending the reaction to 5 minutes saw a 
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reduction in yield of ester rac-126 (42%) but an increase in yield of carbamate 14 (17%) 
(entry 7). Finally, it was hypothesised that having a large excess of i-PrMgCl present 
within the reaction would lead to a reduction in the protonation of the Grignard 
intermediate.  Indeed, using 2.5 eq. i-PrMgCl reduced the yield of carbamate 14 to 5% 
whilst increasing the yield of ester rac-126 (75%) (entry 8).  We postulate that the 
excess i-PrMgCl may deprotonate sulfoxide rac-128 whilst it is being formed. 
However, deuteriation experiments proved inconclusive.  
 
In an attempt to form a sulfoxide by-product without an α-proton, exchange reactions 
were carried using t-BuMgCl and PhMgCl (Scheme 2.27).  Unfortunately, neither of 
these Grignard reagents facilitated sulfoxide → magnesium exchange.  Instead starting 
sulfoxide anti-rac-103 was recovered unchanged in each case. 
 
1. t-BuMgCl or PhMgCl
THF, rt,1 min
2. MeOCOCl
SPh
O
CbO H
anti-rac-103
Ph
OMe
O
rac-126
OCb
Cb = CONiPr2 Not Formed  
Scheme 2.27 
 
The optimised conditions for the synthesis of α-alkoxy Grignard reagents by sulfoxide 
→ magnesium exchange were found to be 2.5 eq. of i-PrMgCl at room temperature for 
1 min (Table 2.3, entry 8).  However, the 75% yield of ester rac-126 is slightly 
disappointing given the high 84% yield of sulfoxide rac-128 that was also isolated.  
 
Finally, diastereomeric sulfoxide syn-rac-103 was shown to give comparable reactivity 
under the optimised conditions (Scheme 2.28). Indeed, ester rac-126 was isolated in 
67% yield and sulfoxide rac-128 in 79% yield.  Furthermore, we isolated carbamate 14 
in 7% yield indicating that protonation of the intermediate Grignard reagent occurred to 
a similar extent as previously observed. 
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1. 2.5 eq. i-PrMgCl,
THF, rt, 1 min
2. 2.5 eq. MeOCOCl
SPh
O
CbO H
syn-rac-103
Ph
OMe
O
rac-126, 67%
Ph OCb
14, 7%
S
pTol
O
rac-128, 79%
OCb
Cb = CONiPr2
Scheme 2.28 
 
2.3.2 Synthesis and Reactions of Enantiopure α-Alkoxy Grignard Reagents  
 
Next, we wanted to undertake a sulfoxide → magnesium exchange on sulfoxides anti-
(S,SS)-103 and syn-(R,SS)-103 of 99:1 er.  In addition to synthesising a wide range of 
products in 99:1 er, this would also allow us to investigate the configurational stability 
of α-alkoxy Grignard reagents at room temperature. 
  
Sulfoxide anti-(S,SS)-103 was treated with 2.5 eq. i-PrMgCl at room temperature for 1 
minute and then methyl chloroformate was added (Scheme 2.29).  To our delight, ester 
(R)-126 was isolated in 73% yield and 99:1 er.  Comparison to the literature data for 
ester (R)-126
127
 allows us to conclude that sulfoxide → magnesium exchange and 
trapping proceeds with retention of configuration at carbon.  Grignard reagent (S)-104 
was also trapped with allyl bromide (with 10 mol% CuBr.SMe2 as a catalyst) and 
cyclohexanone which gave alkene (R)-129 and alcohol (R)-127 in good yields and 
excellent enantioselectivity.  All three racemic compounds were prepared in a similar 
way from anti-rac-103 and separated by CSP-HPLC. 
 
Ph E
HCbO
SPh
O
CbO H
anti-(S,SS)-103, 99:1 er
MgClPh
CbO H
THF, rt, 1 min
i-PrMgCl E+
(S)-104
Ph
OMe
O
HCbO
(R)-126
73%, 99:1 er
E+= MeOCOCl
Ph
HCbO
(R)-129
70%, 99:1 er
E+= allyl-Br
(10 mol% CuBr.SMe2)
(R)-127
71%, 99:1 er
E+= cyclohexanone
Ph
CbO H
HO
 
Scheme 2.29 
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Reaction of Grignard reagent (S)-104 with aldehydes was also explored (Scheme 2.30).  
Grignard reagent (S)-104 was synthesised from sulfoxide (S,SS)-103 and subsequent 
addition of aldehydes gave mono-protected diols (R,S)-130-133 with anti-
diastereoselectivity (70:30 to ≥99:1 dr, inseparable mixtures) in 65-78% yields with 
each diastereoisomer being formed in 99:1 er.   
 
Ph
R
OH
HCbO
Ph
Ph
OH
HCbO
Ph
tBu
OH
HCbO
Ph
iPr
OH
HCbO
Ph
nBu
OH
HCbO
(R,S)-130, 99:1 er
71%, 90:10 dr
PhCHO
(R,S)-131, 99:1 er
78%, 70:30 dr
t-BuCHO
(R,S)-132, 99:1 er
70%, 99:1 dr
i-PrCHO
(R,S)-133, 99:1 er
65%, 90:10 dr
n-BuCHO
SPh
O
CbO H
anti-(S,SS)-103, 99:1 er
MgClPh
CbO H
THF, rt, 1 min
i-PrMgCl RCHO
(S)-104
 
Scheme 2.30 
 
Reduction of (R,S)-133 using LiAlH4 gave known
130
 diol (R,S)-134 in 89% yield 
(Scheme 2.31).  Comparison of the 
1
H NMR and 
13
C NMR spectra allowed assignment 
of the relative stereochemical configuration.  Alcohols (R,S)-130-133 were assigned by 
analogy. 
 
Ph
nBu
OH
HCbO
(R,S)-133, 99:1 er
90:10 dr
THF, reflux, 1 h
LiAlH4
Ph
nBu
OH
HHO
(R,S)-134, 89%
90:10 dr  
Scheme 2.31 
 
Sulfoxide → magnesium exchange and trapping with aldehydes offers an attractive 
connective strategy for the synthesis of anti-1,2-diols which are typically synthesised in 
two steps by Wittig reaction and asymmetric dihydroxylation.  A related approach was 
recently reported by Shen and co-workers starting from TsCH2OCb and aldehydes.
131
  
 
The opposite enantiomer of all the products would be equally accessible from sulfoxide 
(R,SS)-103.  To demonstrate this, treatment of sulfoxide syn-(R,SS)-103 with i-PrMgCl 
Chapter Two: Synthesis and Reactions of α-Alkoxy Grignard Reagents 
 
60 
 
gave Grignard reagent (R)-104 and trapping with cyclohexanone gave alcohol (S)-127 
in 74% yield and 99:1 er (Scheme 2.32).   
 
S
O
SPh
O
CbO H
syn-(R,SS)-103, 99:1 er
MgClPh
CbO H
THF, rt
1 min
i-PrMgCl
(R)-104
Ph
CbO H
HO
(S)-127, 74%
99:1 er
O
(SS)-128, 78%
 
Scheme 2.32 
 
Moreover, sulfoxide (SS)-128 was isolated in 78% yield from this reaction.  Comparison 
of the optical rotation with that reported in the literature confirms the absolute 
configuration of sulfoxide (SS)-128; our synthesised (SS)-128 had [α]D −194.2 (c 1.0 in 
EtOH) and the literature value was [α]D −187 (c 2.4 in EtOH).
115
  Sulfoxide (SS)-128 is 
the expected product of double inversion from Andersen’s sulfinate (SS)-97 and allows 
confirmation of the assignment of the configuration in sulfoxides anti-(S,SS)-103 and 
syn-(R,SS)-103 
 
The major limitation with the use of O-alkyl carbamate 14 is that a carbamate 
deprotection is required to furnish the synthetically desirable secondary alcohols.  
However, boronate rearrangements, as reported initially by Hoppe
30,33
 and later 
developed by Aggarwal,
32
 allow direct access to the alcohol (see Schemes 1.8 and 1.9).  
Hence, we were interested in exploring this chemistry via our methodology.  Therefore, 
i-PrMgCl was added to sulfoxide anti-(S,SS)-103 followed by trapping with i-BuB-
pinacolate.  After refluxing for 16 hours, subsequent oxidation (H2O2, NaOH) gave 
alcohol (R)-135 in 68% yield but only 94:6 er (Scheme 2.33).  
 
2. H2O2, NaOH
rt, 2 h
SPh
O
CbO H
anti-(S,SS)-103, 99:1 er
Ph
HO
(R)-135
68%, 94:6 er
MgClPh
CbO H
THF, rt, 1 min
i-PrMgCl
1. i-BuB(pin),
reflux, 16 h
(S)-104
H
Scheme 2.33 
 
The loss of enantiomeric ratio in the metallate rearrangement with magnesium has been 
previously observed by Blakemore and co-workers (and later commented on by 
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Aggarwal).
32,92,121
  Indeed, reaction of Grignard reagent (S)-81, generated by sulfoxide 
→ magnesium exchange from (R,RS)-80, with Ph(CH2)2B-dioxaborinane and 
subsequent oxidation (H2O2, NaOH) gave alcohol (S)-84 in 49% yield but only 91:9 er 
(Scheme 2.34).  Alternatively, use of organolithium (S)-136 (formed by sulfoxide → 
lithium exchange) allowed access to alcohol (S)-84 in a much improved 98:2 er.  No 
further explanation for this increase in stereochemical fidelity was offered. 
S
O
Cl
Ph Ph
ClMg
Cl
PhMe
_78 °C, 30 min
EtMgCl Ph
OH
Ph
O
B
OPh
2. H2O2, NaOH
EtOH-THF, 0 °C
1.
S
O
Cl
Ph Ph
Li
Cl
THF
_78 °C, 30 min
n-BuLi Ph
OH
Ph
O
B
OPh
2. H2O2, NaOH
EtOH-THF, 0 °C
1.
(S)-84, 49%
91:9 er
(S)-84, 70%
98:2 er
(R,RS)-80, 99:1 er
(R,RS)-80, 99:1 er
(S)-81
(S)-136
 
Scheme 2.34 
 
We too turned to organolithium reagents to solve the loss of configuration within the 
1,2-metallate rearrangement.  To our delight, sulfoxide → lithium exchange of anti-
(S,SS)-103 using n-BuLi (THF, −78 °C, 1 min) and reaction with i-BuB-pinacolate 
followed by oxidation with H2O2 and NaOH gave alcohol (R)-135 in 72% yield and 
99:1 er (Scheme 2.35). 
 
2. H2O2, NaOH
rt, 2 h
SPh
O
CbO H
anti-(S,SS)-103
Ph
HO
(R)-135
72%, 99:1 er
LiPh
CbO H
_78 °C, 1 min
n-BuLi, THF
1. i-BuB(pin),
reflux, 16 h
H
(S)-26
Scheme 2.35 
 
Finally, we investigated the configurational stability of Grignard reagent (S)-104 at 
room temperature over longer times than 1 minute.  Extended sulfoxide → magnesium 
exchange reaction times of 15 and 30 minutes and trapping with cyclohexanone gave 
alcohol (R)-127 in 98:2 er in both cases (Scheme 2.36).  It is believed that reduced 
yields (34% and 24% yield respectively) with extended sulfoxide → magnesium 
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exchange times are due to protonation of Grignard reagent (S)-104 by the sulfoxide by-
product as previously discussed.  Furthermore, no evidence of 1,2-carbamoyl migration 
was observed (this process is reported to take place in corresponding organolithium 
reagents at −20 °C)73.  From this marginal loss of enantiomeric ratio in the products 
(within the error limits of HPLC detection), it is concluded that Grignard reagent (S)-
104 is configurationally table at room temperature for 30 minutes.  This is consistent 
with observations made by Nakai and co-workers.
72
 
 
SPh
O
CbO H
anti-(S,SS)-103, 99:1 er
MgClPh
CbO H
THF, rt,
1-30 min
i-PrMgCl
(S)-104
Ph
CbO H
HO
(R)-127
Exchange Time
1 min: 71%, 99:1 er
15 min: 34%, 98:2 er
30 min: 24%, 98:2 er
O
 
Scheme 2.36 
 
To conclude, we can access α-substituted O-alkyl carbamates via our lithiation-trapping 
and subsequent sulfoxide → magnesium exchange methodology.  For example, ester 
(R)-126 was isolated in 41% yield and 99:1 er over two steps from O-alkyl carbamate 
14 (Scheme 2.37).  Importantly, this reaction sequence does not require the use of (−)-
sparteine and the divergent electrophilic trapping step can be carried out at room 
temperature over short reaction times.  Significantly, α-alkoxy Grignard reagents have 
been shown to be configurationally stable at room temperature for up to 30 minutes.   
 
SPh
O
CbO H
ant i-(S,SS)-103
56%, 99:1 er
Ph
CbO H
(R)-126, 73%
OMe
O
Ph OCb
1. s-BuLi, (R,R)-42
Et2O,
_78 °C, 1 h
2.
14
Cb = CONiPr2
S
O
O
(SS)-97
41% over two steps
99:1 er
2. MeOCOCl
1. i-PrMgCl, THF
rt, 1 min
 
Scheme 2.37 
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2.4 Synthesis of Tertiary Alcohols from Sulfoxides via Sulfoxide → 
Magnesium Exchange 
In 2008, Aggarwal et al. reported the enantioselective synthesis of tertiary alcohols (e.g. 
(R)-137) from secondary benzylic O-alkyl carbamates (e.g. (S)-9) using lithiation-
boronate rearrangement methodology (Scheme 2.38).
34
  This chemistry was reviewed in 
detail in Chapter 1.1.1.  The requirement of the phenyl substituent to lower the pKa of 
the α-proton for the deprotonation reaction is a still a major limitation as the phenyl 
substituent then remains in the product. 
 
Ph
OCb
Ph
Et OH1. s-BuLi, Et2O,
_78 °C, 20 min
2. EtB(pin), 
3. H2O2,NaOH(S)-9
99:1 e.r
(R)-137
95%, 99:1 er  
Scheme 2.38 
 
It was proposed that sulfoxide → magnesium exchange methodology could offer an 
improvement in the synthesis of tertiary alcohols by allowing access to products lacking 
an aryl substituent (Scheme 2.39).  Our plan would be two-fold.  First, the synthesis of 
quaternary α-alkoxy sulfoxides anti-(S,SS)-138 by alkylation of anti-(S,SS)-103 would 
be explored.  Second, sulfoxide → magnesium exchange to give (S)-139 and subsequent 
boronate rearrangement would allow access to a wide range of chiral tertiary alcohols 
140.   
 
anti-(S,Ss)-103 anti-(S,Ss)-138
R2Ph
HO R1
Alkylation
140
SPh
CbO H
O
SPh
CbO R1
O
Ph
CbO R1
MgCl
Ph
CbO R1
B(pin)
R2
i-PrMgCl
THF, rt, 1 min
B(pin)R2
(S)-139
2. H2O2, NaOH
1. reflux, 16 h
 
Scheme 2.39 
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We began by investigating the alkylation of sulfoxide anti-rac-103 using lithium amide 
bases.
120,132
  α-Deprotonation of anti-rac-103 using LDA in THF at −78 °C for 10 
minutes and trapping with methyl iodide gave diastereomeric sulfoxides rac-141a and 
rac-141b in 49% and 35% yield respectively (Scheme 2.40). It was not possible to 
calculate the diastereomeric ratio from the 
1
H NMR spectrum of the crude product.  The 
relative stereochemistry has not been determined.  Isolation of diastereomeric sulfoxides 
indicates that either the reaction proceeds via a planar carbanion or that the lithiated 
intermediate is configurationally unstable.  A similar phenomenon was observed by 
Hoppe in the lithiation-trapping of benzylic O-alkyl carbamates (see Schemes 1.5 and 
1.6).
23
 
1. LDA, THF
_78 °C, 10 min
2. MeI
rac-141a, 49%
rac-141b, 35%
ant i-rac-103
SPh
O
CbO H
SPh
O
CbO Me
 
Scheme 2.40 
 
We attempted to improve the diastereoselectivity of the alkylation by using dimethyl 
sulfate as the methylating agent (Scheme 2.41).  From this reaction sulfoxide rac-141a 
was isolated in 54% yield and rac-141b was isolated in 28% yield. 
 
SPh
O
CbO Me
rac-141a, 54%
rac-141b, 28%
1. LDA, THF
_78 °C, 10 min
2. Me2SO4
ant i-rac-103
SPh
O
CbO H
 
Scheme 2.41 
 
In addition, we investigated using alternative amide bases (Scheme 2.42).  First, 
deprotonation by LiHMDS and trapping with methyl iodide gave sulfoxides rac-141a 
and rac-141b in disappointing yields (29% and 16% yield respectively).  Use of 
KHMDS and trapping with methyl iodide gave none of the desired products and starting 
material was recovered in 87% yield.  
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SPh
O
CbO Me
rac-141a, 29%
rac-141b, 16%
1. LiHMDS, THF
_78 °C, 10 min
2. MeI
+ RSM 87%
ant i-rac-103
SPh
O
CbO H
1. KHMDS, THF
_78 °C, 10 min
2. MeI
ant i-rac-103
SPh
O
CbO H
rac-141a, 0%
rac-141b, 0%
SPh
O
CbO Me
 
Scheme 2.42 
 
In conclusion, we have been able to synthesise diastereomeric sulfoxides rac-141a and 
rac-141b in modest yields.  We have been unable to significantly improve the 
diastereoselectivity within the alkylation procedure.   
 
With sulfoxides rac-141a and rac-141b in hand, sulfoxide → magnesium exchange 
chemistry was attempted in order to synthesise tertiary alcohols.  Therefore, sulfoxide 
rac-141a was treated with i-PrMgCl in THF at room temperature for 1 minute and 
trapped with methyl chloroformate (Scheme 2.43).  Unfortunately, ester rac-142 was 
not formed and the 
1
H NMR spectrum of the crude product showed a complex mixture 
of products.  Purification by flash column chromatography gave no identifiable 
products.  No starting material was remaining at the end of the reaction and sulfoxide 
rac-128, the by-product of sulfoxide → magnesium exchange, was not formed. 
 
rac-141a
SPh
O
CbO Me
Ph
Me OCb
OMe
O
1. i-PrMgCl
THF, rt, 1 min
2. MeOCOCl
rac-142
S
O
rac-128
Not Formed  
Scheme 2.43 
 
We postulated that the Grignard intermediate may be chemically unstable at high 
temperature.  A similar phenomenon has been observed in the lithiation of O-alkyl 
carbamates due to 1,2-carbamoyl migration.
73
  Therefore, we reduced the temperature of 
the sulfoxide → magnesium exchange reaction to −78 °C (Scheme 2.44).  
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Unfortunately, the reaction again gave a complex mixture of unidentified products by 
1
H NMR spectroscopy of the crude mixture. 
 
rac-141a
SPh
O
CbO Me
Ph
Me OCb
OMe
O
1. i-PrMgCl, THF,
_78 °C 1 min
2. MeOCOCl
rac-142
Not Formed
S
O
rac-128
Not Formed  
Scheme 2.44 
 
We postulated that the inability to form the desired product could be due to the choice 
of electrophile.  Therefore, we attempted to trap with benzaldehyde or quench the 
exchange reaction with methanol (Scheme 2.45).  In each case the desired products, 
alcohols rac-143 or carbamate rac-144 respectively, were not isolated. 
 
rac-141a
SPh
O
CbO Me
Ph
Me OCb
Ph
OH
1. i-PrMgCl, THF
_78 °C, 1 min
2. PhCHO or MeOH
rac-143
Not Formed
Ph
Me OCb
Hor
rac-144
Not Formed  
Scheme 2.45 
 
Finally, we turned to sulfoxide → lithium exchange to see if the problems were due to 
the organometallic reagent.  n-BuLi was added to sulfoxide rac-141a at −78 °C in THF 
and trapping with methyl chloroformate gave a complex mixture of products (Scheme 
2.46).  In addition, quenching the sulfoxide → lithium exchange with MeOH also gave 
an unidentified mixture of products. 
 
rac-141a
SPh
O
CbO Me
rac-142
Not Formed
rac-144
Not Formed
Ph
Me OCb
OMe
O
1. n-BuLi, THF
_78 °C, 1 min
2. MeOCOCl or MeOH
Ph
Me OCb
Hor
 
Scheme 2.46 
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To conclude, we have been unable to find conditions to carry out a sulfoxide → 
magnesium exchange of sulfoxide rac-141a.  Unfortunately, all attempts have led to a 
complex mixture of products being formed.  In addition, using n-BuLi to carry out a 
sulfoxide → lithium exchange was unsuccessful.  Therefore, boronate rearrangements 
have not been attempted. 
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2.5 Conclusions and Future Work 
A procedure for the synthesis of α-alkoxy Grignard reagents in 99:1 er has been 
successfully developed.  The method begins with asymmetric lithiation of O-alkyl 
carbamate 14 and trapping with Andersen’s sulfinate (SS)-97 to give diastereomeric 
sulfoxides anti-(S,SS)-103 and syn-(R,SS)-103.  Interestingly, a loss of enantiomeric ratio 
is observed on trapping and we have shown that this is due to sulfoxide → lithium 
taking place under the lithiation-trapping conditions.  Thus, a reverse addition protocol 
(addition of the intermediate organolithium to Andersen’s sulfinate (SS)-97) was utilised 
to improve the enantiomeric ratio of the products.   Furthermore, use of chiral diamine 
ligands allows for the isolation of either sulfoxide anti-(S,SS)-103 or sulfoxide syn-
(R,SS)-103 in 99:1 er via chiral amplification.  Significantly, the procedure does not 
require the use of (−)-sparteine. 
 
Then, a sulfoxide → magnesium exchange protocol was employed to generate α-alkoxy 
Grignard reagents.  The optimised conditions were 2.5 eq. of i-PrMgCl in THF at room 
temperature for 1 minute.  Trapping with electrophiles gave an array of α-substituted 
products in 99:1 er.  For example, ester (R)-126 was formed in 41% yield and 99:1 er 
over two steps from O-alkyl carbamate 14 (Scheme 2.47).  Furthermore, our work is the 
first example of a sulfoxide → magnesium exchange process occurring at room 
temperature.  Of particular note, α-alkoxy Grignard reagents have been shown to be 
configurationally stable for up to 30 minutes at room temperature.  
 
SPh
O
CbO H
anti-(S,SS)-103
56%, 99:1 er
THF, rt,
1 min,
then MeOCOCl
i-PrMgCl
Ph
CbO H
(R)-126, 73%
OMe
O
Ph OCb
1. s-BuLi, (R,R)-42
Et2O,
_78 °C, 1 h
2.
14
Cb = CONiPr2
S
O
O
(SS)-97
41% over two steps
99:1 er
 
Scheme 2.47 
 
The synthesis of tertiary alcohols via sulfoxide → magnesium exchange was attempted.  
Sulfoxide anti-rac-103 was alkylated using LDA and methyl iodide to give a mixture of 
diastereomeric sulfoxides rac-141a and rac-141b.  Unfortunately all attempts to 
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conduct a sulfoxide → magnesium exchange on these substrates were unsuccessful.  In 
addition, sulfoxide → lithium exchange using n-BuLi in THF at −78 °C gave a complex 
mixture of unidentified products. 
 
Future work would see the expansion of our methodology to include other O-alkyl 
carbamates and esters.  This would allow an array of α-alkoxy Grignard reagents to be 
synthesised in ≥99:1 er.  One system of interest is ester 145 which was reported by 
Aggarwal in 2012.
133
  Ester 145 has been shown to be superior in the lithiation-boronate 
rearrangement methodology to carbamates.  However, lithiation of ester 145 using s-
BuLi/(−)-sparteine only give products in ≤96:4 er.  Therefore, using our method to 
generate α-alkoxy Grignard reagent (S)-147 in 99:1 er from sulfoxide anti-(S,SS)-146 
would provide significant benefits (Scheme 2.48).  
 
ant i-(S,SS)-146
SPh
O
O H
Ph
Ar
O
MgClPh
O HAr
O
(S)-147145
OAr
O
1. s-BuLi, Ligand
Et2O,
_78 °C, 1 h
S
O
O
(SS)-97
2.
i-PrMgCl
THF
rt, 1 min
Ar = 2,4,6-(iPr)3C6H2
99:1 er 99:1 er
 
Scheme 2.48 
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Chapter Three: Synthesis and Reactions of α-Amino 
Grignard Reagents 
 
Described in this chapter are our efforts towards the synthesis of chiral α-amino 
Grignard reagents.  Of particular interest was the formation of pyrrolidinyl sulfoxides 
anti-(S,SS)-148 and syn-(R,SS)-148 and piperidinyl sulfoxides anti-(S,SS)-149 and syn-
(R,SS)-149 in ≥99:1 er (Scheme 3.1).  It was proposed that lithiation of N-Boc 
pyrrolidine 39 or N-Boc piperidine 48 and trapping with Andersen’s sulfinate (SS)-97 
would provide an expedient route to the desired sulfoxides. 
N
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pTol
H
S
O
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N
Boc
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ant i-(S,Ss)-148
N
Boc
S
O
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H
syn-(R,Ss)-148
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N
Boc
H
ant i-(S,Ss)-149 syn-(R,Ss)-149
N
Boc
N
Boc
S
O
O
(SS)-97
S
O
O
(SS)-97
+
+
39
48  
Scheme 3.1 
 
Subsequently, a sulfoxide → magnesium exchange protocol would be developed to 
synthesise Grignard reagents in high yield and enantioselectivity.  For example, 
Grignard reagent (S)-150 would be formed from anti-(S,SS)-148 and its enantiomer, (R)-
150, would be synthesised from syn-(R,SS)-148 (Scheme 3.2).  
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O
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H
anti-(S,Ss)-148
N
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O
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H
syn-(R,Ss)-148
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 0 °C
i-PrMgCl
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N
Boc
H
N
Boc
H
MgCl
MgCl
(S)-150
(R)-150   
Scheme 3.2 
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3.1 Previous Syntheses of α-Amino Sulfoxides, Sulfides and Sulfones 
Surprisingly, the synthesis of simple cyclic N-Boc α-amino sulfoxides, such as 148 and 
149 (Figure 3.1), has not been reported previously.  Therefore, in this section a short 
review of the known methods of synthesising cyclic α-amino sulfides and sulfones is 
presented.  In addition, the syntheses of two structurally related α-sulfinyl lactams are 
discussed. 
N
Boc
S
O
pTol
H
S
O
pTol
N
Boc
H
148 149  
Figure 3.1 
 
There are three general synthetic strategies towards cyclic α-amino sulfides: (i) 
deprotonation of N-Boc heterocycles and trapping with disulfides; (ii) addition of thiols 
to cyclic iminium ions; (iii) Pummerer rearrangement of amino sulfoxides.   
 
In 1989, Beak and Lee reported the lithiation of N-Boc piperidine 48 and trapping with 
diphenyl disulfide to give sulfide 151 in 61% yield (Scheme 3.3).
134
 This reaction 
proceeds via organolithium reagent rac-59.  Since then, this approach has been 
expanded to include a number of N-Boc heterocycles, including imidazolidines
135
 and 
pyrimidines.
136
 
N
Boc
N
Boc
S
Ph
1. s-BuLi, TMEDA,
Et2O,
_78 °C, 6 h
2. PhSSPh
48 151, 61%
N
Boc
Li
via
rac-59  
Scheme 3.3 
 
Another popular method of synthesising α-amino sulfides is the addition of thiols to 
cyclic iminium ions. For example, Huang et al. reported the acid-catalysed elimination 
of hydroxy pyrrolidine 152 in the presence of 2-mercaptopyridine gave sulfide 153 in 
90% yield (Scheme 3.4).
137
  This reaction proceeds via iminium ion 154.  A similar 
approach has also been described by Chiba and co-workers to synthesise 2,5-subsituted 
pyrrolidines.
138
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S NN
Boc
OTBDMS
OH PPTS-TsOH
CH2Cl2, rt, 1 d
(S)-153, 90%152
N
Boc
OTBDMS
v ia
154  
Scheme 3.4 
 
Cyclic α-amino sulfides have also been synthesised via an intramolecular Pummerer 
rearrangement.
139
  Sulfoxide 155 was treated with O-silylated ketene acetal 156 (which 
acts as an O-silylation reagent) in the presence of catalytic zinc iodide (Scheme 3.5).  
The reaction proceeded via adduct 158 and gave sulfide 157 in 57% yield. 
viaN
Ac
S
Ph
NH S
O
Ph
Ac
155
MeO OTBDMS
0.1 eq. ZnI2
CH3CN, rt, 25 h
157, 57%
NH S
Ph
Ac
158
156
 
Scheme 3.5 
 
The Pummerer rearrangement was also found to be an expedient method for 
synthesising indolizidine sulfides 160.
140
  Treatment of amino sulfoxides 159 with O-
silylated ketene acetal 156 and catalytic zinc iodide gave indolizidine sulfides 160 in 
85% yield (Scheme 3.6).  In addition, subsequent oxidation of 160 by m-CPBA formed 
sulfones 161 in 30% yield.  Presumably the oxidation proceeds via a sulfoxide 
intermediate. 
NH
O S Ph
O
N
SPhO
0.1 eq. ZnI2
CH3CN, rt, 24 h
MeO OTBDMS
159 160, 85%
N
SO2PhO
mCPBA
CH2Cl2, rt, 16 h
161, 30%
156
HHH
 
Scheme 3.6 
 
Furthermore, 2-sulfonyl pyrrolidines have also been successfully synthesised.  For 
example, Ley and co-workers reported the synthesis of a number of cyclic α-amino 
sulfones.
141
  The typical synthetic procedure is shown in Scheme 3.7 whereby methoxy 
N-formyl pyrrolidine 162 was treated with benzenesulfinic acid.  This reaction 
presumably proceeds via iminium adduct 164 to give sulfone 163 in 89% yield.   
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N
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SO2Ph
163, 89%
N
H O
S
O
OH via
162
CH2Cl2, rt, 20 h
 
 Scheme 3.7  
 
Whilst there are no simple α-amino sulfoxides reported in the literature, two lactams 
have been reported bearing an α-amino sulfoxide moiety.  Thomas et al. synthesised 
pyrrolizidinone sulfoxides 166 in 80% yield by oxidation of sulfides 165 using mCPBA 
(Scheme 3.8).
142
  
N
O S Me
N
O S
O
Me
H
mCPBA
CH2Cl2, 0 °C, 1 h
165 166, 80%
H H
 
Scheme 3.8 
 
Finally, a number of syntheses of 2-sulfinyl azetidinones have been reported due to 
them being a common intermediate for the synthesis of penem-derived antibiotics.
143,144
  
Typically, their synthesis involves oxidation of the sulfide precursor as shown in 
Scheme 3.9.
145
  Oxidation of sulfide 167 using sodium periodate in aqueous methanol 
gave a mixture of diastereomeric sulfoxides 168 in 93% yield. 
MeOH/H2O, rt, 1 hN
O S
N
O S
O
HNaIO4
168, 93%167  
Scheme 3.9 
 
To summarise, there are no examples of simple α-amino sulfoxides such as 148 and 149 
reported in the literature.  In contrast, a number of methods to synthesise α-amino 
sulfides and sulfones have been described. 
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3.2 Attempted synthesis of Pyrrolidinyl and Piperidinyl α-Amino 
Sulfoxides 
 
At the start of our project, there were no examples of compounds containing the N-Boc-
α-sulfinyl motif reported in the literature.  Despite this, we postulated that sulfoxides 
anti-(S,SS)-148 and syn-(R,SS)-148 could be synthesised by lithiation of N-Boc 
pyrrolidine 39 and trapping with Andersen’s sulfinate (SS)-97 (Scheme 3.10).  
Furthermore, we expected that this methodology could be easily expanded to include 
other N-Boc heterocycles. 
N
Boc
1. s-BuLi, Ligand,
Et2O,
_78 °C
2.
39
N
Boc
S
O
H
(S,Ss)-148
N
Boc
S
O
H
(R,Ss)-148S
O
O
(SS)-97  
Scheme 3.10 
 
3.2.1 Attempted Synthesis of Pyrrolidinyl and Piperidinyl α-Amino Sulfoxides via 
Lithiation-Trapping 
 
We began our investigation with the racemic lithiation of N-Boc pyrrolidine 39 and 
trapping with methyl p-toluenesulfinate 121.  N-Boc pyrrolidine 39 was lithiated using a 
diamine-free racemic lithiation protocol developed within our group (s-BuLi, THF, −78 
°C, 1 hour).
146
 However, trapping with sulfinate 121 did not give the expected 
diastereomeric sulfoxides anti-rac-148 and syn-rac-148 (Scheme 3.11).  Instead, after 
column chromatography, we isolated dihydropyrrole 169 in 31% yield.  Key 
spectroscopic data that allowed the structure of dihydropyrrole 169 to be identified 
include two alkene signals at δc 143.8 (quaternary C) and 124.2 (CH) in the 
13
C NMR 
spectrum and an alkene CH signal (δH 5.99) in the 
1
H NMR spectrum.  Compound 169 
also gave satisfactory HRMS data.  In addition, N-Boc pyrrolidine 39 was recovered in 
43% yield from this reaction. 
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Scheme 3.11 
 
The racemic lithiation of N-Boc piperidine 48 and trapping with methyl 
benzenesulfinate 170 was also attempted.  In this case, the lithiation conditions were s-
BuLi/TMEDA in Et2O at −78 °C for 3 hours
147
 since the diamine free protocol does not 
lithiate N-Boc piperidine 48.
146
  The expected sulfoxides anti-rac-149 and syn-rac-149 
were not formed and tetrahydropyridine 171 was isolated in 13% yield (Scheme 3.12).  
This product was identified by two alkene signals (δc 143.5 and 113.7) in the 
13
C NMR 
spectrum and an alkene CH signal (δH 6.37, triplet) in the 
1
H NMR spectrum. N-Boc 
piperidine 48 was also recovered in 52% yield. 
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Scheme 3.12 
 
In response to these disappointing results, we postulated two mechanisms for the 
formation of dihydropyrrole 169 and tetrahydropyridine 171.  These are summarised in 
Schemes 3.13, 3.14 and 3.15 for the pyrrolidine system.  In the first mechanism, 
lithiation and electrophilic trapping would give sulfoxides 148, which could then 
undergo elimination via a cycloreversion process to give dihydropyrrole 172 (Scheme 
3.13).  Vinylic lithiation of adduct 172 as reported by Beak in 1993
148
 and subsequent 
trapping with sulfinate 121 would give dihydropyrrole 169.  Although cycloreversion of 
sulfoxides is a well-established procedure for the synthesis of carbon-carbon double 
bonds,
149-151
 it is typical for elimination of aryl sulfinates to proceed at temperatures of 
25-80 °C.
152
  Therefore, it is possible that this mechanism may not be occurring under 
our low temperature conditions. 
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Alternatively, due to the increased acidity of the α-proton in sulfoxide 148, a second 
deprotonation and trapping could occur to give adduct 173.  This disubstitution could 
increase the propensity for a cycloreversion to occur to give dihydropyrrole 169 
(Scheme 3.14).  Doubly, α,α-substituted products of lithiation-trapping reactions 
analogous to 173 have been previously seen within the group when methyl 
chloroformate was used as the electrophile.
146
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Scheme 3.14 
 
The second mechanism is dependent upon the α-elimination of the sulfoxide moiety by 
the nitrogen lone pair. In this process, sulfoxide 148 would be formed by lithiation-
trapping and subsequent α-elimination would give iminium ion 174.  Deprotonation of 
the β-proton would lead to the formation of dihydropyrrole 172. This could undergo 
vinylic lithiation
148
 and trapping with sulfinate 121 would then give dihydropyrrole 169 
as with the cycloreversion mechanism (Scheme 3.15). It is worth noting that α-amino 
sulfones are commonly used as iminium ion precursors although this is usually 
conducted in the presence of a Lewis acid.
141,153
 
N
Boc
S
O
pTol
N
Boc
N
Boc
148 174 172
H
N
Boc
169
S
O
pTolBase Base
Sulfinate 121
B
 
Scheme 3.15 
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It is possible that the conformation of sulfoxides 148 and 149 may cause α-elimination 
to be favoured (Figure 3.2).  To avoid steric interaction between the sulfoxide and the 
planar NCO moieties (1,3-allylic type strain),
154
 the sulfoxide occupies the axial 
position.  This causes an alignment between the N-lone pair orbital and the anti-bonding 
σ*C-S orbital and hence elimination is potentially favoured. 
 
 
Figure 3.2 
 
Both of the proposed mechanisms require an excess of base to be present within the 
reaction mixture.  Therefore, a reverse addition protocol was explored in which lithiated 
N-Boc pyrrolidine was added to sulfinate 121. This ensured that there was never an 
excess of base during the electrophilic trapping step. From this reaction, a reduction in 
the yield of dihydropyrrole 169 (10%) was observed.  However, hydroxy pyrrolidine 
175 was now isolated as the major product in 52% yield (Scheme 3.16).  The desired 
sulfoxides anti-rac-148 and syn-rac-148 were not evident in the 
1
H NMR spectrum of 
the crude product.   
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Hydroxy pyrrolidine 175 could be formed by either of the elimination processes 
previously discussed.  These mechanisms assume the initial formation of sulfoxide 148 
and are summarised in Scheme 3.17.  In the case of α-elimination of the sulfoxide from 
148 by the nitrogen lone pair, iminium ion 174 would be formed.  Iminium ion 174 may 
then be quenched with water during the aqueous work-up to give hydroxy pyrrolidine 
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175.  On the other hand, cycloreversion of the sulfoxide from 148 would give 
dihydropyrrole 172.  Protonation on work up could lead to the formation of iminium ion 
174 which would be quenched to give hydroxy pyrrolidine 175 as previously discussed. 
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Scheme 3.17 
 
Chiral diamines can modulate the reactivity of organolithium reagents.  Therefore, we 
hoped that use of (−)-sparteine may hinder the formation of formation of dihydropyrrole 
169.  Unfortunately, lithiation of N-Boc pyrrolidine 39 using s-BuLi/(−)-sparteine and 
trapping with sulfinate 121 gave dihydropyrrole in 13% yield.  N-Boc pyrrolidine 39 
was recovered in 65% yield (Scheme 3.18). 
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As an aside, attempts were made to improve the yield of dihydropyrrole sulfoxide 169.  
The formation of dihydropyrrole sulfoxide 169 requires at least two equivalents of base 
and sulfinate 121 and therefore, the amount of s-BuLi and methyl p-toluene sulfinate 
121 was increased. Lithiation of N-Boc pyrrolidine 39 with 2.5 eq. of s-BuLi in THF 
and trapping with 3 eq. of 121 gave dihydropyrrole sulfoxide 169 in 44% yield (Scheme 
3.19).  This is compared to 31% yield when 1.3 eq. of s-BuLi and 2 eq. of 121 were 
used (see Scheme 3.11). 
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Scheme 3.19 
 
As a further attempt to synthesise N-Boc heterocyclic sulfoxides via direct lithiation and 
electrophilic trapping, more electron-rich aryl sulfinates and alkyl sulfinates were used 
with the aim of reducing the leaving group capability of the sulfoxide.  In particular, 
alkyl sulfinates are known to require temperatures of up to 130 °C to facilitate sulfoxide 
elimination via a cycloreversion process.
152
  First, methyl p-methoxybenzenesulfinate 
177 was synthesised in two steps from p-methoxybenzenethiol in 91% overall yield 
(Scheme 3.20).
119,155
 Next, we targeted methyl t-butylsulfinate 179.  Unfortunately, the 
synthesis of sulfinate 179 from t-butyldisulfide 178 using the Meyers procedure (Br2, 
Na2CO3, MeOH)
119
 was unsuccessful, with the reaction returning unreacted starting 
disulfide 178.  However, sulfinothioate 180 was successfully synthesised by oxidation 
of t-butyldisulfide 178 with 30% hydrogen peroxide via a known procedure.
156
  We 
reasoned that sulfinothioate 180 could be used in an analogous way to sulfinate 179. 
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Scheme 3.20 
 
With sulfinate 177 and sulfinothioate 180 in hand, the lithiation and electrophilic 
trapping of N-Boc pyrrolidine 39 was attempted.  Lithiation was carried out using s-
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BuLi in THF and when using sulfinate 177 as the electrophile, sulfoxides 181 were not 
formed.  However, there was limited evidence of a small amount of dihydropyrrole 182 
in the 
1
H NMR spectrum of the crude product (δH 5.96 ppm, double doublet, =CH). 
However, it was not possible to isolate dihydropyrrole 182 after flash column 
chromatography.  In this case, starting N-Boc pyrrolidine 39 was recovered in 84% 
yield.  The reaction using sulfinothioate 180 gave sulfide 184 in 15% yield (formed by 
preferential attack of the lithiated N-Boc pyrrolidine at the sulfanyl centre) and 
recovered starting N-Boc pyrrolidine 39 in 74% yield (Scheme 3.21).  There was no 
evidence for the formation of the desired sulfoxides 183. 
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Scheme 3.21 
 
To conclude, we have been unable to synthesise pyrrolidinyl α-amino sulfoxides 148 via 
lithiation and trapping with sulfinate 121.  In all cases, dihydropyrrole 169 or hydroxy 
pyrrolidine 175 were formed in modest yields.   Similarly, trapping with alternative 
sulfinates was unsuccessful.  Furthermore, piperidinyl α-amino sulfoxides 149 were not 
formed by our lithiation-trapping procedure.  Instead, tetrahydropyridine 171 was 
isolated as the major product. 
 
 
3.2.2 Attempted synthesis of Pyrrolidinyl and Piperidinyl α-Amino Sulfoxides via 
Oxidation of Sulfides 
 
Due to the lack of success with the sulfinate trapping, our attention then turned to the 
lithiation and electrophilic trapping with disulfides followed by a subsequent oxidation 
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to form the desired N-Boc-α-sulfinyl heterocycles.  Investigation of this alternative 
route would also allow us to further investigate whether the desired N-Boc-α-sulfinyl 
heterocycles are inherently unstable or if the instability is due to the conditions used for 
the lithiation and electrophilic trapping. 
 
First, α-amino sulfides were synthesised using a known procedure (see Scheme 3.3).147 
Indeed, lithiation-trapping of N-Boc piperidine 48 was carried out in the same fashion 
(s-BuLi, TMEDA, Et2O, −78 °C, 3 hours) to give sulfide 151 in 63% yield (Scheme 
3.22). With N-Boc pyrrolidine 39, lithiation using s-BuLi in THF (−78 °C, 1 hour) 
worked well and the lithiated intermediate was trapped with a number of alky and aryl 
disulfides giving sulfides 184-187 in 14-59% yield. 
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Scheme 3.22 
 
With sulfide 185 in hand, oxidation using mCPBA was attempted (Scheme 3.23, Table 
3.1).  Using conditions reported by Fodor and Feldman
157
 (mCPBA, Na2CO3, CH2Cl2, 
room temperature), sulfoxides 188 were not formed (entry 1).  However, hydroxy 
pyrrolidine 175 (which had previously been isolated when using the reverse addition 
protocol, see Scheme 3.16) was formed in 31% yield.  Hydroxy pyrrolidine 175 could 
have been formed by sulfoxide α-elimination as previously postulated.  Alternatively, 
over-oxidation to the sulfone may have occurred.  This would act as a better leaving 
group for decomposition by α-elimination by the nitrogen lone pair to give hydroxy 
pyrrolidine 175 on work-up.  In an attempt to ensure over-oxidation was prevented, a 
protocol developed by Ramesh et al.
158
 (mCPBA, KF, CH3CN/H2O, rt) was employed. 
However, this reaction still gave hydroxy pyrrolidine 175 in 57% yield (entry 2).  A 
lower temperature oxidation was also attempted following a known procedure
93
 
(mCPBA, CH2Cl2, −40 °C) and this time hydroxy pyrrolidine 175 was isolated in 86% 
yield (entry 3).  In addition, this procedure was used for the oxidation of sulfides 186, 
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187 and 184, but sulfoxides 148, 181 and 183 were not formed and hydroxy pyrrolidine 
175 was isolated in each case in 74-81% yield (entries 4-6). 
 
N
Boc
S
R
Oxidant / Additive
Solvent, Temp. N
Boc
S
O
R
N
Boc
OH
185, R = Ph
186, R = pTol
187, R = 4-MeOC6H4
184, R = CMe3
188, R = Ph
148, R = pTol
181, R = 4-MeOC6H4
183, R = CMe3
175
Not Formed
H
 
Scheme 3.23 
Table 3.1: Oxidation of N-Boc 2-Sulfanyl Pyrrolidines 
Entry Sulfide Oxidant Additive Solvent 
Temp  
/ °C 
Yield of 
175 / % 
1 185 mCPBA Na2CO3 CH2Cl2   rt 31 
2 185 mCPBA KF MeCN/H2O    rt 57 
3 185 mCPBA - CH2Cl2 −40 86 
4 186 mCPBA - CH2Cl2 −40 81 
5 187 mCPBA - CH2Cl2 −40 74 
6 184 mCPBA - CH2Cl2 −40 77 
7 186 H2O2 - HFIP   rt 43 
8 186 Me3SiCl/KO2 - CH3CN −15 52 
 
As oxidation using mCPBA did not give the desired sulfoxide products, alternative 
oxidation methods were attempted with sulfide 186. These included, a procedure 
published by Bonnet-Delpon et al. that uses hydrogen peroxide in 
hexafluoroisopropanol (HFIP),
159
 and a protocol devised by Huang and co-workers 
mediated by trimethylsilyl chloride and potassium superoxide.
160
  Both these methods 
also gave hydroxy pyrrolidine 175 in 43% and 52% yield respectively (entries 7 and 8).  
 
To conclude, lithiation-trapping of N-Boc pyrrolidine 39 and N-Boc piperidine 48 with 
disulfides was successful giving a number of α-sulfanyl N-Boc heterocycles.  
Unfortunately, oxidation of these products proved to be unsuccessful, with the reaction 
instead giving good yields of hydroxy pyrrolidine 175. 
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3.3 Attempted Synthesis of Cyclic and Acyclic α-Amino Sulfoxides 
 
We wanted to further investigate whether the instability of N-Boc α-amino sulfoxides is 
due to a cycloreversion process or because of an α-elimination of the aryl sulfoxide by 
the nitrogen lone pair.  Therefore, a series of substrates that would allow these two 
mechanisms to be probed were identified (Figure 3.3).  Sulfoxides 189-191, with N-
amido and N-thioamido groups, were designed to have an increased electron 
withdrawing effect on the nitrogen atom. It was hoped that the nitrogen lone pair would 
be less available for α-elimination.  In addition, azetidine sulfoxides 192 were designed 
to have a reduced propensity for elimination via either of the pathways.  This is due to 
placing a double bond (an intermediate in both processes) in the four membered ring 
would cause additional strain in the system.  Finally, sulfoxides 193-196 have no β-
protons and, therefore, a cycloreversion of the sulfoxide moiety could not occur.  
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N S
pTol
OPMP
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Boc
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S
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Figure 3.3 
 
3.3.1 Attempted Synthesis of Cyclic N-Amido and N-Thioamide Sulfoxides 
 
There are limited examples of lithiation-trapping of cyclic amides reported in the 
literature.   In 1981, Seebach and co-workers reported the lithiation and electrophilic 
trapping at the α-position of the triphenylacetamides of azetidine 197, pyrrolidine 198 
and piperidine 199.
161
 The amides were treated with t-BuLi in THF at −40 °C for 10 
minutes, before being allowed to warm to 0 °C for a further 20 minutes.  The lithiated 
intermediates were then trapped with electrophiles to give α-substituted N-heterocycles 
200-203 in 38-62% yield.  Selected results are shown in Scheme 3.24.  These lithiation-
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trappings proceeded in modest yield but the main drawback of this procedure is the use 
of pyrophoric t-BuLi. 
 
N
Ph3C O
2. PhCHO, t -BuCHO,
or Ph2CO
1. t-BuLi, THF,
_40 °C to 0 °C, 30 min N
Ph3C O
n n
N
Ph3C O
200, 62%
Ph
OH N
Ph3C O
201, 38%
OH
N
Ph3C O
202, 52%
OH
Ph
Ph N
Ph3C O
203, 39%
Ph
OH
Ph
E
H H
197, n = 1
198, n = 2
199, n = 3
PhCHO t -BuCHO Ph2CO Ph2CO  
Scheme 3.24 
 
In 1984, Beak et al. described the s-BuLi/TMEDA-mediated lithiation of N-aryl 
piperidine 204 (Scheme 3.25).
162
  Trapping with benzaldehyde or benzophenone gave 
alcohols 205 or 206 respectively, both in 30% yield.  The 2,4,6-triisopropylbenzamide 
was chosen due to its sterically bulky nature, which hinders nucleophilic attack by s-
BuLi at the carbonyl group.  
 
N
Ar O
2. PhCHO or Ph2CO
1. 1.3 eq. s-BuLi, TMEDA
THF, _78 °C, 5 h
204
Ar =
N
Ar O
205, 30%
Ph
OH
N
Ar O
206, 30%
Ph
OH
PhH
PhCHO Ph2CO  
Scheme 3.25 
 
Our investigations focused on the lithiation-trappings of N-triphenylacetyl pyrrolidine 
207 and N-pivaloyl pyrrolidine 209.  First, lithiation and electrophilic trapping of N-
triphenylacetyl pyrrolidine 207 (prepared by acylation of pyrrolidine with pivaloyl 
chloride) was attempted using similar conditions to those reported by Seebach and co-
workers (s-BuLi, THF, −40 °C, 3 hours).161  Unfortunately, when trapping with 
sulfinate 121, sulfoxide 189 was not formed and sulfinamide 208 was isolated in 31% 
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yield (Scheme 3.26).  Presumably, sulfinamide 208 is formed by initial nucleophilic 
attack of s-BuLi at the amide carbonyl group, a phenomenon which has been previously 
observed  by Beak et al. in the attempted lithiation of amides derived from piperidine.
162
  
The lithium amide this generates is then trapped by methyl p-toluenesulfinate 121 to 
give 208.   
N
Ph3C O
N
Ph3C O
2.
1. s-BuLi,
THF, _40 °C, 3 h
N
S
O
208, 31%207
S
O
189
H
S
O
OMe
121
Not Formed  
Scheme 3.26 
 
The lithiation of N-pivaloyl pyrrolidine 209 was attempted at lower temperature and 
using a chiral ligand (s-BuLi, (−)-sparteine, Et2O, −78 °C, 3 hours) (Scheme 3.27).  
Disappointingly, electrophilic trapping with methyl p-toluenesulfinate 121 gave 
sulfinamide 208 in 64% yield.  
 
N
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O
2.
1. s-BuLi, (_)-sparteine
Et2O,
_78 °C, 3 h
N
S
O
208, 64%209 190
S
O
S
O
OMe
121
H
Not Formed  
Scheme 3.27 
 
The lithiation-trapping of amides was unsuccessful due to nucleophilic addition of the 
organometallic base to the amide carbonyl group.  This problem has been seen 
previously in the lithiation of amides by Beak et al.,
162
 therefore it may not be possible 
to access amido sulfoxides 189 and 190 via lithiation chemistry. 
 
It was hoped that the reduced electrophilicity of the thioamide functionality would 
combat the problem of nucleophilic attack of s-BuLi at the carbonyl group of amides 
207 and 209.  Therefore, N-pivaloyl pyrrolidine 209 was treated with phosphorus(V) 
sulfide in pyridine to give N-thiopivaloyl pyrrolidine 210 in quantitative yield.  Initially, 
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N-thiopivaloyl pyrrolidine 210 was lithiated using conditions reported by Hodgson and 
Kloesges for the lithiation of N-thiopivaloyl azetidine 101 (1.2 eq. s-BuLi, 2.4 eq. 
TMEDA, THF, −78 °C, 3 hours),102 but after addition of different electrophiles 
(benzaldehyde, p-tolyldisulfide or methyl p-toluenesulfinate 121) no trapped product 
was observed and starting N-thiopivaloyl pyrrolidine 210 was recovered in high yield. 
Therefore, the lithiation was repeated with 1.3 eq. of s-BuLi and TMEDA.  This led to 
the first example of a successful lithiation-trapping of N-thiopivaloyl pyrrolidine 210.  
Electrophilic trapping with benzaldehyde gave a 60:40 mixture (by 
1
H NMR 
spectroscopy) of diastereomeric alcohols syn-rac-211 anti-rac-211 which were isolated 
in 31% and 27% yields respectively (Scheme 3.28).  The assignment of the relative 
stereochemistry of syn-rac-211 and anti-rac-211 and is presented in Chapter Four (see 
Scheme 4.44).   
 
N
S
N
S2. PhCHO
1. 1.3 eq. s-BuLi, TMEDA
THF, _78 °C, 3 h
210
Ph
OH
N
S
Ph
OH
anti-rac-211, 27% syn-rac-211, 31%
H H
 
Scheme 3.28 
 
Unfortunately, from the lithiation-trapping with methyl p-toluenesulfinate 121 under the 
same lithiation conditions (1.3 eq. s-BuLi/TMEDA, THF, −78 °C, 3 hours), the desired 
N-thiopivaloyl pyrrolidine sulfoxide 191 was not isolated.  The 
1
H NMR spectrum of 
the crude product showed trace amounts of dihydropyrrole 212 (δH 5.92, triplet, =C), 
which could not be isolated by flash column chromatography.  Starting thioamide 210 
was recovered in 59% yield.  In a similar way, when trapping with p-tolyldisulfide, 
sulfide 213 was not formed and thioamide 210 was recovered in 78% yield (Scheme 
3.29).   
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Scheme 3.29 
 
Our attention turned to the synthesis of N-thiopivaloyl azetidine sulfoxides 192.  It was 
hoped that the four membered ring system would inhibit the sulfoxide elimination 
allowing stable compounds to be isolated.  We began our investigation with the  
racemic lithiation of N-thiopivaloyl azetidine 101 (1.2 eq. s-BuLi, 2.4 eq. TMEDA, 
THF, −78 °C, 30 min)102 and trapping with methyl p-tolyl sulfinate 121 (Scheme 3.30).  
From this reaction, a 91:9 mixture of diastereomeric sulfoxides 192 were evident in the 
1
H NMR spectrum of the crude product.  The NCH signal provided key diagnostic 
information (δH 5.55, double doublet for the major diastereoisomer and δH 5.72, double 
doublet for the minor diastereoisomer).   However, after chromatography only the major 
diastereomeric sulfoxide 192 was isolated in 9% yield. Unfortunately, the relative 
stereochemistry was unable to be determined.  In addition, N-thiopivaloyl azetidine 101 
was recovered in 72% yield. 
 
N
S
S
O
H
192, 9%
1. 1.2 eq. s-BuLi, 2.4 eq. TMEDA
THF, _78 °C, 30 min
2.
N
S
101
S
OMe
O
121
+ 72% RSM
 
Scheme 3.30 
 
N-Thiopivaloyl azetidine sulfoxide 192 is the first example of an isolable α-amino 
sulfoxide.  We postulate that due to ring constraints both α-elimination and 
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cycloreversion are disfavoured. Furthermore, the thiopivalamide group provides an 
increased electron withdrawing effect when compared to the Boc protecting group.  
Thus, the nitrogen lone pair may be less available to eliminate the sulfoxide moiety.  
 
It was hoped that the using a chiral ligand may improve the yield of the sulfoxide 
products.  It would also allow the assignment of the configuration in a similar fashion to 
that of O-alkyl carbamate sulfoxides anti-(S,SS)-103 and syn-(R,SS)-103 (see Scheme 
2.24).  N-Thiopivaloyl azetidine 101 was lithiated using s-BuLi/(−)-sparteine in Et2O at 
−78 °C and trapped with Andersen’s sulfinate (SS)-97 (Scheme 3.31).  Unfortunately, no 
product was evident in the 
1
H NMR spectrum of the crude product and N-thiopivaloyl 
azetidine 101 was recovered in 85% yield. 
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Scheme 3.31 
 
To conclude, we were able to successfully synthesise N-thiopivaloyl azetidine sulfoxide 
192 by lithiation-trapping.  However, the yield of the reaction was disappointing and 
our attempts to increase the yield were fruitless.  In contrast, pyrrolidinyl sulfoxides 191 
were not formed from the lithiation of N-thiopivaloyl pyrrolidine 210 and trapping with 
methyl p-toluene sulfinate 121. 
 
3.3.2 Synthesis of Acyclic α-Amino Sulfoxides 
 
The synthesis of sulfoxides without β-protons was targeted next and acyclic sulfoxides 
193-196 were designed to probe this (Figure 3.4).  This would allow us to explore 
whether elimination was occurring via a cycloreversion process as well as varying the 
electron withdrawing groups on the nitrogen atom. 
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Figure 3.4 
 
It was decided that the best route to sulfinyl benzamide 193 would be via alkylation of 
N-PMP benzamide 214 with a chlorosulfide and subsequent oxidation. This route 
avoids the use of lithiation chemistry which may result in nucleophilic attack of the 
organolithium base at the carbonyl of the amide group.   In 1972, Colonna et al. 
reported that α-halogeno sulfoxides are unreactive towards nucleophilic substitution, 
whereas nucleophilic substitution of α-halogeno sulfides is facile.163  Furthermore, 
Hiyama and co-workers reported that alkylation of a similar N-PMP amide with 
chloromethyl phenyl sulfide proceeds in 53% yield.
164
  
 
To start with, benzamide 214 was synthesised by acylation of p-anisidine with benzoyl 
chloride in 83% yield (Scheme 3.32).
165
 Then, alkylation of benzamide 214 with 
chlorosulfide 215 (formed by reaction of methyl p-tolylsulfide and N-
chlorosuccinimide
166
) was attempted.  First, following Hiyama’s method (1.5 eq. 
chlorosulfide 215, room temperature, 1 hour) gave sulfanyl benzamide 216 in 51% yield 
(Table 3.2, entry 1). The alkylation was repeated using 2.0 eq. of chlorosulfide 215 over 
18 hours and sulfanyl benzamide 216 was isolated in 62% yield (entry 2).  The yield 
was further improved by warming the reaction to 50 °C over the same time period.  This 
gave sulfanyl benzamide 216 in 68% yield (entry 3).  A final attempt to optimise this 
alkylation by increasing the amount of chlorosulfide 215 from 2.0 eq. to 2.5 eq. showed 
no improvement in the yield of sulfanyl benzamide 216 (entry 4). 
Chapter Three: Synthesis and Reactions of α-Amino Grignard Reagents 
 
90 
 
Et4N
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O
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PhCOCl, NaHCO3
CH2Cl2, 0 °C, 1 h
Scheme 3.32 
Table 3.2: Optimisation of the alkylation of N-benzoyl anisidine 214 
Entry Eq. Chlorosulfide 215 Temp. / °C Time / h Yield of 216 / % 
1 1.5 rt 1 51 
2 2.0 rt 18 62 
3 2.0 50 18 68 
4 2.5 50 18  68 
 
Sulfanyl benzamide 216 was then oxidised using mCPBA (CH2Cl2, −40 °C, 1 hour) to 
form sulfoxide 193 in 84% yield (Scheme 3.33). To our delight, α-amino sulfoxide 193 
was stable and readily isolatable.  Sulfoxide 193 has no β-protons and therefore 
cycloreversion is not possible.  In addition, the increased electron-withdrawing amide 
group (when compared to Boc) on the nitrogen atom should reduce the propensity for α-
elimination of the aryl sulfoxide by the nitrogen lone pair.  Therefore, the successful 
isolation of α-amino sulfoxide 216 does not discriminate between the two proposed 
mechanisms for the breakdown N-Boc α-sulfinyl heterocycles. 
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Scheme 3.33 
 
The thiobenzamide analogue, sulfoxide 194, was also synthesised via a similar route 
(Scheme 3.34). This synthesis began with the conversion of benzamide 214 using 
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phosphorus(V) sulfide into thiobenzamide 217 which proceeded in a moderate 40% 
yield.   
Et4N
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N
S
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OMe
SSCl
217, 40% 218, 54%
215
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S
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OMe
S
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_40 °C, 1 h
NH
O
Ph
OMe
214
P2S5
Pyridine, 75 °C, 6 h
 
Scheme 3.34  
 
Thiobenzamide 217 was then alkylated under our previously optimised conditions (2.0 
eq. chlorosulfide 215, 50 °C, 18 hours) to give sulfanyl thiobenzamide 218 in 54% 
yield.  Finally, sulfanyl thiobenzamide 218 was oxidised using mCPBA to give 
sulfoxide 194 in 77% yield. Sulfoxide 194 was our second example of an isolable 
acyclic α-amino sulfoxide. 
 
Attempts were also made towards the synthesis of N-Boc sulfoxide 195 but the routes 
investigated were unsuccessful (Schemes 3.35 and 3.36).  Initially, alkylation of N-Boc 
p-anisidine 219 with chlorosulfide 215 using the modified Hiyama method
164
 (2.0 eq. 
chlorosulfide 215, 50 °C, 18 hours) was investigated.  Unfortunately, N-Boc sulfide 220 
was not formed, and N-Boc p-anisidine 219 was recovered quantitatively (Scheme 
3.35).  Then, we attempted an alkylation which began with deprotonation of N-Boc p-
anisidine 219 using sodium hydride and subsequent addition of chlorosulfide 215. The 
reaction did not produce any of the desired N-Boc sulfide 220 and N-Boc p-anisidine 
219 was recovered in 100% yield.  As a result, the planned oxidation to sulfoxide 195 
could not be investigated. 
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Our attention then turned to the use of lithiation chemistry to access either N-Boc 
sulfide 220 or N-Boc sulfoxide 194. N-Boc N-methyl p-anisidine 221 was synthesised 
from N-Boc p-anisidine 220 by alkylation with methyl iodide, but subsequent lithiation-
trapping was unsuccessful (Scheme 3.36).  When attempting to trap with p-tolyl 
disulfide, a product was isolated, but we were unable to determine its structure (we do 
not believe it to be the product of an ortho-lithiation).  In addition, starting N-Boc N-
methyl p-anisidine 221 was recovered in 52% yield.  Finally, when using methyl p-
toluenesulfinate 121 as the electrophile, sulfoxide 194 was not formed.  In addition, N-
Boc N-methyl p-anisidine 221 was recovered in 83% yield.  The reason for the failure of 
these reactions is unclear. 
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Scheme 3.36 
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Unfortunately, the synthesis of N-Boc sulfoxide 194 was unsuccessful via alkylation 
and when using lithiation chemistry.  Currently, there is no evidence that this is because 
the desired sulfoxide is unstable.  Instead, it is suggested that these are not viable routes 
to N-Boc sulfoxide 194. 
 
Finally, we targeted N-Boc dimethylamine sulfoxide 196 as lithiation chemistry would 
provide an expedient route to the desired compound.  In 1989, Beak and Lee reported 
the lithiation-trapping of N-Boc dimethylamine 222 to give substituted products in good 
yield.
147
  In addition, Dieter and co-workers have also used the lithiation of N-Boc 
dimethylamine 222 to exemplify coupling of α-lithio amines with aryl and vinyl 
iodides.
167,168
   
 
The lithiation of N-Boc dimethylamine 222 was carried out using conditions published  
by Beak et al. (s-BuLi, TMEDA, Et2O, −78 °C, 2 hours).
169
 Trapping with methyl p-
toluene sulfinate 121 gave N-Boc dimethylamine sulfoxide 196 in 71% yield (Scheme 
3.37). It should be noted that it was necessary that 1% Et3N to be added to the eluent for 
chromatography to avoid decomposition on silica, possibly via silica-promoted α-
elimination of the sulfoxide group. 
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Scheme 3.37 
 
Sulfoxide 196 is the first example of an isolable compound containing the N-Boc-α-
sulfinyl motif.  In contrast, our attempts to synthesise pyrrolidinyl sulfoxides 148 and 
piperidinyl sulfoxides 149 were unsuccessful (see Schemes 3.11 and 3.12).  Instead, 
dihydropyrrole sulfoxide 169 and tetrahydropyridine sulfoxide 171 were isolated from 
these reactions.  We propose that the stability of sulfoxide 196 could be due to the 
absence of β-protons in the molecule.  Thus, cycloreversion of the sulfoxide moiety is 
possible.  However, as sulfoxide 196 is unstable on silica (in the absence of Et3N), we 
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cannot fully rule out α-elimination of the sulfoxide by the nitrogen lone pair as a cause 
of the general instability of cyclic α-amino sulfoxides. 
 
So far we have managed to synthesise one cyclic and three acyclic α-amino sulfoxides 
either by lithiation-trapping or alkylation-oxidation (Figure 3.5).  Disappointingly, 
cyclic N-Boc α-amino sulfoxides 148 and 149 were not formed using a variety of 
methods. 
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Figure 3.5 
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3.4 Synthesis of Azabicyclo[3.1.0]hexane Sulfoxides 
Our attention turned to designing a cyclic α-amino sulfoxide in which both α-
elimination and cycloreversion were disfavoured.  An attractive option was the 
synthesis of azabicyclo[3.1.0]hexanes sulfoxides syn-(R,R,Ss)-225 and anti-(S,S,Rs)-225.  
From these substrates, sulfoxide elimination is prohibited due to Bredt’s rule.170,171  In 
addition, we proposed that they could be expediently synthesised by lithiation of N-Boc 
4-chloro or 4-tosyloxy piperidines 223 or 224 and trapping with Andersen’s sulfinate 
(SS)-97 (Scheme 3.38).  The lithiation-cyclisation of N-Boc 4-chloro and 4-tosyloxy 
piperidines 223 and 224 has been previously studied by Beak et al. and the highest 
enantioselectivity achieved in these lithiation processes were 78:22 er.
41,172
  Therefore, 
we believed that our methodology could provide significant improvements in this arena. 
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Scheme 3.38 
 
Substituted azabicyclo[3.1.0]hexanes have been shown to have a wide range of 
pharmacological activity.  Indeed, they act as kinase and protease inhibitors
173,174
 and 
also show good efficacy in the treatment of the hepatitis C virus.
175
 Furthermore, one 
analogue, saxagliptin, has recently been approved in the treatment of type II diabetes 
(Figure 3.6).
176,177
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3.4.1 Lithiation-Trapping of N-Boc 4-Chloro and 4-Sulfonyl Piperidines 
 
In 1994, Beak and co-workers reported the facile construction of azabicyclo[3.1.0] 
hexanes in racemic fashion by the lithiation-cyclisation of N-Boc 4-chloro piperidine 
223.  Treatment of  N-Boc 4-chloro piperidine 223 with 2.2 eq. of s-BuLi/TMEDA gave 
2-substituted products 227, 229-232 in 36-75% yield (Scheme 3.39).
178
  This reaction 
proceeds via α-lithiated piperidine 226 which immediately cyclises to give bicycle rac-
227.  In 223, the chlorine atom will presumably be in the equatorial position and 
equatorial α-lithiation will occur to give 2,4-cis-diastereoselectivity.179 In addition, the 
intramolecular cyclisation occurs with inversion of configuration at the α-carbon to give 
rac-227.  Due to the increased acidity of the cyclopropanyl proton in rac-227 when 
compared with starting piperidine 223, this second deprotonation event is favoured 
leading to lithiated intermediate 228.  Finally, trapping with an array of electrophiles 
furnishes the desired 2-subsituted azabicyclo[3.1.0]hexanes 227, 229-232. 
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Scheme 3.39 
 
Two years later, Beak and Park investigated the asymmetric lithiation-trapping of 4-
chloro piperidine 223.
172
  Lithiation of N-Boc 4-chloro piperidine 223 with 2.2 eq. s-
BuLi/(−)-sparteine in Et2O at −78 °C and trapping with trimethylsilyl chloride gave 
bicycle rac-229 in 71% yield but 50:50 er (Scheme 3.40 and Table 3.3, entry 1).   This 
is a surprising result given that lithiation of N-Boc piperidine with s-BuLi/(−)-sparteine 
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and trapping with electrophiles is known to give a 2-subsituted product in low yield but 
good enantioselectivity (87:13 er).
41
  In an attempt to overcome this problem, Beak and 
Park studied whether the leaving group affected the enantioselectivity of the 
intramolecular cyclisation.  Lithiation of tosylate 224 with 2.2 eq. s-BuLi/(−)-sparteine 
at −78 °C in Et2O and trapping with trimethylsilyl chloride gave bicycle (R,R)-229 in 
good yield (77%) and satisfactory enantioselectivity (78:22 er) (entry 2).   
 
N
X
Boc
N
Boc
SiMe3
(R,R)-229
1. 2.2 eq. s-BuLi/(_)-sparteine
solvent, temp., 4 h
2. Me3SiCl
223, X=Cl
224, X=OTs
233, X=ONs Ns = 4-NO2C6H4SO2  
Scheme 3.40 
Table 3.3: Asymmetric lithiation-cyclisation of 4-subsituted piperidines 
Entry SM Solvent Temp. / °C Yield / % er 
1 223 Et2O −78 71 50:50 
2 224 Et2O −78 77 78:22 
3 224 Et2O −100 41 79:21 
4 224 Et2O-pentane −78 51 74:26 
5 224 t-BuOMe −78 63 72:28 
6 224 THF −78 81 59:41 
7 233 Et2O −78 43 71:29 
 
Further attempts to optimise this reaction were unsuccessful: neither lower temperature 
(entry 3) nor different solvents (entries 4-6) improved the enantioselectivity.  When 
nosylate 233 was lithiated under the same conditions used for tosylate 224, bicycle 
(R,R)-229 was formed in 43% yield and 71:29 er (entry 7). 
 
In 2002, Beak and co-workers reported the lithiation-cyclisation of tosylate 224 under 
the same conditions as was previously reported (2.2 eq. s-BuLi/(−)-sparteine, Et2O, −78 
°C, 4 hours).   Although trapping with trimethylsilyl chloride gave bicycle (R,R)-229 in 
comparable enantioselectivity (75:25 er), the yield reported was vastly reduced (26%).
41
 
No explanation for the difference between this result and that shown in Table 3.3, entry 
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2 (78% yield and 78:22 er) was provided.  In this work, the absolute configuration of 
the major enantiomer, (R,R)-229, was established by X-ray crystallography of the p-
bromobenzamide derivative. 
 
3.4.2 s-BuLi/TMEDA-Mediated Lithiation of N-Boc 4-Chloro Piperidine and 
Trapping with Andersen’s Sulfinate 
 
We began our investigation with the racemic lithiation of N-Boc 4-chloro piperidine 
223 using conditions reported by Beak et al. (2.2 eq. s-BuLi/TMEDA, Et2O, −78 °C, 6 
hours
178
) and electrophilic trapping with sulfinate 121.  This gave sulfoxides syn-rac-
225 and anti-rac-225 in 35% and 36% yield respectively (Scheme 3.41, Table 3.4, entry 
1).  Our design had worked; we had successfully isolated a cyclic N-Boc α-amino 
sulfoxide.  The assignment of the stereochemistry of the diastereomeric sulfoxides was 
made from the products of asymmetric lithiation which are presented later.  Crucially, 
the diastereomeric sulfoxides were readily separated by flash column chromatography 
and had distinctive 
1
H and 
13
C NMR spectra.  In addition, each diastereoisomer was 
separable into a 50:50 mix of enantiomers by CSP-HPLC. 
 
1. 2.2 eq. s-BuLi
Conditions
2.
S
O
223 syn-rac-225 ant i-rac-225
N
Boc
Cl
N
Boc
S
O
N
Boc
S
OMe
O
121  
Scheme 3.41 
Table 3.4: Optimisation of the racemic lithiation of 4-chloro piperidine 223 and trapping 
with sulfinate 121 
Entry Conditions 
Yield of 
 syn-rac-225 / % 
Yield of  
anti-rac-225 / % 
1 TMEDA, Et2O, −78 °C, 6 h   35 36 
2 TMEDA, Et2O, −78 °C, 1 h   34 35 
3 THF, −78 °C, 1 h   33 32 
4 THF, −30 °C, 5 min   21 18 
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A reduction in lithiation time from 6 hours to 1 hour showed no reduction in yield, with 
syn-rac-225 and anti-rac-225 being isolated in 34% and 35% yield respectively (entry 
2). This indicated that significant lithiation occurred within 1 hour.  A diamine-free 
lithiation
146
 (s-BuLi/THF, 1 hour) at −78 °C gave both diastereoisomers in good yields 
(entry 3). In contrast, repeating the lithiation at −30 °C for 5 minutes (conditions that 
had previously been optimised by our group for the lithiation of a number of N-Boc 
heterocycles)
146
 gave sulfoxide syn-rac-225 in 21% yield and sulfoxide anti-rac-225 in 
18% yield (entry 4). 
 
The difference in reactivity between N-Boc piperidine 48 and N-Boc 4-chloro piperidine 
223 towards α-lithiation is remarkable. ReactIRTM spectroscopic data recorded within 
our group suggests that full lithiation of N-Boc piperidine 48 with s-BuLi/TMEDA 
takes in excess of 90 minutes. 
180
  However, lithiation of N-Boc 4-chloro piperidine 223 
under the same conditions required only 2 minutes for complete lithiation.  In addition, 
the reactivity difference is also apparent in isolated yields.  It has been reported that the 
s-BuLi/THF complex is unable to lithiate N-Boc piperidine
146
 whereas our results show 
that the diamine-free lithiation of N-Boc 4-chloro piperidine 223 gives significant yields 
at −78 °C (65% yield, Table 3.4, entry 3). 
 
We postulate that the reactivity difference between N-Boc piperidine 48 and N-Boc 4-
chloro piperidine 223 arises due to an overlap between the back lobe of the C-H σ-
bonding orbital and the C-Cl σ* antibonding orbital.  This would cause a weakening of 
the C-H bond, effectively making the proton more acidic.  Therefore, deprotonation is 
more facile in N-Boc 4-chloro piperidine 223 than in N-Boc piperidine 48, where this 
interaction does not exist (Figure 3.7). 
 
Figure 3.7 
 
Our attention then turned to the enantioselective synthesis of sulfoxides syn-(R,R,SS)-
225 and anti-(S,S,SS)-225.  First, the racemic lithiation (2.2 eq. s-BuLi/TMEDA, Et2O, 
−78 °C, 1 hour) of N-Boc 4-chloro piperidine 223 and trapping with 2.2 eq. Andersen’s 
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sulfinate (SS)-97 was investigated because we were concerned about a similar loss of 
enantiomeric ratio during the trapping procedure as was observed in the case of O-alkyl 
carbamate 14 (see Scheme 2.13).  In fact, the reduction in enantiomeric ratio was even 
more dramatic.  Sulfoxide syn-(R,R,SS)-225 was isolated in 38% yield but only 58:42 er 
and sulfoxide anti-(S,S,SS)-225 was isolated in 45% yield and 70:30 er (Scheme 3.42). 
   
1. 2.2 eq. s-BuLi/TMEDA
Et2O,
_78 °C, 1 h
2.
S
O
223 S
O
O
(SS)-97
syn-(R,R,SS)-225
38%, 58:42 er
anti-(S,S,SS)-225
45%, 70:30 er
N
Boc
Cl
N
Boc
S
O
N
Boc
  
Scheme 3.42 
 
We postulate that the loss of enantiomeric ratio in the sulfoxide products occurs via a 
similar process to that identified for α-alkoxy sulfoxides (see Scheme 2.14).  Lithiation-
cyclisation of N-Boc 4-chloro piperidine 223 using s-BuLi/TMEDA will generate a 
50:50 mixture of organolithium reagents (R,R)-228 and (S,S)-228.  As an example, 
trapping of (R,R)-228 with Andersen’s sulfinate (SS)-97 would give sulfoxide syn-
(R,R,SS)-225.  As the amount of syn-(R,R,SS)-225 increases, competitive sulfoxide → 
lithium exchange occurs mediated by (R,R)-228 as shown in Scheme 3.43.  This would 
give sulfoxide anti-(R,R,RS)-225.  An analogous process by sulfoxide anti-(S,S,SS)-225 
and organolithium (S,S)-228 would form sulfoxide syn-(S,S,RS)-225.  It is in this manner 
that the enantiomers of the expected major products, sulfoxides syn-(R,R,SS)-225 and 
anti-(S,S,SS)-225 are formed. Hence a loss of enantiomeric ratio in the products is 
observed.  In addition, we suggest that organolithium reagents (R,R)-228 and (S,S)-228 
are better leaving groups than lithiated O-alkyl carbamate, thus a greater loss of 
enantiomeric ratio is observed in this system. 
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Scheme 3.43 
 
Fortunately, the enantioselectivity was improved by modifying the procedure in a 
similar fashion to that observed for the lithiation-trapping of O-alkyl carbamate 14 
(Scheme 3.44, Table 3.5).   
 
1. 2.2 eq. s-BuLi/TMEDA
Et2O,
_78 °C, 1 h
2.
S
O
223 S
O
O
(SS)-97
syn-(R,R,SS)-225 anti-(S,S,SS)-225
N
Boc
Cl
N
Boc
S
O
N
Boc
 
Scheme 3.44 
Table 3.5: Optimisation of the racemic lithiation of N-Boc 4-choro piperidine 223 and 
trapping with Andersen’s sulfinate (SS)-97. 
Entry 
Reverse 
Addition? 
Length of Trap 
at −78 °C / min 
syn-(R,R,Ss)-225 anti-(S,S,Ss)-225 
Yield / % er
a
 Yield / % er
a
 
1 No 16 h 
b
 38 58:42 45 70:30 
2 No 5 36 80:20 47 78:22 
3 Yes 5 39 89:11 44 88:12 
4
c
 Yes 5 41 90:10 43 91:9 
a
er determined by CSP-HPLC,
 bWarmed from −78 °C to rt, c3.0 eq. of Andersen’s 
sulfinate (SS)-97 used. 
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Indeed, we found that quenching the reaction after 5 minutes at −78 °C gave syn-
(R,R,SS)-225 in 36% yield and 80:20 er and anti-(S,S,SS)-225 in 47% yield and 78:22 er 
(entry 2).  This was a significant improvement compared to allowing the electrophilic 
trapping warm to room temperature overnight (entry 1).  Next, a reverse addition 
protocol further improved the enantioselectivity to 89:11 er and 88:12 er for syn-
(R,R,SS)-225 and anti-(S,S,SS)-225 respectively (entry 3).  Increasing the amount of 
Andersen’s sulfinate (SS)-97 to 3.0 eq. did not further improve the enantiomeric ratio of 
the products (entry 4). 
 
To conclude, we were able to improve the enantiomeric ratio in the lithiation of N-Boc 
4-chloro piperidine 223 and trapping with Andersen’s sulfinate (SS)-97 by using a 
reverse addition protocol.  Unfortunately, a significant loss of enantiomeric ratio during 
the trapping process was still observed and therefore sulfoxides syn-(R,R,SS)-225 and 
anti-(S,S,SS)-225 were not isolated in ≥99:1 er. 
 
3.4.3 s-BuLi/Chiral Diamine-Mediated Lithiation of N-Boc 4-Chloro Piperidine 
and Trapping with Andersen’s Sulfinate 
 
Previously, we successfully carried out a chiral amplification during the asymmetric 
lithiation of O-alkyl carbamate 14 and trapping with Andersen’s sulfinate (SS)-97 (see 
Scheme 2.23).  A similar strategy was envisaged for the synthesis of sulfoxides syn-
(R,R,SS)-225 and anti-(S,S,SS)-225.  Therefore, our next step would be to introduce an 
asymmetric lithiation followed by trapping with Andersen’s sulfinate (SS)-97 to give the 
α-amino sulfoxides in 99:1 er.   
 
Since Beak and co-workers reported that the leaving group has a dramatic effect on the 
enantioselectivity of the lithiation-trapping procedure, we envisaged that using 4-
sulfonyl derivatives would give products in good enantiomeric ratio.  Consequently, we 
investigated the asymmetric lithiation of 4-substituted piperidines 223 (4-Cl), 224 (4-
OTs) and 234 (4-OSO2Ar, Ar = 2,4,6-triisopropylbenzene) with s-BuLi/(−)-sparteine 
(Et2O, −78 °C, 1 hour) and subsequent electrophilic trapping with phenylisocyanate 
(Scheme 3.45, Table 3.6).  Lithiation of N-Boc 4-chloro piperidine 223 with s-BuLi/(−)-
sparteine and electrophilic trapping with phenylisocyanate gave amide (S,R)-235 in 94% 
yield but low enantiomeric ratio (56:44 er) (entry 1).  The low enantioselectivity was 
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unsurprising as Beak had previously shown that lithiation-trapping of N-Boc 4-chloro 
piperidine 223 gave racemic products.
172
 
 
1. s-BuLi, (_)-sparteine
Et2O,
_78 °C, 1 h
2. PhNCO
H
N
(S,R)-235
N
Boc
X
N
Boc
O
Ph
223, X = Cl
224, X = OTs
234, X = OSO2Ar
Ar =
 
Scheme 3.45 
Table 3.6: Asymmetric lithiation of 4-subsituted piperidines 223, 224 and 234 and 
trapping with phenyl isocyanate 
Entry Starting Material Yield / % er
a
 
1 223 94 56:44 
2 224 -
b
 - 
3 234 84 58:42 
a
er determined by CSP-HPLC, 
b
Starting tosylate 224 was recovered in 92% yield. 
 
Then, we attempted the enantioselective lithiation-trapping of N-Boc 4-tosyloxy 
piperidine 224.  However, none of the expected amide (S,R)-235 was isolated and 
starting tosylate 224 was recovered in 92% yield (entry 2).  This result is consistent 
across a number of repeats, and we have been unable to successfully lithiate and trap N-
Boc 4-tosyloxy piperidine 224.  Our result is clearly at odds with those reported by 
Beak (see Table 3.3, entry 2).  It is possible that N-Boc 4-tosyloxy piperidine 224 
undergoes ortho-lithiation but is not trapped by the electrophile and therefore 
reprotonated on work-up. As an alternative to N-Boc 4-tosyloxy piperidine 224, N-Boc 
4-sulfonyl piperidine 234 was lithiated with s-BuLi/(−)-sparteine.  This substrate cannot 
undergo ortho-lithiation.  Subsequent trapping with phenylisocyanate gave amide (S,R)-
235  in good yield (84%) but in only 58:42 er (entry 3). In contrast to Beak’s 
observations, we did not see a significant improvement in enantioselectivity of the 
lithiation-trapping when changing the leaving group.  Unfortunately, such low 
enantioselectivity for the lithiation-trapping would not provide significant benefits for 
our chiral amplification protocol. 
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A higher enantioselectivity was required and so a new approach was considered.  We 
postulated that a kinetic resolution of azabicycle 227 could be carried out to give amide 
(S,R)-235 in high enantioselectivity.  This would require one enantiomer of rac-227 to 
be deprotonated faster than the other enantiomer when using 0.5 eq. of a chiral base. 
The required substrate was prepared by lithiation of N-Boc 4-chloro piperidine 223 with 
s-BuLi/TMEDA and quenching with methanol to furnish azabicycle rac-227 in 87% 
yield (Scheme 3.46). 
1. s-BuLi, TMEDA
Et2O,
_78 °C, 1 h
2. MeOH
rac-227, 87%
N
Boc
Cl
N
Boc
223
H
 
Scheme 3.46 
 
Kinetic resolution of azabicycle rac-227 was then attempted by deprotonation with 0.5 
eq. of a chiral base in Et2O at −78 °C for 1 hour (Scheme 3.47, Table 3.7).  
Deprotonation with s-BuLi/(−)-sparteine and trapping with phenylisocyanate gave 
amide (R,S)-235 in 36% yield and 56:44 er (entry 1). Azabicycle (R,S)-227 was also 
isolated in 30% yield and was presumed to be in improved enantiomeric ratio but this 
has not been determined 
1. 0.5 eq. Base, Et2O
_78 °C, 1 h
2. PhNCO
rac-227
N
Boc
N
Boc
O
H
N
Ph
(S,R)-235
N
Boc
(R,S)-227
N
H
(S)-236
H
 
Scheme 3.47 
Table 3.7: Kinetic resolution of rac-227 
Entry Base 
(S,R)-235 (R,S)-227 
Yield  / % er
a
 Yield / % er
a
 
1 s-BuLi/(−)-sparteine 36 56:44 30 nd 
2 n-BuLi/(−)-sparteine 44 56:44 52 nd 
3 n-BuLi/(S)-236
b
 - - 91 nd 
a
er determined by CSP-HPLC, nd – not determined, breaction carried out in THF  
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We hypothesised that due to the acidity of the cyclopropyl proton in rac-227, s-
BuLi/(−)-sparteine was such a strong base that both enantiomers of azabicycle rac-227 
react at a similar rate under the reaction conditions leading to a trapped product with 
low enantiomeric ratio.   By using the less basic n-BuLi/(−)-sparteine we hoped that we 
would see an improvement in enantioselectivity during the kinetic resolution.  
Unfortunately, amide (S,R)-235 was isolated in 44% yield and only 56:44 er from this 
reaction (entry 2).  The pKa of the base was further reduced by using n-BuLi/(S)-227 in 
THF, which is reported to act as a chiral LDA equivalent.
181
  However, treatment of 
azabicycle rac-227 with n-BuLi/(S)-236 did not lead to the formation of the desired 
amide (S,R)-235 and the starting material was recovered in 91% yield (entry 3).  The 
high recovery of rac-227 suggests that the lithium amide base was not strong enough 
deprotonate the cyclopropyl proton. 
 
Undeterred, we hoped that changing the ligand used in the asymmetric lithiation of N-
Boc 4-chloro piperidine 223 would have a positive influence on the enantioselectivity of 
the reaction (Scheme 3.48, Table 3.8).  Lithiation of N-Boc 4-chloro piperidine 223 by 
s-BuLi/(+)-sparteine surrogate 1 and trapping with phenylisocyanate gave amide (R,S)-
235 in good yield (79%) but low enantiomeric ratio (54:46 er) (entry 2).  When the 
deprotonation was mediated by s-BuLi/(S,S)-42, amide (R,S)-235 was isolated in 74% 
yield and an improved 67:33 er (entry 3).  Finally, lithiation of N-Boc 4-chloro 
piperidine 223 using (R,R)-237
182
 as a ligand and trapping with phenylisocyanate gave 
amide (S,R)-235 in 81% yield and 62:38 er (entry 4). 
 
1. s-BuLi, ligand
Et2O,
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Scheme 3.48 
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Table 3.8: Asymmetric lithiation of N-Boc 4-chloro piperidine 223 using s-BuLi/chiral 
ligands and trapping with phenyl isocyanate 
Entry Ligand Yield / % er (S,R):(R,S)
a
 
1 (−)-sparteine 94 56:44 
2 (+)-sparteine surrogate 1 79 46:54 
3 (S,S)-42 74 33:67 
4 (R,R)-237 81 62:38 
a
er determined by CSP-HPLC 
 
The lithiation of N-Boc 4-chloro piperidine 223 with s-BuLi/(S,S)-42 gave the highest 
enantioselectivity that we have been able to achieve (67:33 er). However, we were 
uncertain if this would be significant enough in the chiral amplification protocol to give 
α-amino sulfoxides in ≥99:1 er.  To investigate this, we repeated the lithiation under the 
same conditions and trapped with Andersen’s sulfinate (SS)-97 using the reverse 
addition procedure (Scheme 3.49).  From the reaction, sulfoxide syn-(R,R,Ss)-225 was 
isolated in 12% yield and 89:11 er and sulfoxide anti-(S,S,Rs)-225 was isolated in 54% 
yield and 87:13 er.  Disappointingly, neither diastereoisomer was isolated in 99:1 er. 
 
1. s-BuLi, (S,S)-42
Et2O,
_78 °C, 1 h
2.
S
O
223 S
O
O
(SS)-97
syn-(R,R,Ss)-225
12%, 89:11 er
anti-(S,S,Ss)-225
54%, 87:13 er
N
Boc
Cl
N
Boc
S
O
N
Boc
Reverse Addition
Me
N
N
Me
tBu
tBu
(S,S)-42
Scheme 3.49 
 
The enantioselective lithiation and trapping with Andersen’s sulfinate (SS)-97 allows 
assignment of the absolute configuration of the diastereomeric sulfoxides.  Lithiation of 
N-Boc 4-chloro piperidine 223 with s-BuLi/(S,S)-42 is believed to give organolithium 
reagents (S,S)-226 and (R,R)-226 in 67:33 er which immediately cyclises to give (R,S)-
227 and (S,R)-227 in 67:33 er (Scheme 3.50).  Lithiation of piperidines by s-BuLi/(S,S)-
42 has been shown to occur with opposite enantioselectivity to s-BuLi/(−)-sparteine.42  
Therefore we are able to compare our result with that reported in the literature for the 
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lithiation of N-Boc 4-tosyloxy piperidine 224 by s-BuLi/(−)-sparteine to confirm the 
stereochemistry of (R,S)-227 and (S,R)-227.
41,172
 Subsequent lithiation of (R,S)-227 and 
trapping with inversion
113
 of Andersen’s sulfinate (SS)-97 would give sulfoxide anti-
(S,S,Ss)-225 as the major diastereoisomer. 
s-BuLi, (S,S)-42
1. s-BuLi, (S,S)-42
2. Andersen's
Sulfinate (SS)-97
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O
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Scheme 3.50 
 
We believed there were two possible reasons for our inability to synthesise the major 
diastereomeric sulfoxide anti-(S,S,Ss)-225 in 99:1 er.  First, we thought that the poor 
enantioselectivity of the initial lithiation reaction was causing a reduction in 
enantiomeric ratio of the trapped products.  Second, there may be a match-mismatch 
effect caused by the chiral lithiated intermediate reacting with a chiral electrophile. 
 
Our initial efforts focused upon improving the enantioselectivity of the lithiation-
cyclisation of N-Boc 4-chloro piperidine 223.  In 2007, the groups of Coldham and 
O’Brien reported that the enantioselectivity of lithiation of N-Boc 4-phenyl piperidine 
238 was improved when using 0.65 eq. of s-BuLi.
42
  It was suggested that N-Boc 4-
phenyl piperidine 238 exists as two rotameric species in solution at −78 °C and ring- 
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flipping is not thought to occur at this temperature due to the substituent at C4.  
Furthermore, it is well established in the literature that during the lithiation of N-Boc 
heterocycles only the equatorial proton is removed.
41,148
  Therefore, when effecting a 
deprotonation using s-BuLi and chiral diamines we see a ‘matched’ rotamer and a 
‘mismatched’ rotamer. An example of this is shown in Scheme 3.51.  Deprotonation of 
N-Boc 4-phenyl piperidine 238 with 1.3 eq. of s-BuLi/diamine (S)-240 gave silyl 
piperidine (S,S)-239 in 68% yield and 58:42 er. An improvement in enantioselectivity 
was observed when using 0.65 eq. of s-BuLi/diamine (S)-240 with silyl piperidine (S,S)-
239 being isolated in 24% yield and 63:37 er.  Although the increase in enantiomeric 
ratio is not large, it provides evidence that there is no rotation of the N-Boc group at −78 
°C. 
1. 1.3 eq. s-BuLi, (S)-240
Et2O,
_78 °C, 1 h
2. Me3SiCl
(S,S)-239
68%, 58:42 er
N
Boc
Ph
238
N
Boc
Ph
SiMe3
1. 0.65 eq. s-BuLi, (S)-240
Et2O,
_78 °C, 1 h
2. Me3SiCl
(S,S)-239
24%, 63:37 er
N
Boc
Ph
238
N
Boc
Ph
SiMe3
Me2N NMe2
Ph
(S)-240
 
Scheme 3.51 
 
We hoped that a similar type of kinetic resolution could be carried out for the 
deprotonation of N-Boc 4-chloro and 4-sulfonyl piperidines 223 and 234.  Therefore, 
piperidines 223 and 234 were treated with 1.1 eq. of s-BuLi/chiral diamine at −78 °C 
and trapped with phenylisocyanate (Scheme 3.52).  One equivalent of s-BuLi will 
deprotonate the piperidine and the second will deprotonate the intermediate cyclopropyl 
proton. The results for lithiation with 2.2 eq. and 1.1 eq. s-BuLi/chiral diamine are 
summarised in Table 3.9.  
 
Overall, no improvement in enantiomeric ratio was observed when reducing the amount 
of s-BuLi/chiral diamine to 1.1 eq. when compared with results obtained with 2.2 eq. of 
s-BuLi/chiral diamine.  This is highlighted with the lithiation of N-Boc 4-chloro 
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piperidine 223 with s-BuLi/(−)-sparteine and trapping with phenylisocyanate which 
gave amide (S,R)-235 in 45% yield and 56:44 er (entry 1). This is the same 
enantiomeric ratio as the product isolated previously (entry 2).  A similar result was 
observed with N-Boc 4-sulfonyl piperidine 234 (entries 3 and 4). 
 
1. n eq. s-BuLi, diamine
Et2O,
_78 °C, 1 h
2. PhNCO
N
Boc
X
N
Boc
O
NHPh
(S,R)-235223, X=Cl
234, X=OSO2Ar
Ar =
 
Scheme 3.52 
Table 3.9: Kinetic resolution of 4-substituted piperidines 223 and 234 
Entry n Starting Material Diamine Yield / % er (S,R):(R,S)
a
 
1 1.1 223 (−)-sparteine 45 56:44 
2 2.2 223 (−)-sparteine 93 56:44 
3 1.1 234 (−)-sparteine 42 58:42 
4
 
 2.2 234 (−)-sparteine 84 58:42 
5 1.1 223 (S,S)-42 43 43:57 
6
 
 2.2 223  (S,S)-42 74 33:67 
a
er determined by CSP-HPLC 
 
When effecting the kinetic resolution of N-Boc 4-chloro piperidine 223 using s-
BuLi/(S,S)-42, amide (R,S)-235 was isolated in 43% yield and 57:43 er (entry 5).  The 
reduction in enantiomeric ratio when compared to the standard reaction (67:33 er, entry 
6) is likely to be due to the capricious nature of the lithiation reaction. 
 
Later, it was postulated that by increasing the temperature of the lithiation step the 
rotamers may be able to freely interconvert around the N-CO bond.  This could allow 
the matched rotamer to be lithiated in both high yield and higher enantiomeric ratio than 
the 67:33 er which is exhibited at −78 °C. Therefore, 4-substituted piperidines 223 and 
234 were deprotonated with s-BuLi/(S,S)-42 at −40 and −30 °C (Scheme 3.53 and Table 
3.10).  First, N-Boc 4-chloro piperidine 223 was lithiated with s-BuLi/(S,S)-42 at −30 
°C for 5 minutes and trapping with phenylisocyanate to give amide (R,S)-235 in 52:48 
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er (entry 2).  Disappointingly, there was a reduction in enantiomeric ratio when 
compared to the product of the lithiation-trapping at −78 °C (67:33 er, entry 1).   
 
1. s-BuLi, (S,S)-42
Et2O, temp., time
2. PhNCO
N
Boc
X
N
Boc
O
NHPh
(R,S)-235223, X=Cl
234, X=OSO2Ar
Ar =
 
Scheme 3.53 
Table 3.10: Investigating the temperature effect on the lithiation-cyclisation of 4-
subsituted piperidine 223 and 234 
Entry 
Starting 
Material 
Temp. / °C Time / min Yield / % er
a
 
1 223 −78 60 74 67:33 
2 223 −30 5 74 52:48 
3 223 −40 60 69 67:33 
4 234 −40 60 73 58:42 
a
er determined by CSP-HPLC 
 
By lowering the temperature of lithiation to −40 °C, amide (R,S)-235 was isolated in 
69% yield and 67:33 er (entry 3).  However, this is not an improvement upon the 
enantiomeric ratio observed at −78 °C.  Finally, lithiation of N-Boc 4-sulfonyl 
piperidine 234 at −40 °C and trapping with phenylisocyanate gave amide (R,S)-235 in 
73% yield and 58:42 er (entry 4).  From these results we could conclude that changing 
the temperature does not have a significant effect on the enantioselectivity of the 
reaction. 
 
In an attempt to improve the control of the reaction conditions, we added s-BuLi to 223 
and 234 via syringe pump over 30 minutes (Scheme 3.54, Table 3.11). Unfortunately, 
no improvement in enantiomeric ratio was seen.  Lithiation of N-Boc 4 chloro 
piperidine 223 with s-BuLi/(S,S)-42 at −78 °C gave amide (R,S)-235 in 53% yield and 
59:41 er (entry 1). However at −40 °C, amide (R,S)-235 was isolated in 69% yield and 
67:33 er (entry 2).  Whilst the enantiomeric ratio was better at −40 °C, it is still 
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comparable to that which can be obtained through the standard lithiation-trapping 
procedure. 
 
1. s-BuLi, (S,S)-42
Et2O, temp., time
2. PhNCO
N
Boc
X
N
Boc
O
NHPh
(R,S)-235223, X=Cl
234, X=OSO2Ar
Ar =
s-BuLi added to
SM/Ligand
 
Scheme 3.54 
Table 3.11: Lithiation of 4-substituted piperidines 223 and 234 with slow addition of s-
BuLi and trapping with phenyl isocyanate 
Entry Starting Material Temp. / °C Yield / % er
a
 
1 223 −78 53 59:41 
2 223 −40 69 67:33 
3 234 −78 76 57:43 
4 234 −40 98 58:42 
a
er determined by CSP-HPLC 
 
In a similar fashion, we added a solution of 4-substitued piperidines 223 and 234 via 
syringe pump over 30 minutes to a stirred solution of s-BuLi/chiral diamines (Scheme 
3.55 and Table 3.12).  No improvement in enantiomeric ratio was observed at −78 °C or 
−40 °C.  Indeed, when (S,S)-42 was used as a ligand, amide (R,S)-235 was isolated in 
62:38 er at −78 °C (entry 1) and 60:40 er at −40 °C (entry 2).  Furthermore, changing 
the ligand to (−)-sparteine led to amide (S,R)-235 being isolated in 54:46 er at −78 °C 
(entry 3) and 58:42 er at −40 °C (entry 4).   
 
 
1. s-BuLi, Ligand
Et2O, temp., time
2. PhNCO
N
Boc
X
N
Boc
O
NHPh
(S,R)-235223, X=Cl
234, X=OSO2Ar
SM added to
s-BuLi/Ligand
Ar =
 
Scheme 3.55 
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Table 3.12: Lithiation-of 4-substituted piperidines 223 and 234 with slow addition of 
starting material and trapping with phenyl isocyanate 
Entry 
Starting 
Material 
Ligand Temp. / °C Yield / % er (S,R):(R,S)
a
 
1 223 (S,S)-42 −78 70 38:62 
2 223 (S,S)-42 −40 71 40:60 
3 223 (−)-sparteine −78 68 54:46 
4 223 (−)-sparteine −40 73 58:42 
5 234 (−)-sparteine −78 99 56:44 
a
er determined by CSP-HPLC 
 
Due to the apparently facile lithiation of N-Boc 4-chloro piperidine 223 using s-
BuLi/(−)-sparteine, we postulated that the deprotonation may be effected with n-BuLi.  
Thus, N-Boc 4-chloro piperidine 223 was treated with 2.2 eq. n-BuLi/(−)-sparteine 
followed by addition of phenylisocyanate (Scheme 3.56).  Unfortunately, amide (S,R)-
235 was not evident in the 
1
H NMR spectrum of the crude product and N-Boc 4-chloro 
piperidine 223 was recovered in 97% yield. 
 
1. n-BuLi, (_)-sparteine
Et2O,
_78 °C, 1 h
2. PhNCO
N
Boc
Cl
N
Boc
O
NHPh
(S,R)-235, 0%223
+ 97% RSM
 
Scheme 3.56 
 
To summarise, it was not possible to improve the enantioselectivity in the lithiation-
trapping of N-Boc 4-chloro piperidine 223 and N-Boc 4-sulfonyl piperidine 234.  We 
have also been unable to reproduce Beak’s result with s-BuLi/(−)-sparteine and N-Boc 
4-tosyloxy piperidine 224.  The best enantiomeric ratio achieved so far has been for the 
lithiation of N-Boc 4-chloro piperidine 223 mediated by s-BuLi/(S,S)-42 and trapping 
with phenyl isocyanate (67:33 er). 
 
Next, we wanted to investigate any match/mismatch effect between the chiral lithiated 
intermediates and Andersen’s sulfinate (SS)-97.  The lithiation of N-Boc 4-chloro 
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piperidine 223 using s-BuLi/(S,S)-42 and trapping with Andersen’s sulfinate (SS)-97 had 
previously given disappointing enantioselectivity: sulfoxides syn-(R,R,Ss)-225 and anti-
(S,S,Rs)-225 were isolated in 89:11 er and 87:13 er respectively (see Scheme 3.49).  
Therefore, we wanted to carry out the “diastereomeric reaction” mediated by s-
BuLi/(R,R)-42 and trapping with the same enantiomer of Andersen’s sulfinate (SS)-97. 
To our delight, we were able to isolate sulfoxide syn-(R,R,Ss)-225 in 51% yield and 99:1 
er together with anti-(S,S,Rs)-225 in 25% yield and 87:13 er (Scheme 3.57).   
 
1. s-BuLi, (R,R)-42
Et2O,
_78 °C, 1 h
2.
S
O
223 S
O
O
(SS)-97
syn-(R,R,Ss)-225
51%, 99:1 er
anti-(S,S,Ss)-225
25%, 87:13 er
N
Boc
Cl
N
Boc
S
O
N
Boc
Reverse Addition
Me
N
N
Me
tBu
tBu
(R,R)-42
Scheme 3.57 
 
To understand this match/mismatch effect, the mechanism which accounts for the 
reduction of enantiomeric ratio of the products needs to be considered.  As we have 
previously shown for O-alkyl carbamate 14 (see Scheme 2.17), a reduction in 
enantiomeric ratio is caused by attack of the lithiated intermediate on the forming 
sulfoxide products causing a second inversion at sulfur to take place.  Based on the 
inherent enantioselectivity of this reaction (67:33 er determined by lithiation-trapping 
with phenylisocyanate, see Scheme 3.48), lithiation-cyclisation of N-Boc 4-chloro 
piperidine 223 mediated by s-BuLi/(R,R)-42 will give diastereomeric lithiated 
intermediates 228 in a 67:33 ratio (Scheme 3.58).  The lithiated intermediates are then 
trapped by Andersen’s sulfinate (SS)-97 with inversion at sulfur to give sulfoxides syn-
(R,R,SS)-225 and anti-(S,S,RS)-225.  Due to the electrophilicity of these products, the 
lithiated intermediates 228 and 228 can attack the sulfoxide moiety, with inversion at 
sulfur, to give enantiomeric sulfoxides syn-(S,S,RS)-225 and anti-(R,R,SS)-225.   
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N
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N
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N
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N
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N
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O
N
Boc
syn-(S,S,Rs)-225 anti-(R,R,Rs)-225
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Scheme 3.58 
 
When the enantiomeric ligand (S,S)-42 is used for the lithiation-trapping process, a 
“diastereomeric reaction” occurs.  For example, consider the minor lithiated species in 
the reaction with the major sulfoxide product formed in each case (Scheme 3.59).  For 
the lithiation mediated by s-BuLi/(R,R)-42, lithiated intermediate 228 reacts with 
sulfoxide syn-(R,R,SS)-225 slowly to give sulfoxide syn-(S,S,RS)-225.  When the 
lithiation is mediated by (S,S)-42 the minor lithiated intermediate is now ent-228 which 
quickly reacts with sulfoxide anti-(S,S,SS)-225 to give anti-(R,R,RS)-225.  The key 
difference is that the major sulfoxides formed in each reaction have the same 
configuration at sulfur, but the lithiated intermediates are enantiomeric.  This gives rise 
to diastereomeric transition states which result in differing rates of reaction.  
Experimental evidence would suggest that the reaction of ent-228 with sulfoxide anti-
(S,S,SS)-225 is a more facile process.  Thus, a greater loss of stereospecificity in the 
trapping reaction is observed. 
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Scheme 3.59 
 
Finally, the lithiation was conducted using (−)-sparteine and (+)-sparteine surrogate 1 
and then trapped with Andersen’s sulfinate (SS)-97 (Scheme 3.60). From the reaction 
mediated by (−)-sparteine, sulfoxide syn-(R,R,SS)-225 was isolated in 27% yield and 
96:4 er and sulfoxide anti-(S,S,SS)-225 was isolated in 24% yield and 89:11 er.  Use of 
(+)-sparteine surrogate 1 gave sulfoxide syn-(R,R,SS)-225 in 26% yield and 99:1 er and 
sulfoxide anti-(S,S,SS)-225 in 27% yield and 93:7 er.  To our surprise the predicted 
minor diastereoisomer from this reaction gave the higher enantiomeric ratio.  However, 
we propose that this is because of a ‘matched’ effect similar to that observed with 
diamine (R,R)-42.  The poor diastereoselectivity in both of these reactions is due to the 
poor enantioselectivity of the initial lithiation-cyclisation reaction (ca. 56:44 er, see 
Scheme 3.49). 
 
1. s-BuLi, diamine
Et2O,
_78 °C, 1 h
2.
S
O
223 S
O
O
(SS)-97
(_)-sp: 27%, 96:4 er
1: 26%, 99:1 er
(_)-sp: 24%, 89:11 er
1: 27%, 93:7 er
N
Boc
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N
Boc
S
O
N
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ant i-(S,S,Ss)-225syn-(R,R,Ss)-225
N
N
H
H
(_)-sparteine
N
N
H
(+)-Sparteine
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Scheme 3.60 
 
To conclude, we have been able to synthesise syn-(R,R,SS)-225 in 99:1 er by the 
lithiation-trapping of N-Boc 4-chloro piperidine 223 with Andersen’s sulfinate (SS)-225.  
Despite the low enantioselectivity (67:33 er) of the initial lithiation-cyclisation, we were 
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able to utilise a matched effect between diamine (R,R)-42 and Andersen’s sulfinate to 
increase the stereochemical fidelity within the reaction.  Unfortunately, diastereomeric 
sulfoxide anti-(S,S,SS)-225 could not be synthesised in 99:1 er.  This was due to a 
mismatch effect between diamine (S,S)-42 and Andersen’s sulfinate (SS)-97 which 
caused an erosion in enantiomeric ratio at sulfur within the trapping reaction.  Sulfoxide 
syn-(S,S,RS)-225 could be synthesised in 99:1 er by lithiation of N-Boc 4-chloro 
piperidine 223 mediated by s-BuLi/(S,S)-42 and trapping with ent-Andersen’s sulfinate 
(RS)-97.  Enantiomeric sulfoxides syn-(R,R,SS)-225 and syn-(S,S,RS)-225 would then 
allow access to α-amino Grignard reagents in both enantiomeric series via sulfoxide → 
magnesium exchange.  Significantly, we do not need to use (−)-sparteine to generate N-
Boc amino sulfoxide syn-(R,R,SS)-225 in 99:1 er. 
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3.5 Sulfoxide → Magnesium Exchange  
Our next goal was to synthesise α-amino Grignard reagent (R,R)-240 in 99:1 er from 
sulfoxide syn-(R,R,SS)-225. It was hoped that sulfoxide → magnesium exchange would 
prove to be an efficient method of accessing a range of 2-subsitited products as single 
enantiomers (Scheme 3.61). 
S
O
N
Boc
syn-(R,R,Ss)-225
MgClN
Boc
i-PrMgCl
THF, rt, 1 min
E+
(R,R)-240
EN
Boc
 
Scheme 3.61 
 
3.5.1 Sulfoxide → Magnesium Exchange Reactions 
 
We began our investigation by using sulfoxide → magnesium exchange conditions 
previously optimised for α-alkoxy sulfoxides anti-(S,Ss)-103 and syn-(R,Ss)-103 (i-
PrMgCl, THF, rt, 1 min, see Scheme 2.26, Table 2.3).  Thus, sulfoxide syn-(R,R,SS)-225 
was treated with i-PrMgCl to form Grignard reagent (R,R)-240 and then electrophiles 
were added (Scheme 3.62).  Trapping with methyl chloroformate gave ester (S,R)-241 
in 89% yield and 99:1 er and trapping with phenylisocyanate gave amide (S,R)-235 in 
67% yield and 99:1 er.  All racemic compounds were prepared from syn-rac-225 and 
separated by CSP-HPLC 
 
S
O
N
Boc
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Boc
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THF, rt, 1 min
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(R,R)-240
N
Boc
O
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N
Boc
O
NHPh
(S,R)-241
89%, 99:1 er
E+= MeOCOCl
(S,R)-235
67%, 99:1 er
E+= PhCHO
 
Scheme 3.62 
 
We also trapped Grignard reagent (R,R)-240 with allyl bromide and benzyl bromide 
(Scheme 3.63).  Use of catalytic CuBr.SMe2 in both cases gave access to alkene (S,R)-
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230 and (R,R)-242 respectively, with both being isolated in good yields and 99:1 er.  If 
CuBr.SMe2 is absent from the trapping procedure then lower yields are observed. 
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Scheme 3.63 
 
Grignard reagent (R,R)-240, formed by sulfoxide → magnesium exchange from syn-
(R,R,SS)-225, was also coupled to aryl bromides (Scheme 3.64).  This process proceeds 
via transmetallation to zinc and palladium-mediated Negishi coupling in similar fashion 
to that developed for α-lithiated N-Boc pyrrolidine by Campos and co-workers.39,40  In 
this way, a series of arylated heterocycles (S,R)-243-246 were generated in good yields 
and 99:1 er.  During the course of this thesis, Bull et al. reported a similar 
transmetallation-Negishi reaction of Grignard reagents formed by sulfoxide → 
magnesium exchange (see Scheme 1.46).
98
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Scheme 3.64 
 
3.5.2 Proof of Stereochemistry and Formal Synthesis of Saxagliptin 
 
We wanted to prove the absolute stereochemistry of sulfoxide syn-(R,R,SS)-225. A 
number of attempts to grow crystals of sulfoxides syn-(R,R,SS)-225 and anti-(S,SS)-225 
for X-ray diffraction proved unsuccessful.  In addition, endeavours were made to 
synthesise a number of derivatives of syn-(R,R,SS)-225 (Scheme 3.65).  Unfortunately, 
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the syntheses of nitrobenzylamine 247 and p-bromobenzamide 248 were unsuccessful 
and all attempts to grow crystals of picrate salt 249 were fruitless.  
S
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syn-(R,R,Ss)-225
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O2N
S
O
N
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O
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Scheme 3.65 
 
Therefore, we planned to convert sulfoxide syn-(R,R,SS)-225 into known alcohol cis-
253.
183
  Alcohols cis-253 and trans-253 are reported in the literature although no 
characterisation data is available.  However, Professor Hanessian kindly supplied full 
data for each compound for comparison.
184
  In addition, synthesis of alcohol cis-253 
would also constitute a formal synthesis of the oral hypoglycaemic drug, 
saxagliptin.
176,177,185
  Saxagliptin was first developed by Bristol-Myers-Squibb in 2004 
and later brought to market in collaboration with AstraZeneca under the brand name 
Onglyza in 2009.  The reported synthesis of saxagliptin concludes with a late-stage 
amide coupling of commerically available amino acid (S)-251 to amine cis-250.
177
  
Amine cis-250 was synthesised from N-Boc amide cis-252 via amide dehydration and 
Boc deprotection.
176
  Finally, amide cis-252 can be synthesised in two steps from 
alcohol cis-253 (Scheme 3.66).  
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Scheme 3.66 
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Our planned synthesis of alcohol cis-253 is shown in Scheme 3.67.  It was envisaged 
that the synthesis would begin by reduction of sulfoxide syn-(R,R,SS)-225 to give sulfide 
(R,R)-254.  The next step would be a diastereoselective lithiation-trapping with carbon 
dioxide.  It was hoped that the sulfide moiety would provide suitable protection of the 
acidic cyclopropyl position.  Moreover, if the substrate-controlled lithiation did not give 
a cis-selective lithiation, a chiral ligand could be used to direct the lithiation to the 
desired product.
29
  Then, reduction of the carboxylic acid would give alcohol cis-255 
and reductive cleavage of the sulfide would complete the synthesis of alcohol cis-253. 
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Scheme 3.67 
 
First, we attempted the reduction of sulfoxide syn-(R,R,SS)-225.  A number of 
conditions were explored but they returned quantitative amounts of unreacted starting 
material (RhCl(PPh3)3/catechol borane,
186
  or sodium borohydride/iodine
187
) or a 
complex mixture of unidentified products  (BF3.Et2O/sodium iodide
188
 or triflic 
anhydride/potassium iodide
189
).  To our delight, reduction of sulfoxide syn-(R,R,SS)-225 
using trifluoroacetic anhydride/sodium iodide (acetone, −40 °C, 10 minutes190,191) gave 
sulfide (R,R)-254 in 99% yield (Scheme 3.68). 
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N
Boc
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syn-(R,R,Ss)-225 (R,R)-254, 99%  
Scheme 3.68 
 
Next, we investigated the diastereoselective lithiation-trapping reaction.  Beak and co-
workers have reported that α-lithiation of 2-substituted piperidines occurred in the 6-
position with almost exclusively trans-diastereoselectivity.
148,192
  This is due to the 2-
substituent preferably occupying an axial position in order to minimise steric interaction 
with the Boc group.  Thus, subsequent equatorial lithiation
41,148
 gives the trans-product.  
Whilst this effect is not as prevalent in 2-subituted pyrrolidines,
148
 we postulated that a 
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similar situation could occur for the lithiation of (R,R)-254 due to configurational 
constraints of the fused cyclopropyl ring (Scheme 3.69). 
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In addition, sulfide (R,R)-254 has the potential to exist in two rotameric forms (Figure 
3.8). The Boc carbonyl group is known to direct the lithiation of N-Boc heterocycles
22
 
and therefore in unsymmetrical systems the rotameric forms would give different 
lithiation regioisomers.  This phenomenon was observed in the lithiation of N-Boc 2-
phenyl pyrrolidine.
193
  In the case of sulfide (R,R)-254, rotamer A would be unreactive 
as there are no α-protons whereas rotamer B would direct lithiation to the required α-
position.  Therefore, a low yield in the lithiation-trapping of sulfide (R,R)-254 could be 
indicative of slow interconversion of the rotameric species at −78 °C. 
 
SN
(R,R)-254
Ot-BuO
SN
Ot -BuO
HH
H H
(R,R)-254
Unreactive Rotamer A Reactive Rotamer B  
Figure 3.8 
 
We began our investigation by undertaking the substrate-directed lithiation of sulfide 
(R,R)-254 using s-BuLi/TMEDA in Et2O at −78 °C for 10 minutes.  Trapping with 
carbon dioxide and subsequent reduction of crude acid 256 with BH3.SMe2 gave alcohol 
cis-255 in 65% yield and trans-255 in 26% yield (Scheme 3.70).  The 
1
H NMR 
spectrum of the crude intermediate acid 256 showed a moderate diastereoselectivity of 
68:32 dr.  Unfortunately, the diastereomeric ratio of alcohols cis-255 and trans-255 
could not be calculated from the 
1
H NMR spectrum of the crude product due to 
overlapping signals.  The high yield from this reaction sequence (91% total yield over 
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two steps) indicates that sulfide (R,R)-254 either exists solely as reactive rotamer B or 
the rotamers are able to rapidly interconvert at −78 °C.  The relative stereochemistry 
was established by conversion of cis-255 into known
183,184
 cis-253 as outlined below 
(see Scheme 3.72). 
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Scheme 3.70 
 
The diastereoselectivity was improved by carrying out a ligand-directed lithiation, an 
approach which has previously been used in our group for the synthesis of 2,5-
substituted pyrrolidines.
29
  Use of s-BuLi/(+)-sparteine surrogate 1 to mediate the 
lithiation of (R,R)-254 and trapping with carbon dioxide gave acid 256 in 92:8 dr 
(Scheme 3.71).  After borane reduction, cis-255 was isolated as the only product in 84% 
yield over the two steps; diastereomeric alcohol trans-255 was not isolated after flash 
column chromatography. 
 
N
Boc
HO
O
N
Boc
S
pTol
S
pTolBH3.SMe2
THF, 67 °C, 1 h
256, 92:8 dr cis-255, 88%
N
Boc
S
pTol
1. s-BuLi, (+)-sp sur 1
Et2O,
_78 °C, 5 min
2. CO2
(R,R)-254
OH
 
Scheme 3.71 
 
Finally, reductive cleavage (Raney-nickel
®
, THF-EtOH, rt, 5 hours) of the sulfide 
moiety gave known
183,184
 alcohol cis-253 in 73% yield (Scheme 3.72).  Comparison of 
key diagnostic signals in the 
1H NMR spectrum (δH 2.46, dddd, J = 13.5, 11.0, 6.5, 1.0 
Hz, 1H, CH) and 
13C NMR spectrum (δC 54.5, CH2OH and 38.8, NCH) to those 
provided by Professor Hanessian allowed assignment of the relative configuration of 
alcohol cis-253.
184
 The spectroscopic data for trans-253 was also provided which 
confirmed that the other diastereomer was not formed.  In addition, the absolute 
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configuration was assigned by comparison of optical rotation: our sample had [α]D +6.6 
(c 0.5 in CHCl3) whereas Hanessian’s sample had [α]D +12.0 (c 0.75 in CHCl3).
184
 
 
N
Boc
S
pTol
cis-255
OH
Raney-Ni
THF-EtOH, rt, 5 h
N
BocOH
cis-253, 73%  
Scheme 3.72 
 
The synthesis of cis-253 allows assignment of each of the compounds in each of the 
synthetic sequence.  Importantly, this allows confirmation of the absolute 
stereochemistry of the core of sulfoxide syn-(R,R,SS)-225 and, coupled with our 
rationale for the sulfoxide configuration (see Scheme 3.50), we can be confident of the 
absolute stereochemical assignment.  In addition, the stereochemistry of all products 
reported in this Chapter formed by sulfoxide → magnesium exchange from sulfoxide 
syn-(R,R,SS)-225 can be assigned. 
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3.6 Conclusions and Future Work 
The synthesis of a number of α-amino sulfoxides has been attempted.  Pyrrolidinyl 
sulfoxides anti-(S,SS)-148 and syn-(R,SS)-148 and piperidinyl sulfoxides anti-(S,SS)-149 
and syn-(R,SS)-149 could not be formed by either lithiation-trapping or oxidation of α-
amino sulfides (Figure 3.9).  We believe that this is due to decomposition of the α-
amino sulfoxides either by cycloreversion or by α-elimination by the nitrogen lone pair. 
N
Boc
S
O
pTol
H
S
O
pTol
N
Boc
H
ant i-(S,SS)-148
N
Boc
S
O
pTol
H
syn-(R,SS)-148
S
O
pTol
N
Boc
H
ant i-(S,SS)-149 syn-(R,SS)-149  
Figure 3.9 
 
N-Thiopivaloyl azetidine sulfoxide 192 was synthesised but the yield of the reaction 
was disappointing. In addition, acyclic amido sulfoxide 193 and thioamide sulfoxide 
194 were successfully isolated.  Their synthesis involved a late-stage oxidation by 
mCPBA.  In addition, acyclic N-Boc dimethylamine sulfoxide 196 was isolated from 
the lithiation-trapping of N-Boc dimethyl amine 222.  This was the first example of a 
stable compound containing the N-Boc α-sulfinyl motif (Figure 3.10). 
 
N
Boc
S
196
O
N
X
Ph
OMe
S
ON
S
S
O
H
192 193, X = O
194, X = S  
Figure 3.10 
 
We then designed an α-substituted system in which sulfoxide elimination was 
prohibited.  Indeed, bicyclic sulfoxide syn-(R,R,SS)-225 was synthesised in 99:1 er by 
lithiation of N-Boc 4-chloro piperidine 223 using s-BuLi/(R,R)-42 and trapping with 
Andersen’s sulfinate (SS)-97 (Figure 3.11).  Unfortunately, lithiation of N-Boc 4-chloro 
piperidine 223 using s-BuLi/(R,R)-42 and trapping with Andersen’s sulfinate (SS)-97 
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did not lead to the isolation of sulfoxide anti-(S,S,SS)-225 as the major diastereomer in 
99:1 er. 
N
Boc
S
pTol
O
syn-(R,R,Ss)-225  
Figure 3.11 
 
Subsequently, a sulfoxide → magnesium exchange protocol was successfully developed 
for bicyclic sulfoxide syn-(R,R,SS)-225 allowing α-amino Grignard reagent (R,R)-240 to 
be formed in 99:1 er.  These Grignard reagents were then trapped with an array of 
electrophiles to give products as single enantiomers.  As an example, ester (S,R)-241 
was isolated in 45% yield and 99:1 er over two steps from N-Boc 4-chloro piperidine 
223 (Scheme 3.73)  In addition, a transmetallation-Negishi coupling protocol was 
developed allowing α-arylated products to be isolated in good yields and in 99:1 er.  
Sulfoxide syn-(R,R,SS)-225 was also transformed into alcohol cis-253 which constituted 
a formal synthesis of saxagliptin. 
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51%, 99:1 er
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O
OMe
THF, rt,
1 min,
then MeOCOCl
i-PrMgCl
(S,R)-241, 89%
1. s-BuLi, (R,R)-42
Et2O,
_78 °C, 1 h
2.
223 S
O
O
(SS)-97
45% over two steps
99:1 er
N
Boc
Cl
 
Scheme 3.73 
 
Future work should synthesise enantiomeric bicyclic sulfoxide syn-(S,S,RS)-225.  
Lithiation of N-Boc 4-chloro piperidine 223 using s-BuLi/(S,S)-42 and trapping with 
ent-Andersen’s sulfinate (RS)-97 (Scheme 3.74) would give sulfoxide syn-(S,S,RS)-225 
in 99:1 er.  Sulfoxide → magnesium of sulfoxide syn-(S,S,RS)-225 would then give 
Grignard (S,S)-240 in 99:1 er. 
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1. s-BuLi, (S,S)-42
Et2O,
_78 °C, 1 h
2.
S
O
223 S
O
O
(RS)-97
syn-(S,S,RS)-225 anti-(R,R,RS)-225
N
Boc
Cl
N
Boc
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O
N
Boc
Reverse Addition
Me
N
N
Me
tBu
tBu
(S,S)-42
 
Scheme 3.74 
 
Finally, we still harbour ambitions to synthesise a number of other cyclic α-amino 
sulfoxides.  However, as the mechanism by which decomposition of α-amino sulfoxides 
occurs is still unknown, initial studies should focus on further elucidating this 
mechanism. 
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Chapter Four: Synthesis of N-Thiopivaloyl Azetidine 
Organolithium Reagents 
 
An expedient method of synthesising α-substituted azetidines is by lithiation-trapping of 
N-thiopivaloyl azetidine 101 using chiral organolithium bases (Scheme 4.1).  However, 
until now, only one example of the asymmetric lithiation-trapping of N-thiopivaloyl 
azetidine 101 has been reported and the mechanism of enantiocontrol remained 
uncertain.
102
  
N
S
101
N
S
Li
Et2O,
_78 °C
s-BuLi, Chiral Diamine E+
N
S
E
257  
Scheme 4.1 
 
Our objective was to study the asymmetric lithiation-trapping of N-thiopivaloyl 
azetidine 101 using s-BuLi and chiral diamines with a view to establishing the 
mechanism by which the enantioselectivity of the products is determined.  To do this, 
the configurational stability of the lithiated intermediate 257 would need to be 
investigated and the electrophilic scope would need to be broadened.  Furthermore, 
comparisons to N-thiopivaloyl pyrrolidine 210 will be made. 
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4.1 Lithiation-Trapping of N-Thiopivaloyl Azetidines 
As well as their appearance in a number of pharmaceutical products,
194-196
 α-substituted 
azetidines are found in a number of natural products.  For example, an 
antithrombotic,
197
 mugineic acid,
198
 peneazetidine A,
199
 and calydaphinone
200
 all 
contain an α-substituted azetidine and are shown in Figure 4.1. 
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COOH
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Figure 4.1 
 
Azetidines have typically been synthesised by cyclisation of amine nucleophiles onto an 
appropriate electrophilic site and these methods have been reviewed in detail by Brandi 
et al.
101
  More recently, lithiation-trapping of N-thiopivaloyl azetidines has provided an 
expedient route to α-substituted azetidines. 
 
4.1.1 Racemic Lithiation-Trapping of N-Thiopivaloyl Azetidines 
 
In 2010, Hodgson and Kloesges reported the first lithiation-trapping of N-thiopivaloyl 
azetidine 101.
102
  Interestingly, the rarely-studied N-thiopivalamide group was essential 
for high yielding α-lithiation-trapping.  Prior to 2010, there is only one reported 
example of successfully using the thiopivaloyl group to direct lithiation α to nitrogen.  
Seebach and Lubosch carried out the s-BuLi/TMEDA-mediated lithiation of N,N-
dimethyl thiopivalamide 258.  Subsequent trapping with a range of electrophiles gave α-
substituted products in 17-82% yield.  Selected examples are shown in Scheme 
4.2.
201,202
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N
S 2. Electrophile (E
+)
1. s-BuLi, TMEDA
THF, _78 °C, 30 min
258
N
S
E
N
S
N
S
4
N
S
Ph
OH
N
S
OH
Ph
Ph
260, 69%
E+ = n-C5H11I
259, 65%
E+ = MeI
261, 78%
E+ = PhCHO
262, 63%
E+ = Ph2CO  
Scheme 4.2 
 
Seebach and co-workers subsequently reported that attempts to use the thiopivalamide 
directing group in the lithiation-trapping of 11 other acyclic and cyclic N-
thopivalamides (including that derived from piperidine) were unsuccessful.
203
  This lack 
of versatility may indicate why the thiopivaloyl group has not been more widely 
adopted.  Furthermore, removal of the thiopivaloyl group can require relatively harsh 
conditions. In 1980, Seebach and Lubosch reported three methods for removing the 
thioamide functionality.
203
 In the first method, addition of methyl fluorosulfonate to 
aniline derived N-thiopivalamide 263 gave a 3:2 mixture of (E)-264 and (Z)-264 in 
quantitative yield.  The mixture was then treated with sodium borohydride and basic-
work up gave amine 265 in 58% yield (Scheme 4.3).  Unfortunately, using this method 
to deprotect products from the lithiation-trapping of N,N-dimethyl thiopivalamide 258 
was unsuccessful.  This may indicate that aniline moiety is essential for the deprotection 
to proceed smoothly. 
N
S CH2Cl2, rt, 1.5 h
263
Ph
MeOSO2F
N
PhMeS
N
MeS
Ph
(Z)-264
(E)-264
1. NaBH4, H2O, DMF,
MeOH, rt, 1h
2. NaOH(aq)
N
H
Ph
265, 58%
 
Scheme 4.3 
 
The second procedure offers a more versatile method for the removal of the thioamide 
group, as shown by the deprotection of benzophenone-trapped product 262 (Scheme 
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4.4).  Ethylene diamine was added to hydroxy thioamide 262 and heated at reflux. After 
cooling to room temperature, hydrochloric acid was added and basic work-up gave 
hydroxy amine 266 in 75% yield. 
N
S
262
1.H2NCH2CH2NH2
OH
Ph
Ph
N
H
266, 75%
OH
Ph
Ph
2. HCl
3. NaOH(aq)
 
Scheme 4.4 
 
Finally, hydroxy thioamide 262 can also be deprotected using an excess of MeLi to 
afford hydroxy amine 266 in 80% yield (Scheme 4.5). These are also the conditions 
preferred by Hodgson and Kloesges.
102
  Presumably, this deprotection proceeds via 
nucleophilic attack at the carbonyl of the thioamide group. 
 
N
S
262
1. 5 eq. MeLi, THF,
0 °C, 5 h
OH
Ph
Ph
N
H
266, 80%
OH
Ph
Ph
2. HCl, H2O
3. NaOH
 
Scheme 4.5 
 
Despite the limitations of using the N-thiopivalamide protecting group to direct α-
lithiation-trapping, Hodgson and Kloesges found that it gave the best results on the 
azetidine system.
102
  Initial attempts to use more common protecting groups gave 
disappointing results (Figure 4.2).  For example, lithiation of N-Boc azetidine 267 with 
either lithium amides or s-BuLi (both with and without TMEDA) gave no reaction and 
N-tert-butylsulfonyl azetidine 268 and N-diethylphosphonyl azetidine 269 similarly 
resisted lithiation under a variety of conditions.  Furthermore, N-sulfinylazetidine 270 
decomposed under lithiation conditions. 
 
N
Boc
N N
S
O
O
P
OEtO
EtO
267 268 269
N
S
270
O
 
Figure 4.2 
 
Conversely, lithiation of N-thiopivaloylazetidine 101 using s-BuLi/TMEDA in THF at 
−78 °C for 30 minutes and subsequent electrophilic trapping gave α-substituted 
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azetidines rac-102, 271-275 in 83-94% yield (Scheme 4.6).  The reaction tolerated a 
wide range of electrophiles, including alkyl halides, aldehydes, ketones, trimethylsilyl 
chloride and trimethyltin chloride.   Interestingly, the product of lithiation and trapping 
with benzaldehyde, alcohol syn-rac-273, was reported to be isolated as a single 
diastereoisomer.  
N
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1. 1.2 eq. s-BuLi, 2.4 eq. TMEDA
THF, _78 °C, 30 min
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rac-274, 94%
E+ = Ph2CO
N
S
SnMe3
N
S
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rac-272, 86%
E+ =Me3SnCl
rac-275, 83%
E+ = BuBr
Scheme 4.6 
 
More recently, Hodgson and co-workers have reported the lithiation-trapping of N-
thiopivaloyl azetidin-3-ol 276.
204
  Lithiation of 276 mediated by 3 eq. s-BuLi/6 eq. 
TMEDA in THF at −78 °C for 30 minutes and trapping with electrophiles gave 2,3 
substituted azetidines rac-277-281 exclusively as the trans-diastereoisomer, with the 
exception of the methyl iodide trapped product rac-278 which had a trans:cis ratio of 
69:31.  Selected results are shown in Scheme 4.7.  This reaction proceeds by 
deprotonation of the hydroxyl moiety before α-lithiation-trapping. 
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Scheme 4.7 
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In contrast to lithiation-trapping with electrophiles, lithiation-deuteriation occurs 
predominantly cis to the hydroxyl group.  Lithiation of N-thiopivaloyl azetidin-3-ol 276 
using 3 eq. s-BuLi/6 eq. TMEDA and addition of MeOD gave cis-282 as a 90:10 
mixture of diastereoisomers (Scheme 4.8).  Further mechanistic study showed that the 
stereochemical outcome of the lithiation-trapping or lithiation-deuteriation is 
independent of which α-proton is removed (cis or trans to the hydroxyl group).  
Electrophiles were shown to have a preference for trans-products and protonation 
occurs with cis-selectivity. 
 
N
S
2. MeOD
1. 3 eq. s-BuLi, 6 eq. TMEDA
THF, _78 °C, 30 min
276
N
S
D
OH OH
cis-282, 90:10 dr
100% D  
Scheme 4.8 
 
 
4.1.2 Asymmetric Lithiation-Trapping of N-Thiopivaloyl Azetidines 
 
There is only one example of an asymmetric lithiation-trapping of N-thiopivaloyl 
azetidine 101 reported in the literature. Hodgson and Kloesges screened four ligands 
and different conditions in order to optimise the asymmetric lithiation and trapping with 
methyl iodide to give enantioenriched methylated azetidine (R)-102 or (S)-102.
102
 The 
stereochemical control for each ligand during the lithiation-trapping is summarised in 
Scheme 4.9 and Table 4.1.  First, the use of (−)-sparteine in Et2O gave (R)-102 in 61:39 
er (entry 1) and changing the solvent to hexane gave (R)-102 in 72:28 er (entry 2).  Use 
of alkoxy amine 283 as the ligand in hexane gave (S)-102 in a disappointing 54:46 er 
(entry 3).  The use of alkoxy diamine 64 gave (S)-102 in 63:37 er (entry 4) and, finally, 
Alexakis diamine
129
 (R,R)-42 gave (R)-102 in 80:20 er (entry 5). 
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Scheme 4.9 
Table 4.1: Asymmetric lithiation-trapping of N-thiopivaloyl azetidine 101 
Entry Ligand Solvent er (R:S) Conversion  (102:101)
a
 
1 (−)-sparteine Et2O 61:39 99:1 
2 (−)-sparteine Hexane 72:28 99:1 
3 283 Hexane 46:54 97:3 
4 64 Et2O 37:63 78:22 
5 (R,R)-42 Et2O 80:20 96
b
 
a
Conversion determined by GC, 
b
Yield of isolated (R)-102 after column 
chromatography 
 
To our surprise, lithiation and trapping proceeded with the opposite sense of induction 
to that observed for the asymmetric lithiation-trapping of a number of N-Boc 
heterocycles.
38,41,136,205
  Scheme 4.10 shows a comparison between the lithiation-
trapping of N-Boc pyrrolidine 39 and N-thiopivaloyl azetidine 101 using s-BuLi and 
diamine (R,R)-42.  Lithiation of N-Boc pyrrolidine 39 using s-BuLi/diamine (R,R)-42 in 
Et2O at −78 °C gave intermediate organolithium (S)-40.(R,R)-42.  Subsequent trapping 
with trimethylsilyl chloride gave (S)-41 in 72% yield and 95:5 er.
29
  Organolithium (S)-
40 has been previously shown to be configurationally stable at −78 °C and an 
enantioselective deprotonation was responsible for the enantioselectivity observed in the 
product (see Chapter 1.1.1).
38,206
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H H
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257.(R,R)-42
 
Scheme 4.10 
 
In contrast, lithiation of N-thiopivaloyl azetidine 101 using s-BuLi/(R,R)-42 and 
trapping with methyl iodide gave (R)-102 in 96% yield and 80:20 er.  The 
configurational stability of organolithium 257.(R,R)-42 at −78 °C is unknown and, 
therefore, the mechanism by which enantiocontrol arises cannot be determined.   
Hodgson and Kloesges offered no explanation for the differing enantio-induction 
between the systems. 
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4.2 Asymmetric Lithiation-Trapping of N-Thiopivaloyl Azetidine 101 
Our objective in this project was to determine the mechanism for the asymmetric 
lithiation-trapping of N-thiopivaloyl azetidine 101.  An introduction to each of the three 
mechanisms (enantioselective deprotonation, dynamic kinetic resolution and dynamic 
thermodynamic resolution) was presented in Chapter 1.1. 
 
Due to the opposite sense of induction being observed in the lithiation-trapping of N-
thiopivaloyl azetidine 101 when compared to N-Boc heterocycles with the same ligand, 
it seemed unlikely that an enantioselective deprotonation was occurring.  However, we 
initially considered that there were five possible scenarios that could explain this 
difference in selectivity. 
 
1. An enantioselective deprotonation occurs at −78 °C to give an 80:20 mixture of 
diastereomeric lithiated intermediates (R)-257.(R,R)-42  and (S)-257.(R,R)-42.  The 
lithiated intermediates are configurationally stable at −78 °C (Scheme 4.11).  
However, the sense of induction of the enantioselective deprotonation was opposite 
to that observed N-Boc pyrrolidine 39 due to conformational changes associated 
with a reduction in ring size.  Alternatively, the sense of induction could be reversed 
due to the use of N-thiopivaloyl group rather than N-Boc for directing the lithiation. 
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Li.(R,R)-42
MeI
N
S
H
(R)-102
N
S
101
s-BuLi, (R,R)-42 80
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Scheme 4.11 
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2. An enantioselective deprotonation occurs at −78 °C and proceeds with the same 
sense of induction to that observed with N-Boc pyrrolidine 39.  This would form an 
80:20 mixture of diastereomeric lithiated intermediates, (S)-257.(R,R)-42  and (R)-
257.(R,R)-42, which are configurationally stable at −78 °C.  Trapping with methyl 
iodide then proceeds with inversion of configuration at −78 °C to give (R)-102 in 
80:20 er (Scheme 4.12). This process usually requires stabilised (e.g. benzylic or 
allylic) organolithium reagents.
23,207
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Scheme 4.12 
 
3. An enantioselective deprotonation occurs at −78 °C to give an unknown mixture of 
diastereomeric lithiated intermediates, (S)-257.(R,R)-42 and (R)-257.(R,R)-42, 
which are configurationally stable at −78 °C.  Methyl iodide does not react with the 
organolithium reagents at −78 °C but instead the reaction is allowed to warm up to a 
temperature where the lithiated intermediates may interconvert.  A dynamic kinetic 
resolution then takes place at this elevated temperature whereby, methyl iodide then 
reacts preferentially with (R)-257.(R,R)-42 (Scheme 4.13).  A similar phenomenon 
was responsible for the loss of enantiomeric ratio when lithiated N-Boc piperidine 
was trapped with methyl iodide.
43
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Scheme 4.13 
 
4. The lithiated intermediates are configurationally unstable at −78 °C and, as a result, 
the sense of induction does not arise from an enantioselective deprotonation.  
Instead, a dynamic kinetic resolution is taking place.  Methyl iodide preferentially 
reacts with (R)-257.(R,R)-42 to give (R)-102 in 80:20 er (Scheme 4.14). 
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Scheme 4.14 
 
5. The lithiated intermediates are configurationally unstable at −78 °C and a dynamic 
thermodynamic resolution process accounts for the enantiomeric ratio observed in 
the product of trapping with methyl iodide.  At −78 °C, an 80:20 thermodynamic 
ratio of lithiated intermediates (R)-257.(R,R)-42  and (S)-257.(R,R)-42  will form.  
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On addition of methyl iodide, the organolithium reagents are trapped to give (R)-102 
in 80:20 er (Scheme 4.15). 
(R)-257.(R,R)-42
(S)-257.(R,R)-42
N
S
Li.(R,R)-42
N
S
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_78 °C
30 min
80:20 er
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Scheme 4.15 
 
Our plan was to design a number of experiments that would reveal which of these 
scenarios gives rise to the enantioselectivity.  Of utmost importance would be the 
determination of the configurational stability of lithiated N-thiopivaloyl azetidine at −78 
°C.  This would allow us conclude whether the enantioselectivity observed in the 
products was due to an enantioselective deprotonation or a dynamic resolution process.  
In addition, alternative electrophiles would be used to establish whether the 
enantioselectivity was electrophile dependent.  Finally, comparisons would be made 
between the asymmetric lithiation-trapping of N-thiopivaloyl azetidine 101 and N-
thiopivaloyl pyrrolidine 210.  This comparison will expose differences between the four 
and five membered heterocycles.  Moreover, N-thiopivaloyl pyrrolidine 210 could be 
directly compared N-Boc pyrrolidine 39 to observe differences between the N-
thiopivalamide and N-Boc protecting groups. 
 
4.2.1 Investigating the Configurational Stability of Lithiated N-Thiopivaloyl 
Azetidine 
 
In order to determine the mechanism by which the asymmetric lithiation-trapping of N-
thiopivaloyl azetidine 101 occurs, it was essential to determine the configurational 
stability of the lithiated intermediates.  If the organolithium reagent was 
configurationally stable at the temperature of the trapping, then we would be able to 
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conclude that an enantioselective deprotonation was occurring.  In contrast, if the 
organolithium reagent was configurationally unstable at the temperature of trapping 
then we could be certain that a dynamic resolution process (kinetic or thermodynamic) 
was taking place.
18
  
 
The method of choice for exploring the configurational stability of the lithiated 
intermediate was tin → lithium exchange from an enantioenriched stannane and 
trapping with an electrophile.  If the enantiomeric ratio of the products after tin  → 
lithium exchange and trapping was lower than that of the starting stannane, then we can 
conclude that the organolithium intermediate was configurationally unstable (see 
Scheme 1.22 for an example).   
 
Before conducting the tin → lithium exchange, an asymmetric lithiation-trapping of N-
thiopivaloyl azetidine 101 needed to be carried out in order for us to have a reaction 
with which to compare our results.  Our choice was using s-BuLi/(−)-sparteine and 
trapping with benzaldehyde.  The absolute configuration of the products of trapping 
lithiated N-thiopivaloyl azetidine with benzaldehyde could be established by 
comparison with products synthesised from commerically available (S)-2-azetidine 
carboxylic acid.  In addition, we were confident that trapping with benzaldehyde would 
occur at −78 °C.180 In contrast, with methyl iodide, it has been shown that trapping of 
lithiated N-Boc piperidine 48 did not occur until temperatures at which the lithiated 
intermediate was configurationally unstable (−40 °C).43  This led to products in reduced 
enantiomeric ratio. 
 
N-Thiopivaloylazetidine 101 was lithiated using conditions reported by Hodgson and 
Kloesges (1.2 eq. s-BuLi, (−)-sparteine, Et2O, −78 °C, 30 min).  Subsequent trapping 
with benzaldehyde at −78 °C for 1 hour and quenching the reaction with hydrochloric 
acid at −78 °C gave diastereomeric alcohols anti-(S,R)-273 and syn-(R,R)-273 in 9% 
yield and 58:42 er and 75% yield and 75:25 er respectively (Scheme 4.16).  
Interestingly, Hodgson and co-workers only isolated a single diastereoisomer from the 
racemic lithiation-trapping with benzaldehyde.
102
  We were able to prove the absolute 
configuration of alcohols anti-(S,R)-273 and syn-(R,R)-273 by conversion into N-Boc 
amino alcohols anti-(S,R)-284 and syn-(R,R)-284 respectively.  This was achieved by 
removal of the thiopivalamide group using excess MeLi and subsequent Boc protection.  
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In addition, the relative configuration of anti-(S,R)-273 was confirmed by X-ray 
crystallography within our group.
208
 The relative configuration of syn-(R,R)-273 was 
confirmed by comparison of the 
1
H and 
13
C NMR spectra to those reported in the 
literature for syn-rac-273.
102
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N
S
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N
S
syn-(R,R)-273
OH OH
PhPhH H
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N
Boc OH
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N
Boc OH
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76%, 57:43 er
[]D = +14.2
(c 0.6 in CHCl3)
syn-(R,R)-284
71%, 75:25 er
[]D =
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(c 1.1 in CHCl3)
14:86 dr
 
Scheme 4.16 
 
Enantiomeric N-Boc amino alcohols anti-(R,S)-284 and syn-(S,S)-284 were synthesised 
from commerically available (S)-2-azetidine carboxylic acid in order to establish the 
absolute configuration (Scheme 4.17).  Boc protection of (S)-2-azetidine carboxylic acid 
proceeded smoothly to give N-Boc amino acid (S)-285 in 99% yield. Subsequent 
EDC/HOBt-mediated amide coupling with N,O-dimethylhydroxylamine.HCl furnished 
the Weinreb amide which was reacted directly with PhMgCl to give ketone (S)-286 in a 
modest 36% yield over two steps.  Reduction of ketone (S)-286 with sodium 
borohydride gave diastereomeric alcohols anti-(R,S)-284 (15%) and syn-(S,S)-284 
(78%) in 93% overall yield. 
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Scheme 4.17 
 
 
By comparison of optical rotation and CSP-HPLC data between alcohols anti-284 and 
syn-284 synthesised from lithiation-trapping and those obtained from (S)-2-azetidine 
carboxylic acid, we concluded that lithiation-trapping proceeded with the opposite sense 
of induction to that reported by Hodgson and Kloesges.
102
  Indeed, lithiation of N-
thiopivaloyl azetidine 101 using s-BuLi/(−)-sparteine and trapping with methyl iodide 
gave (R)-102 in 61:39 er (Scheme 4.18).  In contrast, when we trapped the reaction with 
benzaldehyde, diastereomeric alcohols anti-(S,R)-273 and syn-(R,R)-273 were isolated 
in 58:42 er and 75:25 er respectively.  This difference clearly indicated that the 
enantioselectivity of the lithiation-trapping procedure is electrophile dependent. 
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N
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N
S
101 ant i-(S,R)-273
N
S
syn-(R,R)-273
OH OH
PhPhH H
9%, 58:42 er 75%, 75:25 er
14:86 dr
Our Result:
 
Scheme 4.18 
 
With a suitable comparison reaction in hand, attention turned to the configurational 
stability study using tin → lithium exchange.  The required stannane was synthesised by 
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asymmetric lithiation of N-thiopivaloyl azetidine 101 using s-BuLi/(−)-sparteine and 
trapping with trimethyltin chloride.  Stannane (S)-272 was isolated in 55% yield and 
68:32 er (Scheme 4.19).  The stereochemical assignment was not proven but was 
assigned by analogy with the enantioinduction observed in the benzaldehyde trapping. 
 
N
S
1. s-BuLi, (_)-sparteine
Et2O,
_78 °C, 30 min
2. Me3SnCl
N
S
101 (S)-272
SnMe3
55%, 68:32 er  
Scheme 4.19 
 
With stannane (S)-272 in hand, the configurational stability of the intermediate 
organolithium reagent at −78 °C was investigated.  Treatment of (S)-272 with n-BuLi in 
THF at −78 °C for 5 minutes and trapping with benzaldehyde gave diastereomeric 
alcohols anti-rac-273 and syn-rac-273 in 26% yield and 58% yield respectively 
(Scheme 4.20).  Both alcohols were isolated in 50:50 er.  Thus, we conclude that under 
these reaction conditions (THF, −78 °C) lithiated intermediate 257.THF was 
configurationally unstable over 5 minutes. 
N
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PhH
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N
S
anti-rac-273
OH
PhH
26%, 50:50 er
257.THF
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Scheme 4.20 
 
The conditions used for the tin → lithium exchange reaction (THF, −78 °C) are 
significantly different to those used for the asymmetric lithiation of N-thiopivaloyl 
azetidine 101 (diamine, Et2O, −78 °C).  It is possible that the introduction of a diamine 
to the tin → lithium exchange protocol may result in a configurationally stabilised 
lithiated intermediate and thus, after trapping with benzaldehyde, enantioenriched 
products may be isolated.  Therefore, tin → lithium exchange mediated by n-
BuLi/TMEDA in Et2O at −78 °C for 5 minutes and trapping with benzaldehyde was 
Chapter Four: Synthesis of N-Thiopivaloyl Azetidine Organolithium Reagents 
 
143 
 
undertaken.  However, this also led to the isolation of diastereomeric alcohols anti-rac-
273 (24%) and syn-rac-273 (61%) in 50:50 er (Scheme 4.21).   
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Scheme 4.21 
 
From the tin → lithium exchange reactions, it was concluded that lithiated N-
thiopivaloyl azetidine was configurationally unstable at −78 °C.  This was unexpected 
because lithiated N-Boc pyrrolidine and piperidine are configurationally stable under 
these conditions.
52,56
 Further discussion of this difference is presented in Chapter 4.3. 
Use of a substoichiometric amount of electrophile can be used to detect whether a 
lithiated intermediate is configurationally stable on the timescale of reaction with the 
electrophile. This approach was christened “the poor man’s Hoffmann test” by Beak et 
al. in 1996.
209
  If a change in enantioselectivity is observed with a substoichiometric 
amount of electrophile when compared to an excess of electrophile, then it can be 
concluded that the organolithium is configurationally stable on the timescale of reaction 
with the electrophile.  If the same enantiomeric ratio is observed in both reactions then 
no definitive conclusion can be drawn.
210
 
 
An example of the “poor man’s Hoffmann test” is shown in Scheme 4.22.210  Benzylic 
organolithium reagents (R)-288 and (S)-288 were trapped with an excess of 
trimethylsilyl chloride to give silylated products (R)-289 in 88:12 er.  When the reaction 
was repeated with just 0.17 eq. of trimethylsilyl chloride, (R)-289 was isolated in 80:20 
er.  This change in enantiomeric ratio led to the conclusion that the lithiation 
intermediate showed a degree of configurational stability on the timescale of reaction 
with the electrophile.   
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Scheme 4.22 
 
Hence, we carried out the lithiation of N-thiopivaloyl azetidine 101 using s-BuLi/(−)-
sparteine and trapped with 0.3 equivalents of benzaldehyde (Scheme 4.23).  From this 
reaction, diastereomeric alcohols anti-(S,R)-273 and syn-(R,R)-273 were isolated in 3% 
yield and 58:42 er and 23% yield and 82:18 er respectively.  Yields are with respect to 
N-thiopivaloyl azetidine 101. 
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N
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N
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Scheme 4.23 
 
The enantiomeric ratio of the minor diastereomer, anti-(S,R)-273, isolated from the 
reaction with substoichiometric electrophile was the same as that isolated from the 
reaction with excess electrophile (see Scheme 4.16).  Furthermore, only a small 
difference in enantiomeric ratio was observed in alcohol syn-(R,R)-273 (82:18 er vs. 
75:25 er).  Therefore, we cannot draw any definitive conclusions on the configurational 
stability of the organolithium reagents with respect to rate of trapping with the 
electrophile. 
 
It is thus concluded that the lithiated azetidine is configurationally unstable at −78 °C.   
Therefore, we were confident that the enantioselectivity of the asymmetric lithiation-
trapping of N-thiopivaloyl azetidine 101 was not determined by an enantioselective 
deprotonation mechanism.  Instead, a dynamic resolution process is taking place but, at 
this point, we cannot be certain whether this process is kinetic or thermodynamic in 
nature. 
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4.2.2 Dynamic Resolution of Lithiated N-Thiopivaloyl Azetidine  
 
The conclusion from the configurational stability study was that a dynamic resolution 
process was occurring.  To prove this, it should be possible to resolve a racemic 
lithiated intermediate by the addition of a chiral diamine.  The chiral diamine ligand 
would then cause either one diastereomeric lithiated intermediate to react faster on 
addition of an electrophile (dynamic kinetic resolution, see Chapter 1.1.2) or a 
thermodynamic ratio of diastereomeric lithiated intermediates would form which would 
then be trapped with an electrophile (dynamic thermodynamic resolution, see Chapter 
1.1.3). 
 
Therefore, n-BuLi/(−)-sparteine was added to stannane rac-272 (Et2O, −78 °C, 5 
minutes) and trapped with benzaldehyde.  This gave diastereomeric alcohols anti-(R,S)-
273 and syn-(R,R)-273 in 62:38 er and 73:27 er respectively (Scheme 4.24).  The 
enantiomeric ratios of the products are similar to those obtained by asymmetric 
lithiation of N-thiopivaloyl azetidine 101: alcohol anti-(R,S)-273 was isolated in 58:42 
er and alcohol syn-(R,R)-273 was isolated in 75:25 er (see Scheme 4.16).  This result 
proves that a dynamic resolution process is indeed occurring. 
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N
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Scheme 4.24 
 
In order to better recreate the direct lithiation conditions, formation of a racemic 
lithiated intermediate starting from N-thiopivaloyl azetidine 101 was attempted.  Since 
it is known that (−)-sparteine is unable to displace TMEDA and THF from the lithiated 
intermediate,
127
 Hodgson and Kloesges’ original conditions for the racemic lithiation of 
N-thiopivaloyl azetidine 101 (s-BuLi/TMEDA, THF, −78 °C 30 minutes) were not 
suitable.  Hence, we attempted to find a protocol for the racemic lithiation of N-
thiopivaloyl azetidine 101 in the absence of TMEDA and THF.  
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To our delight, lithiation of N-thiopivaloyl azetidine 101 mediated by s-BuLi in Et2O at 
−40 °C for 1 hour and trapping with benzaldehyde gave diastereomeric alcohols anti-
rac-273 and syn-rac-273 in 21% yield and 41% yield respectively (Scheme 4.25).  It is 
possible that the reduction in yield may be due to the competitive addition of s-BuLi or 
the lithiated intermediate to the thiopivaloyl group. However, thiols of type 290 were 
not isolated from the reaction. 
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Scheme 4.25 
 
With a procedure for the formation of the racemic lithiated intermediate in hand, a 
dynamic resolution process was attempted.  N-Thiopivaloyl azetidine 101 was lithiated 
by s-BuLi in Et2O at −40 °C to give the racemic lithiated intermediate.  The reaction 
was then cooled to −78 °C and (−)-sparteine was added.  However, after trapping with 
benzaldehyde, alcohols anti-rac-273 (19%) and syn-rac-273 (43%) were isolated in 
50:50 er (Scheme 4.26).   
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Scheme 4.26 
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This result is at odds with the tin → lithium exchange approach presented in Scheme 
4.24. Our hypothesis was that (−)-sparteine was not complexing to the lithium at −78 °C 
and hence racemic lithiated intermediate 257.Et2O was being trapped by benzaldehyde 
giving  racemic products.  It was postulated that we could perturb the binding kinetics 
by carrying out the complexation with (−)-sparteine at higher temperature.  Therefore, 
the reaction was repeated but adding (−)-sparteine at −40 °C and incubating at this 
temperature for 15 minutes (Scheme 4.27).  The reaction was then cooled to −78 °C for 
1 hour before benzaldehyde was added.  This gave alcohol anti-(S,R)-273 in 7% yield 
and 59:41 er and alcohol syn-(R,R)-273  in 58% yield and 72:28 er respectively.  
Crucially, isolation of products with similar levels of enantioenrichment to those from 
direct lithiation-trapping at −78 °C (see Scheme 4.16) allows us to conclude that a 
dynamic resolution process is occurring under the reaction conditions.   
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Temperature can have a dramatic effect on the dynamic resolution processes.
53,54,56
 In a 
dynamic kinetic resolution, a change in temperature can affect the rates at which each of 
the diastereomeric lithiated intermediates reacts with the electrophile.  This change of 
rate is reflected in the enantiomeric ratio of the products.  In addition, in a dynamic 
thermodynamic resolution, a change in temperature can affect the diastereomeric ratio 
of the lithiated intermediates.  When an electrophile is added, this diastereomeric ratio 
determines the enantiomeric ratio of the products.  Therefore, we wanted to investigate 
the effect of changing the temperature in the lithiation-trapping of N-thiopivaloyl 
azetidine 101. 
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N-Thiopivaloyl azetidine 101 was lithiated using s-BuLi/(−)-sparteine (Et2O, −78 °C, 30 
minutes).  The reaction was then warmed to a higher temperature and incubated at that 
temperature for 1 hour.  Subsequent trapping with benzaldehyde gave diastereomeric 
alcohols anti-(S,R)-273 and syn-(R,R)-273 (Scheme 4.28, Table 4.2).  For comparison, 
the lithiation-trapping of N-thiopivaloyl azetidine 101 at −78 °C is reported in entry 1. 
When the reaction was warmed to −50 °C, trapping with benzaldehyde led to the 
isolation of alcohol anti-(S,R)-273 in 13% yield and 58:42 er and alcohol syn-(R,R)-273 
in 82% yield and a slightly reduced 68:32 er (entry 2) when compared to the 
enantiomeric ratio at −78 °C. 
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Scheme 4.28 
Table 4.2: Temperature effect on the enantioselectivity of the lithiation-trapping of N-
thiopivaloyl azetidine 101 
Entry T (°C) 
anti-(S,R)-273 syn-(R,R)-273 
Yield (%) er (S,R):(R,S) Yield (%) er (R,R):(S,S)
a
 
1 −78b 9 58:42 75 75:25 
2 −50 13 58:42 82 68:32 
3 −40 14 56:44 84 62:38 
4 −30 11 55:45 76 59:41 
5 −30c 7 59:41 72 75:25 
a
er determined by CSP-HPLC, 
b
Lithiation and trapping conducted at this temperature, 
cReaction cooled to −78 °C for 30 min before addition of electrophile. 
 
More significant reductions in enantioselectivity were observed in the major 
diastereoisomer when warming to −40 °C and −30 °C.  Indeed, alcohol anti-(S,R)-273 
was isolated in 14% yield and 56:44 er and alcohol syn-(R,R)-273 in 84% yield and 
62:38 er at −40 °C (entry 3).  Alcohol anti-(S,R)-273 was isolated in 11% yield and 
55:45 er and alcohol syn-(R,R)-273 in 76% yield and only 59:41 er at −30 °C (entry 4).  
Finally, we carried out a lithiation-trapping with a warm cool cycle.  N-Thiopivaloyl 
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azetidine 101 was lithiated using s-BuLi/(−)-sparteine at −78 °C for 30 minutes.  Then, 
the reaction was warmed to −30 °C and stirred at this temperature for 1 hour, before 
cooling to −78 °C and incubating for a further 30 minutes.  Subsequent electrophilic 
trapping with benzaldehyde gave diastereomeric alcohols anti-(S,R)-273 and syn-(R,R)-
273 in 7% and 59:41 er and 72% and 75:25 er respectively (entry 5).  Significantly, the 
products isolated had equivalent enantioselectivity to those isolated from the direct 
lithiation-trapping at −78 °C.  This further proves that the lithiated intermediate is 
configurationally unstable at −78 °C. 
 
The lithiation of N-thiopivaloyl azetidine 101 using s-BuLi/(−)-sparteine in Et2O at 
−100 °C was also attempted (Scheme 4.29).  Trapping with benzaldehyde gave alcohol 
anti-(S,R)-273 in 7% yield and 57:43 er and alcohol syn-(R,R)-273 in 66% yield and 
77:23 er. It is unknown if lithiated N-thiopivaloyl azetidine 101 is configurationally 
unstable at this temperature. 
101 anti-(S,R)-273 syn-(R,R)-273
1. s-BuLi, (_)-sparteine
Et2O,
_100

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2. PhCHO
N
S
N
S
Ph
OH
H
N
S
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OH
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7%, 57:43 er 66%, 77:23 er  
Scheme 4.29 
 
Using different chiral ligands can have a dramatic effect on the enantioselectivity of the 
dynamic resolution process.
52,56
  Therefore, the lithiation-trapping of N-thiopivaloyl 
azetidine 101 was carried out using other diamine ligands (Scheme 4.30, Table 4.3).  
For comparison, the result when (−)-sparteine was used as the ligand is presented in 
entry 1.  Diamine 42 had previously given the highest enantiomeric ratio in the 
lithiation-trapping of N-thiopivaloyl azetidine 101 reported by Hodgson.
102
  In our 
hands, lithiation of N-thiopivaloyl azetidine 101 using s-BuLi/(S,S)-42 and trapping 
with benzaldehyde gave alcohol anti-(R,S)-273 in 20% yield and 65:35 er and alcohol 
syn-(S,S)-273 in 73% yield and 53:47 er (entry 2).  Disappointingly, this was not an 
improvement on the use of (−)-sparteine as the ligand. 
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Scheme 4.30 
Table 4.3: Asymmetric lithiation-trapping of N-thiopivaloyl azetidine 101 using s-
BuLi/chiral ligands.  
Entry Ligand 
anti-(R,S)-273 syn-(S,S)-273 
Yield (%) er (R,S):(S,R)
a
 Yield (%) er (S,S):(R,R)
a
 
1 (−)-sparteine 9 42:58 75 25:75 
2 (S,S)-42 20 65:35 73 53:47 
3  (+)-sp. surr. 1 7 54:46 70 54:46 
a
er determined by CSP-HPLC 
 
Lithiation of N-thiopivaloyl azetidine 101 using s-BuLi/(+)-sparteine surrogate 1 and 
trapping with benzaldehyde gave alcohol anti-(R,S)-273 in 7% yield and alcohol syn-
(S,S)-273 in 70% yield, with both diastereoisomers giving a disappointing 54:46 er 
(entry 3).  This was surprising given that (+)-sparteine surrogate 1 typically gives 
enantiomeric ratios of similar magnitude to (−)-sparteine.19  In this case, the 
enantiomeric ratios are much lower when (+)-sparteine surrogate 1 is used as the ligand.  
This disparity has been previously observed in dynamic kinetic and dynamic 
thermodynamic resolutions and this lends further support to an enantioselective 
deprotonation not taking place under the asymmetric lithiation conditions.
20
 
 
The s-BuLi/(+)-sparteine surrogate 1 complex has been shown to be more reactive 
towards lithiation than s-BuLi/(−)-sparteine.43  Therefore, it was postulated that 
deprotonation of N-thiopivaloyl azetidine 101 may occur in the presence of 
benzaldehyde giving the intermediate organolithium reagent which would immediately 
react with benzaldehyde.  This experiment would give an indication if an initial 
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enantioselective deprotonation occurred prior to equilibration of the diastereomeric 
lithiated intermediates.   
 
Hence, s-BuLi/(+)-sparteine surrogate 1 was added to N-thiopivaloyl azetidine 101 and 
benzaldehyde (Scheme 4.31).  After purification by flash column chromatography, 
alcohol anti-(R,S)-273 was isolated in 0.5% yield and 56:44 er and alcohol syn-(S,S)-
273 was isolated in 1.5% yield and 60:40 er.   
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Scheme 4.31 
 
The enantiomeric ratio of anti-(R,S)-273 is the same as that from the lithiation of N-
thiopivaloyl azetidine 101 and subsequent trapping with benzaldehyde.  In contrast, 
there is a slight improvement in the enantiomeric ratio of syn-(S,S)-273.  It is possible 
that this indicates the initial deprotonation has a higher enantioselectivity than that 
observed in the trapped products. 
 
In summary, we have shown that a dynamic resolution process is occurring at −78 °C 
during the lithiation-trapping of N-thiopivaloyl azetidine 101.  A racemic lithiated 
intermediate, formed either by tin → lithium exchange or racemic lithiation of N-
thiopivaloyl azetidine 101, was successfully resolved.  Currently, we have not been able 
to prove whether a dynamic kinetic resolution or a dynamic thermodynamic resolution 
is taking place with benzaldehyde.   
 
4.2.3 Lithiation of N-Thiopivaloyl Azetidine 101 and Trapping with Methyl Iodide 
 
Our attention turned to using methyl iodide as the electrophile in the lithiation-trapping 
of N-thiopivaloyl azetidine 101.  Of particular interest was investigating the reason for 
the opposite sense of induction when using methyl iodide when compared to what we 
have shown for benzaldehyde (see Scheme 4.18).
102
  We had three hypotheses that 
could explain this difference.  These are summarised in Schemes 4.32, 4.33 and 4.34 for 
the lithiation using (−)-sparteine as the ligand.  In the first mechanism, a dynamic 
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kinetic resolution was occurring when trapping with either methyl iodide or 
benzaldehyde.  However, methyl iodide would react preferentially with organolithium 
(R)-257.(−)-sp, whereas benzaldehyde reacts faster with the organolithium reagent (S)-
257.(−)-sp (Scheme 4.32).  The difference in rates of trapping would arise from the 
different energies of the transition states. 
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Scheme 4.32 
 
Alternatively, both electrophiles react preferentially with organolithium (S)-257.(−)-sp 
but methyl iodide reacts with inversion of configuration at carbon to give (R)-102 
(Scheme 4.33).  The reaction of organolithium reagents with methyl iodide proceeding 
with inversion of configuration has been previously observed although typically a 
stabilised (e.g. allylic or benzylic) organolithium reagent is necessary.
207
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In the third scenario, we propose that a dynamic thermodynamic resolution is occurring 
with the fast trapping benzaldehyde electrophile.  Therefore, the outcome is dependent 
upon the diastereomeric ratio of the organolithium intermediates.  Based on the 
enantiomeric ratios of anti-(S,R)-273 and syn-(R,R)-273 we suggest that the 
diastereomeric ratio of (S)-257.(−)-sp and (R)-257.(−)-sp would be ca. 70:30 dr at −78 
°C.  In contrast, when methyl iodide is used as the electrophile, a dynamic kinetic 
resolution process takes place.  This could be due to the slower reacting nature of 
methyl iodide when compared to benzaldehyde (Scheme 4.34).  
N
S
(R)-257.(_)-sp
Li.(_)-sp
N
S
(S)-257.(_)-sp
Li.(_)-sp
PhCHO
ant i-(S,R)-273 syn-(R,R)-273
N
S
Ph
OH
H
N
S
Ph
OH
H
N
S
(R)-257.(_)-sp
Li.(_)-sp
N
S
(S)-257.(_)-sp
Li.(_)-sp
MeI
N
S
H
(R)-102
 
Scheme 4.34 
 
Our plan was to design a number of experiments that would distinguish between these 
mechanisms.  In the first place, we wanted to investigate whether the lithiated 
intermediate was trapped by methyl iodide at −78 °C.  Therefore, the lithiation of N-
thiopivaloyl azetidine 101 using s-BuLi/(−)-sparteine was carried out and methyl iodide 
was added at −78 °C (Scheme 4.35).  The reaction was then incubated at −78 °C for 2 
hours before benzaldehyde was then added.   If methyl iodide reacts at −78 °C then we 
would expect the formation of (S)-102 as the only product.  However, if the lithiated 
intermediate is not trapped by methyl iodide at −78 °C then alcohols anti-(S,R)-273 and 
syn-(R,R)-273 would be isolated.   This reaction gave methyl azetidine (S)-102 in 78% 
yield and 58:42 er.  The products of trapping with benzaldehyde, alcohols anti-(S,R)-
273 and syn-(R,R)-273, were not evident in the 
1
H NMR spectrum of the crude product 
indicating that all the lithiated intermediate had reacted with the methyl iodide prior to 
the addition of benzaldehyde. 
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Scheme 4.35 
 
Most significantly, what we believe to be the opposite enantiomer to that reported in the 
literature was isolated from this reaction (see stereochemical assignment in Scheme 
4.37).  Furthermore, repeating this reaction under the same conditions reported by 
Hodgson and Kloesges gave methyl azetidine (S)-102 in 91% yield and 59:41 er 
(Scheme 4.36).   This is the same major enantiomer as we observed when trapping with 
benzaldehyde.  In contrast, Hodgson and Kloesges reported that this reaction gave 
methyl azetidine (R)-102 in 61:39 er (see Scheme 4.9 and Table 1.1).
102
 
 
N
S
1. s-BuLi, (_)-sparteine
Et2O,
_78 °C, 30 min
2. MeI
N
S
101 (S)-102
91%, 59:41 er
H
 
Scheme 4.36 
 
The best enantiomeric ratio reported for trapping the lithiated intermediate with methyl 
iodide was achieved with diamine (R,R)-42.  Indeed, methyl azetidine (R)-102 was 
isolated in 96% yield and 80:20 er (see Scheme 4.9 and Table 1.1).   We conducted the 
enantiomeric reaction, namely the lithiation of N-thiopivaloyl azetidine 101 using s-
BuLi/diamine (S,S)-42 and trapping with methyl iodide.  To our surprise, methyl 
azetidine (R)-102 was isolated in 87% yield and 69:31 er (Scheme 4.37).  This is the 
same enantiomer to that reported by Hodgson and therefore opposite to what we were 
expecting to isolate.  Comparison of optical rotation for (R)-102 to that reported in the 
literature allowed assignment of absolute configuration.   
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Scheme 4.37 
 
Attempts were made to improve the enantioselectivity of the lithiation-trapping 
procedure by adding methyl iodide over 2 hours.  A similar effect has been reported by 
Coldham et al. in the dynamic kinetic resolution of N-Boc-2-lithiopyrrolidine (Scheme 
4.38).
54
  Indeed, tin → lithium exchange of stannane rac-291 using n-BuLi/58 in Et2O 
at −78 °C and then warming to −20 °C before slow addition of trimethylsilyl chloride 
over 90 minutes gave silylated pyrrolidine (S)-41 in 96:4 er.  Warming to −20 °C was 
necessary to ensure that enantiomerisation of the lithiated intermediate could occur.  
The 96:4 er achieved by this slow addition approach is in contrast to the isolation of 
(R)-41 in 58:42 er when trimethylsilyl chloride was added in one portion.  
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Scheme 4.38 
 
N-Thiopivaloyl azetidine 101 was lithiated using s-BuLi/(S,S)-42 and then methyl 
iodide was added over 2 hours at −78 °C (Scheme 4.39).  This gave methyl azetidine 
(R)-102 in 91% yield and 68:32 er. Unfortunately, no improvement in enantiomeric 
ratio was observed when compared to adding the electrophile in one portion (69:31 er, 
see Scheme 4.37).  
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Scheme 4.39 
 
Due to the rather small optical rotation value for our synthesised sample of (R)-102, we 
attempted to transform it into known N-Boc methyl azetidine (R)-292 which has a 
higher optical rotation value ([α]D −40.5 (c 0.80 in CHCl3)).
102
  This would confirm that 
our stereochemical assignment was correct.  Unfortunately, removal of the thiopivaloyl 
group using MeLi and subsequent protection using Boc2O was unsuccessful (Scheme 
4.40).   
1. MeLi, THF, 0 °C, 5 h
2. Boc2O, CH2Cl2, rt, 16 h NBoc
(R)-292
N
S
(R)-102, 69:31 er
H
H
 
Scheme 4.40 
 
We then set about the synthesis of (R)-292 starting from N-Boc acid (S)-285 (previously 
prepared from commerically available (S)-2-azetidine carboxylic acid, see Scheme 
4.14).  First, acid (S)-285 was reduced to alcohol (S)-293 in 93% yield using BH3.SMe2 
(Scheme 4.41).  Treatment of alcohol (S)-293 under Appel iodination conditions 
(iodine, triphenylphosphine, imidazole) gave iodide (S)-294 in 85% yield.  Finally, 
hydrogenolysis of (S)-294 gave N-Boc methyl azetidine (R)-292 in 75% yield. 
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The conversion of N-Boc methyl azetidine (R)-292 into N-thiopivaloyl methyl azetidine 
(R)-102 has been previously reported.
102
 Therefore, we repeated this reaction under the 
same conditions (Scheme 4.42).  Unfortunately, (R)-102 was not evident in the 
1
H NMR 
spectrum of the crude product.  No improvements were obtained when repeating the 
reaction and any attempts to isolate the N-pivalamide intermediate were unsuccessful.  
In addition, alternative acylation conditions (Et3N, DMAP, CH2Cl2) did not lead to any 
of the desired product being isolated. 
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1. TFA, CH2Cl2, rt, 1 h
2. PivCl, py., rt, 16 h
(R)-102(R)-292  
Scheme 4.42 
 
Whilst the absolute configuration of methyl azetidine (R)-102 has not been 
unequivocally established, we are confident that, despite the small magnitude of the 
optical rotation, the sense of induction for the lithiation of N-thiopivaloyl azetidine 101 
and trapping with methyl iodide is the same as that observed when trapping with 
benzaldehyde.  This conclusion is in contradiction to the sense of induction reported by 
Hodgson and Kloesges and therefore further proof will need to be garnered prior to 
publication.   
 
So far, we have shown that lithiated N-thiopivaloyl azetidine 101 is configurationally 
unstable at −78 °C.  Thus, an enantioselective deprotonation mechanism cannot be 
invoked to explain the enantioselectivity observed in the products from lithiation-
trapping reactions.  Instead, a dynamic resolution process must be occurring.  We are 
currently unable to determine whether a dynamic kinetic or a dynamic thermodynamic 
resolution is occurring under the asymmetric lithiation conditions.  Interestingly, the 
products isolated from the lithiation-trapping of N-thiopivaloyl azetidine 101 have the 
opposite configuration to that reported by Hodgson and Kloesges.
102
 
 
The configurational instability of lithiated N-thiopivaloyl azetidine at −78 °C is 
remarkable when compared to lithiated N-Boc pyrrolidine and piperidine, both of which 
are configurationally stable at −78 °C.   We suggest that the configurational instability 
of lithiated N-thiopivaloyl azetidine is due to either the smaller ring size or the N-
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thiopivaloyl protecting group.  Therefore, our next goal was to investigate the 
asymmetric lithiation of N-thiopivaloyl pyrrolidine 210. 
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4.3 Lithiation-Trapping of N-Thiopivaloyl Pyrrolidine 210 
In light of lithiated N-thiopivaloyl azetidine 101 being configurationally unstable at −78 
°C, we were interested in investigating the configurational stability of lithiated N-
thiopivaloyl pyrrolidine 210.  This comparison would allow us to determine whether the 
configurational instability of the lithiated intermediate at −78 °C was due to the 
reduction in ring size or the thiopivaloyl protecting group. 
 
It has previously been shown that lithiated N-Boc pyrrolidine 210 is configurationally 
stable at −78 °C.54,76  For example, Beak and Gross reported that the tin → lithium 
exchange of stannane (S)-295 (95:5 er) using n-BuLi in THF at −78 °C for 2 hours and 
trapping with dimethyl sulfate gave methylated pyrrolidine (S)-296 in 65% yield and 
95:5 er (Scheme 4.43).
206
  The retention of the enantiomeric ratio proves that the 
organolithium intermediate is configurationally stable at −78 °C. 
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65%, 95:5 er 
Scheme 4.43 
 
 
4.3.1 Investigating the Configurational Stability of Lithiated N-Thiopivaloyl 
Pyrrolidine 
 
Our plan to determine the configurational stability of lithiated N-thiopivaloyl 
pyrrolidine 210 was to carry out a tin → lithium exchange from an enantioenriched 
stannane at −78 °C.  First, it was necessary to carry out an asymmetric lithiation of N-
thiopivaloyl pyrrolidine 210 and trapping with benzaldehyde.  This would provide a 
reaction with which to compare our results from the tin → lithium exchange process. 
Therefore, N-thiopivaloyl pyrrolidine 210 was lithiated using s-BuLi/(−)-sparteine in 
Et2O for 3 hours at −78 °C. Trapping with benzaldehyde gave diastereomeric alcohols 
anti-(S,R)-211 in 40% yield and 86:14 er and syn-(R,R)-211 in 37% yield and 82:18 er 
(Scheme 4.44).  Conversion into known
74
 alcohols anti-(S,R)-73and syn-(R,R)-73 by 
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deprotection of the thiopivaloyl group using MeLi and subsequent Boc protection 
allowed the assignment of the relative and absolute configuration.  It can be concluded 
that lithiation-trapping of N-thiopivaloyl pyrrolidine 210 shows the same sense of 
induction as the asymmetric lithiation-trapping of N-Boc pyrrolidine 39.
38
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Scheme 4.44 
 
In addition, stannane (S)-297 was synthesised by lithiation of N-thiopivaloyl pyrrolidine 
210 and trapping with trimethyltin chloride in 68% yield and 78:22 er (Scheme 4.45).  
The absolute configuration of stannane (S)-297 has not been proved but is assigned by 
analogy to the benzaldehyde-trapped products. 
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Scheme 4.45 
 
With stannane (S)-297 in hand, we attempted tin → lithium exchange at −78 °C to 
investigate the configurational stability of the lithiated intermediate.  Treatment of 
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stannane (S)-297 with n-BuLi in THF at −78 °C followed by trapping with 
benzaldehyde gave diastereomeric alcohols anti-rac-211 and syn-rac-211 in 42% yield 
and 51:49 er and 52% yield and 51:49 er respectively.  Similarly, use of n-
BuLi/TMEDA gave alcohols anti-rac-211 (24%) and syn-rac-211 (66%), each in 50:50 
er (Scheme 4.46). 
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Scheme 4.46 
 
Remarkably, from these tin → lithium exchange reactions, we conclude that the 
lithiated intermediate is configurationally unstable at −78 °C.  This is in in contrast with 
α-lithiated N-Boc pyrrolidine which is configurationally stable at −78 °C.54,76  By 
comparison of lithiated N-thiopivaloyl azetidine to N-thiopivaloyl pyrrolidine we can 
conclude that the labile nature of the lithiated intermediates is not due to a decrease in 
ring size.  Instead, it is suggested that the N-thiopivaloyl protecting group is not as 
efficient at stabilising the lithiated intermediate when compared to N-Boc pyrrolidine 
39.  We speculate that this variation may arise from the difference in bond lengths of the 
Boc carbonyl (C=O) and the C=S of the N-thiopivalamide. C=O bonds in carbamates 
are typically ca. 1.25 Å in length whereas C=S bonds in thioamides are ca. 1.67 Å 
long.
211
  The longer C=S bond may cause an increase in length of the C-Li bond due to 
chelation to the lithium to the sulfur.  Thus, a reduction in strength of the C-Li would be 
observed making the barrier to enantiomerisation lower (Figure 4.3). 
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4.3.2 Dynamic Resolution of Lithiated N-Thiopivaloyl Pyrrolidine 
 
Since lithiated N-thiopivaloyl pyrrolidine 210 was shown to be configurationally 
unstable at −78 °C, an enantioselective deprotonation mechanism can be ruled out.  
Therefore, the enantioselectivity observed in the lithiation-trapping of N-thiopivaloyl 
pyrrolidine 210 is due to a dynamic resolution process.  This means that addition of a 
chiral diamine to the racemic organolithium reagent should allow isolation of 
enantioenriched products.  
 
Treatment of stannane rac-297 (formed in 76% yield by racemic lithiation-trapping) 
with n-BuLi/(−)-sparteine in Et2O at −78 °C for 5 minutes and trapping with 
benzaldehyde gave alcohol anti-(S,R)-211 in 39% yield and 88:12 er and syn-(R,R)-211 
37% yield and 82:18 er (Scheme 4.47).  Importantly, the enantiomeric ratio observed 
from the tin → lithium exchange are comparable to those achieved from the asymmetric 
lithiation of N-thiopivaloyl pyrrolidine 210 using s-BuLi/(−)-sparteine (see Scheme 
4.44). 
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Scheme 4.47 
 
The lithiation of N-thiopivaloyl pyrrolidine 210 was also carried out using (+)-sparteine 
surrogate 1 as the ligand.  It was hoped that this would allow access to the opposite 
enantiomeric series of trapped products in high enantiomer ratio.  Indeed, treatment of 
N-thiopivaloyl pyrrolidine 210 with s-BuLi/(+)-sparteine surrogate 1 and trapping with 
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benzaldehyde gave alcohol anti-(R,S)-211 in 62% yield and 85:15 er and alcohol syn-
(S,S)-211 in 24% yield and 92:8 er (Scheme 4.48). This is the highest gave the highest 
enantioselectivity we have achieved (92:8 er), albeit for the minor diastereoisomer. 
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Scheme 4.48 
 
Finally, methyl iodide was used as the electrophile.  Previously, in the lithiation-
trapping of N-thiopivaloyl azetidine 101, methyl iodide had given products with lower 
enantiomeric ratio when compared with benzaldehyde (see Scheme 4.36).  Lithiation of 
N-thiopivaloyl pyrrolidine 210 using s-BuLi/(−)-sparteine and trapping with methyl 
iodide gave (S)-298 in 84% yield and 58:42 er (Scheme 4.49).  The enantiomeric ratio 
of (S)-298 was significantly lower than the products of benzaldehyde-trapping.  Thus, 
we suggest a dynamic kinetic resolution process is occurring, although further work will 
be required to unequivocally establish this.  The absolute configuration of the major 
enantiomer was assigned by comparison to unpublished work within our group.
212
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Scheme 4.49 
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4.4 Conclusions and Future Work 
Remarkably, lithiated N-thiopivaloyl azetidine and N-thiopivaloyl pyrrolidine have been 
shown to be configurationally unstable at −78 °C.  This was established by tin → 
lithium exchange (n-BuLi, TMEDA, Et2O, −78 °C, 5 min) from stannanes (S)-272 
(68:32 er) and (S)-297 (78:22 er) and trapping with benzaldehyde.  In both reactions, 
products were isolated in 50:50 er (Scheme 4.49).  Therefore, we are able to conclude 
that a dynamic resolution process is taking place under the asymmetric lithiation 
conditions (s-BuLi, chiral diamine, Et2O, −78 °C).  Hence, the enantioselectivity 
observed in the products does not arise from an enantioselective deprotonation. 
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Scheme 4.49 
 
The configurational instability of lithiated N-thiopivaloyl azetidine and N-thiopivaloyl 
pyrrolidine is in contrast with lithiated N-Boc pyrrolidine and piperidine which are 
known to be configurationally stable at −78 °C.52,54,56  Therefore, we conclude that the 
configurational instability is due to the thiopivaloyl directing group.  We speculate that 
this may be due to the increased C=S thioamide bond length when compared to the Boc 
carbonyl. 
 
We also found that lithiation of N-thiopivaloyl azetidine 101 using s-BuLi/(−)-sparteine 
and trapping with benzaldehyde gave a diastereomeric mixture of alcohols anti-(S,R)-
273 and syn-(R,R)-273.  The sense of enantiomeric induction was established by 
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comparison to a sample synthesised with known stereochemistry and was found to be 
opposite configuration to that reported in the literature for methyl iodide trapping.
102
  
Similarly, we believe that trapping with methyl iodide gave products with opposite 
configuration to that reported by Hodgson and Kloesges (Scheme 4.50).  However, 
further work is necessary to unequivocally establish the configuration of the methyl 
trapped product. 
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Scheme 4.50 
 
Future work will look to further optimise the asymmetric lithiation-trapping of N-
thiopivaloyl azetidine 101.  In particular, the use of alternative chiral ligands will be 
explored especially those that have been shown to engender good enantiomeric 
induction in dynamic resolution processes of nitrogen heterocycles.
52,56
  Investigations 
will also take place to study the effect of electrophiles on the enantioselectivity of the 
lithiation-trapping process. 
 
Furthermore, the Hoffmann test could be used to determine whether the intermediate 
organolithium reagents are configurationally unstable on the timescale of trapping (see 
Scheme 1.23).  Two reactions will be carried out.  First, organolithium rac-257 will be 
trapped with racemic amide rac-55 to give ketone 299.  Second, organolithium rac-257 
will be trapped with enantiomerically pure amide (S)-55 to give ketone 299 (Scheme 
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4.51).  If the diastereomeric ratios of these two reactions are the same then we can 
conclude that a dynamic thermodynamic resolution process is occurring.  If the 
diastereomeric ratios are different then it can be concluded that a dynamic kinetic 
resolution is taking place. Finally, the Hoffman test will also be used to distinguish 
between a dynamic thermodynamic and a dynamic kinetic resolution in the asymmetric 
lithiation of N-thiopivaloyl pyrrolidine 210. 
N
S
Et2O,
_78 °C, 30 min
N
S
Li
101 rac-257
N
O
MeO NBn2
N
O
MeO NBn2
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Chapter Five: Experimental 
5.1 General Methods 
Water is distilled water. Brine refers to a saturated aqueous solution of NaCl. All non-
aqueous reactions were carried out under oxygen-free Ar using flame-dried glassware.  
Alkyllithiums were titrated against N-benzylbenzamide before use.
170
 All diamines and 
electrophiles were distilled over CaH2 before use. Et2O and THF were freshly distilled 
from sodium and benzophenone ketyl.  Petrol refers to the fraction of petroleum ether 
boiling in the range 40-60 C.  
 
Flash column chromatography was carried out using Fluka Chemie GmbH silica (220-
440 mesh). Thin layer chromatography was carried out using Merck F254 aluminium-
backed silica plates. 
1
H (400 MHz) and 
13
C (100.6 MHz) NMR spectra were recorded 
on a Jeol ECX-400 instrument with an internal deuterium lock. Chemical shifts are 
quoted as parts per million and referenced to CHCl3 (H 7.27) and or CDCl3 (C 77.0, 
central line of triplet). 
13
C NMR spectra were recorded with broadband proton 
decoupling. 
13
C NMR spectra were assigned using DEPT experiments. Coupling 
constants (J) are quoted in Hertz. IR spectra were recorded on an ATI Matteson Genesis 
FT-IR spectrometer.  Melting points were measured on a Gallenkamp melting point 
apparatus. Electrospray high and low resolution mass spectra were recorded on a Bruker 
Daltronics microOTOF spectrometer.  Chiral stationary phase HPLC was performed on 
an Agilent 1200 series instrument and a multiple wavelength, UV/Vis diode array 
detector.   
 
The following diamine ligands were made according to the reported procedures: (+)-
sparteine surrogate 1
19
 and diamines (R,R)-42 and (S,S)-42.
29
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5.2 General Procedures 
General Procedure A: s-BuLi/diamine-mediated lithiation-electrophilic trapping of 
O-alkyl carbamate 14 or O-Alkyl carbamate 125 
s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of carbamate 14 or 125 (1.00 mmol, 1.0 eq.) and diamine 
(1.20 mmol, 1.2 eq.) in Et2O (6 mL) at −78 °C under Ar.  The resulting solution was 
stirred at −78 °C for 1 h.   Then, the electrophile (2.00 mmol, 2.0 eq.) was added 
dropwise and the solution was allowed to warm to rt over 2 h and stirred at rt for 16 h.  
Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous 
layer was extracted with Et2O (3 × 10 mL).  The combined organic layers were dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product. 
 
General Procedure B: s-BuLi/diamine-mediated lithiation-electrophilic trapping of 
O-alkyl carbamate 14 (Quench at −78 °C) 
s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of carbamate 14 (263 mg, 1.00 mmol, 1.0 eq.) and 
diamine (1.20 mmol, 1.2 eq.) in Et2O (6 mL) at −78 °C under Ar.  The resulting solution 
was stirred at −78 °C for 1 h.   Then, the electrophile (2.00 mmol, 2.0 eq.) was added 
dropwise and the solution was stirred at −78 °C for 5 min.  Then, MeOH (2 mL) was 
added and the resulting solution was allowed to warm to rt over 30 min.  The solution 
was poured into 1 M HCl(aq) (10 mL) and the two layers were separated.   The aqueous 
layer was extracted with Et2O (3 × 10 mL).  The combined organic layers were dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product. 
 
General Procedure C: s-BuLi/diamine-mediated lithiation-electrophilic trapping of 
O-alkyl carbamate 14 with reverse addition to Andersen’s sulfinate (Ss)-97  
s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of carbamate 14 (263 mg, 1.00 mmol, 1.0 eq.) and 
diamine (1.20 mmol, 1.2 eq.) in Et2O (6 mL) at −78 °C under Ar.  The resulting solution 
was stirred at −78 °C for 1 h and then added dropwise via cannula transfer to a stirred 
solution of Andersen’s sulfinate (Ss)-97 (589 mg, 2.00 mmol, 2.0 eq.) in THF (4 mL) at 
−78 °C under Ar. The resulting solution was stirred at −78 °C for 5 min. Then, 
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MeOH(aq) (2 mL) was added and the resulting solution was allowed to warm to rt over 
30 min.  The solution was poured into 1 M HCl(aq) (10 mL) and the two layers were 
separated.  The aqueous layer was extracted with Et2O (3 × 10 mL).  The combined 
organic layers were dried (Na2SO4) and evaporated under reduced pressure to give the 
crude product.   
 
General Procedure D: Sulfoxide → Magnesium Exchange Reactions 
i-PrMgCl (0.13-0.25 mL of a 2.0 M solution in THF, 0.26-0.50 mmol, 1.3-2.5 eq.) was 
added dropwise to a stirred solution of the sulfoxide (0.20 mmol, 1.0 eq.) in THF (8 
mL) at  rt under Ar.  The resulting solution was stirred at rt for 1-30 min.  Then, the 
electrophile (0.26-0.50 mmol, 1.3-2.5 eq.) was added dropwise and the resulting 
solution was stirred at rt for 5 min.  Saturated NH4Cl(aq) (7 mL) was added and the two 
layers were separated.  The aqueous layer was extracted with Et2O (3 × 10 mL).  The 
combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product. 
 
General Procedure E: s-BuLi-mediated lithiation-electrophilic trapping of N-Boc 
pyrrolidine 39 in THF 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.30 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc pyrrolidine 39 (171 mg, 1.00 mmol, 1.0 eq.) in THF (7 
mL) at −78 °C under Ar.  The resulting solution was stirred at −78 °C for 1 h.  Then, the 
electrophile (2.00 mmol, 2.0 eq.) was added dropwise. The solution was allowed to 
warm to rt over 2 h and stirred at rt for 16 h.  Saturated NH4Cl(aq) (10 mL) was added 
and the two layers were separated.  The aqueous layer was extracted with Et2O (3 × 15 
mL).  The combined organic layers were dried (Na2SO4) and evaporated under reduced 
pressure to give the crude product. 
 
General Procedure F: s-BuLi/diamine-mediated lithiation-electrophilic trapping of 
N-Boc pyrrolidine 39, N-Boc piperidine 48 or N-pivaloyl pyrrolidine 209 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.30 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc pyrrolidine 39, N-Boc piperidine 48 or N-pivaloyl 
pyrrolidine 209 (1.00 mmol, 1.0 eq.) and diamine (1.30 mmol, 1.3 eq.) in Et2O (6 mL) 
at −78 °C under Ar.  The resulting solution was stirred at −78 °C for 1-3 h.   Then, the 
electrophile (2.00 mmol, 2.0 eq.) was added dropwise and the solution was allowed to 
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warm to rt over 2 h and stirred at rt for 16 h.  Saturated NH4Cl(aq) (10 mL) was added 
and the two layers were separated.  The aqueous layer was extracted with Et2O (3 × 10 
mL).  The combined organic layers were dried (Na2SO4) and evaporated under reduced 
pressure to give the crude product. 
 
General Procedure G: mCPBA oxidation of α-amino sulfides 
mCPBA (208 mg of ~77% purity, 1.20 mmol, 1.1 eq.) was added to a stirred solution of 
the sulfide (1.10 mmol, 1.0 eq.) in CH2Cl2 (3 mL) at −40 °C under Ar.  The resulting 
solution was stirred at −40 °C for 1 h. Then, saturated Na2SO3(aq) (7 mL) and CH2Cl2 
(10 mL) were added and the two layers were separated.  The aqueous layer was 
extracted with CH2Cl2 (2 × 10 mL).  The combined organic layers were dried (Na2SO4) 
and evaporated under reduced pressure to give the crude product. 
 
General Procedure H: s-BuLi/diamine-mediated lithiation-electrophilic trapping 
of N-Boc 4-chloro piperidine 223  
s-BuLi (1.69 mL of a 1.3 M solution in hexanes, 2.20 mmol, 2.2 eq.) was added 
dropwise to a stirred solution of N-Boc 4-chloro piperidine 223 (219 mg, 1.0 mmol, 1.0 
eq.) and diamine (2.20 mmol, 2.2 eq.) in Et2O (6 mL) at −78 °C under Ar.  The resulting 
solution was stirred at −78 °C for 1 h.  Then, the electrophile (2.20 mmol, 2.2 eq.) was 
added dropwise. The solution was allowed to warm to rt over 2 h and stirred at rt for 16 
h.  Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated.  The 
aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organic layers were 
dried (Na2SO4) and evaporated under reduced pressure to give the crude product.   
 
General Procedure I: s-BuLi/diamine-mediated lithiation-electrophilic trapping of 
N-Boc 4-chloro piperidine 223 (Quench at −78 °C) 
s-BuLi (1.69 mL of a 1.3 M solution in hexanes, 2.20 mmol, 2.2 eq.) was added 
dropwise to a stirred solution of N-Boc 4-chloro piperidine 223 (219 mg, 1.0 mmol, 1.0 
eq.) and diamine (2.20 mmol, 2.2 eq.) in Et2O (6 mL) at −78 °C under Ar.  The resulting 
solution was stirred at −78 °C for 1 h.  Then, the electrophile (2.20 mmol, 2.2 eq.) was 
added dropwise and the solution was stirred at −78 °C for 5 min.  Then, MeOH (2 mL) 
was added and the resulting solution was allowed to warm to rt over 30 min.  The 
solution was poured into 1 M HCl(aq) (10 mL) and the two layers were separated.  The 
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aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organic layers were 
dried (Na2SO4) and evaporated under reduced pressure to give the crude product.   
 
General Procedure J: s-BuLi/diamine-mediated lithiation of N-Boc 4-chloro 
piperidine 223 with reverse addition to Andersen’s sulfinate (Ss)-97  
s-BuLi (1.69 mL of a 1.3 M solution in hexanes, 2.20 mmol, 2.2 eq.) was added 
dropwise to a stirred solution of N-Boc 4-chloro piperidine 223 (219 mg, 1.0 mmol, 1.0 
eq.) and diamine (2.20 mmol, 2.2 eq.) in Et2O (6 mL) at −78 °C under Ar.  The resulting 
solution was stirred at −78 °C for 1 h and then added dropwise via cannula transfer to a 
stirred solution of Andersen’s sulfinate (Ss)-97 (647 mg, 2.20 mmol, 2.2 eq.) in THF (5 
mL) at −78 °C under Ar. The resulting solution was stirred at −78 °C for 5 min. Then, 
MeOH (2 mL) was added and the resulting solution was allowed to warm to rt over 30 
min.  The solution was poured into 1 M HCl(aq) (10 mL) and the two layers were 
separated.  The aqueous layer was extracted with Et2O (3 × 10 mL).  The combined 
organic layers were dried (Na2SO4) and evaporated under reduced pressure to give the 
crude product.   
 
General Procedure K: Sulfoxide → Magnesium Exchange Reactions with 
Transmetallation-Negishi Coupling 
i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.5 mmol, 2.5 eq.) was added dropwise 
to a stirred solution of sulfoxide syn-(R,R,SS)-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF 
(8 mL) at rt under Ar.  The resulting solution was stirred at rt for 1 min.  Then, ZnCl2 
(0.12 mmol of a 1.0 M solution in Et2O, 0.6 eq.) was added dropwise. The solution was 
stirred at rt for 30 min. Then, Pd(OAc)2 (3 mg, 0.01 mmol, 0.05 eq.), t-Bu3PH.BF4 (3.5 
mg, 0.012 mmol, 0.06 eq.) and aryl bromide (0.24 mmol, 1.2 eq.) were added 
sequentially.  The resulting brown solution was stirred at rt for 16 h.  Then, NH4OH(aq) 
(0.1 mL) was added and the resulting solution was stirred for 30 min.  The solids were 
removed by filtration through Celite
®
 and the filtrate was washed with water (5 mL).  
The organic layer was dried (Na2SO4) and evaporated under reduced pressure to give 
the crude product. 
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General Procedure L: s-BuLi/diamine-mediated lithiation-electrophilic trapping of 
N-thiopivaloyl azetidine 101 
s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.60 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of N-thiopivaloyl azetidine 101 (79 mg, 0.50 mmol, 1.0 
eq.) and diamine (0.60 mmol, 1.2 eq.) in Et2O (5 mL) at −78 °C under Ar.  The resulting 
solution was stirred at −78 °C for 30 min.  Then, the electrophile (0.75 mmol, 1.5 eq.) 
was added dropwise and the solution was stirred at −78 °C for 1 h.  1 M HCl(aq) (10 mL) 
was added and the two layers were separated. The aqueous layer was extracted with 
Et2O (3 × 10 mL).  The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product.  
  
General Procedure M: s-BuLi/diamine-mediated lithiation-electrophilic trapping 
of N-thiopivaloyl pyrrolidine 210 
s-BuLi (0.50 mL of a 1.3 M solution in hexanes, 0.65 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of N-thiopivaloyl pyrrolidine 210 (86 mg, 0.50 mmol, 1.0 
eq.) and diamine (0.65mmol, 1.3 eq.) in Et2O (5 mL) at −78 °C under Ar.  The resulting 
solution was stirred at −78 °C for 1 h.  Then, the electrophile (0.75 mmol, 1.5 eq.) was 
added dropwise and the solution was stirred at −78 °C for 1 h. 1 M HCl(aq) (10 mL) was 
added and the two layers were separated. The aqueous layer was extracted with Et2O (3 
× 10 mL).  The combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product.  
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5.3 Experimental for Chapter Two 
3-Phenylpropyl diisopropylcarbamate 14
29
 
14
O N
O
Ph
 
3-Phenyl-1-propanol (2.00 g, 14.68 mmol, 1.2 eq.) was added dropwise to a stirred 
suspension of NaH (0.70 g of 60% wt in mineral oil, 17.12 mmol, 1.4 eq., prewashed 
with 3 × 10 mL Et2O) in Et2O (5 mL) at rt under Ar.  The resulting suspension was 
stirred at rt for 5 min.  Then, a solution of N,N-diisopropylcarbamoyl chloride (2.02 g, 
12.22 mmol, 1.0 eq.) in Et2O (16 mL) was added dropwise.  The resulting solution was 
stirred at rt for 18 h.  Then, 2 M HCl(aq) (10 mL) was added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 10 mL).  The combined 
organic layers were washed with 1 M NaOH(aq), dried (2:1 MgSO4/NaHCO3) and 
evaporated under reduced pressure to give the crude product as a yellow oil. Purification 
by flash column chromatography on silica with 3:2 petrol-Et2O as eluent gave 
carbamate 14 (2.82 g, 88%) as a colourless oil,  RF (3:2 petrol-Et2O) 0.4;
 1
H NMR (400 
MHz, CDCl3) δ 7.32-7.27 (m, 2H, Ph), 7.22-7.20 (m, 3H, Ph), 4.21-3.61 (br m, 2H, 
NCH), 4.13 (t, J = 6.5 Hz, 2H, OCH2), 2.73 (t, J = 7.5 Hz, 2H, CH2Ph), 2.01-1.97 (m, 
2H, CH2), 1.23 (d, J = 7.0 Hz, 12H, NCHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 155.8 
(C=O), 141.5 (ipso-Ph), 128.4 (Ph), 128.3 (Ph), 125.9 (Ph), 64.0 (OCH2), 45.7 (NCH), 
32.5 (CH2), 30.9 (CH2), 20.9 (Me).  Spectroscopic data consistent with those reported in 
the literature.
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Lab Book Reference: PJR 1/52A 
 
Methyl p-toluenesulfinate 121 
121
S
OMe
O
 
Bromine (4.36 g, 1.40 mL, 27.6 mmol, 3.0 eq.) was added to a stirred suspension of 
Na2CO3 (4.87 g, 46.0 mmol, 5.0 eq.) and p-tolyl disulfide (2.27 g, 9.2 mmol, 1.0 eq.) in 
MeOH (195 mL) at rt. The resulting yellow suspension was stirred at rt for 3 h during 
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which time the suspension became colourless.  Then, the solvent was evaporated under 
reduced pressure. CH2Cl2 (100 mL) and water (100 mL) were added to the residue and 
the two layers were separated.  The aqueous layer was extracted with CH2Cl2 (2 × 50 
mL).  The combined organic layers were washed with saturated NH4Cl(aq) (50 mL) and 
brine (50 mL), dried (Na2SO4) and evaporated under reduced pressure to give the crude 
product as a colourless oil.  Purification by Kügelrohr distillation gave sulfinate 121 
(2.93 g, 93%) as a colourless oil, bp 91-94 °C/2.0 mmHg (lit.,
214
  129-130 °C/16.0 
mmHg); 
1
H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 8.0 Hz, 2H, m-C6H4Me), 7.25 (d, J 
= 8.0 Hz, 2H, o-C6H4Me), 3.37 (s, 3H, OMe), 2.34 (s, 3H, Me); 
13
C NMR (100.6 MHz, 
CDCl3) δ 142.8 (ipso-Ar), 140.7 (ipso-Ar), 129.7 (Ar), 125.3 (Ar), 49.3 (OMe), 21.4 
(Me).  Spectroscopic data consistent with those reported in the literature.
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(S)-(−)-Menthyl p-toluenesulfinate (SS)-97  
(SS)-97
O
S
O
 
 
Thionyl chloride (46.0 mL, 828 mmol, 4.5 eq.) was added dropwise to a stirred 
suspension of sodium p-toluenesulfinate (32.8 g, 184 mmol, 1.0 eq., dried via 
azeotropic distillation from 3 x 75 mL toluene) in toluene (110 mL) at 0 °C over 30 
min.  The resulting solution was stirred at rt for 2 h.  Then, the volatiles were 
evaporated under reduced pressure and the residue was dissolved in toluene (75 mL).  
The volatiles were evaporated under reduced pressure to give the crude sulfinyl 
chloride.  The crude sulfinyl chloride was dissolved in Et2O (90 mL) and added 
dropwise over 30 min to a stirred solution of (−)-menthol (35.9 g, 230 mmol, 1.25 eq.) 
in pyridine (33 mL) and Et2O (150 mL) at 0 °C.  A white precipitate immediately 
formed and the resulting suspension was stirred at rt for 16 h.  Then, the suspension was 
poured into water (150 mL) and the two layers were separated.  The aqueous layer was 
extracted with Et2O (2 x 50 mL) and the combined organic layers were washed with 1 
M HCl(aq) (3 x 60 mL), dried (Na2SO4) and evaporated under reduced pressure.  The 
resulting solid was recrystallised from hot acetone (20 mL).  A second recrystallisation 
of the solid from hot acetone (20 mL) gave Andersen’s sulfinate (SS)-97 (8.65 g, 16%)   
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as colourless needles. Then, 3 drops of conc. HCl(aq) were added to the mother liquor to 
effect equilibrium of the sulfinate diastereomers.  This resulted in crystallisation of 
Andersen’s sulfinate (SS)-97.  A recrystallisation of the solid from hot acetone (20 mL) 
gave Andersen’s sulfinate (SS)-97 (18.23 g, 34%) as colourless needles.  Total yield 
from two crops = 26.88 g (50 %) as colourless needles, mp 107-108 °C (lit.,
92
 mp 107-
109 °C); 
1
H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 8.0 Hz, 2H, m-C6H4Me), 7.33 (d, J 
= 8.0 Hz, 2H, o-C6H4Me), 4.13 (td, J = 10.5, 4.5 Hz, 1H, CHOS(O)), 2.42 (s, 3H, 
C6H4Me), 2.31-2.26 (m, 1H), 2.14 (dtd,  J = 14.0, 7.0, 3.0 Hz, 1H), 1.72-1.66 (m, 2H), 
1.50 (m, 1H), 1.36 (ddt, J = 14.0, 10.5, 3.0 Hz, 1H), 1.28-1.24 (m, 1H), 1.10-0.79 (m, 
2H), 0.97 (d, J = 8.0 Hz, 3H, Me), 0.87 (d, J = 8.0 Hz, 3H, Me), 0.72 (d, J = 8.0 Hz, 3H, 
Me); 
13
C NMR (100.6 MHz, CDCl3) δ 143.1 (ipso-Ar), 142.4 (ipso-Ar), 129.6 (Ar), 
125.0 (Ar), 80.1 (CHO), 47.8 (CH), 42.9 (CH2), 34.0 (CH2), 31.7 (CH), 25.2 (CH), 23.1 
(CH2), 22.1 (Me), 21.5 (Me), 20.8 (Me), 14.4 (Me); [α]D −199.3 (c 1.05 in acetone) 
(lit.,
92
 [α]D −204 (c 2.24 in acetone)).  Spectroscopic data consistent with those reported 
in the literature.
92
 
  
(1S)-1-(p-Tolylsulfinyl)-3-phenylpropyl N,N-diisopropylcarbamate anti-(S,Ss)-103 
and (1R)-1-(p-tolylsulfinyl)-3-phenylpropyl N,N-diisopropylcarbamate syn-(R,Ss)-
103 
 
(Table 2.1, Entry 1) 
syn-(R,Ss)-103
SPh
O H
O
O
iPr2N
ant i-(S,Ss)-103
SPh
O H
O
O
iPr2N
 
 
Using general procedure A, s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 
mmol, 1.2 eq.), carbamate 14 (263 mg, 1.00 mmol, 1.0 eq.) and TMEDA (139 mg, 1.20 
mmol, 1.2 eq.) in Et2O (5 mL) and a solution of Andersen’s sulfinate (Ss)-97 (382 mg, 
1.3 mmol, 1.3 eq.) in THF (1 mL) gave the crude product.  Purification by flash column 
chromatography on silica with 3:1 petrol-EtOAc + 1% Et3N as eluent gave sulfoxide 
anti-(S,Ss)-103 (100 mg, 25%, 83:17 er by CSP-HPLC) as a white solid, mp 58-60 °C; 
RF (3:1 petrol-EtOAc) 0.3;
 
IR (CHCl3) 2971, 1697 (C=O), 1436, 1370, 1286, 1091, 
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1035, 910, 812, 731 cm
−1
; 
1
H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 8.0 Hz, 2H, m-
C6H4Me), 7.28 (d, J = 8.0 Hz, 2H, o-C6H4Me), 7.21 (t, J = 7.0 Hz, 2H, m-Ph), 7.16 (d, J 
= 7.0 Hz, 1H, p-Ph), 7.02 (d, J = 7.0 Hz, 2H, o-Ph), 5.45 (dd, J = 10.0, 3.0 Hz, 1H, 
OCH), 3.94 (br s, 2H, NCH), 2.74 (ddd, J = 14.0, 10.0, 5.0 Hz, 1H, PhCHAHB), 2.56 
(ddd, J = 14.0, 10.0, 7.0 Hz, 1H, PhCHAHB), 2.40 (s, 3H, Me) 2.36-2.25 (m, 1H, CH), 
2.06-1.98 (m, 1H, CH), 1.26 (br s, 12H, NCHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 
153.5 (C=O), 141.2 (ipso-Ar), 140.3 (ipso-Ar), 137.4 (ipso-Ar), 129.7 (Ar), 128.3 (Ar), 
128.1 (Ar), 126.0 (Ar), 124.4 (Ar), 91.7 (OCH), 46.7 (br, NCH), 46.0 (br, NCH), 31.1 
(CH2), 26.0 (CH2), 21.3 (Me), 20.2 (br, Me); MS (ESI) m/z 424 [(M + Na)
+
, 100], 402 
[(M + H)
+
, 20]; HRMS m/z calcd for C23H31NO3S (M + Na)
+
 424.1917 (+1.3 ppm 
error), found 424.1911; CSP-HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL 
min
-1
) anti-(R,Rs)-103 12.8 min, anti-(S,Ss)-103 14.0 min and sulfoxide syn-(R,Ss)-103 
(84 mg, 21%, 85:15 er by CSP-HPLC) as a colourless oil, RF (3:1 petrol-EtOAc) 0.20;
 
IR (film) 2971, 2968, 1707 (C=O), 1434, 1370, 1291, 1136, 1091, 1038, 809 cm
−1
; 
1
H 
NMR (400 MHz, CDCl3) δ 7.46 (d, J = 8.0 Hz, 2H, m-C6H4Me), 7.28-7.24 (m, 4H, Ar), 
7.21-7.14 (m, 3H, Ar), 5.72 (dd, J = 9.5, 4.0 Hz, 1H, OCH), 3.99 (br s, 1H, NCH), 3.57 
(br s, 1H, NCH), 2.79-2.75 (m, 2H, PhCH2), 2.41-2.33 (m, 1H, CH), 2.37 (s, 3H, Me), 
2.17-2.08 (m, 1H, CH), 1.21-0.99 (m, 12H, CHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 
152.3 (C=O), 141.5 (ipso-Ar), 140.3 (ipso-Ar), 136.0 (ipso-Ar), 129.5 (Ar), 128.5 (Ar), 
128.4 (Ar), 126.3 (Ar), 125.3 (Ar), 86.8 (OCH), 46.3 (br, NCH) 45.9 (br, NCH), 31.7 
(CH2), 30.3 (CH2), 21.3 (Me), 21.1 (Me), 20.8 (Me), 20.2 (Me), 20.1 (Me); MS (ESI) 
m/z 424 [(M + Na)
+
, 90], 402 [(M + H)
+
, 100]; HRMS m/z calcd for C23H31NO3S (M + 
Na)
+
 424.1917, found 424.1905 (+2.7 ppm error); CSP-HPLC: Chiracel OD (97.5:2.5 
Hexane-iPrOH, 1.0 mL min
-1
) syn-(S,Rs)-103 21.3 min, syn-(R,Ss)-103 23.8 min. 
 
(Table 2.1, Entry 2) 
Using general procedure B, s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 
mmol, 1.2 eq.), carbamate 14 (263 mg, 1.00 mmol, 1.0 eq.) and TMEDA (139 mg, 1.20 
mmol, 1.2 eq.) in Et2O (5 mL) and a solution of Andersen’s sulfinate (Ss)-97 (382 mg, 
1.3 mmol, 1.3 eq.) in THF (4 mL) gave the crude product.  Purification by flash column 
chromatography on silica with 3:1 petrol-EtOAc + 1% Et3N as eluent gave sulfoxide 
anti-(S,Ss)-103 (93 mg, 23%, 88:12 er by CSP-HPLC) as a white solid, CSP-HPLC: 
Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) anti-(R,Rs)-103 12.9 min, anti-
(S,Ss)-103 14.2 min and sulfoxide syn-(R,Ss)-103 (130 mg, 32%, 91:9 er by CSP-HPLC) 
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as a colourless oil, CSP-HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) 
syn-(S,Rs)-103 22.3 min, syn-(R,Ss)-103 24.5 min. 
 
(Table 2.1, Entry 3) 
Using general procedure C, s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 
mmol, 1.2 eq.), carbamate 14 (263 mg, 1.00 mmol, 1.0 eq.) and TMEDA (139 mg, 1.20 
mmol, 1.2 eq.) in Et2O (5 mL) and a solution of Andersen’s sulfinate (Ss)-97 (382 mg, 
1.3 mmol, 1.3 eq.) in THF (4 mL) gave the crude product.  Purification by flash column 
chromatography on silica with 3:1 petrol-EtOAc + 1% Et3N as eluent gave sulfoxide 
anti-(S,Ss)-103 (100 mg, 25%, 87:13 er by CSP-HPLC) as a white solid, CSP-HPLC: 
Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) anti-(R,Rs)-103 13.0 min, anti-
(S,Ss)-103 14.3 min and sulfoxide syn-(R,Ss)-103 (116 mg, 29%, 90:10 er by CSP-
HPLC) as a colourless oil, CSP-HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL 
min
-1
) syn-(S,Rs)-103 22.3 min, syn-(R,Ss)-103 24.5 min. 
 
(Table 2.1, Entry 4) 
Using general procedure B, s-BuLi (0.92 mL of a 1.3M solution in hexanes, 1.20 mmol, 
1.2 eq.), carbamate 14 (263 mg, 1.00 mmol, 1.0 eq.) and TMEDA (139 mg, 1.20 mmol, 
1.2 eq.) in Et2O (5 mL) and a solution of Andersen’s sulfinate (Ss)-97 (587 mg, 2.0 
mmol, 2.0 eq.) in THF (6 mL) gave the crude product.  Purification by flash column 
chromatography on silica with 3:1 petrol-EtOAc + 1% Et3N as eluent gave sulfoxide 
anti-(S,Ss)-103 (84 mg, 21%, 92:8 er by CSP-HPLC) as a white solid, CSP-HPLC: 
Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) anti-(R,Rs)-103 13.2 min, anti-
(S,Ss)-103 14.6 min and sulfoxide syn-(R,Ss)-103 (96 mg, 24%, 95:5 er by CSP-HPLC) 
as a colourless oil, CSP-HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) 
syn-(S,Rs)-103 21.9 min, syn-(R,Ss)-103 24.2 min and sulfoxide. 
Lab Book Reference: PJR 3/224 
 
(Table 2.1, Entry 5) 
Using general procedure B, s-BuLi (0.92 mL of a 1.3M solution in hexanes, 1.20 mmol, 
1.2 eq.), carbamate 14 (263 mg, 1.00 mmol, 1.0 eq.) and TMEDA (139 mg, 1.20 mmol, 
1.2 eq.) in Et2O (5 mL) and a solution of Andersen’s sulfinate (Ss)-97 (882 mg, 3.0 
mmol, 3.0 eq.) in THF (8 mL) gave the crude product.  Purification by flash column 
chromatography on silica with 3:1 petrol-EtOAc + 1% Et3N as eluent gave sulfoxide 
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anti-(S,Ss)-103 (104 mg, 26%, 90:10 er by CSP-HPLC) as a white solid, CSP-HPLC: 
Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) anti-(R,Rs)-103 13.1 min, anti-
(S,Ss)-103 14.4 min and sulfoxide syn-(R,Ss)-103 (125 mg, 31%, 93:7 er by CSP-HPLC) 
as a colourless oil, CSP-HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) 
syn-(S,Rs)-103 22.0 min, syn-(R,Ss)-103 24.4 min and sulfoxide. 
Lab Book Reference: PJR 3/228 
 
(Table 2.1, Entry 6) 
s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of carbamate 14 (263 mg, 1.00 mmol, 1.0 eq.) and 
TMEDA (139 mg, 1.20 mmol, 1.2 eq.) in Et2O (5.0 mL) at −78 °C under Ar.  The 
resulting solution was stirred at −78 °C for 1 h.   Then, a freshly prepared solution of 
MgBr2 [prepared from 1,2-dibromoethane (0.12 mL, 1.3 mmol) and Mg turnings (50 
mg, 1.95 mmol)] in THF was added.  Resulting solution is stirred at −78 °C for 1 h and 
then a  solution of Andersen’s sulfinate (Ss)-97  (382 mg, 2.0 mmol, 2.0 eq.) in THF 
(4.0 mL) at −78 °C. The resulting solution was stirred at −78 °C for 5 min.  Then, 
MeOH (2.0 mL) was added and the resulting solution allowed to warm to rt.  The 
solution was then poured into sat. NH4Cl(aq) (10 mL) and the two layers were separated.  
The aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organic layers 
were dried (Na2SO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 3:1 petrol-EtOAc + 1% 
Et3N as eluent gave sulfoxide anti-(S,Ss)-103 (32 mg, 8%, 92:8 er by CSP-HPLC) as a 
white solid, CSP-HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) anti-
(R,Rs)-103 12.9 min, anti-(S,Ss)-103 13.9 min and sulfoxide syn-(R,Ss)-103 (30 mg, 8%, 
87:13 er by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiracel OD (97.5:2.5 
Hexane-iPrOH, 1.0 mL min
-1
) syn-(S,Rs)-103 21.7 min, syn-(R,Ss)-103 23.4 min and 
sulfoxide. 
Lab Book Reference: PJR 4/225 
 
 
(Table 2.2, Entry 1) 
Using general procedure A, s-BuLi (1.38 mL of a 1.3 M solution in hexanes, 1.80 
mmol, 1.2 eq.), carbamate 14 (395 mg, 1.50 mmol, 1.0 eq.) and (−)-sparteine (422 mg, 
1.80 mmol, 1.2 eq.) in Et2O (6 mL) and a solution of Andersen’s sulfinate (Ss)-97 (882 
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mg, 3.0 mmol, 2.0 eq.) in THF (2 mL) gave the crude product.  Purification by flash 
column chromatography on silica with 3:1 petrol-EtOAc + 1% Et3N as eluent gave 
sulfoxide anti-(S,Ss)-103 (319 mg, 53%, 99:1 er by CSP-HPLC) as a white solid, CSP-
HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) anti-(R,Rs)-103 13.1 min, 
anti-(S,Ss)-103 14.2 min and sulfoxide syn-(R,Ss)-103 (1.5 mg, 0.2%, er not determined) 
as a colourless oil. 
 
(Table 2.2, Entry 2) 
Using general procedure A, s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 
mmol, 1.2 eq.), carbamate 14 (263 mg, 1.00 mmol, 1.0 eq.) and the (+)-sparteine 
surrogate (233 mg, 1.20 mmol, 1.2 eq.) in Et2O (5 mL) and a solution of Andersen’s 
sulfinate (Ss)-97 (382 mg, 1.3 mmol, 1.3 eq.) in THF (1 mL) gave the crude product.  
Purification by flash column chromatography on silica with 3:1 petrol-EtOAc + 1% 
Et3N as eluent gave sulfoxide anti-(S,Ss)-103  (32 mg, 7%, 87:13 er by CSP-HPLC) as a 
white solid, CSP-HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) anti-
(R,Rs)-103 12.7 min, anti-(S,Ss)-103 13.5 min and sulfoxide syn-(R,Ss)-103 (180 mg, 
45%, 99:1 er by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiracel OD (97.5:2.5 
Hexane-iPrOH, 1.0 mL min
-1
) syn-(S,Rs)-103 21.1 min, syn-(R,Ss)-103 23.6 min. 
 
(Table 2.2, Entry 3) 
Using general procedure C, s-BuLi (1.85 mL of a 1.3 M solution in hexanes, 2.4 mmol, 
1.2 eq.), carbamate 14 (526 mg, 2.0 mmol, 1.0 eq.) and diamine (S,S)-42 (745 mg, 2.4 
mmol, 1.2 eq.) in Et2O (10 mL) and a solution of Andersen’s sulfinate (Ss)-97 (1176 
mg, 4.0 mmol, 2.0 eq.) in THF (8 mL) gave the crude product.  Purification by flash 
column chromatography on silica with 3:1 petrol-EtOAc + 1% Et3N as eluent gave 
sulfoxide anti-(S,Ss)-103 (133 mg, 17%, 95:5 er by CSP-HPLC) as a white solid, [α]D 
+27.6 (c 1.0 in CHCl3); CSP-HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL 
min
-1
) anti-(R,Rs)-103 13.9 min, anti-(S,Ss)-103 15.1 min and sulfoxide syn-(R,Ss)-103 
(436 mg, 54%, 99:1 er by CSP-HPLC) as a colourless oil, [α]D +43.7 (c 1.0 in CHCl3); 
CSP-HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) syn-(S,Rs)-103 25.0 
min, syn-(R,Ss)-103 26.6 min. 
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 (Table 2.2, Entry 4) 
Using general procedure C, s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.2 mmol, 
1.2 eq.), carbamate 14 (263 mg, 1.0 mmol, 1.0 eq.) and diamine (R,R)-42 (371 mg, 1.2 
mmol, 1.2 eq.) in Et2O (5 mL) and a solution of Andersen’s sulfinate (Ss)-97 (589 mg, 
2.0 mmol, 2.0 eq.) in THF (4 mL) gave the crude product.  Purification by flash column 
chromatography on silica with 3:1 petrol-EtOAc + 1% Et3N as eluent gave sulfoxide 
anti-(S,Ss)-103 (225 mg, 56%, 99:1 er by CSP-HPLC) as a white solid, [α]D +26.9 (c 1.0 
in CHCl3); CSP-HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) anti-
(R,Rs)-103 13.0 min, anti-(S,Ss)-103 14.0 min and sulfoxide syn-(R,Ss)-103 (56 mg, 
14%, 93:7 er by CSP-HPLC) as a colourless oil, [α]D +43.4 (c 0.55 in CHCl3); CSP-
HPLC: Chiracel OD (97.5:2.5 Hexane-iPrOH, 1.0 mL min
-1
) syn-(S,Rs)-103 22.1 min, 
syn-(R,Ss)-103 24.7 min. 
 
1-(p-Tolylsulfinyl)-3-phenylpropyl N,N-diisopropylcarbamate anti-rac-103 and 
syn-rac-103 
syn-rac-103
SPh
O H
O
O
iPr2N
ant i-rac-103
SPh
O H
O
O
iPr2N
 
 
Using general procedure A, s-BuLi (1.38 mL of a 1.3 M solution in hexanes, 1.80 
mmol, 1.2 eq.), carbamate 14 (395 mg, 1.50 mmol, 1.0 eq.) and TMEDA (208 mg, 1.80 
mmol, 1.2 eq.) in Et2O (6 mL) and methyl p-toluenesulfinate 121 (510 mg, 2.00 mmol, 
1.3 eq.) gave the crude product.  Purification by flash column chromatography on silica 
with 3:1 petrol-EtOAc + 1% Et3N as eluent gave sulfoxide anti-rac-103 (148 mg, 25%) 
as a viscous colourless oil and sulfoxide syn-rac-103 (190 mg, 32%) as a colourless oil.   
 
Ethyl diisopropylcarbamate 124
123
 
124
O N
O
 
Diisopropylamine (8.39 mL, 60 mmol, 3.0 eq.) was added dropwise to a stirred solution 
of ethyl chloroformate (1.89 mL, 20 mmol, 1.0 eq.) in CH2Cl2 (20 mL) at 0 °C under 
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Ar.  The resulting solution was stirred at 0 °C for 30 min.  Then, 1 M HCl(aq) (15 mL) 
was added and the two layers were separated. The aqueous layer was extracted with 
Et2O (3 × 10 mL).  The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 9:1 petrol-Et2O as eluent gave carbamate 124 (3.39 g, 
98%) as a colourless oil,  RF (9:1 petrol-Et2O) 0.2;
 1
H NMR (400 MHz, CDCl3) δ 4.10 
(q, J = 7.0 Hz, 2H, OCH2), 4.12-3.62 (m, 2H, NCH), 1.23 (t, J = 7.0 Hz, 3H, OCH2Me), 
1.17 (d, J = 6.5 Hz, 12H, NCHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 155.7 (C=O), 
60.2 (OCH2), 45.7 (br, NCH), 20.7 (Me), 14.5 (Me).  Spectroscopic data consistent with 
those reported in the literature.
32
 
Lab Book Reference: PJR 8/670 
 
(1S)-(p-Tolylsulfinyl)-ethyl N,N-diisopropylcarbamate anti-(S,Ss)-123 and (1R)-(p-
Tolylsulfinyl)-ethyl N,N-diisopropylcarbamate syn-(R,Ss)-123 
syn-(R,SS)-123
Me S
O H
O
O
iPr2N
ant i-(S,SS)-123
Me S
O H
O
O
iPr2N
 
 
Using general procedure A, s-BuLi (1.85 mL of a 1.3 M solution in hexanes, 2.40 
mmol, 1.2 eq.), carbamate 124 (346 mg, 2.00 mmol, 1.0 eq.) and diamine (S,S)-42 (744 
mg, 2.40 mmol, 1.2 eq.) in Et2O (12 mL) and a solution of Andersen’s sulfinate (Ss)-97 
(1.18 g, 4.0 mmol, 2.0 eq.) in THF (10 mL) gave the crude product.  Purification by 
flash column chromatography on silica with 3:1 petrol-EtOAc + 1% Et3N as eluent gave 
sulfoxide anti-(S,Ss)-123 (24 mg, 4%, er not determined) as a colourless oil, RF (7:3 
petrol-EtOAc) 0.4;
 
IR (film) 2971, 2959, 1694 (C=O), 1531, 1475, 1312, 1296, 1050, 
910, 854, 732 cm
−1
; 
1
H NMR (400 MHz, CDCl3) δ 7.58 (d, J = 8.0 Hz, 2H, m-C6H4Me), 
7.32 (d, J = 8.0 Hz, 2H, o-C6H4Me), 5.52 (q, J = 6.5 Hz, 1H, OCH), 4.04 (br s, 1H, 
NCH), 3.86 (br s, 1H, NCH), 2.40 (s, 3H, Me) 1.36 (d, J = 6.5 Hz, 1H, Me), 1.29-1.21 
(br m, 12H, NCHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 153.8 (C=O), 141.2 (ipso-Ar), 
137.7 (ipso-Ar), 129.8 (Ar), 124.3 (Ar), 89.3 (OCH), 46.8 (br, NCH), 45.9 (br, NCH), 
21.5 (br, Me), 21.4 (Me), 20.3 (br, Me), 9.4 (Me); MS (ESI) m/z 334 [(M + Na)
+
, 100], 
312 [(M + H)
+
, 80]; HRMS m/z calcd for C16H25NO3S (M + Na)
+
 334.1447, found 
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334.1448 (−0.1 ppm error) and sulfoxide syn-(R,Ss)-123 (55 mg, 9%, er not determined) 
as a colourless oil, RF (7:3 petrol-EtOAc) 0.30;
 
IR (film) 2992, 2978, 2970, 1700 (C=O), 
1530, 1472, 1450, 1390, 1291, 1122, 1078, 910, 730 cm
−1
; 
1
H NMR (400 MHz, CDCl3) 
δ 7.49 (d, J = 8.0 Hz, 2H, m-C6H4Me), 7.29 (d, J = 8.0 Hz, 2H, o-C6H4Me), 5.80 (q, J = 
6.5 Hz, 1H, OCH), 3.90 (br s, 1H, NCH), 3.70 (br s, 1H, NCH), 2.39 (s, 3H, Me), 1.48 
(d, J = 6.5 Hz, 1H, Me), 1.15-1.04 (m, 12H, CHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 
152.5 (C=O), 141.7 (ipso-Ar), 136.0 (ipso-Ar), 129.4 (Ar), 125.4 (Ar), 84.0 (OCH), 
47.6 (NCH) 46.1 (NCH), 21.5 (Me), 21.4 (Me), 20.8 (Me), 20.5 (Me), 20.1 (Me), 13.7 
(Me); MS (ESI) m/z 334 [(M + Na)
+
, 70], 312 [(M + H)
+
, 100]; HRMS m/z calcd for 
C16H25NO3S (M + Na)
+
 334.1447, found 334.1447 (+0.1 ppm error). 
 
1-(p-Tolylsulfinyl)-ethyl N,N-diisopropylcarbamate anti-rac-123 and 1-(p-
tolylsulfinyl)-ethyl N,N-diisopropylcarbamate syn-rac-123 
syn-rac-123
Me S
O H
O
O
iPr2N
ant i-rac-123
Me S
O H
O
O
iPr2N
 
 
Using general procedure A, s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 
mmol, 1.2 eq.), carbamate 124 (173 mg, 1.00 mmol, 1.0 eq.) and TMEDA (179 μL, 1.20 
mmol, 1.2 eq.) in Et2O (5 mL) and methyl p-tolyl sulfinate 121 (255 mg, 1.5 mmol, 1.5 
eq.) gave the crude product.  Purification by flash column chromatography on silica 
with 3:1 petrol-EtOAc + 1% Et3N as eluent gave sulfoxide anti-rac-123 (90 mg, 29%) 
as a colourless oil and sulfoxide syn-rac-123 (69 mg, 22%)  as a colourless oil. 
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1-(p-Tolylsulfinyl)-3-phenylpropyl N,N-diisopropylcarbamate anti-rac-103, 1-(p-
tolylsulfinyl)-3-phenylpropyl N,N-diisopropylcarbamate syn-rac-103, 1-(p-
tolylsulfinyl)-ethyl N,N-diisopropylcarbamate anti-rac-123 and 1-(p-tolylsulfinyl)-
ethyl N,N-diisopropylcarbamate syn-rac 123 (Scheme 2.17) 
syn-rac-103
SPh
O H
pTol
O
O
iPr2N
anti-rac-103
SPh
O H
pTol
O
O
iPr2N
syn-rac-123
Me S
O H
pTol
O
O
iPr2N
anti-rac-123
Me S
O H
pTol
O
O
iPr2N
 
 
s-BuLi (0.38 mL of a 1.3 M solution in hexanes, 0.50 mmol, 1.0 eq.) was added to a 
stirred solution of carbamate 124 (87 mg, 0.50 mmol, 1.0 eq.) and TMEDA (75 μL, 0.50 
mmol, 1.0 eq.) in Et2O (5 mL) at −78 °C under Ar.  The resulting solution was stirred at 
−78 °C for 1 h.  Then, a solution of sulfoxide anti-rac-103 (200 mg, 0.50 mmol, 1.0 eq.) 
in Et2O (2 mL) was added dropwise and the resulting solution was stirred at −78 °C for 
1 h.  MeOH (1 mL) was added and the solution was warmed to rt over 30 min.  The 
solution was poured into saturated NH4Cl(aq) (10 mL) and the two layers were separated.  
The aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organic layers 
were dried (Na2SO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 4:1-3:1 petrol-EtOAc + 1% 
Et3N as eluent gave recovered carbamate 124 (51 mg, 59%) as a colourless oil and a 
70:5:13:12 mixture (by 
1
H NMR spectroscopy) of sulfoxides anti-rac-103, syn-rac-103, 
anti-rac-123, syn-rac-123 (180 mg, 66%, 5%, 13%, 12% respectively based on 
sulfoxide anti-rac-103) as a pale yellow oil. 
 
Optimisation of Sulfoxide → Mg Exchange Reaction (Table 2.3) 
Methyl 2-[(N,N-diisopropylcarbamoyl)oxy]-4-phenylbutanoate rac-126, O-alkyl 
carbamate 14, and i-propyl p-tolyl sulfoxide rac-128  
 
(Table 2.3, Entry 1) 
rac-126
Ph
O
OMe
O
O
iPr2N
S
pTol
O
rac-128
Ph O NiPr2
O
14  
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Using general procedure D, i-PrMgCl (0.11 mL of a 2.0 M solution in THF, 0.22 mmol, 
1.1 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at 0 °C 
for 10 s and methyl chloroformate (19 mg, 0.22 mmol, 1.1 eq.) at 0 °C for 5 min gave 
the crude product. Purification by flash column chromatography on silica with 9:1 
petrol-EtOAc as eluent gave ester rac-126 (31 mg, 49%) as a colourless oil, recovered 
sulfoxide anti-rac-103 (16 mg, 20%) and sulfoxide rac-128 (20 mg, 54%) as a 
colourless oil. 
Lab Book Reference: PJR 4/282 
 
(Table 2.3, Entry 2) 
Using general procedure D, i-PrMgCl (0.13 mL of a 2.0 M solution in THF, 0.26 mmol, 
1.3 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at 0 °C 
for 1 min and methyl chloroformate (25 mg, 0.26 mmol, 1.3 eq.) at 0 °C for 5 min gave 
the crude product. Purification by flash column chromatography on silica with 9:1 
petrol-EtOAc as eluent gave ester rac-126 (37 mg, 58%) as a colourless oil, O-alkyl 
carbamate 14 (2 mg, 3 %) as a colourless oil, recovered sulfoxide anti-rac-103 (3 mg, 
3%) and sulfoxide rac-128 (27 mg, 74%). 
Lab Book Reference: PJR 4/284 
 
(Table 2.3, Entry 3) 
Using general procedure D, i-PrMgCl (0.13 mL of a 2.0 M solution in THF, 0.26 mmol, 
1.3 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 
20 s and methyl chloroformate (25 mg, 0.26 mmol, 1.3 eq.) at rt for 5 min gave the 
crude product. Purification by flash column chromatography on silica with 9:1 petrol-
EtOAc as eluent gave ester rac-126 (35 mg, 56%) as a colourless oil, O-alkyl carbamate 
14 (1 mg, 1%) as a colourless oil, recovered sulfoxide anti-rac-103 (4 mg, 5%) and 
sulfoxide rac-128 (26 mg, 71%). 
Lab Book Reference: PJR 4/288 
 
(Table 2.3, Entry 4) 
Using general procedure D, i-PrMgCl (0.13 mL of a 2.0 M solution in THF, 0.26 mmol, 
1.3 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 
1 min and methyl chloroformate (25 mg, 0.26 mmol, 1.3 eq.) at rt for 5 min gave the 
crude product. Purification by flash column chromatography on silica with 9:1 petrol-
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EtOAc as eluent gave ester rac-126 (37 mg, 65%) as a colourless oil, O-alkyl carbamate 
14 (4 mg, 6%) as a colourless oil, recovered sulfoxide anti-rac-103 (16 mg, 8%) and 
sulfoxide rac-128 (27 mg, 73%).  
 
(Table 2.3, Entry 5) 
Using general procedure D, i-PrMgCl (0.13 mL of a 2.0 M solution in THF, 0.26 mmol, 
1.3 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 
5 min and methyl chloroformate (25 mg, 0.26 mmol, 1.3 eq.) at rt for 5 min gave the 
crude product. Purification by flash column chromatography on silica with 9:1 petrol-
EtOAc as eluent gave ester rac-126 (27 mg, 48%) as a colourless oil, O-alkyl carbamate 
14 (9 mg, 14%) as a colourless oil, recovered sulfoxide anti-rac-103 (8 mg, 4%) and 
sulfoxide rac-128 (30 mg, 81%).  
  
(Table 2.3, Entry 6) 
Using general procedure D, i-PrMgCl (0.15 mL of a 2.0 M solution in THF, 0.30 mmol, 
1.5 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 
1 min and methyl chloroformate (29 mg, 0.30 mmol, 1.5 eq.) at rt for 5 min gave the 
crude product. Purification by flash column chromatography on silica with 9:1 petrol-
EtOAc as eluent gave ester rac-126 (38 mg, 67%) as a colourless oil, O-alkyl carbamate 
14 (6 mg, 9%) as a colourless oil and sulfoxide rac-128 (31 mg, 84%).  
 
(Table 2.3, Entry 7) 
Using general procedure D, i-PrMgCl (0.15 mL of a 2.0 M solution in THF, 0.30 mmol, 
1.5 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 
5 min and methyl chloroformate (29 mg, 0.30 mmol, 1.5 eq.) at rt for 5 min gave the 
crude product. Purification by flash column chromatography on silica with 9:1 petrol-
EtOAc as eluent gave ester rac-126 (24 mg, 42%) as a colourless oil, O-alkyl carbamate 
14 (9 mg, 17%) as a colourless oil and sulfoxide rac-128 (30 mg, 82%).  
 
(Table 2.3, Entry 8) 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 
1 min and methyl chloroformate (48 mg, 0.50 mmol, 2.5 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 9:1 petrol-EtOAc as eluent 
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gave ester rac-126 (48 mg, 75%) as a colourless oil, O-alkyl carbamate 14 (2.5 mg, 5%) 
as a colourless oil and sulfoxide rac-128 (31 mg, 84%).  
 
Methyl (2R)-[N,N-(diisopropylcarbamoyl)oxy]-4-phenylbutanoate (R)-126  
(R)-126
Ph
O H
OMe
O
O
iPr2N
 
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-(S,Ss)-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) and 
methyl chloroformate (48 mg, 0.50 mmol, 2.5 eq.) gave the crude product. Purification 
by flash column chromatography on silica with 9:1 petrol-EtOAc as eluent gave ester 
(R)-126 (46 mg, 73%, 99:1 er by CSP-HPLC) as a colourless oil, RF (9:1 petrol-EtOAc) 
0.2;
 1
H NMR (400 MHz, CDCl3) δ 7.30 (t, J = 7.5 Hz, 2H, m-Ph), 7.23-7.19 (m, 3H, 
Ph), 5.08 (t, J = 6.5 Hz, 1H, OCH), 4.11 (br s, 1H, NCH), 3.80 (br s, 1H, NCH), 3.73 (s, 
3H, OMe), 2.79-2.75 (m, 2H, PhCH2), 2.21-2.15 (m, 2H, CH), 1.35-1.20 (br m, 12H, 
NCHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 171.6 (CO2Me), 154.8 (i-Pr2NC=O), 140.7 
(ipso-Ph), 128.5 (Ph), 128.3 (Ph), 126.2 (Ph), 72.0 (OCH), 52.0 (OMe), 45.4 (br, NCH), 
33.3 (CH2), 31.8 (CH2), 20.4 (br, Me); [α]D −17.8 (c 0.55 in CH2Cl2) [lit.
127, [α]D −17.3 
(c 1.0 in CH2Cl2) for (R)-126 of 97:3 er)]; CSP-HPLC: Chiracel OD (95:5 Hexane-
iPrOH, 0.5 mL min
-1
) (S)-126 10.7 min, (R)-126 11.9 min.  Spectroscopic data 
consistent with those reported in the literature.
127
  
 
1-Phenylhex-5-en-(3R)-yl N,N-diisopropylcarbamate (R)-129 
(R)-129
Ph
O
O
iPr2N
 
 
i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 2.5 eq.) was added 
dropwise to a stirred solution of sulfoxide anti-(S,Ss)-103 (80 mg, 0.20 mmol, 1.0 eq.) in 
THF (8 mL) at rt under Ar.  The resulting solution was stirred at rt for 1 min.  Then, a 
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solution of CuBr.SMe2 (8.2 mg, 0.04 mmol, 0.2 eq.) in THF (1.0 mL) and allyl bromide 
(43 μL, 0.50 mmol, 2.5 eq.) were added sequentially. The solution was stirred at rt for 2 
h.  Then, saturated NH4Cl(aq) (10 mL) was added and the two layers were separated.  
The aqueous layer was extracted with Et2O (3 x 10 mL). The combined organic layers 
were dried (Na2SO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 9:1 petrol-Et2O as eluent 
gave carbamate (R)-129 (43 mg, 70%, 99:1 er by CSP-HPLC) as a colourless oil, RF 
(9:1 petrol-Et2O) 0.3; IR (film) 3047, 2901, 2874, 1654 (C=O),  1597, 1487, 1301, 
1298, 1275, 1117, 1054, 893 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.29-7.25 (m, 2H, 
Ph), 7.19-7.15 (m, 3H, Ph), 5.85-5.76 (m, 1H, CH2=CH), 5.11-5.04 (m, 2H, CH2=CH), 
5.00-4.93 (m, 1H, OCH), 4.10 (br s, 1H, NCH), 3.74 (br s, 1H, NCH), 2.74-2.60 (m, 
2H, CH), 1.96-1.83 (m, 2H, CH), 1.25-1.21 (br m, 12H, NCHMe2); 
13
C NMR (100.6 
MHz, CDCl3) δ 155.4 (C=O), 142.0 (ipso-Ph), 134.1 (CH2=CH), 128.4 (Ph), 128.3 (Ph) 
125.8 (Ph), 117.5 (CH2=CH), 73.2 (OCH), 46.2 (br, NCH),  39.0 (CH2), 35.9 (CH2), 
31.9 (CH2), 20.8 (br, NCHMe2); MS (ESI) m/z 326 [(M + Na)
+
, 100], 304 [(M + H)
+
, 
20]; HRMS m/z calcd for C19H29NO2 (M + Na)
+
 326.2091, found 326.2082 (+2.5 ppm 
error).  [α]D +3.0 (c 0.45 in CHCl3); CSP-HPLC: Chiracel OD-H (99:1 Hexane-iPrOH, 
1.0 mLmin
-1
) (R)-129 5.4 min, (S)-129 6.7 min.   
 
1-Phenylhex-5-en-3-yl N,N-diisopropylcarbamate rac-129 
rac-129
Ph
O
O
iPr2N
 
 
i-PrMgCl (0.15 mL of a 2.0 M solution in THF, 0.30 mmol, 1.5 eq.) was added 
dropwise to a stirred solution of sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in 
THF (8 mL) at rt under Ar.  The resulting solution was stirred at rt for 1 min.  Then, a 
solution of CuBr.SMe2 (8.2 mg, 0.04 mmol, 0.2 eq.) in THF (1.0 mL) and allyl bromide 
(26 μL, 0.30 mmol, 1.5 eq.) were added sequentially. The solution was stirred at rt for 2 
h.  Then, saturated NH4Cl(aq) (10 mL) was added and the two layers were separated.  
The aqueous layer was extracted with Et2O (3 x 10 mL). The combined organic layers 
were dried (Na2SO4) and evaporated under reduced pressure to give the crude product. 
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Purification by flash column chromatography on silica with 9:1 petrol-Et2O as eluent 
gave carbamate rac-129 (31 mg, 51%) as a colourless oil. 
 
(1R)-(1-Hydroxycyclohexyl)-3-phenylpropyl N,N-diisopropylcarbamate (R)-127  
(R)-127
Ph
O
O
iPr2N
OH
 
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-(S,Ss)-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt 
for 1 min and cyclohexanone (52 μL, 0.50 mmol, 2.5 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 95:5 CH2Cl2-Et2O as eluent 
gave alcohol (R)-127 (52 mg, 71%, 99:1 er by CSP-HPLC) as a colourless oil, RF (95:5 
CH2Cl2-Et2O) 0.2; IR (film) 3392 (OH), 2920, 2889, 1647 (C=O), 1417, 1347, 1278, 
1138, 1117, 1034, 894 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.30-7.27 (m, 2H, Ph), 7.20-
7.17 (m, 3H, Ph), 4.88-4.81 (m, 1H, OCH), 4.09 (br s, 1H, NCH), 3.87 (br s, 1H, NCH), 
2.75-2.58 (m, 2H, CH), 1.98-1.94 (m, 2H, CH), 1.84 (br s, 1H, OH), 1.63-1.25 (br m, 
22H, CH + NCHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 155.9 (C=O), 142.1 (ipso-Ph), 
128.4 (Ph), 128.3 (Ph) 125.8 (Ph), 80.1 (OCH), 73.2 (COH), 46.5 (br, NCH), 45.4 (br, 
NCH), 34.3 (CH2), 33.2 (CH2), 32.7 (CH2), 31.2 (CH2), 25.8 (CH2), 21.8 (br, NCHMe2), 
21.5 (CH2), 21.4 (CH2), 20.5 (br, NCHMe2); MS (ESI) m/z 384 [(M + Na)
+
, 90], 219 
(100), 90 (80); HRMS m/z calcd for C22H35NO3 (M + Na)
+
 384.2509, found 384.2493 
(+4.1 ppm error); [α]D +29.1 (c 0.6 in CHCl3); CSP-HPLC: Chiracel OD (98:2 Hexane-
iPrOH, 0.5 mLmin
-1
) (R)-127 14.5 min, (S)-127 21.2 min. 
 
Using general procedure D, i-PrMgCl (0.13 mL of a 2.0 M solution in THF, 0.25 mmol, 
2.5 eq.) and sulfoxide anti-(S,Ss)-103 (40 mg, 0.10 mmol, 1.0 eq.) in THF (4 mL) at rt 
for 15 min and cyclohexanone (26 μL, 0.50 mmol, 2.5 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 95:5 CH2Cl2-Et2O as eluent 
gave alcohol (R)-127 (12 mg, 34%, 98:2 er by CSP-HPLC) as a colourless oil. 
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Using general procedure D, i-PrMgCl (0.13 mL of a 2.0 M solution in THF, 0.25 mmol, 
2.5 eq.) and sulfoxide anti-(S,Ss)-103 (40 mg, 0.10 mmol, 1.0 eq.) in THF (4 mL) at rt 
for 30 min and cyclohexanone (26 μL, 0.50 mmol, 2.5 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 95:5 CH2Cl2-Et2O as eluent 
gave alcohol (R)-127 (8.5 mg, 24%, 98:2 er by CSP-HPLC) as a colourless oil. 
 
 
(1S)-(1-Hydroxycyclohexyl)-3-phenylpropyl N,N-diisopropylcarbamate (S)-127 
and (S)-isopropyl p-tolyl sulfoxide (S)-128  
(S)-127
Ph
O
O
iPr2N
OH
S
O
(S)-128  
 
Using general procedure D, i-PrMgCl (0.43 mL of a 2.0 M solution in THF, 0.60 mmol, 
2.5 eq.) and sulfoxide syn-(R,Ss)-103 (96 mg, 0.24 mmol, 1.0 eq.) in THF (9 mL) at rt 
for 1 min and cyclohexanone (62 μL, 0.60 mmol, 2.5 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 95:5 CH2Cl2-Et2O as eluent 
gave alcohol (S)-127 (65 mg, 74%, 99:1 er by CSP-HPLC) as a colourless oil,  [α]D 
−28.6 (c 1.0 in CHCl3); CSP-HPLC: Chiracel OD (98:2 Hexane-iPrOH, 0.5 mLmin
-1
) 
(R)-127 13.4 min, (S)-127 21.4 min and sulfoxide (S)-128 (31 mg, 78%) as a colourless 
oil, RF (95:5 CH2Cl2-Et2O) 0.05;
 1
H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 8.0 Hz, 2H, 
m-C6H4Me), 7.31 (d, J = 8.0 Hz, 2H, o-C6H4Me), 2.82 (sept, J = 7.0 Hz, 1H, S(O)CH), 
2.82 (s, 3H, Me), 1.19 (d, J = 7.0 Hz, 3H, CHMe), 1.15 (d, J = 7.0 Hz, 3H, CHMe); 
13
C 
NMR (100.6 MHz, CDCl3) δ 141.5 (ipso-Ar), 138.5 (ipso-Ar), 129.6 (Ar), 125.1 (Ar), 
54.6 (CHMe2), 21.5 (Me), 15.8 (Me), 14.2 (Me); [α]D −194.2 (c 1.0 in EtOH) [lit.
115
, 
[α]D −187 (c 2.4 in EtOH)].  Spectroscopic data consistent with those reported in the 
literature.
216
 
 
The isolation of sulfoxide (S)-128 allows assignment of the configuration in sulfoxides 
anti-(S,Ss)-103 and syn-(R,Ss)-103.  Sulfoxide (S)-128 is the expected product of double 
inversion from Andersen’s sulfinate (SS)-97. 
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1-(1-Hydroxycyclohexyl)-3-phenylpropyl N,N-diisopropylcarbamate rac-127 
rac-127
Ph
O
O
iPr2N
OH
 
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 
1 min and cyclohexanone (52 μL, 0.50 mmol, 2.5 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 95:5 CH2Cl2-Et2O as eluent 
gave alcohol rac-127 (45 mg, 62%) as a colourless oil. 
 
1-Hydroxy-1,4-diphenylbutan-2-yl N,N-diisopropylcarbamate (R,S)-130 and (R,R)-
130 
(R,S)-130
Ph
O
O
iPr2N
OH
Ph
Ph
O
O
iPr2N
OH
Ph
(R,R)-130  
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-(S,Ss)-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt 
for 1 min and benzaldehyde (51 μL, 0.50 mmol, 2.5 eq.) gave the crude product which 
contained a 90:10 mixture of (R,S)-130 and (R,R)-130 by 
1
H NMR spectroscopy.    
Purification by flash column chromatography on silica with 95:5-9:1 petrol-EtOAc as 
eluent gave a 96:4 mixture (by 
1
H NMR spectroscopy) of alcohols (R,S)-130 and (R,R)-
130 (42 mg, 58%, each diastereoisomer 99:1 er by CSP-HPLC) as a colourless oil, RF 
(9:1 petrol-EtOAc) 0.2; IR (film) 3378 (OH), 2923, 2881, 1653 (C=O), 1572, 1451, 
1358, 1139, 1118, 943 cm
-1 1
H NMR (400 MHz, CDCl3) δ 7.34-7.32 (m, 4H, Ph), 7.28-
7.26 (m, 3H, Ph), 7.21-7.17 (m, 1H, Ph), 7.14-7.12 (m, 2H, Ph),  5.12-5.08 (m, 0.96H, 
OCH), 5.06-5.01 (m, 0.04H, OCH), 4.89 (d, J = 3.0 Hz,  1H, CHOH), 3.98-3.81 (m, 2H, 
NCH), 2.77-2.70 (m, 1H, PhCHAHB), 2.64-2.57 (m, 1H, PhCHAHB), 1.94-1.88 (m, 2H, 
CH), 1.27-1.08 (m, 12H, NCHMe2), OH not resolved;
 13
C NMR (100.6 MHz, CDCl3) 
for (R,S)-130 δ 156.1 (C=O), 141.4 (ipso-Ph), 140.1 (ipso-Ph), 128.4 (Ph), 128.3 (Ph) 
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128.0 (Ph), 127.5 (Ph), 127.0 (Ph), 126.8 (Ph), 78.6 (OCH), 76.3 (OCH), 46.3 (br, 
NCH),  32.4 (CH2), 32.0 (CH2), 20.4 (br, NCHMe2); MS (ESI) m/z 392 [(M + Na)
+
, 
100], 370 [(M + H)
+
, 35]; HRMS m/z calcd for C19H29NO2 (M + Na)
+
 392.2202, found 
392.2202 (+0.3 ppm error), CSP-HPLC: Chiracel OD (95:5 Hexane-iPrOH, 1.0 mLmin
-
1
) (S,S)-130 14.5 min, (R,S)-130 16.7 min, (R,R)-130 18.6 min, (S,R)-130 26.5 min.  
 
1-Hydroxy-1,4-diphenylbutan-2-yl N,N-diisopropylcarbamate anti-rac-130 and 
syn-rac-130 
anti-rac-130
Ph
O
O
iPr2N
OH
Ph
Ph
O
O
iPr2N
OH
Ph
syn-rac-130  
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-(S,Ss)-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt 
for 1 min and benzaldehyde (51 μL, 0.50 mmol, 2.5 eq.) gave the crude product which 
contained a 90:10 mixture of (R,S)-130 and (R,R)-130 by 
1
H NMR spectroscopy.    
Purification by flash column chromatography on silica with 95:5-9:1 petrol-EtOAc as 
eluent gave a 92:8 mixture (by 
1
H NMR spectroscopy) of alcohols (R,S)-130 and (R,R)-
130 (36 mg, 49%) as a colourless oil. 
 
4-Hydroxy-5,5-dimethyl-1-phenylhexan-3-yl N,N-bis(propan-2-yl)carbamate (R,S)-
131 and (R,R)-131 
(R,S)-131
Ph
O
O
iPr2N
OH
Ph
O
O
iPr2N
OH
(R,R)-131  
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and  sulfoxide anti-(S,Ss)-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt 
for 1 min and pivaldehyde (54 μL, 0.50 mmol, 2.5 eq.) gave the crude product which 
contained a 60:40 mixture of (R,S)-131 and (R,R)-131 by 
1
H NMR spectroscopy.  
Purification by flash column chromatography on silica with 9:1-8:2 petrol-Et2O as 
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eluent gave a 70:30 mixture (by 
1
H NMR spectroscopy) of alcohols (R,S)-131 and 
(R,R)-131 (54 mg, 78%, minor diastereoisomer 99:1 er by CSP-HPLC of the diol, major 
diastereoisomer er not determined) as a colourless oil, RF (8:2 petrol-Et2O) 0.2; IR 
(film) 3383 (OH), 2914, 2889, 1648 (C=O), 1429, 1300, 1271, 1045 cm
-1
;
 1
H NMR 
(400 MHz, CDCl3)  δ 7.31-7.27 (m, 2H, Ph), 7.22-7.17 (m, 3H, Ph), 5.19 (br t, J = 8.0 
Hz, 0.3H, OCH), 4.98 (dt, J = 10.0, 2.5 Hz, 0.7H, OCH), 4.04-3.90 (br m, 2H, NCH), 
3.48 (d, J = 2.5 Hz, 0.7H, CHOH), 3.24 (d, J = 1.0 Hz, 0.3H, CHOH), 2.78 (ddd, J = 
14.0, 10.5, 5.0 Hz, 0.7H, CH), 2.68-2.60 (m, 1.3H, CH), 2.32 (br s, 1H, OH), 2.20-2.10 
(m, 1H, CH), 2.00-1.91 (m, 1H, CH), 1.28-1.26 (m, 12H, NCHMe2), 0.96 (s, 6.3H, 
CMe3), 0.95 (s, 2.7H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) for (R,S)-131 and (R,R)-
131  δ 155.3 (C=O), 154.3 (C=O), 142.0 (ipso-Ph), 141.7 (ipso-Ph), 128.4 (Ph), 128.3 
(Ph) 128.3 (Ph), 128.3 (Ph), 125.8 (Ph) 125.8 (Ph),  80.9 (OCH), 79.8 (OCH), 76.2 
(OCH), 72.8 (OCH), 46.0 (br, NCH), 45.5 (br, NCH),  35.1 (CMe3), 34.6 (CMe3), 32.41 
(CH2), 32.40 (CH2), 32.1 (CH2), 26.6 (CMe3), 26.4 (CMe3) 21.6 (br, NCHMe2), 20.5 
(br, NCHMe2); MS (ESI) m/z 372 [(M + Na)
+
, 100], 350 [(M + H)
+
, 50]; HRMS m/z 
calcd for C20H34NO3 (M + Na)
+
 372.2509, found 372.2496 (+3.4 ppm error).   
 
4-Hydroxy-5,5-dimethyl-1-phenylhexan-3-yl N,N-bis(propan-2-yl)carbamate anti-
rac-131 and syn-rac-131 
anti-rac-131
Ph
O
O
iPr2N
OH
Ph
O
O
iPr2N
OH
syn-rac-131  
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-rac-6 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 1 
min and pivaldehyde (54 μL, 0.50 mmol, 2.5 eq.) gave the crude product which 
contained a 60:40 mixture of anti-rac-19 and syn-rac-19 by 
1
H NMR spectroscopy.  
Purification by flash column chromatography on silica with 9:1-8:2 petrol-Et2O as 
eluent gave a 70:30 mixture (by 
1
H NMR spectroscopy) of alcohols anti-rac-19 and 
syn-rac-19 (48 mg, 69%) as a colourless oil. 
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(3R,4R)-5,5-Dimethyl-1-phenylhexane-3,4-diol syn-(R,R)-300 and (3R,4S)-5,5-
dimethyl-1-phenylhexane-3,4-diol anti-(R,S)-300 
 
ant i-(R,S)-300
Ph
OH
OH
Ph
OH
OH
syn-(R,R)-300  
 
A 70:30 mixture of alcohols anti-(R,S)-131 and syn-(R,R)-131 (13 mg, 0.037 mmol, 1.0 
eq.) in THF (1 mL) was added dropwise to a stirred suspension of  LiAlH4 (9 mg, 0.22 
mmol, 6.0 eq.) in THF (2 mL) at 0 °C under Ar.  The resulting solution was stirred and 
heated at 70 °C for 1 h.  Then, the solution was cooled to 0 °C and water (1 mL), 2 M 
NaOH(aq) (2 mL) and MgSO4 were added sequentially. The solids were removed by 
filtration. The filtrate was washed with water (5 mL), dried (MgSO4) and evaporated 
under reduced pressure to give the crude product which contained a 70:30 mixture of 
anti-(R,S)-300 and syn-(R,R)-300 by 
1
H NMR spectroscopy.  Purification by flash 
column chromatography on silica with 4:1-3:1 petrol-EtOAc as eluent gave diol syn-
(R,R)-300 (1.5 mg, 18%, 99:1 er by CSP-HPLC) as a colourless oil, RF (3:1 petrol-
EtOAc) 0.3; 
1
H NMR (400 MHz, CDCl3) δ 7.32-7.28 (m, 2H, Ph), 7.23-7.18 (m, 3H, 
Ph), 3.82 (ddd, J = 8.0, 5.0, 1.0 Hz 1H, CHOH), 3.10 (d, J = 1.0 Hz, 1H, CHOH), 2.80 
(ddd, J = 14.0 10.0, 6.0 Hz, 1H, PhCHAHB), 2.70 (ddd, J = 14.0, 9.5, 6.5 Hz, 1H, CH), 
1.98 (br s, 2H, OH), 1.93 (dddd, J = 14.0, 9.5, 8.0, 6.0 Hz 1H, CH), 1.80 (dddd, J = 
14.0, 10.0, 6.5, 5.0 Hz, 1H, CH), 0.94 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 
141.8 (ipso-Ph), 128.41 (Ph), 128.37 (Ph) 125.9 (Ph), 79.9 (CHOH), 68.9 (CHOH), 38.5 
(CH2), 35.0 (CMe3) 32.1 (CH2), 26.2 (CMe3); MS (ESI) m/z 245 [(M + Na)
+
, 100]; 
HRMS m/z calcd for C14H22O2 (M + Na)
+
 245.1512, found 245.1505 (+2.8 ppm error); 
CSP-HPLC: Chiracel AD-H (98:2 Hexane-iPrOH, 1.0 mLmin
-1
) (R,R)-300 20.5 min, 
(S,S)-300 22.2 min and diol anti-(R,S)-300 (4.5 mg, 55%, er not determined) as a 
colourless oil, RF (3:1 petrol-EtOAc) 0.2; 
1
H NMR (400 MHz, CDCl3) δ 7.32-7.28 (m, 
2H, Ph), 7.24-7.17 (m, 3H, Ph), 3.73 (ddd, J = 10.0, 4.0, 3.0 Hz 1H, CHOH), 3.39 (d, J 
= 4.0 Hz, CHOH), 2.92 (ddd, J = 14.0 10.0 (9.5), 5.0 Hz, 1H, PhCHAHB), 2.69 (ddd, J = 
14.0, 9.5, 7.0 Hz, 1H, CH), 1.96 (dddd, J = 14.0, 9.5, 7.0, 3.0 Hz 1H, CH), 1.89-1.79 
(m, 3H, CH + OH), 0.95 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 142.1 (ipso-
Ph), 128.5 (Ph), 128.4 (Ph) 125.8 (Ph), 82.8 (CHOH), 72.0 (CHOH), 34.3 (CMe3), 33.9 
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(CH2), 32.2 (CH2), 26.7 (CMe3); MS (ESI) m/z 245 [(M + Na)
+
, 100]; HRMS m/z calcd 
for C14H22O2 (M + Na)
+
 245.1512, found 245.1514 (−0.6 ppm error).  
 
5,5-Dimethyl-1-phenylhexane-3,4-diol syn-rac-300 and anti-rac-300 
 
anti-rac-300
Ph
OH
OH
Ph
OH
OH
syn-rac-300  
 
An 80:20 mixture of alcohols anti-rac-131 and syn-rac-131 (90 mg, 0.26 mmol, 1.0 eq.) 
in THF (4 mL) was added dropwise to a stirred suspension of  LiAlH4 (60 mg, 1.56 
mmol, 6.0 eq.) in THF (5 mL) at 0 °C under Ar.  The resulting solution was stirred and 
heated at 70 °C for 1 h.  Then, the solution was cooled to 0 °C and water (2 mL), 2 M 
NaOH(aq) (4 mL) and MgSO4 were added sequentially. The solids were removed by 
filtration. The filtrate was washed with water (5 mL), dried (MgSO4) and evaporated 
under reduced pressure to give the crude product which contained an 80:20 mixture of 
anti-rac-300 and syn-rac-300 by 
1
H NMR spectroscopy.  Purification by flash column 
chromatography on silica with 4:1-3:1 petrol-EtOAc as eluent gave diol syn-rac-300 (9 
mg, 16%) as a colourless oil and diol anti-rac-300 (28 mg, 49%) as a colourless oil  
 
(3R,4S) 4-Hydroxy-5-methyl-1-phenylhexan-3-yl N,N-diisopropylcarbamate (R,S)-
132 
(R,S)-132
Ph
O
O
iPr2N
OH
 
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-(S,Ss)-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt 
for 1 min and isobutyraldehyde (46 μL, 0.50 mmol, 2.5 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 9:1-8:2 petrol-Et2O as 
eluent gave alcohol (R,S)-132 (46 mg, 70%, 99:1 er by CSP-HPLC) as a colourless oil, 
RF (8:2 petrol-Et2O) 0.3; IR (film) 3389 (OH), 2923, 2889, 1648 (C=O), 1418, 1348, 
Chapter Five: Experimental 
 
195 
 
1280, 1139, 1118, 1045 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.29-7.27 (m, 2H, Ph), 
7.20-7.18 (m, 3H, Ph), 4.98 (dt, J = 10.5, 3.5 Hz, 1H, OCH), 4.10-3.89 (br m, 2H, 
NCH), 3.48 (dd, J = 7.0, 3.5 Hz, 1H, CHOH), 2.78 (ddd, J = 14.0, 10.5, 5.0 Hz, 1H, 
PhCHAHB), 2.64 (ddd, J = 14.0, 10.5, 6.5 Hz, 1H, PhCHAHB), 2.17 (br s, 1H, OH), 2.06 
(dtd, J = 14.5, 10.5, 5.0 Hz, 1H, CH), 1.91 (dddd, J = 14.5, 10.5, 6.5, 3.5 Hz, 1H, CH), 
1.70 (oct, J = 7.0 Hz, 1H, CHMe2), 1.26 (d, J = 7.0 Hz, 12H, NCHMe2), 0.99 (d, J = 7.0 
Hz, 3H, CHMe2), 0.91 (d, J = 7.0 Hz, 3H, CHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 
155.3 (C=O), 141.9 (ipso-Ph), 128.4 (Ph), 128.3 (Ph) 125.9 (Ph), 78.3 (OCH), 76.1 
(CHOH), 46.0 (br, NCH),  32.3 (CH2), 31.0 (CH2), 30.2 (CHMe2), 21.5 (br, NCHMe2), 
20.5 (br, NCHMe2), 19.3 (Me), 18.4 (Me); MS (ESI) m/z 358 [(M + Na)
+
, 100], 336 [(M 
+ H)
+
, 80]; HRMS m/z calcd for C20H34NO3 (M + Na)
+
 358.2353, found 358.2347 (+1.5 
ppm error); [α]D +21.22 (c 0.40 in CHCl3); CSP-HPLC: Chiracel OD (95:5 Hexane-
iPrOH, 1.0 mLmin
-1
) (R,S)-132 5.8 min, (S,R)-132 7.8 min. 
 
4-Hydroxy-5-methyl-1-phenylhexan-3-yl N,N-diisopropylcarbamate anti-rac-132  
anti-rac-132
Ph
O
O
iPr2N
OH
 
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 
1 min and isobutyraldehyde (46 μL, 0.50 mmol, 2.5 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 9:1-8:2 petrol-Et2O as 
eluent gave alcohol anti-rac-132 (49 mg, 75%) a colourless oil. 
 
4-Hydroxy-1-phenyloctan-3-yl N,N-diisopropylcarbamate (R,S)-133 and (R,R)-133 
(R,S)-133
Ph
O
O
iPr2N
OH
Ph
O
O
iPr2N
OH
(R,R)-133  
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-(S,Ss)-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt 
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for 1 min and valeraldehyde (53 μL, 0.50 mmol, 2.5 eq.) gave the crude product which 
contained a 90:10 mixture of (R,S)-133 and (R,R)-133 by 
1
H NMR spectroscopy.  
Purification by flash column chromatography on silica with 9:1-8:2 petrol-Et2O as 
eluent gave a 90:10 mixture (by 
1
H NMR spectroscopy) of alcohols (R,S)-133 and 
(R,R)-133 (45 mg, 65%, each diastereoisomer 99:1 er by CSP:HPLC) as a colourless 
oil, RF (8:2 petrol-Et2O) 0.3; IR (film) 3399 (OH), 2923, 2878, 1647 (C=O), 1428, 1291, 
1239, 1117, 1035 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.30-7.26 (m, 2H, Ph), 7.20-7.16 
(m, 3H, Ph), 4.87 (dt, J = 8.0, 3.5 Hz, 0.9H, OCH), 4.85-4.80 (m, 0.1H, OCH), 4.06 (br 
s, 1H, NCH), 3.84 (br s, 1H, NCH), 3.69 (dt, J = 9.0, 3.5 Hz, 0.9H, CHOH), 3.65-3.61 
(m, 0.1H, CHOH),  2.79-2.59 (m, 2H, CH), 2.04-1.94 (m, 1H, CH), 1.90-1.81 (m, 1H, 
CH), 1.55-1.24 (m, 18H), 0.88 (t, J = 8.0 Hz, 3H, Me); 
13
C NMR (100.6 MHz, CDCl3) 
for (R,S)-21 δ 156.2 (C=O), 141.6 (ipso-Ph), 128.4 (Ph), 128.3 (Ph) 126.0 (Ph), 78.6 
(OCH), 73.9 (CHOH), 45.6 (br, NCH),  32.5 (CH2), 32.2 (CH2), 32.0 (CH2), 30.2 
(CHMe2), 31.9 (CH2), 22.7 (CH2), 20.4 (br, NCHMe2), 14.0 (Me); MS (ESI) m/z 372 
[(M + Na)
+
, 100], 350 [(M + H)
+
, 30]; HRMS m/z calcd for C21H35NO3 (M + Na)
+
 
372.2509, found 372.2493 (+4.3 ppm error); CSP-HPLC: Chiracel OD (99:1 Hexane-
iPrOH, 1.0 mLmin
-1
) (R,R)-133 16.8 min, (R,S)-133 19.3 min, (S,S)-133 19.3 min, 
(S,R)-133 28.3 min. 
 
4-Hydroxy-1-phenyloctan-3-yl N,N-diisopropylcarbamate anti-rac-133 and syn-
rac-133 
ant i-rac-133
Ph
O
O
iPr2N
OH
Ph
O
O
iPr2N
OH
syn-rac-133  
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 
1 min and valeraldehyde (53 μL, 0.50 mmol, 2.5 eq.) gave the crude product which 
contained a 90:10 mixture of (R,S)-133 and (R,R)-133 by 
1
H NMR spectroscopy.  
Purification by flash column chromatography on silica with 9:1-8:2 petrol-Et2O as 
eluent gave a 90:10 mixture (by 
1
H NMR spectroscopy) of alcohols anti-rac-133 and 
syn-rac-133 (37 mg, 53%) as a colourless oil. 
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1-Phenyloctane-3,4-diol anti-rac-134 and syn-rac-134 
 
ant i-rac-134
Ph
OH
OH
Ph
OH
OH
syn-rac-134  
 
A 90:10 mixture of alcohols anti-rac-134 and syn-rac-134 (30 mg, 0.086 mmol, 1.0 eq.) 
in THF (1 mL) was added dropwise to a stirred suspension of LiAlH4 (20 mg, 0.52 
mmol, 6.0 eq.) in THF (2 mL) at 0 °C under Ar.  The resulting solution was stirred and 
heated at 70 °C for 1 h.  Then, the solution was cooled to 0 °C and water (1 mL), 2 M 
NaOH(aq) (2 mL) and MgSO4 were added sequentially. The solids were removed by 
filtration. The filtrate was washed with water (5 mL), dried (MgSO4) and evaporated 
under reduced pressure to give the crude product which contained a 90:10 mixture of 
anti-rac-134 and syn-rac-134 by 
1
H NMR spectroscopy.  Purification by flash column 
chromatography on silica with 3:1 petrol-EtOAc as eluent gave a 90:10 mixture (by 
1
H 
NMR spectroscopy) of diols anti-rac-134 and syn-rac-134 (17 mg, 89%) as a colourless 
oil, RF (3:1 petrol-EtOAc) 0.2; 
1
H NMR (400 MHz, CDCl3) δ 7.32-7.28 (m, 2H, Ph), 
7.24-7.18 (m, 3H, Ph), 3.65-3.60 (m, 1.8H, CHOH), 3.46-3.44 (m, 0.2H, CHOH), 2.93-
2.83 (m, 1H, CH), 2.76-2.64 (m, 1H, CH), 2.04-1.94 (m, 1H, CH), 1.81-1.77 (m, 5H, 
CH + OH), 1.50-1.25 (m, 6H, CH), 0.91 (t, J = 8.0 Hz, 3H, Me); 
13
C NMR (100.6 MHz, 
CDCl3) for anti-rac-134 δ 142.0 (ipso-Ph), 128.6 (Ph), 128.5 (Ph) 126.2 (Ph), 74.5 
(CHOH), 74.0 (CHOH), 32.9 (CH2), 32.4 (CH2), 31.1 (CH2), 28.2 (CH2), 22.8 (CH2), 
14.1 (Me).  Spectroscopic data for syn-rac-134 consistent with those reported in the 
literature.
130
  
 
This experiment enabled the relative stereochemistry of anti-rac-133 to be 
unequivocally established. 
 
 
Isobutyl boronic acid pinacol ester 301
217
 
301
B
O
O
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Isobutyl boronic acid (1.0 g, 9.90 mmol, 1.0 eq.) was added to a stirred suspension of 
pinacol (1.17 g, 9.90 mmol, 1.0 eq.) and MgSO4 (1.78 g, 14.85 mmol, 1.0 eq.) in Et2O 
(12 mL) at rt under Ar.  The resulting suspension was stirred at rt for 18 h.  The 
suspension was filtered and the filtrate was evaporated under reduced pressure.  The 
residue was dissolved in hexane (15 mL), washed with water (3 x 10 mL), dried 
(MgSO4) and (100.6 MHz, CDCl3) evaporated under reduced pressure to give the crude 
product.  Purification by Kügelrohr distillation gave  isobutyl boronic acid pinacol ester 
301 (1.40 g, 77%) as a colourless oil, bp 52-55 °C/8 mmHg (lit.,
217
 71 °C/14 mmHg) 
1
H 
NMR (400 MHz, CDCl3) δ 1.84 (nontet, J = 6.5 Hz, 1H, CHMe2), 1.22 (s, 12H, Me), 
0.90 (d, J = 6.5 Hz, 6H, CHMe2), 0.71 (d, J = 6.5 Hz, 2H, CH2); 
13
C NMR (100.6 MHz, 
CDCl3) δ 82.8 (OC), 25.3 (Me), 24.8 (CH2), 24.75 (Me), 15.8 (CH).  Spectroscopic data 
consistent with those reported in the literature.
217
 
Lab Book Reference PJR 6/486 
 
(3R)-5-Methyl-1-phenylhexan-3-ol (R)-135 
(R)-135
OH
 
 
i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 2.5 eq.) was added 
dropwise to a stirred solution of sulfoxide anti-(S,Ss)-103 (80 mg, 0.20 mmol, 1.0 eq.) in 
THF (8 mL) at rt under Ar.  The resulting solution was stirred at rt for 1 min.  Then, a 
solution of isobutylboronic acid pinacol ester 301 (107 μL, 0.50 mmol, 2.5 eq.) in THF 
(1 mL) was added dropwise. The solution was stirred at rt for 30 min and then stirred 
and heated at 67 °C for 16 h.  The reaction mixture was cooled to 0 °C and 3 M 
NaOH(aq) (0.5 mL) and 30 % H2O2(aq) (0.25 mL) were added sequentially.  The resulting 
solution was stirred at rt for 2 h and then 2 M NaOH(aq) (7 mL) was added. The two 
layers were separated and the aqueous layer was extracted with Et2O (3 x 10 mL).  The 
combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product.  Purification by flash column chromatography on silica with 
95:5-9:1 petrol-EtOAc as eluent gave alcohol (R)-135 (26 mg, 68%, 94:6 er by CSP-
HPLC) as a white solid, mp 44-45 °C (lit.,
217
 45-47 °C); RF (8:2 petrol-Et2O) 0.3; 
1
H 
NMR (400 MHz, CDCl3) δ 7.32-7.28 (m, 2H, Ph), 7.23-7.18 (m, 3H, Ph), 3.76-3.70 (m, 
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1H, CHOH), 2.81 (ddd, J = 13.5, 10.0, 6.0 Hz, 1H, PhCHAHB), 2.69 (ddd, J = 13.5, 
10.0, 6.5 Hz, 1H, PhCHAHB), 1.82-1.68 (m, 3H, PhCH2CH2 + CH), 1.48-1.40 (m, 2H, 
CH + OH), 1.30-1.28 (m, 1H, CH), 0.93 (d, J = 8.0 Hz, 3H, CHMe2), 0.91 (d, J = 8.0 
Hz, 3H, CHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 142.2 (ipso-Ph), 128.4 (4, Ph), 125.8 
(Ph) 69.5 (CHOH), 46.8 (CH2), 39.8 (CH2), 32.2 (CH2), 24.8 (CH or Me), 23.6 (CH or 
Me), 22.2 (CH or Me); [α]D +16.0 (c 0.55 in CHCl3) [lit.
217
 , [α]D +16.00 (c 0.70 in 
CHCl3) for (R)-135 of 97:3 er)]; CSP-HPLC: Chiracel OD (98:2 Hexane-iPrOH, 1.0 
mLmin
-1
) (S)-135 13.4 min, (R)-135 22.2 min. Spectroscopic data consistent with those 
reported in the literature.
217
  
 
n-BuLi (0.23 mL of a 2.2 M solution in hexanes, 0.50 mmol, 2.5 eq.) was added 
dropwise to a stirred solution of sulfoxide anti-(S,Ss)-103 (80 mg, 0.20 mmol, 1.0 eq.) in 
THF (8 mL) at −78 °C under Ar.  The resulting solution was stirred at −78 °C for 1 min.  
Then, a solution of isobutylboronic pinacol ester 301 (107 μL, 0.50 mmol, 2.5 eq.) was 
added dropwise. The solution was stirred at −78 °C for 30 min and then stirred and 
heated at 67 °C for 16 h.  The reaction mixture was cooled to 0 °C and 3 M NaOH(aq) 
(0.5 mL) and 30 % H2O2(aq) (0.25 mL) were added sequentially.  The resulting solution 
was stirred at rt for 2 h and then 2 M NaOH(aq) (7 mL) was added. The two layers were 
separated and the aqueous layer was extracted with Et2O (3 x 10 mL).  The combined 
organic layers were dried (Na2SO4) and evaporated under reduced pressure to give the 
crude product.  Purification by flash column chromatography on silica with 9:1 petrol-
EtOAc as eluent gave alcohol (R)-135 (28 mg, 72%, 99:1 er by CSP-HPLC) as a white 
solid, mp 47-48 °C (lit.,
217
 45-47 °C);  [α]D +15.6 (c 0.65 in CHCl3) [lit.,
217
 [α]D +16.00 
(c 0.70 in CHCl3) for (R)-135 of 97:3 er)]; CSP-HPLC: Chiracel OD-H (98:2 Hexane-
iPrOH, 1.0 mLmin
-1
) (S)-135 12.9 min, (R)-135 21.4 min. Spectroscopic data consistent 
with those reported in the literature.
217
  
 
 
5-Methyl-1-phenylhexan-3-ol rac-135 
rac-135
OH
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i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 2.5 eq.) was added 
dropwise to a stirred solution of sulfoxide anti-rac-103 (80 mg, 0.20 mmol, 1.0 eq.) in 
THF (8 mL) at rt under Ar.  The resulting solution was stirred at rt for 1 min.  Then, a 
solution of isobutylboronic acid pinacol ester 301 (107 μL, 0.50 mmol, 2.5 eq.) in THF 
(1 mL) was added dropwise. The solution was stirred at rt for 30 min and then stirred 
and heated at 67 °C for 16 h.  The reaction mixture was cooled to 0 °C and 3 M 
NaOH(aq) (0.5 mL) and 30 % H2O2(aq) (0.25 mL) were added sequentially.  The resulting 
solution was stirred at rt for 2 h and then 2 M NaOH(aq) (7 mL) was added. The two 
layers were separated and the aqueous layer was extracted with Et2O (3 x 10 mL).  The 
combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product.  Purification by flash column chromatography on silica with 
95:5-90:10 petrol-EtOAc as eluent gave alcohol rac-135 (25 mg, 65%) as a white solid. 
 
2-[(4-Methylbenzene)sulfinyl]-4-phenylbutan-2-yl N,N-diisopropylcarbamate 141a 
and 141b 
141a/141b
SPh
O
CbO Me
 
 
n-BuLi (0.31 mL of a 2.5 M solution in hexane, 0.78 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of diisopropylamine (110 μL, 0.78 mmol, 1.2 eq.) in THF 
(3 mL) at −78 °C under Ar.  The resulting solution was warmed to 0 °C over 5 min and 
stirred at 0 °C for 15 min.  Then, the solution was cooled to −78 °C, stirred at −78 °C 
for 10 min and a solution of sulfoxide anti-rac-103 (260 mg, 0.65 mmol, 1.0 eq.) in 
THF (7 mL) was added dropwise over 10 min.  The resulting solution was stirred at −78 
°C for 10 min and MeI (62 μL, 0.98 mmol, 1.5 eq.) was added and the solution was 
allowed to warm to rt over 2 h and stirred at rt for 16 h.  Then, saturated NH4Cl(aq) (10 
mL) was added and the two layers were separated.  The aqueous layer was extracted 
with Et2O (3 x 10 mL). The combined organic layers were dried (Na2SO4) and 
evaporated under reduced pressure to give the crude product.  Purification by flash 
column chromatography on silica with 98:2-95:5 CH2Cl2-Et2O as eluent gave sulfoxide 
141a (132 mg, 49%) as a colourless oil, RF (95:5 CH2Cl2-Et2O) 0.3; IR (film) 2970, 
2963, 1693 (C=O), 1541, 1465, 1321, 1296, 1052, 910, 850, 732 cm
-1
;
 1
H NMR (400 
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MHz, CDCl3) δ 7.57 (d, J = 8.0 Hz, 2H, m-C6H4Me), 7.31-7.20 (m, 7H, Ar), 4.01-3.94 
(m, 1H, NCH), 3.78-3.68 (m, 1H, NCH), 3.07 (ddd, J = 14.0, 10.0, 7.0 Hz, 1H, 
PhCHAHB), 2.79-2.67 (m, 2H, PhCHAHB + CH), 2.52-2.41 (m, 1H, CH), 2.41 (s, 3H, 
C6H4Me), 1.46 (s, 3H, Me), 1.31 (d, J = 6.5 Hz, 3H, NCHMe2), 1.28 (d, J = 6.5 Hz, 3H, 
NCHMe2), 1.12 (d, J = 6.5 Hz, 3H, NCHMe2), 0.93 (d, J = 6.5 Hz, 3H, NCHMe2); 
13
C 
NMR (100.6 MHz, CDCl3) δ 152.5 (C=O), 141.5 (ipso-Ar), 140.9 (ipso-Ar), 136.7 
(ipso-Ar), 130.0 (Ar), 129.1 (Ar) 128.5 (Ar), 126.4 (Ar), 124.8 (Ar), 96.6 (OC), 46.4 
(br, NCH), 36.0 (CH2), 30.1 (CH2), 21.4 (Me), 20.9 (br, Me), 20.4 (br, Me), 15.5 (Me); 
MS (ESI) m/z 438 [(M + Na)
+
, 100], 416 [(M + H)
+
, 70]; HRMS m/z calcd for 
C24H33NO3S (M + Na)
+
 438.2089, found 438.2089 (+0.0 ppm error) and sulfoxide 141b 
(94 mg, 35%) as a colourless oil, RF (95:5 CH2Cl2-Et2O) 0.2; IR (film) 2965, 2959, 
1690 (C=O), 1528, 1480, 1450, 1326, 1286, 1052, 912, 732 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 7.54 (d, J = 8.0 Hz, 2H, m-C6H4Me), 7.29-7.24 (m, 4H, Ar), 7.20 (tt, J = 7.5, 
2.0 Hz, 1H, p-Ph), 7.14-7.12 (m, 2H, Ar), 4.05-3.99 (m, 1H, NCH), 3.76-3.70 (m, 1H, 
NCH), 2.72-2.59 (m, 2H, CH), 2.39 (s, 3H, C6H4Me), 2.26-2.13 (m, 2H, CH), 1.81 (s, 
3H, Me), 1.30 (d, J = 6.5 Hz, 3H, NCHMe2), 1.28 (d, J = 6.5 Hz, 3H, NCHMe2), 1.19 
(d, J = 6.5 Hz, 3H, NCHMe2), 1.08 (d, J = 6.5 Hz, 3H, NCHMe2); 
13
C NMR (100.6 
MHz, CDCl3) δ 152.9 (C=O), 141.5 (ipso-Ar), 141.0 (ipso-Ar), 136.8 (ipso-Ar), 129.3 
(Ar), 128.5 (Ar) 128.3 (Ar), 126.2 (Ar), 126.1 (Ar), 96.9 (OC), 46.5 (br, NCH), 46.2 
(br, NCH), 32.9 (CH2), 30.0 (CH2), 21.4 (Me), 20.6 (br, Me), 20.4 (br, Me), 18.3 (Me);  
MS (ESI) m/z 438 [(M + Na)
+
, 100], 416 [(M + H)
+
, 70]; HRMS m/z calcd for 
C24H33NO3S (M + Na)
+
 438.2079, found 438.2083 (+0.5 ppm error).  
Lab Book Reference PJR 8/667 
 
n-BuLi (0.20 mL of a 2.5 M solution in hexane, 0.50 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of diisopropylamine (70 μL, 0.50 mmol, 1.2 eq.) in THF 
(2 mL) at −78 °C under Ar.  The resulting solution was warmed to 0 °C over 5 min and 
stirred at 0 °C for 15 min.  Then, the solution was cooled to −78 °C, stirred at −78 °C 
for 10 min and a solution of sulfoxide anti-rac-103 (170 mg, 0.42 mmol, 1.0 eq.) in 
THF (4 mL) was added dropwise over 10 min.  The resulting solution was stirred at −78 
°C for 10 min and Me2SO4 (59 μL, 0.63 mmol, 1.5 eq.) was added and the solution was 
allowed to warm to rt over 2 h and stirred at rt for 16 h.  Then, saturated NH4Cl(aq) (10 
mL) was added and the two layers were separated.  The aqueous layer was extracted 
with Et2O (3 x 10 mL). The combined organic layers were dried (Na2SO4) and 
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evaporated under reduced pressure to give the crude product.  Purification by flash 
column chromatography on silica with 98:2-95:5 CH2Cl2-Et2O as eluent gave sulfoxide 
141a (94 mg, 54%) as a colourless oil and sulfoxide 141b (49  mg, 28%) as a colourless 
oil. 
Lab Book Reference 5/374 
 
A solution of sulfoxide anti-rac-103 (170 mg, 0.42 mmol, 1.0 eq.) in THF (4 mL) was 
added dropwise over 10 min to a stirred solution of LHMDS (0.50 mL of a 1.0 M 
solution in THF, 0.50 mmol, 1.2 eq.) in THF (2 mL) at −78 °C under Ar.  The resulting 
solution was stirred at −78 °C for 10 min.  Then, MeI (40 μL, 0.63 mmol, 1.5 eq.) was 
added and the solution was allowed to warm to rt over 2 h and stirred at rt for 16 h.  
Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous 
layer was extracted with Et2O (3 x 10 mL). The combined organic layers were dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product.  Purification 
by flash column chromatography on silica with 98:2-95:5 CH2Cl2-Et2O as eluent gave 
sulfoxide 141a (51 mg, 29%) as a colourless oil and sulfoxide 141b (28 mg, 16%) as a 
colourless oil. 
Lab Book Reference 8/610 
 
Attempted synthesis of methyl 2-(diisopropylcarbamoyloxy)-2-methyl-4-
phenylbutanoate rac-142 
 
rac-141a
SPh
O
CbO Me
Ph
Me OCb
OMe
O
1. i-PrMgCl
THF, rt, 1 min
2. MeOCOCl
rac-142
S
O
rac-128
Not Formed  
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide rac-141a (83 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 1 
min and methyl chloroformate (38 μL, 0.50 mmol, 2.5 eq.) gave the crude product.  The 
1
H NMR spectrum of the crude product showed a complex mixture of products. 
Sulfoxide rac-141a or sulfoxide rac-128 were not evident.  No further purification was 
attempted. 
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Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide rac-141a (83 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at −78 °C 
for 1 min and methyl chloroformate (38 μL, 0.50 mmol, 2.5 eq.) gave the crude product.  
The 
1
H NMR spectrum of the crude product showed a complex mixture of products. 
Sulfoxide rac-141a or sulfoxide rac-128 were not evident.  No further purification was 
attempted. 
 
n-BuLi (0.20 mL of a 2.5 M solution in hexanes, 0.50 mmol, 2.5 eq.) was added 
dropwise to a stirred solution of sulfoxide rac-141a (0.20 mmol, 1.0 eq.) in THF (8 mL) 
at  −78 °C under Ar.  The resulting solution was stirred at −78 °C for 1 min.  Then,  
methyl chloroformate (38 μL, 0.50 mmol, 2.5 eq.) was added dropwise and the resulting 
solution was stirred at −78 °C for 1 h.  Saturated NH4Cl(aq) (7 mL) was added and the 
two layers were separated.  The aqueous layer was extracted with Et2O (3 × 10 mL).  
The combined organic layers were dried (Na2SO4) and evaporated under reduced 
pressure to give the crude product. The 
1
H NMR spectrum of the crude product showed 
a complex mixture of products and no further purification was attempted. 
 
Attempted synthesis of 1-hydroxy-2-methyl-1,4-diphenylbutan-2-yl 
diisopropylcarbamates 143 
rac-141a
SPh
O
CbO Me
Ph
Me OCb
Ph
OH
1. i-PrMgCl, THF
_78 °C, 1 min
2. PhCHO
rac-143
Not Formed  
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide rac-141a (83 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at −78 °C 
for 1 min and benzaldehyde (50 μL, 0.50 mmol, 2.5 eq.) gave the crude product.  The 
1
H NMR spectrum of the crude product showed a complex mixture of products and no 
further purification was attempted. 
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Attempted synthesis of 4-phenylbutan-2-yl diisopropylcarbamate 144 
 
rac-141a
SPh
O
CbO Me
rac-144
Not Formed
1. n-BuLi, THF
_78 °C, 1 min
2. MeOH
Ph
Me OCb
H
 
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide rac-141a (83 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at −78 °C 
for 1 min and MeOH (1 mL) gave the crude product.  The 
1
H NMR spectrum of the 
crude product showed a complex mixture of products and no further purification was 
attempted 
 
n-BuLi (0.20 mL of a 2.5 M solution in hexanes, 0.50 mmol, 2.5 eq.) was added 
dropwise to a stirred solution of sulfoxide rac-141a (0.20 mmol, 1.0 eq.) in THF (8 mL) 
at  −78 °C under Ar.  The resulting solution was stirred at −78 °C for 1 min.  Then,  
MeOH (1 mL) was added dropwise. Saturated NH4Cl(aq) (7 mL) was added and the two 
layers were separated.  The aqueous layer was extracted with Et2O (3 × 10 mL).  The 
combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product. The 
1
H NMR spectrum of the crude product showed a complex 
mixture of products and no further purification was attempted. 
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5.4 Experimental for Chapter Three 
N-tert-Butoxycarbonyl pyrrolidine 39
167
 
N
Boc
39  
 
A solution of di-tert-butyl dicarbonate (2.84 g, 13.0 mmol, 1.0 eq.) in CH2Cl2 (8 mL) 
was added to a stirred solution of pyrrolidine (1.17 mL, 14.0 mmol, 1.1 eq.) in CH2Cl2 
(15 mL) at 0 °C under Ar. The resulting solution was allowed to warm to rt and stirred 
at rt for 3 h. The solvent was evaporated under reduced pressure to give the crude 
product.  Purification by Kügelrohr distillation gave N-Boc pyrrolidine 39 (2.07 g, 93%) 
as a colourless oil, bp 86-92 °C/2.0 mmHg (lit.,
167
 77-75 °C/0.5 mmHg); 
1
H NMR (400 
MHz, CDCl3) δ 3.28-3.20 (m, 4H, NCH2), 1.80-1.76 (m, 4H,CH2), 1.40 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) rotamers δ 154.7 (C=O), 78.8 (CMe3), 45.9 (CH2N), 
45.6 (CH2N), 28.5 (CMe3), 25.7 (CH2), 24.9 (CH2).  Spectroscopic data consistent with 
those reported in the literature.
167 
Lab Book Reference: PJR 1/1 
 
N-tert-Butoxycarbonyl-5-(p-tolylsulfinyl)-2,3-dihydropyrrole 169 
N
Boc
S
O
169  
 
Using general procedure E, s-BuLi (1.50 mL of a 1.3 M solution in hexanes, 1.95 mmol, 
1.3 eq.) and N-Boc pyrrolidine 39 (257 mg, 1.50 mmol, 1.0 eq.) in THF (6 mL) and 
methyl p-toluenesulfinate 121 (510 mg, 3.0 mmol, 2.0 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 1:1 petrol-EtOAc as eluent 
gave dihydropyrrole 169 (145 mg, 31%) as a colourless oil, RF (1:1 petrol-EtOAc) 0.3; 
IR (CHCl3) 2980, 1678 (C=O), 1369, 1306, 1153, 1093, 901, 809, 722 cm
−1
; 
1
H NMR 
(400 MHz, CDCl3) δ 7.68 (br d, J = 8.0 Hz, 2H, m-C6H4Me), 7.24 (d, J = 8.0 Hz, 2H, o-
C6H4Me), 5.96 (t, J = 3.0 Hz 1H, =CH), 3.97 (br s, 1H, NCH2), 3.85-3.76 (m, 1H, 
NCH2), 2.84-2.74 (m, 1H, NCH2CH2), 2.64 (dddd, J = 17.0, 11.5, 6.0, 3.0 Hz, 1H, 
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NCH2CH2), 2.37 (s, 3H, Me), 1.37 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) 
rotamers δ 174.3 (C=O), 150.2 (C=O), 142.1 (ipso-Ar), 140.9 (=C)140.8 (=C), 136.5 
(Ar), 135.4 (Ar), 130.2 (Ar), 127.7 (Ar), 126.6 (ipso-Ar), 126.2 (ipso-Ar), 124.3 (=CH), 
82.7 (CMe3), 46.4 (NCH2), 32.9 (CH2), 28.1 (CMe3), 28.0 (CMe3), 21.5 (br, Me), 17.4 
(CH2); (MS (ESI) m/z 330 [(M + Na)
+
, 100], 208 (40), 238 (100); HRMS (ESI) m/z  
calcd for C16H21NO3S (M + Na)
+ 
330.1134, found, 330.1122 (3.7 ppm error). 
Lab Book Reference: PJR 1/32 
 
Using general procedure E, s-BuLi (1.92 mL of a 1.3 M solution in hexanes, 2.50 mmol, 
2.5 eq.) and N-Boc pyrrolidine 39 (171 mg, 1.00 mmol, 1.0 eq.) in THF (6 mL) and 
methyl p-toluenesulfinate 121 (510 mg, 3.0 mmol, 3.0 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 1:1 petrol-EtOAc as eluent 
gave dihydropyrrole 169 (136 mg, 44%) as a colourless oil. 
Lab Book Reference: PJR 1/68 
 
N-tert-Butyl piperidine-1-carboxylate 48
148
 
N
Boc
48  
 
Piperidine (7.33 g, 8.50 mL, 68.7 mmol, 1.0 eq.) was added dropwise to a stirred 
solution of di-tert-butyl dicarbonate (12.51 g, 57.3 mmol, 0.8) in THF (62.5 mL) at 0 °C 
under Ar. The resulting solution was stirred at 0 °C for 10 min and then allowed to 
warm to rt and stirred at rt for 1 h. 10% NaHCO3(aq) (70 mL) was added and the mixture 
was extracted with Et2O (2 × 150 mL).  The combined organic layers were washed with 
brine (100 mL), dried (K2CO3) and evaporated under reduced pressure to give the crude 
product.  Purification by Kügelrohr distillation gave N-Boc piperidine 48 (9.68 g, 64%) 
as a colourless oil, bp 72-74 °C/1.3 mmHg (lit.,
148
 65 °C/1.0 mmHg); 
1
H NMR (400 
MHz, CDCl3) δ 3.30-3.27 (m, 4H, NCH2), 1.51-1.42 (m, 6H, CH2), 1.38 (s, 9H, CMe3).  
Spectroscopic data consistent with those reported in the literature.
148 
Lab Book Reference: PJR 1/21 
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N-tert-Butylcarbonyl-6-(phenylsulfinyl)-3,4-dihydro-2H-pyridine 171 
N
Boc
171
S
Ph
O
 
 
Using general procedure F, s-BuLi (2.50 mL of a 1.3 M solution in hexanes, 3.25 mmol, 
1.3 eq.), TMEDA (378 mg, 0.49 mL, 3.25 mmol, 1.3 eq.) and N-Boc piperidine 48 (463 
mg, 2.50 mmol, 1.0 eq.) in Et2O (8 mL) at −78 °C for 3 h and methyl benzenesulfinate 
170 (624 mg, 4.00 mmol, 1.6 eq.) gave the crude product.  Purification by flash column 
chromatography on silica with 1:1 petrol-EtOAc as eluent gave tetrahydropyridine 171 
(100 mg, 13%) as a colourless oil, RF (1:1 petrol-EtOAc) 0.30; IR (Film) 2975, 1693 
(C=O), 1511, 1454, 1391, 1366, 1246, 1166, 1033, 700 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 7.65 (d, J = 8.0 Hz, 2H, o-Ph), 7.41-4.40 (m, 3H, Ph), 6.37 (t, J = 3.5 Hz, 1H, 
=CH), 3.97 (br d, J = 11.5 Hz, 1H, NCHAHB), 2.71 (br s, 1H, NCHAHB), 2.39 (ddt, J = 
18.5, 6.5, 3.5 Hz, 1H, =CHCH2), 2.28 (dddd, J = 18.5, 10.0, 7.0, 3.5 Hz, 1H, =CHCH2), 
1.86-1.69 (m, 2H, CH2), 1.37 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 152.3 
(C=O), 144.7 (ipso-Ph), 143.5 (=C) 131.0 (Ph), 128.7 (Ph), 126.4 (Ph), 113.7 (br, =CH), 
82.1 (CMe3), 44.9 (NCH2), 28.1 (CMe3), 23.2 (CH2), 22.0 (CH2);  MS (ESI) m/z 330 
[(M + Na)
+
, 100], 308 [(M + H)
+
, 30], 252 (70); HRMS m/z calcd for C16H21NO3S (M + 
Na)
+
 330.1134, found 330.1127 (2.2 ppm error).  
Lab Book Reference: PJR 1/22C 
 
p-Methoxybenzene disulfide 176
218
 
176
S
MeO
S
OMe
 
 
NaBO3.4H2O (2.46 g, 16.0 mmol, 2.0 eq.) was added to a stirred solution of p-
methoxybenzenethiol (1.12 g, 8.0 mmol, 1.0 eq.) in 7:3 MeOH/water (28 mL) at rt. The 
resulting solution was stirred at rt for 2 h.  Then, water (20 mL) and Et2O (20 mL) were 
added and the two layers were separated.  The aqueous layer was then extracted with 
Et2O (2 × 20 mL). The combined organic layers were washed with brine (30 mL), dried 
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(Na2SO4) and evaporated under reduced pressure to give crude disulfide 176 (1.08 g, 
97%) as a colourless oil which was sufficiently pure (by 
1
H NMR spectroscopy) for 
subsequent use, 
1
H NMR (400 MHz, CDCl3) δ 7.42 (d, J = 8.5 Hz, 4H, m-C6H4OMe), 
6.85 (d, J = 8.5 Hz, 4H, o-C6H4OMe), 3.81 (s, 3H, OMe);
 13
C NMR (100.6 MHz, 
CDCl3) δ 160.0 (ipso-C6H4OMe), 132.8 (Ar), 128.5 (ipso-C6H4S), 114.7 (Ar), 55.5 
(OMe).  Spectroscopic data consistent with those reported in the literature.
218
 
Lab Book Reference: PJR 2/99 
 
Methyl p-methoxybenzenesulfinate 177
119
 
177
S
MeO
OMe
O
 
 
Bromine (0.46 mL, 9.0 mmol, 3.0 eq.) was added to a stirred suspension of Na2CO3 
(1.58 g, 15.0 mmol, 5.0 eq.) and p-methoxybenzenedisulfide 176 (832 mg, 3.0 mmol, 
1.0 eq.) in MeOH (75 mL) at rt. The resulting yellow suspension was stirred at rt for 3 h 
during which time the suspension became colourless.  Then, the solvent was evaporated 
under reduced pressure. CH2Cl2 (50 mL) and water (50 mL) were added to the residue 
and the two layers were separated.  The aqueous layer was extracted with CH2Cl2 (2 × 
30 mL).  The combined organic layers were washed with saturated NH4Cl(aq) (50 mL) 
and brine (50 mL), dried (Na2SO4) and evaporated under reduced pressure to give the 
crude product as a colourless oil.  Purification by Kügelrohr distillation gave sulfinate 
177 (1.05 g, 94%) as a colourless oil, bp 111-116 °C/0.8 mmHg; 
1
H NMR (400 MHz, 
CDCl3) δ 7.60 (d, J = 8.5 Hz, 2H, m-C6H4OMe), 7.00 (d, J = 8.0 Hz, 2H, o-C6H4OMe), 
3.84 (s, 3H, C6H4OMe), 3.42 (s, 3H, OMe); 
13
C NMR (100.6 MHz, CDCl3) δ 160.1 
(ipso-C6H4OMe), 132.9 (Ar), 141.8 (ipso-C6H4S), 114.7 (Ar), 55.6 (OMe). 
Spectroscopic data consistent with those reported in the literature.
219
 
Lab Book Reference: PJR 2/105 
 
Attempted synthesis of methyl tert-butylsulfinate 179
119
 
179
S
OMe
O
S
S
Br2, NaCO3
MeOH, rt, 3 h
178
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Bromine (1.71 mL, 33.6 mmol, 3.0 eq.) was added to a stirred suspension of Na2CO3 
(5.93 g, 56.0 mmol, 5.0 eq.) and t-butyldisulfide 178 (2.00 g, 11.2 mmol, 1.0 eq.) in 
MeOH (200 mL) at rt. The resulting yellow suspension was stirred at rt for 3 h during 
which time the suspension became colourless.  Then, the solvent was evaporated under 
reduced pressure. CH2Cl2 (100 mL) and water (100 mL) were added to the residue and 
the two layers were separated.  The aqueous layer was extracted with CH2Cl2 (2 × 50 
mL).  The combined organic layers were washed with saturated NH4Cl(aq) (100 mL) and 
brine (100 mL), dried (Na2SO4) and evaporated under reduced pressure to give the 
crude product as a colourless oil.  The 
1
H NMR spectrum of the crude product showed 
only unreacted t-butyldisulfide 179 and no purification was attempted. 
Lab Book Reference: PJR 2/91 
 
(tert-Butyl) 2-methylpropane-2-sulfinothioate 180
156
 
180
S
S
O
 
 
t-Butyl disulfide 178 (2.00 mL, 12.0 mmol, 1.0 eq.) was added dropwise to a stirred 
solution of glacial AcOH (8.30 mL) and 30% H2O2(aq) (1.26 mL, 41.0 mmol, 3.4 eq.) at 
0 °C. The resulting solution was stirred at rt for 15 h.  Then, the solution was cooled to 
0 °C and water (10 mL) and CH2Cl2 (10 mL) were added.  The two layers were 
separated and the aqueous layer was extracted with CH2Cl2 (2 × 10 mL).  The combined 
organic layers were washed with saturated NaHSO3(aq) (15 mL), NaHCO3(aq) (3 × 10  
mL), and water (15 mL), dried (MgSO4) and evaporated under reduced pressure to give 
the crude product as a pale yellow oil.  Purification by Kügelrohr distillation gave 
sulfinothioate 180 (1.99 g, 85%) as a colourless oil, bp 74-77 °C/2.0 mmHg (lit.,
220
  70-
71 °C/1.7 mmHg); 
1
H NMR (400 MHz, CDCl3) δ 1.54 (s, 9H, S(O)CMe3), 1.36 (s, 9H, 
SCMe3);
 13
C NMR (100.6 MHz, CDCl3) δ 59.4 (CMe3), 48.4 (CMe3), 32.5 (CMe3), 25.1 
(CMe3).  Spectroscopic data consistent with those reported in the literature.
156
  
Lab Book Reference: PJR 2/93 
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N-tert-Butylcarbonyl-2-(phenylsulfanyl)pyrrolidine 185 
N
Boc
S
Ph
185  
 
Using general procedure E, s-BuLi (2.62 mL of a 1.3 M solution in hexanes, 3.40 mmol, 
1.3 eq.) and N-Boc pyrrolidine 39 (445 mg, 2.60 mmol, 1.0 eq.) in THF (10 mL) and a 
solution of diphenyl disulfide (1.14 g, 5.2 mmol, 2.0 eq.) in THF (2 mL) gave the crude 
product.  Purification by flash column chromatography on silica with 98:2 CH2Cl2-
acetone as eluent gave sulfide 185 (301 mg, 44%) as a colourless oil, RF (98:2 CH2Cl2-
acetone) 0.7;
 
IR (film) 2976, 2931, 1695 (C=O), 1444, 1406, 1367, 1143, 1078, 1049, 
750 cm
−1
; 
1
H NMR (400 MHz, CDCl3) (60:40 mixture of rotamers) δ 7.54-7.42 (m, 2H, 
Ph), 7.31-7.29 (m, 3H, Ph), 5.38 (br s, 0.4H, NCH), 5.29-5.27 (m, 0.6H, NCH), 3.51-
3.34 (m, 1.2H, NCH), 3.33-2.22 (m, 0.8H, NCH), 2.20-1.98 (m, 2.4H, CH2CH2), 1.93-
1.83 (m, 1.6H, CH2CH2), 1.44 (s, 3.6H, CMe3), 1.35 (s, 5.4H, CMe3); 
13
C NMR (100.6 
MHz, CDCl3) δ 153.3 (C=O), 134.4 (ipso-Ph), 133.8 (Ph), 128.7 (Ph), 127.7 (Ph), 79.8 
(CMe3), 66.8 (NCH), 45.3 (NCH2), 33.7 (CH2), 28.0 (CMe3), 22.0 (CH2); MS (ESI) m/z 
302 [(M + Na)
+
, 100], 208 (25), 114 (50); HRMS m/z calcd for C15H21NO2S (M + Na)
+
 
302.1185, found, 302.1181 (+1.4 ppm error).  
Lab Book Reference: PJR 1/4A 
 
N-tert-Butylcarbonyl-2-(p-tolylsulfanyl)pyrrolidine 186 
N
Boc
S
186  
 
Using general procedure E, s-BuLi (1.50 mL of a 1.3 M solution in hexanes, 1.95 mmol, 
1.3 eq.) and N-Boc pyrrolidine 39 (257 mg, 1.50 mmol, 1.0 eq.) in THF (6 mL) and a 
solution of p-tolyl disulfide (739 mg, 3.0 mmol, 2.0 eq.) in THF (2 mL) gave the crude 
product.  Purification by flash column chromatography on silica with 98:2 CH2Cl2-
acetone as eluent gave sulfide 186 (301 mg, 44%) as a colourless oil, RF (98:2 CH2Cl2-
acetone) 0.40;
 
IR (film) 2974, 2933, 1710 (C=O), 1527, 1390, 1366, 1165 cm
−1
; 
1
H 
NMR (400 MHz, CDCl3) (60:40 mixture of rotamers) δ 7.43 (d, J = 7.5 Hz, 0.8H, o-
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C6H4Me), 7.38 (d, J = 7.5 Hz, 1.2H, o-C6H4Me), 7.12 (d, J = 7.5 Hz, 2H, m-C6H4Me), 
5.32 (br s, 0.4H, NCH), 5.22 (br d, J = 5.5 Hz, 0.6H, NCH), 3.46-3.39 (m, 1.2H, NCH), 
3.30-3.27 (m, 0.8H, NCH), 2.34 (s, 3H, Me), 2.21-2.03 (m, 2.4H, CH2CH2), 2.01-1.86 
(m, 1.6H, CH2CH2), 1.45 (s, 3.6H, CMe3), 1.36 (s, 5.4H, CMe3); 
13
C NMR (100.6 MHz, 
CDCl3) δ 153.7 (C=O), 138.3 (ipso-Ar), 135.1 (Ar), 130.3 (ipso-Ar), 129.8 (Ar), 80.1 
(CMe3), 67.1 (NCH), 45.6 (NCH2), 33.8 (CH2), 32.5 (CH2), 28.5 (CMe3), 21.3 (Me); 
MS (ESI) m/z 316 [(M + Na)
+
, 100]; HRMS m/z calcd for C16H23NO2S (M + Na)
+
 
316.1342, found 316.1342 (0.0 ppm error).  
Lab Book Reference: PJR 1/35B 
 
N-tert-Butylcarbonyl-2-(p-methoxyphenylsulfanyl)pyrrolidine 187 
 
N
Boc
S
187
OMe
 
 
Using general procedure E, s-BuLi (1.50 mL of a 1.3 M solution in hexanes, 1.95 mmol, 
1.3 eq.) and N-Boc pyrrolidine 39 (257 mg, 1.50 mmol, 1.0 eq.) in THF (6 mL) and p-
methoxyphenyldisulfide 176 (745 mg, 3.0 mmol, 2.0 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent 
gave sulfide 187 (65 mg, 14%) as a colourless oil, RF (98:2 CH2Cl2-Et2O) 0.30; 
1
H 
NMR (400 MHz, CDCl3) (60:40 mixture of rotamers) δ 7.48 (d, J = 8.0 Hz, 0.8H, o-
C6H4OMe), 7.42 (d, J = 8.0 Hz, 1.2H, o-C6H4OMe), 6.84 (d, J = 8.0 Hz, 2H, m-
C6H4OMe), 5.25 (br s, 0.4H, NCH), 5.16 (br d, J = 6.0 Hz, 0.6H, NCH), 3.80 (s, 3H, 
C6H4OMe), 3.45-3.28 (m, 2H, NCH), 2.14-1.99 (m, 2.4H, CH), 1.89-1.81 (m, 1.6H, 
CH), 1.43 (s, 3.6H, CMe3), 1.36 (s, 5.4H, CMe3; MS (ESI) m/z 332 [(M + Na)
+
, 100]; 
HRMS m/z calcd for C16H23NO3S (M + Na)
+
 332.1291, found 332.1289 (+0.5 ppm 
error).  
Lab Book Reference: PJR 2/103B 
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N-tert-Butylcarbonyl-2-(tert-butylsulfanyl)pyrrolidine 184 
N
Boc
S
184  
 
Using general procedure E, s-BuLi (1.50 mL of a 1.3 M solution in hexanes, 1.95 mmol, 
1.3 eq.) and N-Boc pyrrolidine 39 (257 mg, 1.50 mmol, 1.0 eq.) in THF (6 mL) and p-
tolyldisulfide 178 (535 mg, 3.0 mmol, 2.0 eq) gave the crude product.  Purification by 
flash column chromatography on silica with 4:1 petrol-Et2O as eluent gave sulfide 184 
(230 mg, 59%) as a colourless oil, RF (4:1 petrol-Et2O) 0.40;
 
IR (film) 2979, 1689 
(C=O), 1393, 1367, 1254, 1163, 1117, 1042, 921, 870 cm
−1
; 
1
H NMR (400 MHz, 
CDCl3) (50:50 mixture of rotamers) δ 5.22 (br s, 0.5H, NCH), 5.03 (br s, 0.5H, NCH), 
3.39-3.34 (m, 1H, NCH), 3.30-3.22 (m, 1H, NCH), 2.20-2.03 (m, 2H, CH), 1.99-1.85 
(m, 2H, CH), 1.44 (br s, 9H, CMe3), 1.38 (br s, 9H, CMe3); 
13
C NMR (100.6 MHz, 
CDCl3) δ 153.4 (C=O), 82.7 (CMe3), 79.4 (CMe3), 60.7 (NCH), 45.3 (br, NCH2), 43.5 
(br, NCH2),  36.6 (CH2), 35.6 (CH2), 31.5 (CMe3), 28.5 (CMe3); MS (ESI) m/z 282 [(M 
+ Na)
+
, 90], 210 (50), 114 (100); HRMS m/z calcd for C13H25NO2S (M + Na)
+
 
282.1498, found 282.1477 (+7.7 ppm error).  
Lab Book Reference: PJR 2/94A 
 
Using general procedure E, s-BuLi (1.50 mL of a 1.3 M solution in hexanes, 1.95 mmol, 
1.3 eq.) and N-Boc pyrrolidine 39 (257 mg, 1.50 mmol, 1.0 eq.) in THF (6 mL) and t-
butylsulfinothioate 180 (582 mg, 3.0 mmol, 2.0 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 4:1 CH2Cl2-Et2O as eluent 
gave sulfide 184 (60 mg, 15%) as a colourless oil. 
Lab Book Reference: PJR 2/95A 
 
N-tert-Butylcarbonyl-2-(phenylsulfanyl)piperidine 151 
N
Boc
151
S
Ph
 
 
Chapter Five: Experimental 
 
213 
 
Using general procedure F, s-BuLi (2.50 mL of a 1.3 M solution in hexanes, 3.25 mmol, 
1.3 eq.), TMEDA (378 mg, 0.49 mL, 3.25 mmol, 1.3 eq.) and N-Boc piperidine 48 (463 
mg, 2.50 mmol, 1.0 eq.) in Et2O (8 mL) at −78 °C for 3 h and a solution of diphenyl 
disulfide (1.36 g, 6.25 mmol, 2.5 eq.) in Et2O (3 mL) gave the crude product.  
Purification by flash column chromatography on silica with 98:2 CH2Cl2-acetone as 
eluent gave sulfide 151 (460 mg, 63%) as a colourless oil, RF (98:2 CH2Cl2-acetone) 
0.5;
 1
H NMR (400 MHz, CDCl3) (65:35 mixture of rotamers) δ 7.49 (br s, 2H, Ph), 7.29 
(br s, 3H, Ph), 6.05 (br s, 0.35H, NCH), 5.79 (br s, 0.65H, NCH), 4.07 (br d, J = 11.5 
Hz, 0.65H, NCH), 3.86 (br s, 0.35H, NCH), 3.29 (td, J = 13.0, 3.0 Hz, 1H, NCH), 1.98-
1.49 (m, 6H, CH), 1.30 (s, 3.15H, CMe3), 1.15 (s, 6.85H, CMe3); 
13
C NMR (100.6 
MHz, CDCl3) rotamers δ 153.8 (C=O), 135.1 (ipso-Ar), 133.9 (br, Ar), 129.4 (Ar), 
129.0 (Ar), 128.9 (br, Ar), 128.0 (br, Ar), 125.7 (Ar), 79.8 (CMe3), 64.1 (br, NCH), 61.7 
(br, NCH), 39.4 (br, NCH2), 38.0 (br, NCH2), 31.2 (br, CH2), 30.2 (br, CH2), 28.3 
(CMe3), 27.9 (br, CH2), 25.4 (CH2), 19.8 (CH2). Spectroscopic data consistent with 
those reported in the literature.
147
  
Lab Book Reference: PJR 1/25C 
 
N-tert-Butyl carbonyl-2-hydroxypyrrolidine 175 
(Table 3.1, entry 1) 
N
Boc
175
OH
 
 
mCPBA (77 mg of ~77% purity, 0.35 mmol, 1.0 eq) was added dropwise to a stirred 
solution of phenylsulfanyl pyrrolidine 185 (100 mg, 0.35 mmol, 1.0 eq.) and Na2CO3 
(80 mg, 0.74 mmol, 2.1 eq.) in CH2Cl2 (5 mL) at rt under Ar.  The resulting solution 
was stirred at rt for 30 min.  Then, saturated Na2SO3(aq) (7 mL) and CH2Cl2 (7 mL) was 
added.  The two layers were separated and the aqueous layer was extracted with CH2Cl2 
(3 × 7 mL).  The combined organic layers were dried (Na2SO4) and evaporated under 
reduced pressure to give the crude product.  Purification by flash column 
chromatography on silica with 9:1 CH2Cl2-aceteone as eluent gave recovered sulfanyl 
pyrrolidine 185 (26 mg, 26%) as a colourless oil and hydroxy pyrrolidine 175 (21 mg, 
31%) as a colourless oil, RF (9:1 CH2Cl2-acetone) 0.3; IR (Film) 3452 (OH), 2976, 1695 
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(C=O), 1478, 1392, 1254, 1163, 1112, 1041, 916 cm
−1
;
 1
H NMR (400 MHz, CDCl3) 
(60:40 mixture of rotamers) δ 5.48 (br s, 0.6H, NCH), 5.39 (br m, 0.4H, NCH), 3.56-
3.46 (m, 1H, NCH), 3.34-3.17 (m, 1H, NCH), 2.11-1.78 (m, 4H, CH), 1.50 (s, 3.6H, 
CMe3), 1.47 (s, 5.4H, CMe3);
 13
C NMR (100.6 MHz, CDCl3) δ 155.3 (C=O), 81.5 
(NCHOH), 80.0 (CMe3), 45.9 (NCH2), 32.6 (CH2), 28.4 (CMe3), 22.7 (CH2); MS (ESI) 
m/z 379 [(M Dimer + Na)
+
, 100], 266 (50), 210 [(M + Na)
+
, 20]; HRMS m/z calcd for 
C9H17NO3 (M + Na)
+
 210.1101, found 210.101 (−0.1 ppm error). Spectroscopic data 
consistent with those reported in the literature.
167
 
Lab Book Reference: PJR 1/8 
 
(Table 3.1, entry 2) 
mCPBA (89 mg of ~77% purity, 0.41 mmol, 1.1 eq) was added to a stirred solution of 
KF (40 mg, 0.69 mmol, 1.8 eq.) in 4:1 MeCN-water (3 mL) at 0 °C.  The resulting 
solution was stirred at 0 °C for 30 min.  Then, phenylsulfanyl pyrrolidine 185 (107 mg, 
0.38 mmol, 1.0 eq.) was added.  The resulting solution was stirred at 0 °C for 30 min.  
Then, saturated Na2SO3(aq) (7 mL) and Et2O (7 mL) was added.  The two layers were 
separated and the aqueous layer was extracted with Et2O (3 × 7 mL).  The combined 
organic layers were dried (Na2SO4) and evaporated under reduced pressure to give the 
crude product.  Purification by flash column chromatography on silica with 9:1 CH2Cl2-
acetone as eluent gave hydroxy pyrrolidine 175 (40 mg, 57%) as a colourless oil. 
Lab Book Reference: PJR 1/7 
 
(Table 3.1, entry 3) 
Using general procedure G, mCPBA (208 mg of ~77% purity, 1.20 mmol, 1.1 eq.) and 
phenylsulfanyl pyrrolidine 185 (309 mg, 1.10 mmol, 1.0 eq.) in CH2Cl2 (2.2 mL) gave 
the crude product.  Purification by flash column chromatography on silica with 9:1 
CH2Cl2-acetone as eluent gave hydroxy pyrrolidine 175 (179 mg, 86%) as a colourless 
oil. 
Lab Book Reference: PJR 1/19 
 
(Table 3.1, entry 4) 
Using general procedure G, mCPBA (118 mg of ~77% purity, 0.52 mmol, 1.1 eq.) and 
p-tolylsulfanyl pyrrolidine 186 (140 mg, 0.47 mmol, 1.0 eq.) in CH2Cl2 (1.5 mL) gave 
the crude product.  Purification by flash column chromatography on silica with 9:1 
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CH2Cl2-acetone as eluent gave hydroxy pyrrolidine 175 (72 mg, 81%) as a colourless 
oil. 
Lab Book Reference: PJR 1/36 
 
(Table 3.1, entry 5) 
Using general procedure G, mCPBA (47 mg of ~77% purity, 0.21 mmol, 1.1 eq.) and p-
methoxyphenylsulfanyl pyrrolidine 187 (60 mg, 0.19 mmol, 1.0 eq.) in CH2Cl2 (1.0 
mL) gave the crude product.  Purification by flash column chromatography on silica 
with 3:2 petrol-EtOAc as eluent gave hydroxy pyrrolidine 175 (27 mg, 74%) as a 
colourless oil. 
Lab Book Reference: PJR 2/106 
 
(Table 3.1, entry 6) 
Using general procedure G, mCPBA (112 mg of ~77% purity, 0.51 mmol, 1.1 eq.) and 
t-butylsulfanyl 184 (120 mg, 0.46 mmol, 1.0 eq.) in CH2Cl2 (1.5 mL) gave the crude 
product.  Purification by flash column chromatography on silica with 7:3 petrol-EtOAc 
as eluent gave hydroxy pyrrolidine 175 (65 mg, 77%) as a colourless oil. 
Lab Book Reference: PJR 2/96 
 
(Table 3.1, entry 7) 
H2O2 (0.07 mL of a 30% aqueous solution, 0.61 mmol, 1.8 eq.) was added dropwise to a 
stirred solution of sulfanyl pyrrolidine 186 (100 mg, 0.34 mmol, 1.0 eq.) in 
hexafluoroisopropanol (0.7 mL) at rt under Ar.  The resulting solution was stirred at rt 
for 10 min.  Then, saturated Na2SO3(aq) (5 mL) and Et2O (5 mL) was added.  The two 
layers were separated and the aqueous layer was extracted with Et2O (3 × 5 mL).  The 
combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product.  Purification by flash column chromatography on silica with 9:1 
CH2Cl2-aceteone as eluent gave recovered sulfanyl pyrrolidine 186 (42 mg, 42%) and 
hydroxy pyrrolidine 175 (26 mg, 43%) as a colourless oil.  
Lab Book Reference: PJR 1/42 
 
(Table 3.1, entry 8) 
s-BuLi (1.50 mL of a 1.3 M solution in hexanes, 1.95 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of N-Boc pyrrolidine 39 (257 mg, 1.50 mmol, 1.0 eq.) in 
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THF (6 mL) at −78 °C under Ar.  The resulting solution was stirred at −78 °C for 1 h 
and then added dropwise via cannula transfer to methyl p-toluenesulfinate 121 (765 mg, 
4.50 mmol, 3.0 eq.) at 0 °C under Ar.  The resulting solution was stirred at 0 °C for 15 
min.  Then, saturated NH4Cl(aq) (7 mL) was added and the two layers were separated.  
The aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 9:1 CH2Cl2-acetone as 
eluent gave dihydropyrrole 169 (45 mg, 10%) and hydroxy pyrrolidine 175 (142 mg, 
52%) as a colourless oil. 
Lab Book Reference: PJR 1/50 
 
s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 mmol, 0.8 eq.) was added 
dropwise to a stirred solution of N-Boc pyrrolidine 39 (257 mg, 1.50 mmol, 1.0 eq.) in 
THF (6 mL) at −78 °C under Ar.  The resulting solution was stirred at −78 °C for 1 h 
and then added dropwise via cannula transfer to methyl p-toluenesulfinate 121 (765 mg, 
4.50 mmol, 3.0 eq.) at 0 °C under Ar.  The resulting solution was stirred at 0 °C for 15 
min.  Then, saturated NH4Cl(aq) (7 mL) was added and the two layers were separated.  
The aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 9:1 CH2Cl2-acetone as 
eluent gave hydroxy pyrrolidine 175 (135 mg, 48%) as a colourless oil.  
Lab Book Reference: PJR 1/51 
 
2,2,2-Triphenyl-1-pyrrolidin-1-ylethanone 207 
207
N
OPh3C
 
 
Thionyl chloride (3.0 mL, 15.4 mmol, 1.5 eq.) was added to a stirred solution of 
triphenylacetic acid (2.97 g, 10.3 mmol, 1.0 eq.) in THF (30 mL) at room temperature 
under Ar.  The resulting solution was heated at 70 °C and for 3 h. Then, the solution 
was allowed to cool to rt.  The solvent was evaporated under reduced pressure to give 
the crude acid chloride (3.51 g) as a brown solid (3.51 g).  To a stirred solution of the 
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crude acid chloride in THF (20 mL) at 0 °C, pyridine (0.90 mL, 12.5 mmol, 1.2 eq.) and 
pyrrolidine (0.85 mL, 10.3 mmol, 1.0 eq.) were added. The resulting solution was 
heated at 70 °C for 16 h. The solution was allowed to cool to rt and then saturated 
NH4Cl(aq) (30 mL) was added.  The two layers were separated and the aqueous layer 
was extracted with Et2O (3 × 25 mL). The combined organic layers were dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product as yellow 
solid.  Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as 
eluent gave amide 207 (3.01 g, 86%) as a white solid, mp 186-189 °C (lit.,
221
 188.5 °C); 
RF (7:3 petrol-EtOAc) 0.3; 
1
H NMR (400 MHz, CDCl3) δ 7.31-7.21 (m, 15H, Ph), 3.68 
(t, J = 7.0, 2H, NCH2), 2.46 (t, J = 7.0, 2H, NCH2), 1.71 (quintet, J = 7.0, 2H, CH2), 
1.57 (quintet, J = 7.0, 2H, CH2); 
13
C NMR (100.6 MHz, CDCl3) δ 170.7 (C=O), 142.9 
(ipso-Ph), 130.5 (Ph), 127.7 (Ph), 126.6 (Ph), 54.8 (CPh3), 48.3 (NCH2), 26.6 (CH2). 
Spectroscopic data consistent with those reported in the literature.
221  
Lab Book Reference: PJR 2/62A 
 
2,2-Dimethyl-1-pyrrolidin-1-yl-propanone 209 
N
209
O
 
 
Trimethylacetyl chloride (3.87 g, 32.0 mmol, 1.0 eq.) was added to a stirred solution of 
pyridine (4.30 mL, 54.0 mmol, 1.7 eq.) and pyrrolidine (2.89 mL, 32.0 mmol, 1.0 eq.) in 
CHCl3 (28 mL) at 0 °C. The resulting solution was heated at 65 °C and stirred for 16 h. 
The solution was allowed to cool to rt and then water (50 mL) was added.  The two 
layers were separated and the aqueous layer was extracted with CH2Cl2 (3 × 50 mL). 
The combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product as a yellow solid.  Recrystallisation from CHCl3 gave 
amide 209 (5.09 g, 100%) as colourless needles, mp 53-56 °C (lit.,
222
 56-59 °C); 
1
H 
NMR (400 MHz, CDCl3) δ 3.54 (br s, 4H, NCH2), 1.86 (br s, 4H, CH2), 1.25 (s, 9H, 
CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 176.4 (C=O), 47.8 (NCH2), 38.9 (CMe3), 27.5 
(CMe3), 23.0 (CH2).  Spectroscopic data consistent with those reported in the 
literature.
223 
Lab Book Reference: PJR 1/55 
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1-(Toluene-4-sulfinyl)pyrrolidine 208 
N
S
208
O
 
 
Using general procedure F, s-BuLi (1.30 mL of a 1.3 M solution in hexanes, 1.69 mmol, 
1.3 eq.), (−)-sparteine (396 mg, 1.69 mmol, 1.3 eq.) and amide 207 (208 mg, 1.30 
mmol, 1.0 eq.) in Et2O (5 mL) at −78 °C for 3 h and methyl p-toluenesulfinate 121 (443 
mg, 2.60 mmol, 2.0 eq.) gave the crude product.  Purification by flash column 
chromatography on silica with 1:1 petrol-EtOAc as eluent gave sulfinamide 208 (171 
mg, 64%) as a colourless oil, RF (1:1 petrol-EtOAc) 0.3;
 1
H NMR (400 MHz, CDCl3) δ 
7.50 (d, J = 8.0 Hz, 2H, m-C6H4Me), 7.23 (d, J = 8.0 Hz, 2H, o-C6H4Me), 3.33-3.26 (m, 
2H, NCH2), 2.98-2.92 (m, 2H, NCH2), 2.35 (s, 3H, Me), 1.82-1.76 (m, 4H, CH2); 
13
C 
NMR (100.6 MHz, CDCl3) δ 141.4 (ipso-Ar), 140.7 (ipso-Ar), 129.4 (Ar), 125.7 (Ar), 
45.9 (NCH2), 25.9 (CH2), 21.3 (Me). Spectroscopic data consistent with those reported 
in the literature.
224
 
Lab Book Reference: PJR 1/57B 
 
s-BuLi (1.58 mL of a 1.3 M solution in hexanes, 1.50 mmol, 1.0 eq.) was added 
dropwise to a stirred solution of triphenylacetamide 209 (512 mg, 1.50 mmol, 1.0 eq.) in 
THF (15 mL) at −40 °C under Ar.  The resulting solution was stirred at −40 °C for 3 h.  
Then, methyl p-toluenesulfinate 121 (255 mg, 1.5 mmol, 1.0 eq.) was added dropwise. 
The resulting solution was stirred at −40 °C for 1 h.  Saturated NH4Cl(aq) (10 mL) was 
added and the two layers were separated.  The aqueous layer was extracted with Et2O (3 
× 15 mL).  The combined organic layers were dried (Na2SO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 1:1 petrol-EtOAc as eluent gave sulfinamide 208 (83 mg, 
31%) as a colourless oil, 
 Lab Book Reference: PJR 2/69 
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Attempted synthesis of 1-[2-(p-tolylsulfinyl)pyrrolidin-1-yl]-2,2-dimethyl-
propanthione 191 
N
191
S
S
O
N
210
S
1. s-BuLi/TMEDA
Et2O,
_78 °C, 3 h
2. pTolS(O)OMe, 18 h
 
 
Using general procedure M, s-BuLi (1.50 mL of a 1.3 M solution in hexanes, 1.95 
mmol, 1.3 eq.), TMEDA (227 mg, 1.95 mmol, 1.3 eq.) and thioamide 210 (257 mg, 
1.50 mmol, 1.0 eq.) in Et2O (6 mL) at −78 °C for 3 h and methyl p-toluenesulfinate 191 
(510 mg, 3.0 mmol, 2.0 eq.) gave the crude product which contained none of the desired 
product by 
1
H NMR spectroscopy.  Purification by flash column chromatography on 
silica with 4:1 petrol-Et2O as eluent gave starting thioamide 210 (151 mg, 59%) as pale 
yellow needles. 
Lab Book Reference: PJR 2/113 
 
 
Attempted synthesis of 1-[2-(p-tolylsulfanyl)pyrrolidin-1-yl]-2,2-dimethyl-
propanthione 213 
N
210
S
N
213
S
S
1. s-BuLi, TMEDA,
Et2O,
_78 °C, 3 h
2. pTolSSpTol, 18 h
 
Using general procedure M, s-BuLi (1.50 mL of a 1.3 M solution in hexanes, 1.95 
mmol, 1.3 eq.), TMEDA (227 mg, 1.95 mmol, 1.3 eq.) and thioamide 210 (257 mg, 
1.50 mmol, 1.0 eq.) in THF (6 mL) at −78 °C for 3 h and a solution of p-tolyldisulfide 
(739 mg, 3.0 mmol, 2.0 eq.) in THF (1 mL) gave the crude product which contained 
none of the desired product by 
1
H NMR spectroscopy.  Purification by flash column 
chromatography on silica with 4:1 petrol-Et2O as eluent gave starting thioamide 210 
(201 mg, 78%) as pale yellow needles. 
Lab Book Reference: PJR 2/114 
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2,2-Dimethyl-1-(2-(p-tolylsulfinyl)azetidin-1-yl)propane-1-thione 192 
N
S
S
O
H
192  
 
s-BuLi (0.92 mL of a 1.3 M solution in hexanes, 1.20 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of  N-thiopivaloyl azetidine 101 (157 mg, 1.00 mmol, 1.0 
eq.) and TMEDA (358 μL, 2.40 mmol, 2.4 eq.) in THF (6 mL) at −78 °C under Ar.  The 
resulting solution was stirred at −78 °C for 30 min.  Then, methyl p-toluenesulfinate 
121 (340 mg, 2.0 mmol, 2.0 eq.) and the solution was allowed to warm to rt over 2 h 
and stirred at rt for 16h.  Saturated NH4Cl(aq) (10 mL) was added and the two layers 
were separated.  The aqueous layer was extracted with Et2O (3 × 10 mL).  The 
combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product which contained a 91:9 mixture of diastereoisomers by 
1
H NMR.  
Purification by flash column chromatography on silica with 8:2-1:1 petrol-EtOAc as 
eluent gave sulfoxide 192 (27 mg, 9%) as a colourless oil, RF (7:3 petrol-EtOAc) 0.2; IR 
(film) 2987, 2954, 1502, 1480, 1424, 1395, 1240, 1140, 1025, 728 cm
−1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.56 (d, J = 8.0 Hz, 1H, m-C6H4Me), 7.32 (d, J = 8.0 Hz, 1H, o-
C6H4Me), 5.55 (dd, J = 9.0, 4.5 Hz, 1H, NCH), 4.50 (dt, J = 9.0, 7.0 Hz, 1H, 
NCHACHB), 4.34 (dt, J = 9.0, 4.5 Hz, 1H, NCHACHB), 2.83 (ddt, J = 12.0, 9.0, 4.5 Hz, 
1H, CHACHB), 2.41 (s, 3H, Me), 2.06 (dtd, J = 12.0, 9.0, 7.0 Hz, 1H, CHACHB), 1.39 (s, 
9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 213.5 (C=S), 141.3 (ipso-Ar), 137.3 (ipso-
Ar), 129.9 (Ar), 123.9 (Ar), 86.0 (NCH), 56.5 (NCH2), 43.8 (CMe3), 29.7 (CMe3), 21.3 
(Me) 17.3 (CH2); MS (ESI) m/z 318 [(M + Na)
+
, 100], 296 [(M + H)
+
, 50]; HRMS m/z 
calcd for C15H21NOS2 (M + Na)
+
 318.0962, found 318.0960 (−0.5 ppm error) and 
recovered N-thiopivaloyl azetidine 101 (113 mg, 72%).  Diagnostic signal for other 
diastereoisomer: 
1
H NMR (400 MHz, CDCl3) δ 5.72 (dd, J = 9.0, 4.0 Hz, 1H, NCH). 
Lab Book Reference: PJR 5/360 
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Attempted synthesis of 2,2-dimethyl-1-((S)-2-((S)-p-tolylsulfinyl)azetidin-1-
yl)propane-1-thione (S,SS)-192 and 2,2-dimethyl-1-((R)-2-((S)-p-
tolylsulfinyl)azetidin-1-yl)propane-1-thione (R,SS)-192 
N
S
S
O
H
N
S
S
O
H
(R,SS)-192(S,SS)-192
1. s-BuLi, (_)-sparteine,
Et2O,
_78 °C, 30 min
2.
N
S
101 S O
O
(SS)-97  
 
Using general procedure L, s-BuLi (0.92 mL of a 1.3M solution in hexanes, 1.20 mmol, 
1.2 eq.), N-thiopivaloyl azetidine 101 (158 mg, 1.00 mmol, 1.0 eq.) and (−)-sparteine 
(0.28 mL, 1.20 mmol, 1.2 eq.) in Et2O (7 mL) and a solution of Andersen’s sulfinate 
(441 mg, 1.50 mmol, 1.5 eq.) gave the crude product. The 
1
H NMR spectrum of the 
crude product showed no evidence of sulfoxides (S,SS)-192 and (R,SS)-192.  Purification 
by flash column chromatography on silica with 9:1-8:2 petrol-Et2O gave recovered N-
thiopivaloyl azetidine 101 (134 mg, 85%) 
Lab Book Reference 8/692 
 
 
Chloromethyl p-tolylsulfide 215
166
 
215
Cl S
 
 
N-Chlorosuccinimide (3.67 g, 27.5 mmol, 1.1 eq., recrystallised from glacial AcOH) 
was added to a stirred solution of methyl p-tolylsulfide (3.45 g, 25.0 mmol, 1.0 eq.) in 
CHCl3 (25 mL) at 0 °C.  The resulting solution was allowed to warm to rt over 5 min 
and then stirred at rt for 18 h. Then, 4% NaI(aq) (50 mL) was added and the two layers 
were separated. The organic layer was washed with 10% Na2S2O3(aq) (50 mL), dried 
(Na2SO4) and evaporated under reduced pressure to give a 90:10 mixture (by 
1
H NMR 
spectroscopy) of chlorosulfide 215 and methyl p-tolylsulfide (4.12 g, 90% yield of 
chlorosulfide 215) as a pale yellow oil,  
1
H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.0 
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Hz, 2 H, o-C6H4Me), 7.18 (d, J = 8.0 Hz, 2 H, m-C6H4Me), 4.92 (s, 2H, CH2), 2.36 (s, 
3H, Me).  Attempted purification by flash column chromatography on silica gel and by 
fractional distillation led to product decomposition. 
Lab Book Reference: PJR 1/31 
 
N-(4-Methoxyphenyl)benzamide 214
165
 
214
OMe
NH
O
Ph
 
 
Benzoyl chloride (2.92 mL, 25.1 mmol, 1.1 eq.) was added dropwise to a stirred 
suspension of p-anisidine (2.80 g, 22.8 mmol, 1.0 eq.) and NaHCO3 (5.76 g, 68.4 mmol, 
3.0 eq.) in CH2Cl2 (120 mL) at 0 °C under Ar.  The resulting suspension was stirred at 0 
°C for 1 h. Then, water (100 mL) was added and the two layers were separated.  The 
aqueous layer was extracted with CH2Cl2 (2 × 50 mL).  The combined organic layers 
were washed with brine (100 mL), dried (Na2SO4) and evaporated under reduced 
pressure to give the crude product.  Purification by flash column chromatography on 
silica with 7:3 petrol-EtOAc as eluent gave benzamide 214 (4.28 g, 83%) as purple 
crystals, mp 146-149 °C, (lit.,
225
 153-156 °C); RF (7:3 petrol-EtOAc) 0.3; 
1
H NMR (400 
MHz, CDCl3) δ 7.87 (d, J = 7.5 Hz, 2H, o-Ph), 7.73 (br s, 1H, NH), 7.57-7.50 (m, 5H, 
Ar), 6.92 (d, J = 9.0 Hz, 2H, Ar), 3.83 (s, 3H, OMe); 
13
C NMR (100.6 MHz, CDCl3) δ 
165.6 (C=O), 156.6 (ipso-C6H4OMe), 135.0 (ipso-Ar), 131.7 (Ar), 131.0 (ipso-Ar), 
128.8 (Ar), 128.4 (Ar), 127.1 (Ar), 122.2 (Ar), 114.3 (Ar), 55.6 (OMe).  Spectroscopic 
data consistent with those reported in the literature.
226
  
Lab Book Reference: PJR 2/64A 
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N-(4-Methoxyphenyl)-N-p-tolylsulfanylmethyl benzamide 216
164
 
216
OMe
N
O
Ph S
 
 
A 90:10 mixture (by 
1
H NMR spectroscopy) of chlorosulfide 215 and methyl p-
tolylsulfide (1.80 g, 9.38 mmol of chlorosulfide 215, 2.5 eq.) was added to a stirred 
solution of tetraethylammonium iodide (430 mg, 1.88 mmol, 0.5 eq.) and benzamide 
214 (850 mg, 3.75 mmol, 1.0 eq.) in CH2Cl2 (7.5 mL) at rt.  The resulting solution was 
cooled to 0 °C and 50% NaOH(aq) (17.5 mL) was added.  The resulting solution was 
heated at 50 °C for 18 h. Then, the solution was allowed to cool to rt and poured into 
saturated NH4Cl(aq) (50 mL).  The two layers were separated and the aqueous layer was 
extracted with Et2O (3 × 30 mL).  The combined organic layers were dried (Na2SO4) 
and evaporated under reduced pressure to give the crude product.  Purification by flash 
column chromatography on silica with 65:35 petrol-EtOAc as eluent gave benzamide 
216 (922 mg, 67%) as a colourless oil, RF (65:35 petrol-EtOAc) 0.4; IR (film) 2955, 
1649 (C=O), 1510, 1493, 1446, 1372, 1250, 1144, 1039, 729 cm
−1
;
 1
H NMR (400 MHz, 
CDCl3) δ 7.27-7.21 (m, 5H, Ar), 7.16 (t, J = 7.5 Hz, 2H, Ar), 7.04 (d, J = 8.0 Hz, 2H, 
Ar), 6.93 (d, J = 8.0 Hz, 2H, Ar), 6.69 (d, J = 8.0 Hz, 2H, Ar), 5.30 (s, 2H, NCH2), 3.73 
(s, 3H, OMe), 3.00 (s, 3H, Me); 
13
C NMR (100.6 MHz, CDCl3) δ 170.4 (C=O), 158.3 
(ipso-C6H4OMe), 137.1 (ipso-Ar), 135.3 (ipso-Ar), 135.1 (ipso-Ar), 132.2 (Ar), 130.9 
(ipso-Ar), 130.4 (Ar), 129.7 (Ar), 129.4 (Ar), 128.6 (Ar), 127.6 (Ar), 114.2 (Ar), 55.9 
(NCH2), 55.3 (OMe), 21.0 (Me); MS (ESI) m/z 386 [(M + Na)
+
, 100], 364 [(M + H)
+
, 
20], 240 (50); HRMS m/z calcd for C22H21NO2S (M + Na)
+
 386.1185, found 386.1175 
(+2.6 ppm error).  
Lab Book Reference: PJR 2/70A 
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N-(4-Methoxyphenyl)-N-p-tolylsulfinylmethyl benzamide 193  
193
OMe
N
O
Ph S
O
 
 
Using general procedure G, m-CPBA (68 mg of ~77% purity, 0.31 mmol, 1.1 eq.) and 
sulfanyl benzamide 216 (100 mg, 0.28 mmol, 1.0 eq.) in CH2Cl2 (1.8 mL) gave the 
crude product as a viscous foam.  Purification by flash column chromatography on 
silica with 7:3 EtOAc-petrol as eluent gave sulfoxide 193 (88 mg, 84%) as an orange 
oil, RF (7:3 EtOAc-petrol) 0.3; IR (film) 3056, 2932, 2837, 1650 (C=O), 1513, 1446, 
1359, 1294, 1178, 1084, 1045 cm
−1
;
 1
H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 8.0 Hz, 
2H, m-C6H4Me), 7.32 (d, J = 7.5, 2H Hz, o-Ph), 7.30 (d, J = 8.0 Hz, 2H, o-C6H4Me), 
7.26 (br t, J = 7.5 Hz, 1H, p-Ph), 7.16 (t, J = 7.5 Hz, 2H, m-Ph), 7.10 (d, J = 8.5 Hz, 2H, 
Ar), 6.69 (d, J = 8.5 Hz, 2H, Ar), 5.20 (d, J = 12.5 Hz, 1H, NCH2), 4.49 (d, J = 12.5 Hz, 
1H, NCH2), 3.70 (s, 3H, OMe), 2.38 (s, 3H, Me);
 13
C NMR (100.6 MHz, CDCl3) δ 
170.7 (C=O), 158.3 (ipso-C6H4OMe), 141.7 (ipso-Ar), 138.8 (ipso-Ar), 135.9 (ipso-Ar), 
134.3 (ipso-Ar), 130.2 (Ar), 129.9 (Ar), 128.9 (Ar), 128.8 (Ar), 127.8 (Ar), 124.3 (Ar), 
114.3 (Ar), 76.9 (NCH2), 55.3 (OMe), 21.4 (Me); MS (ESI) m/z 402 [(M + Na)
+
, 100], 
240 [(M – S(O)C6H4Me)
+
, 50]; HRMS m/z calcd for C22H21NO3S (M + Na)
+
 402.1134, 
found 402.1124 (+2.5 ppm error).  
Lab Book Reference: PJR 2/74A 
 
N-(4-Methoxyphenyl)thiobenzamide 217  
217
OMe
NH
S
Ph
 
 
Phosphorous(V) sulfide (918 mg, 4.13 mmol, 1.25 eq.) was added to a stirred solution 
benzamide 214 (750 mg, 3.30 mmol, 1.0 eq.) in pyridine (15 mL) at rt under Ar. The 
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resulting solution was heated at 75 °C for 6 h. The solution was allowed to cool to rt and 
then poured into 1 M HCl(aq) (50 mL).  1 M HCl(aq) was added until pH 3 was obtained. 
The resulting solution was stirred for 2 h and then extracted with CH2Cl2 (3 × 50 ml). 
Combined organic extracts were washed with 1 M HCl(aq) (50 mL), water (50 mL) and 
brine (50 mL), dried (Na2SO4) and evaporated under reduced pressure to give the crude 
product.  Purification by flash column chromatography on silica with 4:1 petrol-EtOAc 
as eluent gave thiobenzamide 217 (320 mg, 40%) as a pale yellow oil, RF (4:1 petrol-
EtOAc) 0.2; 
1
H NMR (400 MHz, CDCl3) δ 8.94 (br s, 1H, NH), 7.88 (dd, J = 7.0, 1.5 
Hz, 2H, o-Ph), 7.67 (d, J = 8.5 Hz, 2H, Ar), 7.52 (dddd, J = 7.0, 7.0, 1.5, 1.5 Hz, 1H, p-
Ph), 7.45 (dd, J = 7.0, 7.0 1.5 Hz, 2H, m-Ph), 6.98 (d, J = 8.5 Hz, 2H, Ar), 3.86 (s, 3H, 
OMe); MS (ESI) m/z 266 [(M + Na)
+
, 20], 244 [(M + H)
+
, 100], 159 (30), 141 (30), 125 
(30); HRMS m/z calcd for C14H13NOS (M + H)
+
 244.0791, found 244.0786 (+2.0 ppm 
error).  
Lab Book Reference: PJR 2/119A 
 
N-(4-Methoxyphenyl)-N-p-tolylsulfanylmethylthiobenzamide 218
164
  
218
OMe
N
S
Ph S
 
 
A 90:10 mixture (by 
1
H NMR spectroscopy) of chlorosulfide 215 and methyl p-
tolylsulfide (481 mg, 2.48 mmol of chlorosulfide 215, 2.5 eq.) was added to a stirred 
solution of tetraethylammonium iodide (112 mg, 0.50 mmol, 0.5 eq.) and 
thiobenzamide 217 (240 mg, 0.99 mmol, 1.0 eq.) in CH2Cl2 (4.5 mL) at rt.  The 
resulting solution was cooled to 0 °C and then 50% NaOH(aq) (2.5 mL) was added.  The 
resulting solution was heated at 50 °C for 18 h. Then, the solution was allowed to cool 
to rt and poured into saturated NH4Cl(aq) (10 mL).  The two layers were separated and 
the aqueous layer was extracted with Et2O (3 × 15 mL).  The combined organic layers 
were dried (Na2SO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 9:1 petrol-EtOAc as eluent 
gave sulfanyl thiobenzamide 218 (204 mg, 54%) as a colourless oil, RF (9:1 petrol-
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EtOAc) 0.3; 
1
H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 8.0 Hz, 2H, Ar), 7.24-7.14 (m, 
5H, Ar), 6.93 (br s, 2H, Ar), 6.70 (d, J = 8.5 Hz, 2H, Ar), 6.60 (d, J = 8.5 Hz, 2H, Ar), 
4.64 (s, 2H, NCH2), 3.74 (s, 3H, OMe), 2.35 (s, 3H, Me); MS (ESI) m/z 402 [(M + 
Na)
+
, 100], 380 [(M + H)
+
, 50]; HRMS m/z calcd for C22H21NOS2 (M + Na)
+
 402.0962, 
found 402.0968 (+2.5 ppm error).  
Lab Book Reference: PJR 2/130A 
 
N-(4-Methoxyphenyl)-N-p-tolylsulfinylmethyl thiobenzamide 194 
194
OMe
N
S
Ph S
O
 
 
Using general procedure G, m-CPBA (141 mg of ~70% purity, 0.57 mmol, 1.1 eq.) and 
sulfanyl thiobenzamide 218 (200 mg, 0.52 mmol, 1.0 eq.) in CH2Cl2 (3.5 mL) gave the 
crude product as a viscous foam.  Purification by flash column chromatography on 
silica with 7:3 EtOAc-petrol as eluent gave sulfoxide 194 (158 mg, 77%) as a viscous 
orange foam, RF (7:3 EtOAc-petrol) 0.2; IR (CHCl3) 2833, 1613 (C=S), 1502, 1443, 
1242, 1178, 1047, 956, 832 cm
−1
;
 1
H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 8.0 Hz, 
2H, m-C6H4Me), 7.34-7.19 (m, 7H, Ar), 6.69 (d, J = 8.0 Hz, 2H, Ar), 6.51 (d, J = 8.5 
Hz, 2H, Ar), 4.57 (d, J = 13.0 Hz, 1H, NCHAHB), 4.45 (d, J = 13.0 Hz, 1H, NCHAHB), 
3.74 (s, 3H, OMe), 2.40 (s, 3H, Me);
 13
C NMR (100.6 MHz, CDCl3) rotamers δ 208.1 
(C=S), 156.1 (ipso-C6H4OMe), 141.7 (ipso-Ar), 140.1 (ipso-Ar), 135.1 (br, ipso-Ar), 
130.0 (ipso-Ar), 129.6 (Ar), 128.5 (Ar), 128.0 (Ar), 127.5 (Ar), 124.7 (Ar), 122.7 (Ar), 
113.9 (Ar), 60.4 (NCH2), 55.8 (OMe), 55.3 (OMe), 21.4 (Me), 14.6 (Me); MS (ESI) m/z 
396 [(M + H)
+
, 100]; HRMS m/z calcd for C22H21NO2S2 (M + H)
+
 396.1086, found 
396.1092 (−0.4 ppm error).  
Lab Book Reference: PJR 2/134A 
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tert-Butyl N-(4-methoxyphenyl)carbamate 219
227
 
219
OMe
NH
Boc
 
 
A solution of di-tert-butyl dicarbonate (4.80 g, 22.0 mmol, 1.0 eq.) in THF (15 mL) was 
added to a stirred solution of p-Anisidine (3.69, 30.0 mmol, 1.3 eq.) in THF (15 mL) at 
rt under Ar. The resulting solution was stirred at rt for 18 h. Then, CH2Cl2 (50 mL) and 
water (50 mL) were added and the two layers were separated.  The aqueous layer was 
extracted with CH2Cl2 (2 × 50 mL).  The combined organic layers were washed with 
brine (50 mL), dried (Na2SO4) and evaporated under reduced pressure to give the crude 
product as colourless oil.  Purification by flash column chromatography on silica with 
7:3 EtOAc-petrol as eluent gave N-Boc p-anisidine 219 (3.98 g, 81%) as a white solid, 
mp 84-87 °C, (lit.,
227
 92-94 °C); RF (7:3 petrol-EtOAc) 0.5; 
1
H NMR (400 MHz, 
CDCl3) δ 7.27 (br d, J = 8.0 Hz, 2H, Ar), 6.84 (d, J = 8.0 Hz, 2H, Ar), 6.34 (br s, 1H, 
NH), 3.79 (s, 3H, OMe), 1.57 (s, 9H, CMe3), Spectroscopic data consistent with those 
reported in the literature.
227
 
Lab Book Reference: PJR 2/65A 
 
tert-Butyl N-(4-methoxyphenyl) N-methylcarbamate 221
228
 
221
OMe
N
Boc
 
 
A solution of N-Boc p-anisidine 219 (256 mg, 1.15 mmol, 1.0 eq.) in THF (3 mL) was 
added to a stirred solution of NaH (51 mg of 60% wt in mineral oil, 1.27 mmol, 1.1 eq.) 
and methyl iodide (179 mg, 1.27 mmol, 1.1 eq.) in THF (2 mL) at rt under Ar. The 
resulting solution was stirred at rt for 18 h. Then, the reaction was cooled to 0 °C and 
water (7 mL) and Et2O (7 mL) were added. The two layers were separated and the 
aqueous layer was extracted with E2O (2 × 10 mL).  The combined organic layers were 
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dried (MgSO4) and evaporated under reduced pressure to give N-Boc N-methyl p-
ansidine 221 (265 mg, 98%) as colourless oil which was sufficiently pure (by 
1
H NMR 
spectroscopy) for subsequent use, 
1
H NMR (400 MHz, CDCl3) δ 7.27 (br d, J = 8.0 Hz, 
2H, Ar), 6.85 (d, J = 8.0 Hz, 2H, Ar), 3.80 (s, 3H, OMe), 3.22 (s, 3H, NMe), 1.44 (s, 
9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 159.9 (ipso-C6H4OMe), 155.2 (C=O), 
135.2 (ipso-Ar), 122.6 (Ar), 117.5 (Ar), 79.8 (CMe3), 57.6 (OMe), 28.7 (CMe3), 28.3 
(NMe). Spectroscopic data consistent with those reported in the literature.
229
  
Lab Book Reference: PJR 2/82 
 
Attempted synthesis of tert-Butyl N-(4-Methoxyphenyl)-N-p-tolylsulfanylmethyl 
carbamate 220 (via alkylation) 
Et4NI, 50% NaOH(aq),
CH2Cl2, 50 °C, 18h
N
Boc
OMe
S
SCl
215
NH
Boc
OMe
219 220  
 
A 90:10 mixture (by 
1
H NMR spectroscopy) of chlorosulfide 215 and methyl p-
tolylsulfide (430 mg, 2.25 mmol of chlorosulfide 215, 3.0 eq.) was added to a stirred 
solution of tetraethylammonium iodide (86 mg, 0.38 mmol, 0.5 eq.) and N-Boc p-
anisidine 219 (167 mg, 0.75 mmol, 1.0 eq.) in CH2Cl2 (3.5 mL) at rt.  The resulting 
solution was cooled to 0 °C and then 50% NaOH(aq) (1.5 mL) was added.  The resulting 
solution was heated at 50 °C for 18 h. Then, the solution was allowed to cool to rt and 
poured into saturated NH4Cl(aq) (10 mL).  The two layers were separated and the 
aqueous layer was extracted with Et2O (3 × 15 mL).  The combined organic layers were 
dried (Na2SO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 7:3 petrol-EtOAc as eluent 
gave recovered N-Boc p-anisidine 219 (165 mg, 100%) as a white solid.  
Lab Book Reference: PJR 2/75 
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N
Boc
OMe
S
SCl
215
NH
Boc
OMe
219 220
1. NaH, 0 °C,15 min
2. 215, rt, 18 h
 
 
A solution of N-Boc p-anisidine 219 (256 mg, 1.15 mmol, 1.0 eq.) in THF (3 mL) was 
added to a stirred solution of NaH (51 mg of 60% wt in mineral oil, 1.27 mmol, 1.1 eq.) 
in THF (2 mL) at rt under Ar. The resulting solution was stirred at rt for 15 min. Then, a 
90:10 mixture (by 
1
H NMR spectroscopy) of chlorosulfide 215 and methyl p-
tolylsulfide (287 mg, 1.50 mmol of chlorosulfide 215, 2.0 eq.) was added.  The resulting 
solution was stirred for 18 h at rt.  Then, water (7 mL) and Et2O (7 mL) were added. 
The two layers were separated and the aqueous layer was extracted with E2O (2 × 10 
mL).  The combined organic layers were dried (Na2SO4) and evaporated under reduced 
pressure to give the crude product.  The 
1
H NMR spectrum of the crude product showed 
no formation of sulfanyl anisidine 220, therefore no further purification was attempted. 
Lab Book Reference: PJR 2/79 
 
Attempted synthesis of tert-Butyl N-(4-Methoxyphenyl)-N-p-tolylsulfanylmethyl 
carbamate 220 (via lithiation-trapping) 
N
Boc
OMe
SN
Boc
OMe
221
Me
1. s-BuLi, TMEDA,
THF, _78 °C, 2 h
220
2. pTolSSpTol, 18 h
 
 
s-BuLi (1.97 mL of a 1.3 M solution in hexanes, 1.51 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of the N-Boc N-methyl p-anisidine 221 (300 mg, 1.26 
mmol, 1.0 eq.) and TMEDA (288 mg, 2.52 mmol, 2.0 eq.) in THF (5.0 mL) at −78 °C 
under Ar.  The resulting solution was stirred at −78 °C for 2 h.  Then, a solution of p-
tolyldisulfide (610 mg, 2.52 mmol, 2.0 eq.) in THF (1.0 mL) was added dropwise. The 
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solution was allowed to warm slowly to rt over 2 h and stirred at rt for 16 h.  Saturated 
NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous layer was 
extracted with Et2O (3 × 15 mL).  The combined organic layers were dried (Na2SO4) 
and evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 7:3 petrol-Et2O as eluent gave recovered N-Boc 
N-methyl p-anisidine 221 (155 mg, 52%) as a colourless oil. 
Lab Book Reference: PJR 2/85 
 
N-tert-Butoxycarbonyl-N,N-dimethylamine 222
167
 
222
Nt-BuO
O
 
 
A solution of di-tert-butyl dicarbonate (5.24 g, 24.0 mmol, 1.2 eq.) in 1:1 THF-water 
(100 mL) was added to a stirred solution of dimethylamine (2.28 mL of a 40% wt 
solution in water, 20.0 mmol, 1.0 eq.) and NaHCO3 (2.00 g, 24.0 mmol, 1.2 eq.) in 1:1 
THF-water (100 mL) at rt under Ar. The resulting solution was stirred at rt for 18 h. 
Then, Et2O (100 mL) was added and the two layers were separated.  The aqueous layer 
was extracted with Et2O (2 × 50 mL).  The combined organic layers were dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product as colourless 
oil.  Purification by Kügelrohr distillation gave N-Boc dimethylamine 222 (2.09 g, 72%) 
as a colourless oil, bp 84-86 °C/2.0 mmHg (lit.,
167
 75-80 °C/16-17 mmHg); 
1
H NMR 
(400 MHz, CDCl3) δ 2.86 (s, 6H, NMe2), 1.44 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, 
CDCl3) δ 156.2 (C=O), 79.8 (CMe3), 36.5 (NMe2), 28.4 (CMe3). Spectroscopic data 
consistent with those reported in the literature.
167 
Lab Book Reference: PJR 3/174 
 
N-Methyl N-p-tolylsulfinylmethyl carbamic acid tert-butyl ester 196 
196
Nt -BuO
O
S
O
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Using general procedure F, s-BuLi (1.00 mL of a 1.3 M solution in hexanes, 1.30 mmol, 
1.3 eq.), TMEDA (151 mg, 0.19 mL, 1.30 mmol, 1.3 eq.) and N-Boc dimethylamine 
222 (145 mg, 1.00 mmol, 1.0 eq.) in Et2O (2 mL) at −78 °C for 2 h and methyl p-
toluenesulfinate 121 (340 mg, 2.00 mmol, 2.0 eq.) gave the crude product.  Purification 
by flash column chromatography on silica with 98:2: CH2Cl2-acetone with 1% Et3N as 
eluent gave sulfoxide 196 (202 mg, 71%) as a colourless oil, RF (98:2 CH2Cl2-acetone 
with 1% Et3N) 0.3; IR (Film) 2977, 2930, 1712 (C=O), 1493, 1454, 1370, 1288, 1163, 
1045, 871 cm
−1
;
 1
H NMR (400 MHz, CDCl3) (50:50 mixture of rotamers) δ 7.55 (d, J = 
8.0 Hz, 1H, m-C6H4Me), 7.51 (d, J = 8.0 Hz, 1H, m-C6H4Me), 7.35 (d, J = 8.0 Hz, 1H, 
o-C6H4Me), 7.33 (d, J = 8.0 Hz, 1H, o-C6H4Me), 4.58 (d, J = 13.0 Hz, 0.5H, NCHAHB), 
4.37 (d, J = 13.0 Hz, 0.5H, NCHAHB), 4.30 (d, J = 13.0 Hz, 0.5H, NCHAHB), 4.11 (d, J 
= 13.0 Hz, 0.5H, NCHAHB), 3.06 (s, 1.5H, NMe), 2.94 (s, 1.5H, NMe), 2.42 (s, 1.5H, 
C6H4Me), 2.41 (s, 1.5H, C6H4Me), 1.43 (s, 4.5H, CMe3), 1.39 (s, 4.5H, CMe3); 
13
C 
NMR (100.6 MHz, CDCl3) rotamers δ 155.2 (C=O), 154.2 (C=O), 142.0 (ipso-
C6H4S(O)), 141.7 (ipso-C6H4S(O)), 138.7 (ipso-C6H4Me), 138.4 (ipso-C6H4Me), 130.1 
(Ar), 129.9 (Ar), 124.3 (Ar), 124.2 (Ar), 81.2 (CMe3), 81.0 (CMe3), 74.6 (NCH2), 74.5 
(NCH2), 37.0 (NMe), 36.3 (NMe), 28.2 (CMe3), 28.0 (CMe3), 21.4 (br, C6H4Me);  MS 
(ESI) m/z 306 [(M + Na)
+
, 100]; HRMS m/z calcd for C14H21NO3S (M + Na)
+
 306.1134, 
found 306.1135 (−0.3 ppm error).  
Lab Book Reference: PJR 3/178B 
 
tert-Butyl 4-hydroxypiperidine-1-carboxylate 302 
N
Boc
OH
302  
 
NaBH4 (200 mg, 7.5 mmol, 1.5 eq.) was added to a stirred solution of N-Boc piperidin-
4-one (1.00 g, 5.0 mmol, 1.0 eq.) in EtOH (5 mL) at 0 °C under Ar. The resulting 
solution was allowed to warm to rt and stirred at rt for 4 h. Then, the mixture was 
cooled to 0 °C and saturated NH4Cl(aq) (20 mL) was added dropwise.  The solvent was 
evaporated under reduced pressure and EtOAc (15 mL) was added.  The two layers 
were separated and the aqueous layer was extracted with EtOAc (2 × 15 mL).  The 
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combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product.  Purification by flash column chromatography on silica with 9:1 
CH2Cl2-acetone as eluent gave N-Boc 4-hydoxy piperidine 302 (984 mg, 98%) as a 
white solid, mp 66-68 °C (lit.,
230
 64.6-66.5 °C);  RF (9:1 CH2Cl2-Acetone) 0.2; 
1
H NMR 
(400 MHz, CDCl3) δ 3.82-3.72 (m, 3H, NCHAHB + CHOH ), 2.97 (ddd, J = 13.0, 10.0, 
3.0 Hz, 2H, NCHAHB), 2.67 (br s, 1H, OH), 1.83-1.78 (m, 2H, NCH2CHAHB), 1.46-1.37 
(m, 2H, NCH2CHAHB), 1.41 (s, 9H, CMe3);  
13
C NMR (100.6 MHz, CDCl3) δ 154.7 
(C=O), 79.5 (CMe3), 67.4 (CHOH), 41.3 (br, NCH2), 34.0 (NCH2CH2), 28.3 (CMe3).  
Spectroscopic data consistent with those reported in the literature.
230 
 
tert-Butyl 4-chloropiperidine-1-carboxylate 223 
N
Boc
223
Cl
 
 
A solution of hexachloroethane (7.05 g, 29.8 mmol, 2.0 eq.) in CH2Cl2 (25 mL) was 
added to a stirred solution of N-Boc 4-hydroxy piperidine 302 (3.00 g, 14.9 mmol, 1.0 
eq.) and PPh3 (7.82 g, 29.8 mmol, 2.0 eq.) in CH2Cl2 (75 mL) at rt under Ar. The 
resulting solution was stirred at rt for 16 h. The solvent was evaporated under reduced 
pressure to give the crude product.  Purification by flash column chromatography on 
silica with 4:1 petrol-Et2O as eluent gave N-Boc 4-chloro piperidine 223 (2.13 g, 67%) 
as a colourless oil, RF (4:1 petrol-Et2O) 0.3; IR (film) 2974, 2932, 1696 (C=O), 1477, 
1420, 1365, 1277, 1169, 1112, 1002 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 4.20 (tt, J = 
7.5, 3.5 Hz, 1H, CHCl), 3.69 (ddd, J = 13.0, 7.0, 3.5 Hz, 2H, NCHAHB), 3.29 (ddd, J = 
13.0, 7.5 Hz, 2H, NCHAHB), 2.01 (ddt, J = 13.5, 7.0, 3.5 Hz, 2H, NCH2CHAHB), 1.78 
(dtd, J = 13.5, 7.5, 3.5 Hz, 2H, NCH2CHAHB), 1.45 (s, 9H, CMe3); 
13
C NMR (100.6 
MHz, CDCl3) δ 154.6 (C=O), 79.7 (CMe3), 56.9 (CHCl), 41.2 (br, NCH2), 34.8 
(NCH2CH2), 28.3 (CMe3); MS (ESI) m/z 244 [(
37
M + Na)
+
, 10], 242 [(
35
M + Na)
+
, 30], 
166 (30), 164 (100); HRMS m/z calcd for C10H18
35
ClNO2 (M + Na)
+
 242.0918, found 
242.0911 (+3.1 ppm error). 
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tert-Butyl (1R,5R)-(p-tolylsulfinyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate syn-
(R,R,Ss)-225 and tert-Butyl (1S,5S)-(p-tolylsulfinyl)-2-azabicyclo[3.1.0]hexane-2-
carboxylate anti-(S,S,Ss)-225 
(Table 3.5, Entry 1) 
syn-(R,R,SS)-225
N
Boc
S
O
anti-(S,S,SS)-225
N
Boc
S
O
 
 
Using general procedure H, s-BuLi (1.70 mL of a 1.3 M solution in hexanes, 2.20 
mmol, 2.2 eq.), N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and 
TMEDA (256 mg, 2.20 mmol, 2.2 eq.) in Et2O (6 mL) at −78 °C for 1 h and a solution 
of Andersen’s sulfinate (SS)-97 (647 mg, 2.20 mmol, 2.2 eq.) in THF (2 mL) gave the 
crude product.  Purification by flash column chromatography on silica with 3:2 petrol-
EtOAc + 1% Et3N as eluent gave sulfoxide syn-(R,R,SS)-225 (129 mg, 38%, 58:42 er by 
CSP-HPLC) as a white solid, mp 163-166 °C; RF (3:2 petrol-EtOAc) 0.3; IR (CHCl3) 
2975, 2931, 1703 (C=O), 1492, 1454, 1393, 1368, 1257, 1168, 1083, 810 cm
-1
;
 1
H NMR 
(400 MHz, CDCl3) δ 7.50-7.48 (m, 2H, m-C6H4Me), 7.28 (d, J = 8.0 Hz, 2H, o-
C6H4Me), 3.47 (br s, 1H, NCHAHB), 2.84 (br s, 1H, NCHAHB), 2.41 (s, 3H, Me), 2.28 
(br s, 1H, CH), 1.93-1.90 (m, 1H, CH), 1.77-1.74 (m, 2H, CH), 1.52 (br s, 9H, CMe3), 
1.16-1.13 (m, 1H, CH); 
13
C NMR (100.6 MHz, CDCl3) (rotamers) δ 155.0 (br, C=O), 
141.9 (ipso-Ar), 141.6 (ipso-Ar), 141.1 (ipso-Ar), 139.5 (ipso-Ar), 129.7 (br, Ar), 125.5 
(Ar), 124.8 (Ar), 81.2 (br, CMe3), 61.2 (NCS(O)Ar), 61.1 (NCS(O)Ar), 52.3 (br, 
NCH2), 28.5 (CMe3), 26.1 (br, CH2), 23.7 (CH2), 22.3 (CH2), 21.6 (Me), 11.9 (CH), 
11.7 (CH); MS (ESI) m/z 344 [(M + Na)
+
, 30], 322 [(M + H)
+
, 100]; HRMS m/z calcd 
for C17H23NO3S (M + Na)
+
 344.1291, found 344.1286 (+1.5 ppm error); CSP-HPLC: 
Chiralcel AD (90:10 Hexane-i-PrOH, 1.0 mL min
-1
) syn-(S,S,RS)-225 10.1 min, syn-
(R,R,SS)-225 11.5 min and sulfoxide anti-(S,S,SS)-225 (152 mg, 45%, 70:30 er by CSP-
HPLC) as a colourless oil, RF (3:2 petrol-EtOAc) 0.2; IR (film) 2977, 2932, 1696 
(C=O), 1477, 1384, 1335, 1257, 1168, 1083, 1048, 810 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 7.48 (d, J = 8.0 Hz, 2H, m-C6H4Me), 7.26 (d, J = 8.0 Hz, 2H, o-C6H4Me), 
3.79-3.72 (m, 1H, NCHAHB), 3.61 (br s, 1H, NCHAHB), 2.37 (s, 3H, Me), 2.27-2.18 (m, 
1H, CH), 2.05 (dtd, J = 8.0, 7.0, 1.5 Hz, 1H, NCCH), 1.83-1.75 (m, 1H, CH), 1.49 (s, 
9H, CMe3), 1.09 (t, J = 7.0 Hz, 1H, H), 1.05-1.01 (br m, 1H, CH); 
13
C NMR (100.6 
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MHz, CDCl3) δ 155.5 (C=O), 141.4 (ipso-Ar), 138.0 (ipso-Ar), 129.5 (Ar), 124.8 (Ar), 
80.9 (CMe3), 69.9 (br, NCS(O)Ar), 52.5 (br, NCH2), 29.9 (br, CH2), 28.4 (CMe3), 26.8 
(CH2), 24.3 (br, CH), 21.3 (Me); MS (ESI) m/z 344 [(M + Na)
+
, 40], 322 [(M + H)
+
, 
100]; HRMS m/z calcd for C17H23NO3S (M + Na)
+
 344.1291, found 344.1286 (+1.3 
ppm error); CSP-HPLC: Chiralcel AD (90:10 Hexane-iPrOH, 1.0 mL min
-1
) anti-
(S,S,Ss)-225 9.0 min, anti-(R,R,Rs)-225 12.3 min. 
 
(Table 3.5, Entry 2) 
Using general procedure I, s-BuLi (1.70 mL of a 1.3 M solution in hexanes, 2.20 mmol, 
2.2 eq.), N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and TMEDA (256 
mg, 2.20 mmol, 2.2 eq.) in Et2O (6 mL) at −78 °C for 1 h and a solution of Andersen’s 
sulfinate (Ss)-97  (647 mg, 2.20 mmol, 2.2 eq.) in THF (2 mL) gave the crude product.  
Purification by flash column chromatography on silica with 3:2 petrol-EtOAc + 1% 
Et3N as eluent gave sulfoxide syn-(R,R,SS)-225 (122 mg, 36%, 80:20 er by CSP-HPLC) 
as a white solid, CSP-HPLC: Chiralcel AD (90:10 Hexane-i-PrOH, 1.0 mL min
-1
) syn-
(S,S,RS)-225 10.7 min, syn-(R,R,SS)-7 12.3 min and sulfoxide anti-(S,S,SS)-225 (157 mg, 
47%, 78:22 er by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel AD (90:10 
Hexane-iPrOH, 1.0 mL min
-1
) anti-(S,S,Ss)-225 9.4 min, syn-(R,R,Rs)-225 13.1 min. 
 
(Table 3.5, Entry 3) 
Using general procedure J, s-BuLi (1.70 mL of a 1.3 M solution in hexanes, 2.20 mmol, 
2.2 eq.), N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and TMEDA (256 
mg, 2.20 mmol, 2.2 eq.) in Et2O (6 mL) and a solution of Andersen’s sulfinate (Ss)-97 
(647 mg, 2.20 mmol, 2.2 eq.) in THF (5 mL) gave the crude product.  Purification by 
flash column chromatography on silica with 3:2 petrol-EtOAc + 1% Et3N as eluent gave 
sulfoxide syn-(R,R,SS)-225 (132 mg, 39%, 89:11 er by CSP-HPLC) as a white solid, 
CSP-HPLC: Chiralcel AD (90:10 Hexane-i-PrOH, 1.0 mL min
-1
) syn-(S,S,RS)-225 13.2 
min, syn-(R,R,SS)-225 15.2 min and sulfoxide anti-(S,S,SS)-225 (146 mg, 44%, 88:12 er 
by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel AD (90:10 Hexane-iPrOH, 
1.0 mL min
-1
) anti-(S,S,Ss)-225 11.8 min, syn-(R,R,Rs)-225 16.1 min. 
 
Using general procedure J, s-BuLi (1.70 mL of a 1.3 M solution in hexanes, 2.20 mmol, 
2.2 eq.), N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and (−)-sparteine 
(504 mg, 2.20 mmol, 2.2 eq.) in Et2O (6 mL) and a solution of Andersen’s sulfinate 
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(Ss)-97  (647 mg, 2.20 mmol, 2.2 eq.) in THF (5 mL) gave the crude product.  
Purification by flash column chromatography on silica with 3:2 petrol-EtOAc + 1% 
Et3N as eluent gave sulfoxide syn-(R,R,SS)-7 (88 mg, 27%, 96:4 er by CSP-HPLC) as a 
white solid, CSP-HPLC: Chiralcel AD (90:10 Hexane-i-PrOH, 1.0 mL min
-1
) syn-
(S,S,RS)-7 10.2 min, syn-(R,R,SS)-7 11.6 min and sulfoxide anti-(S,S,SS)-7 (78 mg, 24%, 
89:11 er by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel AD (90:10 Hexane-
iPrOH, 1.0 mL min
-1
) anti-(S,S,Ss)-225 8.7 min, syn-(R,R,Rs)-225 11.9 min. 
 
Using general procedure J, s-BuLi (0.85 mL of a 1.3 M solution in hexanes, 1.10 mmol, 
2.2 eq.), N-Boc 4-chloro piperidine 223 (110 mg, 0.50 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (213 mg, 1.10 mmol, 2.2 eq.) in Et2O (4 mL) and a solution of Andersen’s 
sulfinate (Ss)-97  (324 mg, 1.10 mmol, 2.2 eq.) in THF (3 mL) gave the crude product.  
Purification by flash column chromatography on silica with 3:2 petrol-EtOAc + 1% 
Et3N as eluent gave sulfoxide syn-(R,R,SS)-225 (42 mg, 26%, 99:1 er by CSP-HPLC) as 
a white solid, CSP-HPLC: Chiralcel AD (90:10 Hexane-i-PrOH, 1.0 mL min
-1
) syn-
(S,S,RS)-225 9.6 min, syn-(R,R,SS)-225 10.9 min and sulfoxide anti-(S,S,SS)-225 (43 mg, 
27%, 93:7 er by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel AD (90:10 
Hexane-iPrOH, 1.0 mL min
-1
) anti-(S,S,Ss)-225 8.6 min, syn-(R,R,Rs)-225 11.6 min. 
 
Using general procedure J, s-BuLi (1.70 mL of a 1.3 M solution in hexanes, 2.20 mmol, 
2.2 eq.), N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and diamine 
(R,R)-42 (683 mg, 2.20 mmol, 2.2 eq.) in Et2O (6 mL) and a solution of Andersen’s 
sulfinate (Ss)-97  (647 mg, 2.20 mmol, 2.2 eq.) in THF (5 mL) gave the crude product.  
Purification by flash column chromatography on silica with 3:2 petrol-EtOAc + 1% 
Et3N as eluent gave sulfoxide syn-(R,R,SS)-225 (163 mg, 51%, 99:1 er by CSP-HPLC) 
as a white solid, [α]D −43.7 (c 0.65 in CHCl3); CSP-HPLC: Chiralcel AD (90:10 
Hexane-i-PrOH, 1.0 mL min
-1
) syn-(S,S,RS)-225 9.9 min, syn-(R,R,SS)-225 11.5 min and 
sulfoxide anti-(S,S,SS)-225 (80 mg, 25%, 87:13 er by CSP-HPLC) as a colourless oil, 
[α]D +64.6 (c 0.9 in CHCl3); CSP-HPLC: Chiralcel AD (90:10 Hexane-iPrOH, 1.0 mL 
min
-1
) anti-(S,S,Ss)-225 8.7 min, syn-(R,R,Rs)-225 12.4 min. 
 
Using general procedure J, s-BuLi (1.70 mL of a 1.3 M solution in hexanes, 2.20 mmol, 
2.2 eq.), N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and diamine 
(S,S)-42 (683 mg, 2.20 mmol, 2.2 eq.) in Et2O (6 mL) and a solution of Andersen’s 
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sulfinate (Ss)-97 (647 mg, 2.20 mmol, 2.2 eq.) in THF (5 mL) gave the crude product.  
Purification by flash column chromatography on silica with 3:2 petrol-EtOAc + 1% 
Et3N as eluent gave sulfoxide syn-(R,R,SS)-225 (38 mg, 12%, 89:11 er by CSP-HPLC) 
as a white solid, [α]D −43.2 (c 0.7 in CHCl3); CSP-HPLC: Chiralcel AD (90:10 Hexane-
i-PrOH, 1.0 mL min
-1
) syn-(S,S,RS)-225 12.2 min, syn-(R,R,SS)-225 14.2 min and 
sulfoxide anti-(S,S,SS)-225 (174 mg, 54%, 87:13 er by CSP-HPLC) as a colourless oil, 
[α]D +86.1 (c 0.7 in CHCl3); CSP-HPLC: Chiralcel AD (90:10 Hexane-iPrOH, 1.0 mL 
min
-1
) anti-(S,S,Ss)-225 8.1 min, syn-(R,R,Rs)-225 11.4 min. 
 
tert-Butyl 1-(p-tolylsulfinyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate syn-rac-225 
and anti-rac-225 
syn-rac-225
N
Boc
S
O
anti-rac-225
N
Boc
S
O
 
(Table 3.4, entry 1) 
Using General procedure H, s-BuLi (2.11 mL of a 1.3 M solution in hexanes, 2.75 
mmol, 2.2 eq.), N-Boc 4-chloro piperidine 223 (275 mg, 1.25 mmol, 1.0 eq.) and 
TMEDA (319 mg, 2.75 mmol, 2.2 eq.) in Et2O (8 mL) at −78 °C for 6 h and methyl p-
toluenesulfinate 121 (468 mg, 2.75 mmol, 2.2 eq.) gave the crude product.  Purification 
by flash column chromatography on silica with 3:2 petrol-EtOAc + 1% Et3N as eluent 
gave sulfoxide syn-rac-225 (142 mg, 35%) as a white solid, mp 161-163 °C and 
sulfoxide anti-rac-225 (144 mg, 36%) as a colourless oil.   
 
(Table 3.4, entry 2) 
Using General procedure H, s-BuLi (2.11 mL of a 1.3 M solution in hexanes, 2.75 
mmol, 2.2 eq.), N-Boc 4-chloro piperidine 223 (275 mg, 1.25 mmol, 1.0 eq.) and 
TMEDA (319 mg, 2.75 mmol, 2.2 eq.) in Et2O (8 mL) at −78 °C for 1 h and methyl p-
toluenesulfinate 121 (468 mg, 2.75 mmol, 2.2 eq.) gave the crude product.  Purification 
by flash column chromatography on silica with 3:2 petrol-EtOAc + 1% Et3N as eluent 
gave sulfoxide syn-rac-225 (138 mg, 35%) as a white solid and sulfoxide anti-rac-225 
(141 mg, 35%) as a colourless oil.   
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(Table 3.4, entry 3) 
s-BuLi (2.11 mL of a 1.3 M solution in hexanes, 2.75 mmol, 2.2 eq.) was added to a 
stirred solution of N-Boc 4-chloro piperidine 223 (275 mg, 1.25 mmol, 1.0 eq.) in THF 
(8 mL) at −78 °C under Ar.  The resulting solution was stirred at −78 °C for 1 h.  Then, 
methyl p-toluenesulfinate 121 (468 mg, 2.75 mmol, 2.2 eq.) was added and the resulting 
solution was allowed to warm to rt over 2 h and stirred at rt for 16 h.  Saturated 
NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous layer was 
extracted with Et2O (3 × 10 mL).  The combined organic layers were dried (Na2SO4) 
and evaporated under reduced pressure to give the crude product.  Purification by flash 
column chromatography on silica with 3:2 petrol-EtOAc + 1% Et3N as eluent gave 
sulfoxide syn-rac-225 (132 mg, 33%) as a white solid and sulfoxide anti-rac-225 (129 
mg, 36%) as a colourless oil.   
 
(Table 3.4, entry 4) 
s-BuLi (2.11 mL of a 1.3 M solution in hexanes, 2.75 mmol, 2.2 eq.) was added to a 
stirred solution of N-Boc 4-chloro piperidine 223 (275 mg, 1.25 mmol, 1.0 eq.) in THF 
(8 mL) at −30 °C under Ar.  The resulting solution was stirred at −30 °C for 5 min.  
Then, methyl p-toluenesulfinate 121 (468 mg, 2.75 mmol, 2.2 eq.) was added and the 
resulting solution was allowed to warm to rt over 2 h and stirred at rt for 16 h.  
Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous 
layer was extracted with Et2O (3 × 10 mL).  The combined organic layers were dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product.  Purification 
by flash column chromatography on silica with 3:2 petrol-EtOAc + 1% Et3N as eluent 
gave sulfoxide syn-rac-225 (85 mg, 21%) as a white solid and sulfoxide anti-rac-225 
(72 mg, 18%) as a colourless oil.   
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tert-Butyl 4-[[(2,4,6-triisopropylbenzene)sulfonyl]oxy]piperidine-1-carboxylate 234 
N
Boc
234
O
S
O
O
 
 
Triisopropylsulfonyl chloride (4.89 g, 16.15 mmol, 1.3 eq.) was added portionwise to a 
stirred solution of N-Boc 4-hydroxy piperidine 302 (2.50 g, 12.42  mmol, 1.0 eq.), Et3N 
(1.90 mL, 13.66 mmol, 1.1 eq.) and DMAP (14 mg, 0.12 mmol, 0.01 eq.)  in CH2Cl2 
(30 mL) at 0 °C under Ar. The resulting solution was allowed to warm to rt and stirred 
at rt for 3 h. Then, water (20 mL) was added and the two layers were separated.  The 
organic layer was washed with 1 M HCl(aq) (20 mL), dried (Na2SO4) and evaporated 
under reduced pressure to give the crude product.  Purification by flash column 
chromatography on silica with 4:1 petrol-EtOAc as eluent gave N-Boc 4-sulfonyl 
piperidine 234 (984 mg, 98%) as a pale yellow solid, mp 71-73 °C;  RF (4:1 petrol-
EtOAc) 0.2; 
1
H NMR (400 MHz, CDCl3) δ 7.19 (s, 2H, Ar), 4.84 (tt, J = 7.5, 4.0 Hz, 
1H, CHOSO2Ar), 4.16 (sept, J = 7.0 Hz, 2H, CHMe2), 3.67 (ddd, J = 13.0, 7.0, 4.0 Hz, 
2H, NCHAHB),  3.26 (ddd, J = 13.0, 8.0, 4.0 Hz, 2H, NCHAHB), 2.92 (sept, J = 7.0 Hz, 
1H, CHMe2), 1.88 (ddt, J = 13.5, 7.0, 4.0, 2H, NCH2CHAHB), 1.76 (dtd, J = 13.5, 7.0, 
4.0, 2H, NCH2CHAHB), 1.45 (s, 9H, CMe3) 1.27 (d, J = 7.0 Hz, 12H, CHMe2), 1.27 (d, 
J = 7.0 Hz, 6H, CHMe2); 
13
C NMR (100.6 MHz, CDCl3) δ 154.7 (C=O), 153.7 (ipso-
Ar), 150.4 (ipso-Ar), 130.8 (ipso-Ar), 123.8 (Ar), 80.0 (CMe3), 76.9 (CHOSO2Ar), 34.3 
(CHMe2), 31.7 (br, NCH2), 29.8 (br, NCH2CH2), 29.7 (CHMe2) 28.5 (CMe3), 24.8 
(CHMe2), 23.6 (CHMe2).
 
Lab Book Reference: PJR 3/245 
 
tert-Butyl 2-azabicyclo[3.1.0]hexane-2-dicarboxylate rac-227 
rac-227
N
Boc
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Using general procedure H, s-BuLi (7.70 mL of a 1.3M solution in hexanes, 10.01 
mmol, 2.2 eq.), N-Boc 4-chloro piperidine 223 (1.00 g, 4.55 mmol, 1.0 eq.) and 
TMEDA (1.16 g, 10.01 mmol, 2.2 eq.) in Et2O (20.0 mL) at −78 °C for 1 h and MeOH 
(2.0 mL) gave the crude product.  Purification by flash column chromatography on 
silica with 4:1 petrol-Et2O as eluent gave bicycle rac-227 (723 mg, 87%) as a colourless 
oil, RF (4:1 petrol-Et2O) 0.3; IR (film) 2974, 2879, 1670 (C=O), 1411, 1365, 1344, 
1254, 1171, 1111, 1081 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 3.54 (br s, 1H, NCHAHB), 
3.33-3.26 (br m, 1H, NCH), 2.82 (q, J = 9.0 Hz,  1H, NCHAHB), 1.97 (br s, 1H, 
NCH2CHAHB), 1.82 (dtd, J = 12.5, 9.0, 3.0 Hz, 1H, NCH2CHAHB), 1.45-1.34 (m, 1H, 
NCHCH), 1.37 (s, 9H, CMe3), 0.57 (br s, 1H, NCHCHAHB), 0.42 (td, J = 5.0, 3.0 Hz, 
1H, NCHCHAHB); 
13
C NMR (100.6 MHz, CDCl3) δ 155.1 (C=O), 79.0 (CMe3), 43.4 
(br, NCH2), 35.3 (NCH), 28.3 (CMe3), 25.4 (CH2), 14.8 (NCHCH), 10.7 (CH2); MS 
(ESI) m/z 206 [(M + Na)
+
, 80], 128 (100); HRMS m/z calcd for C10H17NO2 (M + Na)
+
 
206.1156, found 206.1151 (−2.0 ppm error). 
Lab Book Reference: PJR 4/251 + PJR 4/256 
 
[(1S)-1-phenylethyl]isopropylamine 236
231
 
(S)-236
Ph N
H
 
 
A stirred solution of (S)-α-methylbenzylamine (3.87 mL, 30.0 mmol, 1.0 eq.) in acetone 
(300 mL) was heated to 60 °C and stirred at 60°C for 16 h.  Then, the solution was 
cooled to rt and the solvent was removed under reduced pressure.  The residue was 
dissolved in MeOH (100 mL) and NaBH4 (1.70 g, 45.0 mmol, 1.5eq.) was added 
portionwise at 0°C under Ar.  The resulting solution was stirred at rt for 2h.  Then, the 
solution was cooled to 0 °C and sat. NH4Cl(aq) (40 mL) was added dropwise.  The 
solvent was evaporated under reduced pressure and the reaction mixture was taken up in 
EtOAc (25mL).  The two layers were separated and the aqueous layer was extracted 
with EtOAc (2 x 25 mL).  Combined organic layers were dried (Na2SO4) and 
evaporated under reduced pressure to give the crude product.  Purification by Kügelrohr 
distillation gave amine (S)-236 (4.86 g, 99%) as a colourless oil, bp 84-86 °C at 9 mm 
Hg  (lit., 104 °C at 20 mm Hg);  
1
H NMR (400 MHz, CDCl3) δ 7.34-7.20 (m, 5H, Ph ), 
3.88 (q, J = 6.5 Hz, 1H, NCHPh), 2.61 (sept., J = 6.0 Hz, 1H, NCHMe2), 1.34 (d, J = 
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6.5 Hz, 3H, NCH(Ph)Me), 1.02 (d, J = 6.0 Hz, 6H, NCHMeAMeB), 0.99 (d, J = 6.0 Hz, 
6H, NCHMeAMeB);  
13
C NMR (100.6 MHz, CDCl3) δ 145.9 (ipso-Ph), 128.4 (Ph), 
126.7 (Ph), 126.4 (Ph), 55.0 (NCHPh), 45.6 (NCHMe2), 24.8 (Me), 24.0 (Me), 22.1 
(Me).  Spectroscopic data consistent with those reported in the literature.
231
  
Lab Book Reference: PJR 5/352 
 
tert-Butyl-(1S,5R)-(phenylcarbamoyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate 
(S,R)-235 
(Table 3.6, Entry 1) 
(S,R)-235
N
Boc
H
N
O
Ph
 
 
Using general procedure H, s-BuLi (1.69 mL of a 1.3 M solution in hexanes, 2.20 
mmol, 2.2 eq.), N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and (−)-
sparteine (516 mg, 2.20 mmol, 2.2 eq.) in Et2O (8 mL) and phenylisocyanate (262 mg, 
2.20 mmol, 2.2 eq.) gave the crude product.  Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide (S,R)-235 (283 
mg, 94%, 56:44 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: Chiracel OD 
(90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.2 min, (S,R)-235 13.6 min.  Full 
characterisation data is presented later. 
 
(Table 3.6, Entry 3) 
Using general procedure H, s-BuLi (1.95 mL of a 1.3M solution in hexanes, 2.53 mmol, 
2.2 eq.), N-Boc 4-sulfonyl piperidine 234 (540 mg, 1.15 mmol, 1.0 eq.) and (−)-
sparteine (593 mg, 2.53 mmol, 2.2 eq.) in Et2O (6.5 mL) at −78 °C for 1 h and 
phenylisocyanate (301 mg, 2.53 mmol, 2.2 eq.) gave the crude product.  Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide 
(S,R)-234 (291 mg, 84%, 58:42 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-234 7.2 min, (S,R)-234 14.1 
min. 
Lab Book Reference: PJR 4/246 
 
Chapter Five: Experimental 
 
241 
 
Kinetic Resolution of rac-227 
(Table 3.7, Entry 1) 
s-BuLi (0.70 mL of a 1.3M solution in hexanes, 0.91 mmol, 0.5 eq.) was added 
dropwise to a stirred solution of azabicyco[3.1.0] hexane rac-227 (333 mg, 1.82 mmol, 
1.0 eq.) and (−)-sparteine (213 mg, 0.91 mmol, 0.5 eq.) in Et2O (5.5 mL) at −78 °C 
under Ar.  The resulting solution was stirred at −78 °C for 1 h.  Then, phenylisocyanate 
(130 mg, 1.09 mmol, 0.6 eq.) was added dropwise. The solution was allowed to warm 
slowly to rt over 2 h and stirred at rt for 16 h.  Saturated NH4Cl(aq) (10 mL) was added 
and the two layers were separated.  The aqueous layer was extracted with Et2O (3 × 10 
mL).  The combined organic layers were dried (Na2SO4) and evaporated under reduced 
pressure to give the crude product.  Purification by flash column chromatography on 
silica with 98:2 CH2Cl2-Et2O as eluent gave recovered azabicyco[3.1.0] hexane (R,S)-
227 (99 mg, 30%, er not determined) and  amide (S,R)-235 (198 mg, 36%, 56:44 er by 
CSP-HPLC) as a pale yellow solid, CSP-HPLC: Chiracel OD (90:10 Hexane-iPrOH, 
1.0 mLmin
-1
) (R,S)-235 7.1 min, (S,R)-235 13.7 min. 
Lab Book Reference: PJR 4/252 
 
(Table 3.7, Entry 2) 
n-BuLi (0.23 mL of a 2.5M solution in hexanes, 0.58 mmol, 0.5 eq.) was added 
dropwise to a stirred solution of azabicyco[3.1.0] hexane rac-227 (210 mg, 1.15 mmol, 
1.0 eq.) and (−)-sparteine (136 mg, 0.58 mmol, 0.5 eq.) in Et2O (5.0 mL) at −78 °C 
under Ar.  The resulting solution was stirred at −78 °C for 1 h.  Then, phenylisocyanate 
(69 mg, 0.58 mmol, 0.5 eq.) was added dropwise. The solution was allowed to warm 
slowly to rt over 2 h and stirred at rt for 16 h.  Saturated NH4Cl(aq) (10 mL) was added 
and the two layers were separated.  The aqueous layer was extracted with Et2O (3 × 10 
mL).  The combined organic layers were dried (Na2SO4) and evaporated under reduced 
pressure to give the crude product.  Purification by flash column chromatography on 
silica with 98:2 CH2Cl2-Et2O as eluent gave recovered azabicyco[3.1.0] hexane (R,S)-
227 (110 mg, 52%, er not determined) and  amide (S,R)-235 (146 mg, 42%, 56:44 er by 
CSP-HPLC) as a pale yellow solid, CSP-HPLC: Chiracel OD (90:10 Hexane-iPrOH, 
1.0 mLmin
-1
) (R,S)-235 7.4 min, (S,R)-235 14.8 min.. 
Lab Book Reference: PJR 4/257 
 
 
Chapter Five: Experimental 
 
242 
 
(Table 3.8, Entry 4) 
Using general procedure H, s-BuLi (1.27 mL of a 1.3M solution in hexanes, 1.65 mmol, 
2.2 eq.), N-Boc 4-chloro piperidine 223 (164 mg, 0.75 mmol, 1.0 eq.) and diamine 
(R,R)-237 (572 mg, 1.65 mmol, 2.2 eq.) in Et2O (5 mL) at −78 °C for 1 h and 
phenylisocyanate (196 mg, 1.65 mmol, 2.2 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide 
(S,R)-235 (182 mg, 81%, 62:38 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.4 min, (S,R)-235 14.8 
min. 
Lab Book Reference: PJR 4/263 
 
(Table 3.9, Entry 1) 
Using general procedure H, s-BuLi (0.84 mL of a 1.3M solution in hexanes, 1.20 mmol, 
1.2 eq.), N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and (−)-sparteine 
(281 mg, 1.20 mmol, 1.2 eq.) in Et2O (8 mL) at −78 °C for 1 h and phenylisocyanate 
(143 mg, 1.20 mmol, 1.2 eq.) gave the crude product.  Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide (S,R)-235 (138 
mg, 45%, 56:44 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: Chiracel OD 
(90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.2 min, (S,R)-235 13.3 min.. 
Lab Book Reference: PJR 4/241 
 
(Table 3.9, Entry 3) 
Using general procedure H, s-BuLi (0.98 mL of a 1.3M solution in hexanes, 1.26 mmol, 
1.1 eq.), N-Boc 4-sulfonyl piperidine 234 (540 mg, 1.15 mmol, 1.0 eq.) and (−)-
sparteine (296 mg, 1.26 mmol, 1.1 eq.) in Et2O (6.5 mL) at −78 °C for 1 h and 
phenylisocyanate (151 mg, 1.26 mmol, 1.1 eq.) gave the crude product.  Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide 
(S,R)-235 (145 mg, 42%, 58:42 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.4 min, (S,R)-235 14.5 
min. 
Lab Book Reference: PJR 4/248 
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 (Table 3.12, Entry 3) 
A solution of N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) in Et2O (3.0 
mL) was added dropwise over 30 min to a stirred solution of s-BuLi (1.69 mL of a 1.3M 
solution in hexanes, 2.20 mmol, 2.2 eq.) and (−)-sparteine (515 mg, 2.20 mmol, 2.2 eq.) 
in Et2O (3.5 mL) at −78 °C under Ar.  The resulting solution was stirred at −78 °C for 3 
h.  Then, phenylisocyanate (262 mg, 2.20 mmol, 2.2 eq.) was added dropwise. The 
solution was allowed to warm slowly to rt over 2 h and stirred at rt for 16 h.  Saturated 
NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous layer was 
extracted with Et2O (3 × 10 mL).  The combined organic layers were dried (Na2SO4) 
and evaporated under reduced pressure to give the crude product.  Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide (S,R)-
235 (205 mg, 68%, 54:46 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.0 min, (S,R)-235 13.4 
min. 
Lab Book Reference: PJR 5/348 
 
(Table 3.12, Entry 4) 
A solution of N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) in Et2O (3.0 
mL) was added dropwise to a stirred solution of s-BuLi (1.69 mL of a 1.3M solution in 
hexanes, 2.20 mmol, 2.2 eq.) and (−)-sparteine (515 mg, 2.20 mmol, 2.2 eq.) in Et2O 
(3.5 mL) at −78 °C under Ar.  The resulting solution was stirred at −40 °C for 1 h.  
Then, phenylisocyanate (262 mg, 2.20 mmol, 2.2 eq.) was added dropwise. The solution 
was allowed to warm slowly to rt over 2 h and stirred at rt for 16 h.  Saturated NH4Cl(aq) 
(10 mL) was added and the two layers were separated.  The aqueous layer was extracted 
with Et2O (3 × 10 mL).  The combined organic layers were dried (Na2SO4) and 
evaporated under reduced pressure to give the crude product.  Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide (S,R)-
235 (205 mg, 73%, 58:42 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.2 min, (S,R)-235 14.1 
min. 
Lab Book Reference: PJR 5/350 
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(Table 3.12, Entry 5) 
A solution of N-Boc 4-sulfonyl piperidine 234 (350 mg, 0.75 mmol, 1.0 eq.) in Et2O 
(3.0 mL) was added dropwise over 30 min via syringe pump to a stirred solution of s-
BuLi (1.28 mL of a 1.3M solution in hexanes, 1.65 mmol, 2.2 eq.) and (−)-sparteine 
(386 mg, 1.65 mmol, 2.2 eq.) in Et2O (3.5 mL) at −78 °C under Ar.  The resulting 
solution was stirred at −78 °C for 3 h.  Then, phenylisocyanate (196 mg, 1.65 mmol, 2.2 
eq.) was added dropwise. The solution was allowed to warm slowly to rt over 2 h and 
stirred at rt for 16 h.  Saturated NH4Cl(aq) (10 mL) was added and the two layers were 
separated.  The aqueous layer was extracted with Et2O (3 × 10 mL).  The combined 
organic layers were dried (Na2SO4) and evaporated under reduced pressure to give the 
crude product.  Purification by flash column chromatography on silica with 98:2 
CH2Cl2-Et2O as eluent gave amide (S,R)-235 (227 mg, 99%, 56:44 er by CSP-HPLC) as 
a pale yellow solid, CSP-HPLC: Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) 
(R,S)-235 7.0 min, (S,R)-235 13.5 min. 
 
tert-Butyl (1R,5S)-(phenylcarbamoyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate 
(R,S)-235 
(R,S)-235
N
Boc
H
N
O
Ph
 
(Table 3.8, entry 2) 
Using general procedure H, s-BuLi (1.51 mL of a 1.3 M solution in hexanes, 1.96 
mmol, 2.2 eq.), N-Boc 4-chloro piperidine 223 (194 mg, 0.89 mmol, 1.0 eq.) and (+)-
sparteine surrogate 1 (381 mg, 1.96 mmol, 2.2 eq.) in Et2O (5.5 mL) and 
phenylisocyanate (233 mg, 1.96 mmol, 2.2 eq.) gave the crude product.  Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide 
(R,S)-235 (212 mg, 79%, 54:46 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.4 min, (S,R)-235 14.8 
min.   
 
(Table 3.8, entry 3) 
Using general procedure H, s-BuLi (1.35 mL of a 1.3 M solution in hexanes, 1.76 
mmol, 2.2 eq.), N-Boc 4-chloro piperidine 223 (175 mg, 0.80 mmol, 1.0 eq.) and 
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diamine (S,S)-42 (547 mg, 1.76 mmol, 2.2 eq.) in Et2O (5.0 mL) and phenylisocyanate 
(124 mg, 1.04 mmol, 1.3 eq.) gave the crude product.  Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide (R,S)-235 (178 
mg, 74%, 67:33 er by CSP-HPLC) as a pale yellow solid, ); [α]D +45.5 (c 1.1 in 
CHCl3); CSP-HPLC: Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.3 
min, (S,R)-235 14.3 min .   
 
(Table 3.9, Entry 5) 
Using general procedure H, s-BuLi (0.68 mL of a 1.3M solution in hexanes, 0.88 mmol, 
1.1 eq.), N-Boc 4-chloro piperidine 223 (175 mg, 0.80 mmol, 1.0 eq.) and diamine 
(S,S)-42 (274 mg, 0.88 mmol, 1.1 eq.) in Et2O (5.0 mL) at −78 °C for 1 h and 
phenylisocyanate (124 mg, 1.04 mmol, 1.3 eq.) gave the crude product.  Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide 
(R,S)-235 (178 mg, 43%, 57:43 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.3 min, (S,R)-235 14.3 
min. 
Lab Book Reference: PJR 4/281 
 
(Table 3.10, Entry 2) 
A solution of N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) in Et2O (3.0 
mL) was added dropwise to a stirred solution of s-BuLi (1.69 mL of a 1.3M solution in 
hexanes, 2.20 mmol, 2.2 eq.) and diamine (S,S)-42 (683 mg, 2.20 mmol, 2.2 eq.) in 
Et2O (3.5 mL) at −78 °C under Ar.  The resulting solution was stirred at −30 °C for 5 
min.  Then, phenylisocyanate (262 mg, 2.20 mmol, 2.2 eq.) was added dropwise. The 
solution was allowed to warm slowly to rt over 2 h and stirred at rt for 16 h.  Saturated 
NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous layer was 
extracted with Et2O (3 × 10 mL).  The combined organic layers were dried (Na2SO4) 
and evaporated under reduced pressure to give the crude product.  Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide (R,S)-
235 (223 mg, 74%, 52:48 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.1 min, (S,R)-235 14.0 
min. 
Lab Book Reference: PJR 5/337 
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(Table 3.10, Entry 3) 
Using general procedure H, s-BuLi (1.69 mL of a 1.3M solution in hexanes, 2.40 mmol, 
2.2 eq.), N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and diamine 
(S,S)-42 (683 mg, 2.40 mmol, 2.2 eq.) in Et2O (8.0 mL) at −40 °C for 1 h and 
phenylisocyanate (262 mg, 2.40 mmol, 2.2 eq.) gave the crude product.  Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide 
(R,S)-235 (208 mg, 69%, 67:33 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.4 min, (S,R)-235 13.3 
min. 
Lab Book Reference: PJR 4/275 
 
(Table 3.10, Entry 4) 
Using general procedure H, s-BuLi (1.69 mL of a 1.3M solution in hexanes, 2.40 mmol, 
2.2 eq.), N-Boc 4-sulfonyl piperidine 234 (466 mg, 1.00 mmol, 1.0 eq.) and diamine 
(S,S)-42 (683 mg, 2.40 mmol, 2.2 eq.) in Et2O (8.0 mL) at −40 °C for 1 h and 
phenylisocyanate (262 mg, 2.40 mmol, 2.2 eq.) gave the crude product.  Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide 
(R,S)-235 (220 mg, 73%, 58:42 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.4 min, (S,R)-235 14.5 
min. 
Lab Book Reference: PJR 4/275 
 
(Table 3.11, Entry 1) 
s-BuLi (1.69 mL of a 1.3M solution in hexanes, 2.20 mmol, 2.2 eq.) was added 
dropwise over 30 min via syringe pump to a stirred solution of N-Boc 4-chloro 
piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and diamine (S,S)-42 (683 mg, 2.20 mmol, 
2.2 eq.) in Et2O (5.0 mL) at −78 °C under Ar.  The resulting solution was stirred at −78 
°C for 1 h.  Then, phenylisocyanate (262 mg, 2.20 mmol, 2.2 eq.) was added dropwise. 
The solution was allowed to warm slowly to rt over 2 h and stirred at rt for 16 h.  
Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous 
layer was extracted with Et2O (3 × 10 mL).  The combined organic layers were dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product.  Purification 
by flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide 
(R,S)-235 (160 mg, 53%, 59:41 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chapter Five: Experimental 
 
247 
 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.2 min, (S,R)-235 13.9 
min. 
Lab Book Reference: PJR 5/346 
 
(Table 3.11, Entry 2) 
s-BuLi (1.69 mL of a 1.3M solution in hexanes, 2.20 mmol, 2.2 eq.) was added 
dropwise over 30 min via syringe pump to a stirred solution of N-Boc 4-chloro 
piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and diamine (S,S)-42 (683 mg, 2.20 mmol, 
2.2 eq.) in Et2O (5.0 mL) at −40 °C under Ar.  The resulting solution was stirred at −40 
°C for 1 h.  Then, phenylisocyanate (262 mg, 2.20 mmol, 2.2 eq.) was added dropwise. 
The solution was allowed to warm slowly to rt over 2 h and stirred at rt for 16 h.  
Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous 
layer was extracted with Et2O (3 × 10 mL).  The combined organic layers were dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product.  Purification 
by flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide 
(R,S)-235 (208mg, 69%, 67:33 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.0 min, (S,R)-235 13.5 
min. 
Lab Book Reference: PJR 5/351 
 
(Table 3.11, Entry 3) 
s-BuLi (1.28 mL of a 1.3M solution in hexanes, 1.65 mmol, 2.2 eq.) was added 
dropwise over 30 min via syringe pump to a stirred solution of N-Boc 4-sulfonyl 
piperidine 234 (350 mg, 0.75 mmol, 1.0 eq.) and (S,S)-42 (683 mg, 2.20 mmol, 2.2 eq.) 
in Et2O (5.0 mL) at −40 °C under Ar.  The resulting solution was stirred at −78 °C for 1 
h.  Then, phenylisocyanate (262 mg, 2.20 mmol, 2.2 eq.) was added dropwise. The 
solution was allowed to warm slowly to rt over 2 h and stirred at rt for 16 h.  Saturated 
NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous layer was 
extracted with Et2O (3 × 10 mL).  The combined organic layers were dried (Na2SO4) 
and evaporated under reduced pressure to give the crude product.  Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide (R,S)-
235 (160 mg, 76%, 57:43 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.3 min, (S,R)-235 12.7 
min. 
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Lab Book Reference: PJR 5/348 
 
(Table 3.11, Entry 4) 
s-BuLi (1.28 mL of a 1.3M solution in hexanes, 1.65 mmol, 2.2 eq.) was added 
dropwise over 30 min via syringe pump to a stirred solution of N-Boc 4-sulfonyl 
piperidine 234 (350 mg, 0.75 mmol, 1.0 eq.) and (S,S)-42 (683 mg, 2.20 mmol, 2.2 eq.) 
in Et2O (5.0 mL) at −40 °C under Ar.  The resulting solution was stirred at −40 °C for 1 
h.  Then, phenylisocyanate (262 mg, 2.20 mmol, 2.2 eq.) was added dropwise. The 
solution was allowed to warm slowly to rt over 2 h and stirred at rt for 16 h.  Saturated 
NH4Cl(aq) (10 mL) was added and the two layers were separated.  The aqueous layer was 
extracted with Et2O (3 × 10 mL).  The combined organic layers were dried (Na2SO4) 
and evaporated under reduced pressure to give the crude product.  Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide (R,S)-
235 (221mg, 98%, 58:42 er by CSP-HPLC) as a pale yellow solid, CSP-HPLC: 
Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.1 min, (S,R)-235 13.7 
min. 
Lab Book Reference: PJR 5/357 
 
(Table 3.12, Entry 1) 
A solution of N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) in Et2O (3.0 
mL) was added dropwise over 30 min via syringe pump to a stirred solution of s-BuLi 
(1.69 mL of a 1.3M solution in hexanes, 2.20 mmol, 2.2 eq.) and diamine (S,S)-42 (683 
mg, 2.20 mmol, 2.2 eq.) in Et2O (3.5 mL) at −78 °C under Ar.  The resulting solution 
was stirred at −78 °C for 3 h.  Then, phenylisocyanate (262 mg, 2.20 mmol, 2.2 eq.) was 
added dropwise. The solution was allowed to warm slowly to rt over 2 h and stirred at rt 
for 16 h.  Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated.  
The aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organic layers 
were dried (Na2SO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent 
gave amide (R,S)-235 (210 mg, 70%, 62:38 er by CSP-HPLC) as a pale yellow solid, 
CSP-HPLC: Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.1 min, 
(S,R)-235 13.8 min. 
Lab Book Reference: PJR 5/345 
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(Table 3.12, Entry 2) 
A solution of N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) in Et2O (3.0 
mL) was added dropwise over 30 min via syringe pump to a stirred solution of s-BuLi 
(1.69 mL of a 1.3M solution in hexanes, 2.20 mmol, 2.2 eq.) and diamine (S,S)-42 (683 
mg, 2.20 mmol, 2.2 eq.) in Et2O (3.5 mL) at −78 °C under Ar.  The resulting solution 
was stirred at −40 °C for 1 h.  Then, phenylisocyanate (262 mg, 2.20 mmol, 2.2 eq.) was 
added dropwise. The solution was allowed to warm slowly to rt over 2 h and stirred at rt 
for 16 h.  Saturated NH4Cl(aq) (10 mL) was added and the two layers were separated.  
The aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organic layers 
were dried (Na2SO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 98:2 CH2Cl2-Et2O as eluent 
gave amide (R,S)-235 (210 mg, 71%, 60:40 er by CSP-HPLC) as a pale yellow solid, 
CSP-HPLC: Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) (R,S)-235 7.1 min, 
(S,R)-235 13.6 min. 
Lab Book Reference: PJR 5/341 
 
Sulfoxide → Magnesium Exchange Reactions 
2-tert-Butyl (1S,5R)-1-methyl-2-azabicyclo[3.1.0]hexane-1,2-dicarboxylate (1S,5R)-
241 
(S,R)-241
N
Boc
OMe
O
 
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide syn-(R,R,SS)-225 (65 mg, 0.20 mmol, 1.0 eq., 99:1 er) in THF (8 
mL) at rt for 1 min and methyl chloroformate (39 μL, 0.50 mmol, 2.5 eq.) gave the 
crude product.  Purification by flash column chromatography on silica with 9:1 petrol-
EtOAc as eluent gave ester (S,R)-241 (43 mg, 89%, 99:1 er by CSP-HPLC) as a 
colourless oil, RF (9:1 petrol-EtOAc) 0.3; IR (CDCl3) 2979, 1732 (C=O, CO2Me), 1682 
(C=O, Boc), 1529, 1444, 1368, 1164, 908, 881, 732 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 
3.79 (ddd, J = 11.0, 9.5, 6.0 Hz, 1H, NCHAHB), 3.73 (s, 3H, OMe), 3.50 (br s, 1H, 
NCHAHB), 2.25 (ddt, J = 13.0, 9.5, 6.0 Hz,  1H, CH), 2.08-2.02 (m, 1H, CH), 1.96 (dd, 
J = 9.0, 5.5, Hz, 1H, CH), 1.98-1.87 (m, 1H, CH), 1.43 (s, 9H, CMe3), 1.02 (t, J = 5.5 
Chapter Five: Experimental 
 
250 
 
Hz, 1H, CH); 
13
C NMR (100.6 MHz, CDCl3) δ 171.5 (CO2Me) 155.5 (NCO2CMe3), 
80.0 (CMe3), 52.1 (OMe), 50.2 (NCH2), 47.5 (NC), 31.0 (br, CH2), 28.4 (CH), 28.3 
(CMe3), 26.4 (br, CH2); MS (ESI) m/z 264 [(M + Na)
+
, 100], 186 (20), 142 (30); HRMS 
m/z calcd for C12H19NO4 (M + Na)
+
 264.1203, found 264.1206 (+1.3 ppm error); [α]D 
−121.05 (c 0.20 in CHCl3); CSP-HPLC: Chiracel OD (99:1 Hexane-iPrOH, 1.0 mLmin
-
1
) (S,R)-241 13.0 min, (R,S)-241 15.4 min. 
 
2-tert-Butyl 1-methyl-2-azabicyclo[3.1.0]hexane-1,2-dicarboxylate rac-241 
rac-241
N
Boc
OMe
O
 
 
Using general procedure D, i-PrMgCl (0.15 mL of a 2.0 M solution in THF, 0.30 mmol, 
1.5 eq.) and sulfoxide syn-rac-225 (65 mg, 0.20 mmol, 1.0 eq.,) in THF (8 mL) at rt for 
1 min and methyl chloroformate (23 μL, 0.30 mmol, 1.5 eq.) gave the crude product.  
Purification by flash column chromatography on silica with 9:1 petrol-EtOAc as eluent 
gave ester rac-241 (24 mg, 50%) as a colourless oil. 
 
tert-Butyl (1S,5R)-(phenylcarbamoyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate 
(S,R)-235 
(S,R)-235
N
Boc
H
N
O
Ph
 
 
Using general procedure D, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide syn-(R,R,Ss)-225 (65 mg, 0.20 mmol, 1.0 eq., 99:1 er) in THF (8 
mL) at rt for 1 min and phenylisocyanate (60 mg, 0.50 mmol, 2.5 eq.) gave the crude 
product. Purification by flash column chromatography on silica with 98:2 CH2Cl2-Et2O 
as eluent gave amide (S,R)-235 (31 mg, 67%, 99:1 er by CSP-HPLC) as a pale yellow 
solid, mp 102-103 °C; RF (98:2 CH2Cl2-Et2O) 0.2; IR (CDCl3) 3408 (NH), 2979, 1689 
(C=O), 1682 (C=O), 1529, 1444, 1368, 1164, 908, 732 cm
-1
;
 1
H  NMR (400 MHz, 
CDCl3) δ 8.32 (br s, 1H, NH), 7.49 (d, J = 8.0 Hz, 2H, o-Ph), 7.30 (t, J = 8.0 Hz, 2H, m-
Ph), 7.07 (d, J = 8.0 Hz, 1H, p-Ph), 3.75 (ddd, J = 11.5, 9.0, 6.5 Hz, 1H, NCHAHB), 3.66 
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(ddd, J = 11.5, 8.5, 5.5 Hz, 1H, NCHAHB), 2.24 (ddt, J = 13.0, 9.0, 6.5 Hz,  1H, CH), 
2.17-2.12 (m, 1H,CH), 2.07 (dd, J = 9.0, 5.0 Hz, 1H, CH), 1.94 (dddd, J = 13.0, 8.5, 6.5, 
1.5  Hz, 1H, CH), 1.42 (s, 9H, CMe3), 1.02 (t, J = 5.0 Hz, 1H, CH); 
13
C NMR (100.6 
MHz, CDCl3) δ 168.6 (PhNCO) 156.9 (NCO2CMe3), 137.8 (ipso-Ph), 128.9 (Ph), 123.9 
(Ph), 119.3 (Ph), 81.2 (CMe3), 51.3 (NCH2), 50.6  (NC), 31.1 (CH), 28.1 (CMe3), 26.4 
(CH2), 24.8 (CH2); MS (ESI) m/z 325 [(M + Na)
+
, 30], 303 [(M + H)
+
, 100]; HRMS m/z 
calcd for C17H22N2O3 (M + Na)
+
 325.1523, found 325.1523 (−0.2 ppm error); ); [α]D 
−58.6 (c 0.7 in CHCl3); CSP-HPLC: Chiracel OD (90:10 Hexane-iPrOH, 1.0 mLmin
-1
) 
(R,S)-235 7.4 min, (S,R)-235 14.5 min.. 
 
tert-Butyl 1-(phenylcarbamoyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate rac-235 
rac-235
N
Boc
H
N
O
Ph
 
 
Using general procedure D, s-BuLi (1.69 mL of a 1.3 M solution in hexanes, 2.20 
mmol, 2.2 eq.), N-Boc 4-chloro piperidine 223 (219 mg, 1.00 mmol, 1.0 eq.) and 
TMEDA (255 mg, 2.20 mmol, 2.2 eq.) in Et2O (8 mL) and phenylisocyanate (262 mg, 
2.20 mmol, 2.2 eq.) gave the crude product.  Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-Et2O as eluent gave amide rac-235 (290 
mg, 96%) as a pale yellow solid. 
 
tert-Butyl (1S,5R)-1-(prop-2-en-1-yl)-2-azabicyclo[3.1.0]hexane-2-carboxylate 
(S,R)-230 
(S,R)-230
N
Boc
 
 
i-PrMgCl (0.25 mL, 0.50 mmol, 2.5 eq.) was added dropwise to a stirred solution of 
sulfoxide syn-(R,R,SS)-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 1 min at 
rt under Ar.  The resulting solution was stirred at rt for 1 min.  Then, a solution of 
CuBr.SMe2 (8 mg, 20 mol%, 0.2 eq.) in THF (1 mL) was added dropwise. The solution 
was stirred at rt for 10 min. Then, allyl bromide (63 mg, 0.50 mmol, 2.5 eq.) was added 
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dropwise and the resulting solution was stirred at rt for 2 h.  Saturated NH4Cl(aq) (7 mL) 
was added and the two were layers separated.  The aqueous layer was extracted with 
Et2O (3 x 10 mL).  The combined organic layers were dried (Na2SO4) and evaporated 
under reduced pressure to give the crude product.  Purification by flash column 
chromatography on silica with 95:5 petrol-EtOAc as eluent gave allylated pyrrolidine 
(S,R)-230 (31 mg, 69%) as a colourless oil, RF (95:5 petrol-EtOAc) 0.3; IR (CDCl3) 
2941, 1685 (C=O), 1519, 1434, 1378, 1164, 1062, 910, 732 cm
-1
;
 1
H NMR (400 MHz, 
CDCl3) δ 5.78 (dtd, J = 14.0, 7.0, 6.5 Hz, 1H, CH=CH2), 5.10-5.01 (m, 2H, =CH2), 3.62 
(ddd, J = 11.0, 9.5, 6.0 Hz, 1H, NCHAHB), 3.38 (br s, 1H, NCHAHB), 3.21 (br s, 1H, 
CH), 2.13-2.00 (m, 2H, CH), 1.82-1.75 (m, 1H, CH), 1.47 (s, 9H, CMe3), 1.40-1.34 (m, 
1H, CH), 0.91 (dd, J = 8.5, 5.5 Hz, 1H, CH), 0.67 (t, J = 5.5 Hz, 1H, CH) ; 
13
C NMR 
(100.6 MHz, CDCl3) δ 156.0 (C=O), 135.2 (CH=CH2), 116.7 (CH=CH2), 79.3 (br, 
CMe3), 50.0 (br, NCH2), 46.7 (NC), 37.5 (br, CH2CH=), 28.5 (CMe3), 25.9 (CH2), 23.3 
(CH), 21.8 (CH2); MS (ESI) m/z 246 [(M + Na)
+
, 70], 168 (100); HRMS m/z calcd for 
C13H21NO2 (M + Na)
+
 246.1466, found 246.1465 (−0.5 ppm error); [α]D +2.4 (c 0.45 in 
CHCl3); CSP-HPLC: Chiracel AD-H (99.5:0.5 Hexane-iPrOH, 0.3 mLmin
-1
) (R,S)-230 
11.0 min, (S,R)-230 11.8 min. 
 
tert-Butyl 1-(prop-2-en-1-yl)-2-azabicyclo[3.1.0]hexane-2-carboxylate rac-230 
rac-230
N
Boc
 
 
i-PrMgCl (0.15 mL, 0.30 mmol, 1.5 eq.) was added dropwise to a stirred solution of 
sulfoxide syn-rac-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) at rt for 1 min at rt 
under Ar.  The resulting solution was stirred at rt for 1 min.  Then, a solution of 
CuBr.SMe2 (8 mg, 20 mol%, 0.2 eq.) in THF (1 mL) was added dropwise. The solution 
was stirred at rt for 10 min. Then, allyl bromide (38 mg, 0.30 mmol, 1.5 eq.) was added 
dropwise and the resulting solution was stirred at rt for 2 h.  Saturated NH4Cl(aq) (7 mL) 
was added and the two layers were separated.  The aqueous layer was extracted with 
Et2O (3 x 10 mL).  The combined organic layers were dried (Na2SO4) and evaporated 
under reduced pressure to give the crude product.  Purification by flash column 
Chapter Five: Experimental 
 
253 
 
chromatography on silica with 95:5 petrol-EtOAc as eluent gave allylated pyrrolidine 
rac-230 (26 mg, 58%) as a colourless oil. 
 
 
tert-Butyl (1R,5R)-1-benzyl-2-azabicyclo[3.1.0]hexane-2-carboxylate (R,R)-242 
(R,R)-242
N
Boc
Ph
 
 
i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 2.5 eq.) was added to a 
stirred solution of sulfoxide syn-(R,R,Ss)-225 (65 mg, 0.20 mmol, 1.0 eq., 99:1 er) in 
THF (8 mL) at rt under Ar. The resulting solution was stirred at rt for 1 min.  Then, a 
solution of CuBr.SMe2 (8 mg, 0.04 mmol, 0.2 eq.) in THF (0.5 mL) and benzyl bromide 
(89 mg, 0.50 mmol, 2.5 eq.) was added sequentially and the solution was stirred at rt for 
2 h. Saturated NH4Cl(aq) (7 mL) was added and the two layers were separated.  The 
aqueous layer was extracted with Et2O (3 × 10 mL).  The combined organic layers were 
dried (Na2SO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 4:1 petrol-Et2O as eluent 
gave benzylated pyrrolidine (R,R)-242 (35 mg, 64%, 99:1 er by CSP-HPLC) as a 
colourless oil, RF (4:1 petrol-Et2O) 0.2; IR (CDCl3) 2985, 2810, 1679 (C=O), 1559, 
1487, 1378, 1201, 1164, 908, 732 cm
-1
;
 1
H  NMR (400 MHz, CDCl3) δ 7.29-7.26 (m, 
2H, Ph), 7.22-7.19 (m, 3H, Ph), 3.76 (br s, 1H, NCHAHB), 3.42-3.16 (br m, 2H,CH), 
2.57 (d, J = 14.0 Hz, 1H, CH), 1.99 (tdd, J = 14.0, 7.0, 2.8 Hz,  1H, CH), 1.77-1.70 (m, 
1H, CH), 1.50-1.44 (m, 1H, CH), 1.50 (s, 9H, CMe3), 0.98 (dd, J = 9.0, 5.0 Hz, 1H, CH) 
0.73 (t, J = 5.0 Hz, 1H, CH); 
13
C NMR (100.6 MHz, CDCl3) δ 153.9 (C=O), 139.4 
(ipso-Ph), 129.4 (Ph), 128.2 (Ph), 126.2 (Ph), 79.4 (CMe3), 48.4 (br, NCH2), 43.5  (br, 
NC), 41.0 (br PhCH2), 32.6 (br, CH), 28.6 (CMe3), 26.1 (CH2), 23.7 (CH2); MS (ESI) 
m/z 296 [(M + Na)
+
, 70], 218 (100); HRMS m/z calcd for C17H24NO2 (M + Na)
+
 
296.1621, found 296.1611 (+3.2 ppm error); [α]D −13.6 (c 0.2 in CHCl3); CSP-HPLC: 
Chiracel OD (99:1 Hexane-iPrOH, 1.0 mLmin
-1
) (R,R)-242 5.6 min, (S,S)-242 6.6 min. 
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tert-Butyl 1-benzyl-2-azabicyclo[3.1.0]hexane-2-carboxylate rac-242 
rac-242
N
Boc
Ph
 
 
i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 2.5 eq.) was added to a 
stirred solution of sulfoxide syn-rac-225 (65 mg, 0.20 mmol, 1.0 eq., 99:1 er) in THF (8 
mL) at rt under Ar. The resulting solution was stirred at rt for 1 min.  Then, a solution of 
CuBr.SMe2 (8 mg, 0.04 mmol, 0.2 eq.) in THF (0.5 mL) and benzyl bromide (89 mg, 
0.50 mmol, 2.5 eq.) was added sequentially and the solution was stirred at rt for 2 h. 
Saturated NH4Cl(aq) (7 mL) was added and the two layers were separated.  The aqueous 
layer was extracted with Et2O (3 × 10 mL).  The combined organic layers were dried 
(Na2SO4) and evaporated under reduced pressure to give the crude product. Purification 
by flash column chromatography on silica with 4:1 petrol-Et2O as eluent gave 
benzylated pyrrolidine rac-242 (32 mg, 59%) as a colourless oil. 
 
2-tert-Butyl (1S,5R)-1-phenyl-2-azabicyclo[3.1.0]hexane-2-carboxylate (1S,5R)-243 
 
(1S,5R)-243
N
Boc
Ph
 
 
Using general procedure K, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and  sulfoxide syn-(R,R,SS)-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) and 
ZnCl2 (0.12 mL of a 1.0 M solution in Et2O, 0.12 mmol, 0.6 eq.),  Pd(OAc)2 (3 mg, 0.01 
mmol, 0.05 eq.), t-Bu3PH.BF4 (3.5 mg, 0.012 mmol, 0.06 eq.) and bromobenzene (39 
mg, 0.24 mmol, 1.2 eq.) gave the crude product.  Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-petrol as eluent gave arylated pyrrolidine 
(1S,5R)-243 (35 mg, 68%, 99:1 er by CSP-HPLC) as a colourless oil, RF (98:2 CH2Cl2-
petrol) 0.3; IR (CDCl3) 2874, 2791, 1681 (C=O) 1540, 1521, 1444, 1368, 908, 732 cm
-
1
;
 1
H NMR (400 MHz, CDCl3) δ 7.31-7.24 (m, 4H, Ph), 7.21-7.16 (m, 1H, Ph), 3.90 
(ddd, J = 11.5, 9.5, 6.0 Hz, 1H, NCHAHB), 3.61 (ddd, J = 11.5, 9.0, 6.0 Hz, 1H, 
NCHAHB), 2.32 (ddt, J = 12.5, 9.5, 6.0 Hz, 1H, CH), 1.97 (dddd, J = 12.5, 9.0, 6.0, 1.0 
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Hz, 1H, CH), 1.81 (dd, J = 9.0, 5.5 Hz, 1H, CH), 1.62-1.56 (m, 1H, CH), 1.22 (br s, 9H, 
CMe3), 1.02 (t, J = 5.5 Hz, 1H, CH); 
13
C NMR (100.6 MHz, CDCl3) δ 154.7 (C=O), 
133.6 (ipso-Ph), 132.7 (Ph), 127.9 (Ph), 125.9 (Ph), 79.4 (CMe3), 50.1 (NCH2), 49.7 
(NC), 30.3 (NCCH), 28.2 (CMe3), 26.7 (CH2), 22.3 (CH2); MS (ESI) m/z 282 [(M + 
Na)
+
, 100], 204 (30); HRMS m/z calcd for C16H21NO2 (M + Na)
+
 282.1465, found 
282.1470 (−2.1 ppm error); [α]D +8.2 (c 0.65 in CHCl3); CSP-HPLC: Chiracel AD-H 
(99:1 Hexane-iPrOH, 0.5 mLmin
-1
) (1S,5R)-36 8.5 min, (1S,5R)-36 10.0 min. 
 
tert-Butyl 1-phenyl-2-azabicyclo[3.1.0]hexane-2-carboxylate rac-243 
rac-243
N
Boc
Ph
 
 
Using general procedure K, i-PrMgCl (0.15 mL of a 2.0 M solution in THF, 0.30 mmol, 
1.5 eq.) and sulfoxide syn-rac-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) and 
ZnCl2 (0.12 mL of a 1.0 M solution in Et2O, 0.12 mmol, 0.6 eq.),  Pd(OAc)2 (3 mg, 0.01 
mmol, 0.05 eq.), t-Bu3PH.BF4 (3.5 mg, 0.012 mmol, 0.06 eq.) and bromobenzene (22 
mg, 0.14 mmol, 0.7 eq.) gave the crude product.  Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-petrol as eluent gave arylated pyrrolidine 
rac-243 (20 mg, 55%) as a colourless oil. 
 
tert-Butyl 1-[2-methoxyphenyl]-2-azabicyclo[3.1.0]hexane-2-carboxylate (1S,5R)-
244 
(1S,5R)-244
N
Boc
OMe
 
 
Using general procedure K, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide syn-(R,R,SS)-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) and 
ZnCl2 (0.12 mL of a 1.0 M solution in Et2O, 0.12 mmol, 0.6 eq.),  Pd(OAc)2 (3 mg, 0.01 
mmol, 0.05 eq.), t-Bu3PH.BF4 (3.5 mg, 0.012 mmol, 0.06 eq.) and methyl 2-
bromoanisole (45 mg, 0.24 mmol, 1.20 eq.) gave the crude product.  Purification by 
flash column chromatography on silica with 7:3 petrol-Et2O as eluent gave arylated 
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pyrrolidine (1S,5R)-244 (39 mg, 68%) as a colourless oil, RF (7:3 petrol-Et2O) 0.2; IR 
(CDCl3) 2875, 2782, 1685 (C=O), 1421, 1444, 1368, 913, 742 cm
-1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.30 (br d, J = 7.5 Hz, 1H, Ar), 7.22 (td, J = 7.5, 2.0 Hz, 1H, Ar), 6.88 
(br t, J = 7.5 Hz, 1H, Ar), 6.83 (br d, J = 7.5 Hz, 1H, Ar), 3.97 (td, J = 12.0, 4.5 Hz, 1H, 
NCHAHB),  3.84 (s, 3H, OMe), 3.60-3.53 (br m, 1H, NCHAHB), 2.37 (dddd, J = 12.5, 
7.5, 4.5, 1.5 Hz, 1H, CH), 1.97-1.90 (m, 1H, CH), 1.60-1.53 (m, 2H, CH), 1.22 (br s, 
9H, CMe3), 0.90 (t, J = 4.0 Hz, 1H, CH); 
13
C NMR (100.6 MHz, CDCl3) δ 158.8 
(C=O), 155.5 (ipso-C6H4OMe), 131.6 (Ar), 128.7 (Ar), 128.2 (ipso-Ar), 119.6 (Ar), 
110.1 (Ar), 79.0 (CMe3), 55.5 (OMe), 50.5 (NCH2), 46.8 (NC), 28.3 (CMe3), 27.3 (br, 
CH), 26.9 (CH2), 22.8 (CH2); MS (ESI) m/z 312 [(M + Na)
+
, 100], 234 (70), 190 (30); 
HRMS m/z calcd for C17H23NO3 (M + Na)
+
 321.1572, found 312.1570 (−0.5 ppm 
error);  [α]D −6.9 (c 0.65 in CHCl3); CSP-HPLC: Chiracel AD-H (99:1 Hexane-iPrOH, 
0.5 mLmin
-1
) (1S,5R)-244 7.5 min, (1R,5S)-244 8.3 min. 
 
tert-Butyl 1-[2-methoxyphenyl]-2-azabicyclo[3.1.0]hexane-2-carboxylate rac-244 
rac-244
N
Boc
OMe
 
 
Using general procedure K, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide syn-rac-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) and 
ZnCl2 (0.12 mL of a 1.0 M solution in Et2O, 0.12 mmol, 0.6 eq.),  Pd(OAc)2 (3 mg, 0.01 
mmol, 0.05 eq.), t-Bu3PH.BF4 (3.5 mg, 0.012 mmol, 0.06 eq.) and methyl 2-
bromoanisole (26 mg, 0.14 mmol, 0.7 eq.) gave the crude product.  Purification by flash 
column chromatography on silica with 7:3 petrol-Et2O as eluent gave arylated 
pyrrolidine rac-244 (19 mg, 48%) as a colourless oil. 
 
tert-Butyl 1-[2-(methoxycabronyl)phenyl]-2-azabicyclo[3.1.0]hexane-2-carboxylate 
(1S,5R)-245 
(1S,5R)-245
N
Boc
CO2Me
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Using general procedure K, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.), sulfoxide syn-(R,R,SS)-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL), ZnCl2 
(0.12 mL of a 1.0 M solution in Et2O, 0.12 mmol, 0.6 eq.),  Pd(OAc)2 (3 mg, 0.01 
mmol, 0.05 eq.), t-Bu3PH.BF4 (3.5 mg, 0.012 mmol, 0.06 eq.) and methyl 2-
bromobenzoate (51 mg, 0.24 mmol, 1.2 eq.) gave the crude product.  Purification by 
flash column chromatography on silica with 7:3 petrol-Et2O as eluent gave arylated 
pyrrolidine (1S,5R)-245 (47 mg, 74%) as a colourless oil, RF (7:3 petrol-Et2O) 0.1; IR 
(CDCl3) 2874, 1726 (C=O, CO2Me), 1679 (C=O, Boc), 1532, 1454, 1268, 908, 732 cm
-
1
;
 1
H NMR (400 MHz, CDCl3) δ 7.56 (dd, J = 8.0, 1.5 Hz, 1H, o-C6H4CO2Me), 7.38 (br 
t, J = 8.0 Hz 1H, p-C6H4CO2Me), 7.32-7.25 (m, 2H, Ar), 3.87 (s, 3H, OMe), 3.76 (dt, J 
= 11.0, 4.0 Hz, 1H, NCHAHB), 3.37-3.30 (br m, 1H, NCHAHB), 2.58-2.49 (m, 1H, CH), 
2.00 (dtd, J = 12.0, 9.0, 4.0 Hz, 1H, CH), 1.79-1.74 (m, 1H, CH), 1.81 (dd, J = 9.0, 5.5 
Hz, 1H, CH), 1.07 (br s, 9H, CMe3), 0.90 (t, J = 5.5 Hz, 1H, CH); 
13
C NMR (100.6 
MHz, CDCl3) δ 169.3 (CO2Me), 155.9 (NCO2CMe3), 134.4 (ipso-Ar), 132.1 (Ar), 130.5 
(br, Ar), 128.9 (Ar), 128.8 (Ar), 126.5 (Ar), 79.4 (CMe3), 52.0 (OMe), 48.7 (NC), 48.6 
(NCH2), 30.0 (CH), 27.9 (CMe3), 25.6 (CH2), 18.5 (CH2); MS (ESI) m/z 340 [(M + 
Na)
+
, 100], 318[(M + H)
+
, 40], 262 (40), 218 (40); HRMS m/z calcd for C18H23NO4 (M 
+ Na)
+
 340.1518, found 340.1519 (+0.4 ppm error);  [α]D −46.4 (c 1.00 in CHCl3); CSP-
HPLC: Chiracel AD-H (99:1 Hexane-iPrOH, 1.0 mLmin
-1
) (1S,5R)-245 9.7 min, 
(1R,5S)-245 15.8 min. 
 
tert-Butyl 1-[2-(methoxycabronyl)phenyl]-2-azabicyclo[3.1.0]hexane-2-carboxylate 
rac-245 
rac-245
N
Boc
CO2Me
 
 
Using general procedure K, i-PrMgCl (0.15 mL of a 2.0 M solution in THF, 0.30 mmol, 
1.5 eq.) and sulfoxide syn-rac-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) and 
ZnCl2 (0.12 mL of a 1.0 M solution in Et2O, 0.12 mmol, 0.6 eq.),  Pd(OAc)2 (3 mg, 0.01 
mmol, 0.05 eq.), t-Bu3PH.BF4 (3.5 mg, 0.012 mmol, 0.06 eq.) and methyl 2-
bromobenzoate (30 mg, 0.14 mmol, 0.7 eq.) gave the crude product.  Purification by 
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flash column chromatography on silica with 7:3 petrol-Et2O as eluent gave arylated 
pyrrolidine rac-245 (32 mg, 72%) as a colourless oil. 
 
2-tert-Butyl (1S,5R)-1-(thiophen-3-yl)-2-azabicyclo[3.1.0]hexane-2-carboxylate 
(1S,5R)-246 
(1S,5R)-246
N
Boc S
H4
H5
H2
 
 
Using general procedure K, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide syn-(R,R,SS)-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) and 
ZnCl2 (0.12 mL of a 1.0 M solution in Et2O, 0.12 mmol, 0.6 eq.),  Pd(OAc)2 (3 mg, 0.01 
mmol, 0.05 eq.), t-Bu3PH.BF4 (3.5 mg, 0.012 mmol, 0.06 eq.) and 3-bromothiophene 
(23 μL, 0.24 mmol, 1.2 eq.) gave the crude product.  Purification by flash column 
chromatography on silica with 99:1-98:2 CH2Cl2-Et2O as eluent gave arylated 
pyrrolidine (1S,5R)-246 (38 mg, 72%) as a colourless oil, RF (98:2 CH2Cl2-Et2O) 0.5; 
IR (CDCl3) 2910, 2874, 1675 (C=O), 1555, 1532, 1268, 908, 732 cm
-1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.22 (dd, J = 5.0, 3.0 Hz, 1H, H
5
), 6.98 (dd, J = 5.0, 1.5 Hz 1H, H
4
), 
6.94 (dd, J = 3.0, 1.5 Hz, 1H, H
2
), 3.86 (ddd, J = 11.5, 9.5, 6.0 Hz, 1H, NCHAHB), 3.55 
(ddd, J = 11.5, 9.0, 6.0 Hz, 1H, NCHAHB), 2.34-2.25 (m, 1H, CH), 1.93 (dddd, J = 13.0, 
9.0, 6.0, 1.5 Hz, 1H, CH), 1.68-1.60 (m, 2H, CH), 1.28 (br s, 9H, CMe3), 1.04 (t, J = 5.0 
Hz, 1H, NCCHAHB); 
13
C NMR (100.6 MHz, CDCl3) δ 156.2 (C=O), 132.6 (ipso-Ar), 
126.4 (Ar), 125.0 (br, Ar), 118.7 (Ar), 79.4 (CMe3), 49.9 (NC), 46.6 (NCH2), 30.8 (br, 
CH), 28.2 (CMe3), 26.5 (CH2), 23.5 (CH2); MS (ESI) m/z 288 [(M + Na)
+
, 100], 210 
(40); HRMS m/z calcd for C14H19NO2S (M + Na)
+
 288.1029, found 288.1027 (+0.6 ppm 
error); [α]D −42.0 (c 0.5 in CHCl3); CSP-HPLC: Chiracel OD-H (99:1 Hexane-iPrOH, 
1.0 mLmin
-1
) (S,R)-246 7.7 min, (R,S)-246 8.6 min. 
 
2-tert-Butyl 1-(thiophen-3-yl)-2-azabicyclo[3.1.0]hexane-2-carboxylate rac-246 
rac-246
N
Boc S
H4
H5
H2
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Using general procedure K, i-PrMgCl (0.25 mL of a 2.0 M solution in THF, 0.50 mmol, 
2.5 eq.) and sulfoxide syn-rac-225 (65 mg, 0.20 mmol, 1.0 eq.) in THF (8 mL) and 
ZnCl2 (0.12 mL of a 1.0 M solution in Et2O, 0.12 mmol, 0.6 eq.),  Pd(OAc)2 (3 mg, 0.01 
mmol, 0.05 eq.), t-Bu3PH.BF4 (3.5 mg, 0.012 mmol, 0.06 eq.) and 3-bromothiophene 
(23 μL, 0.24 mmol, 1.2 eq.) gave the crude product.  Purification by flash column 
chromatography on silica with 99:1-98:2 CH2Cl2-Et2O as eluent gave arylated 
pyrrolidine rac-246 (33 mg, 62%) as a colourless oil. 
 
tert-Butyl 3-(hydroxymethyl)-1-[(4-methylphenyl)sulfanyl]-2-
azabicyclo[3.1.0]hexane-2-carboxylate (1R,5R)-254
190,191
 
(R,R)-254
N
Boc
S
 
 
Trifluoroacetic anhydride (318 μL, 2.25 mmol, 3.0 eq.) was added dropwise to a stirred 
suspension of sulfoxide syn-(R,R,SS)-225 (240 mg, 0.75 mmol, 1.0 eq.) and NaI (225 
mg, 1.50 mmol, 2.0 eq.) in acetone (9 mL) at −40 °C under Ar.  The resulting solution 
was stirred at −40 °C for 10 min.  Then, saturated Na2SO3(aq) (5 mL) and saturated 
NaHCO3(aq) (5 mL) were added sequentially and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 x 10 mL)   The combined organic layers were 
dried (Na2SO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 9:1-8:2 petrol-EtOAc as 
eluent gave sulfide 254 (228 mg, 99%) as a pale yellow oil, RF (8:2 petrol-EtOAc) 0.4; 
IR (film) 2948, 2912, 2877, 1656 (C=O), 1557, 1552, 1348, 1278, 912, 732 cm
-1
;
  1
H 
NMR (400 MHz, CDCl3) δ 7.33 (d, J = 8.0 Hz, 2H, o-C6H4Me), 7.11 (d, J = 8.0 Hz, 2H, 
m-C6H4Me), 3.52-3.48 (m, 2H, NCH2),  2.34 (s, 3H, Me), 2.11-2.00 (m, 1H, CH), 1.82-
1.72 (m, 2H, CH), 1.63 (dd, J = 9.0, 5.0 Hz, 1H, CH), 1.52 (s, 9H, CMe3), 1.13 (t, J = 
5.0 Hz, 1H, CHAHB); 
13
C NMR (100.6 MHz, CDCl3) δ 155.5 (C=O), 137.3 (ipso-
C6H4S), 132.1 (ipso-C6H4Me), 132.0 (Ar), 129.5 (Ar), 80.0 (CMe3), 53.7 (NC), 51.2 
(NCH2), 29.1 (CH2), 28.6 (CMe3), 28.4 (CH), 26.8 (CH2), 21.2 (Me); MS (ESI) m/z 328 
[(M + Na)
+
, 100], 306 [(M + H)
+
, 25]; HRMS m/z calcd for C17H23NO2S (M + Na)
+
 
328.1347, found 328.1347 (0.0 ppm error); [α]D –45.8 (c 0.6 in CHCl3).  
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tert-Butyl 3-(hydroxymethyl)-1-[(4-methylphenyl)sulfanyl]-2-
azabicyclo[3.1.0]hexane-2-carboxylate cis-(1R,3S,5R)-255 
256
N
Boc
HO
S
cis-255
N
Boc
HO
S
O
 
 
s-BuLi (0.75 mL of a 1.3 M solution in hexanes, 0.98 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of sulfide 254 (228 mg, 0.75 mmol, 1.0 eq.) and (+)-
sparteine surrogate (191 mg, 0.98 mmol, 1.3 eq.) in Et2O (5 mL) at −78 °C under Ar.  
The resulting solution was stirred at −78 °C for 5 min.   Then, CO2 was bubbled through 
the solution for 10 min and the resulting solution allowed to warm to rt.  Water (5 mL) 
and 1 M NaOH(aq) (10 mL) were added and the two layers were separated.  The aqueous 
layer was acidified (pH 1) with 2 M HCl(aq) and extracted with Et2O (3 × 10 mL).  The 
combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product which contained a 92:8 mixture (by 
1
H NMR spectroscopy) of 
diastereoisomeric acids 256 which required no further purification: 
1
H NMR (400 MHz, 
CDCl3) δ 8.50 (br s, 1H, OH), 7.28 (d, J = 8.0 Hz, 2H, o-C6H4Me), 7.12 (d, J = 8.0 Hz, 
2H, m-C6H4Me), 4.55 (br s, 0.92H, NCH), 4.21 (dd, J = 10.0, 5.0 Hz, 0.08H, NCH), 
2.68 (br s, 0.08H, 1H, CH), 2.54-2.50 (br m, 0.92H, 1H, CH), 2.34 (s, 2.76H, Me), 2.33 
(s, 0.24, Me), 2.07 (dd, J = 13.0, 4.5 Hz, 0.08H, CHAHB), 1.99 (dd, J = 13.0, 7.0 Hz, 
0.92H, CHAHB), 1.78-1.76 (m, 1H, CH), 1.70-1.65 (m, 1H, CH), 1.52-1.43 (m, 1H, 
CH), 1.47 (br s, 9H, CMe3).  Borane dimethyl sulfide complex (77 μL, 0.82 mmol, 1.3 
eq.) was added dropwise to a stirred solution of the crude acids 256 (218 mg, 0.63 
mmol, 1.0 eq.) in THF (5 mL) at 0 °C under Ar.  After gas evolution ceased, the 
resulting solution was stirred and heated at 66 °C for 1 h.  Then, the solution was cooled 
to rt and MeOH (5 mL) was added dropwise. The solvent was evaporated under reduced 
pressure to give the crude product.  Purification by flash column chromatography on 
silica with 9:1-8:2 petrol-EtOAc as eluent gave alcohol cis-(1R,3S,5R)-255 (211 mg, 
84% over two steps) as a colourless oil, RF (8:2 petrol-EtOAc) 0.3; IR (film) 3315 (OH), 
2892, 2877, 1688 (C=O), 1565, 1488, 1258, 912, 732 cm
-1
;
 1
H NMR (400 MHz, CDCl3) 
δ 7.31 (d, J = 8.0 Hz, 2H, o-C6H4Me), 7.14 (d, J = 8.0 Hz, 2H, m-C6H4Me), 5.32 (br s, 
1H, OH), 4.03-3.97 (m, 1H, NCH), 3.52-3.42 (m, 2H, CH2OH), 2.35 (s, 3H, Me), 2.18-
2.11 (m, 1H, CH), 1.64-1.60 (m, 2H, CH), 1.57 (s, 9H, CMe3), 1.33-1.25 (m, 1H, CH), 
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1.16-1.14 (m, 1H, CH); 
13
C NMR (100.6 MHz, CDCl3) δ 155.6 (C=O), 138.1 (ipso-
C6H4S),  133.1 (Ar), 131.2 (ipso-C6H4Me), 129.8 (Ar), 81.1 (CMe3), 70.4 (NCH), 65.0 
(CH2OH), 57.0 (NC), 34.2 (CH2), 31.9 (CH2), 28.4 (CMe3), 25.7 (CH), 21.1 (Me); MS 
(ESI) m/z 358 [(M + Na)
+
, 90], 336 [(M + H)
+
, 40], 280 (100); HRMS m/z calcd for 
C18H25NO3S (M + Na)
+
 358.1447, found 358.1443 (+1.1 ppm error); [α]D –139.8 (c 0.7 
in CHCl3).  
 
tert-Butyl 3-(hydroxymethyl)-1-[(4-methylphenyl)sulfanyl]-2-
azabicyclo[3.1.0]hexane-2-carboxylate cis-rac-255 and tert-Butyl 3-
(hydroxymethyl)-1-[(4-methylphenyl)sulfanyl]-2-azabicyclo[3.1.0]hexane-2-
carboxylate trans-rac-255 
cis-256
N
Boc
HO
S
cis-rac-255
N
Boc
HO
S
pTol
O
trans-rac-255
N
Boc
HO
S
pTol
t rans-256
N
Boc
HO
S
pTol
O
pTol
 
 
s-BuLi (3.61 mL of a 1.3 M solution in hexanes, 4.69 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of sulfide rac-254 (1.10 g, 3.61 mmol, 1.0 eq.) and 
TMEDA (701 μL, 4.69 mmol, 1.3 eq.) in Et2O (15 mL) at −78 °C under Ar.  The 
resulting solution was stirred at −78 °C for 5 min.   Then, CO2 was bubbled through the 
solution for 10 min and the resulting solution allowed to warm to rt.  Water (5 mL) and 
1 M NaOH(aq) (10 mL) were added and the two layers were separated.  The aqueous 
layer was acidified (pH 1) with 2 M HCl(aq) and extracted with Et2O (3 × 10 mL).  The 
combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product which contained a 68:32 mixture (by 
1
H NMR spectroscopy) of 
diastereoisomeric acids 256 which required no further purification.  Borane dimethyl 
sulfide complex (0.36 mL, 3.72 mmol, 1.3 eq.) was added dropwise to a stirred solution 
of the crude acids 256 (1.00 g, 2.86 mmol, 1.0 eq.) in THF (20 mL) at 0 °C under Ar.  
After gas evolution ceased, the resulting solution was stirred and heated at 66 °C for 1 
h.  Then, the solution was cooled to rt and MeOH (5 mL) was added dropwise. The 
solvent was evaporated under reduced pressure to give the crude product.  Purification 
by flash column chromatography on silica with 9:1-8:2 petrol-EtOAc as eluent gave 
alcohol cis-rac-255 (615 mg, 51% over two steps) as a colourless oil and trans-rac-255 
(258 mg, 21% over two steps) as a colourless oil, RF (8:2 petrol-EtOAc) 0.2; IR (film) 
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3312 (OH), 2901, 2896, 2867, 1698 (C=O), 1495, 1487, 1305, 1132, 915, 730 cm
-1
;
 1
H 
NMR (400 MHz, CDCl3) δ 7.39 (d, J = 8.0 Hz, 2H, o-C6H4Me), 7.17 (d, J = 8.0 Hz, 2H, 
m-C6H4Me), 3.88-3.82 (m, 1H, NCH), 3.30 (br s, 1H, OH), 3.25-3.23 (m, 1H, 
CHAHBOH), 2.97 (t, J = 8.5 Hz, 1H, CHAHBOH) 2.36 (s, 3H, Me), 2.03-1.98 (m, 1H, 
CH), 1.76-1.64 (m, 3H, CH), 1.57 (s, 9H, CMe3), 1.04 (t, J = 5.5 Hz, 1H, CH); 
13
C 
NMR (100.6 MHz, CDCl3) δ 152.0 (C=O), 138.8 (ipso-C6H4S),  134.5 (Ar), 130.5 
(ipso-C6H4Me), 129.8 (Ar), 81.3 (CMe3), 66.5 (CH2OH), 64.7 (NCH), 55.5 (NC), 29.8 
(CH2), 29.7 (CH2), 28.4 (CMe3), 27.4 (CH), 21.2 (Me); MS (ESI) m/z 358 [(M + Na)
+
, 
100], 336 [(M + H)
+
, 30], 280 (100); HRMS m/z calcd for C18H25NO3S (M + Na)
+
 
358.1447, found 358.1449 (−0.5 ppm error). 
 
tert-Butyl 3-(hydroxymethyl)-2-azabicyclo[3.1.0]hexane-2-carboxylate cis-
(1S,3S,5R)-253 
cis-253
N
Boc
HO
 
 
Raney
®
-Nickel 2400 (1.5 mL of a 50% suspension in water) was added dropwise to a 
stirred solution of alcohol cis-(1R,3S,5R)-255 (211 mg, 0.63 mmol, 1.0 eq.) in 1:2 THF-
EtOH (6 mL) at rt under Ar.  The resulting solution was stirred at rt for 5 h.  Then, 
CH2Cl2 (10 mL) and MgSO4 were added and the solids were removed by filtration 
through Celite
®
. The filtrate was evaporated under reduced pressure to give the crude 
product.  Purification by flash column chromatography on silica with 9:1-8:2 petrol-
acetone as eluent gave alcohol cis-(1S,3S,5R)-253 (98 mg, 73%) as a colourless oil, RF 
(8:2 petrol-acetone) 0.3;
 1
H NMR (400 MHz, CDCl3) δ 4.32-4.28 (br m, 1H, CH), 3.51-
3.43 (m, 4H, CH + OH), 2.46 (dddd, J = 13.5, 11.0, 6.5, 1.0 Hz, 1H, CH), 1.58-1.52 (m, 
1H, CH), 1.50 (s, 9H, CMe3), 1.50-1.47 (m, 1H, CHAHB), 0.80 (dtd, J = 9.0, 6.0, 1.0 Hz, 
1H, CH), 0.43-0.40 (br m, 1H, CH); 
13
C NMR (100.6 MHz, CDCl3) (rotamers) δ 156.6 
(br, C=O), 80.6 (CMe3), 80.3 (CMe3), 67.6 (br, NCHCH2OH), 54.5 (CH2OH), 38.8 
(NCH), 37.4 (CH2), 32.0 (CH), 30.6 (CH2), 28.4 (CMe3), 28.4 (CMe3), 16.9 (CH2), 14.7 
(CH2); MS (ESI) m/z 236 [(M + Na)
+
, 100], 213 [(M + H)
+
, 40]; HRMS m/z calcd for 
C11H19NO3 (M + Na)
+
 236.1263, found 236.1263 (0.0 ppm error); [α]D +6.6 (c 0.5 in 
CHCl3) [lit.
184, [α]D +12.0 (c 0.75 in CHCl3)]. Spectroscopic data consistent with those 
reported in the literature.
184
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5.5 Experimental for Chapter Four 
2,2-Dimethyl-1-azetidinyl-1-ylpropan-1-thione 101
102
 
N
101
S
 
 
Trimethylacetyl chloride (7.21 mL, 58.6 mmol, 1.1 eq.) was added to a stirred solution 
of azetidine hydrochloride (5.00 g , 53.3 mmol, 1.0 eq.) and Et3N (37.1 mL, 266 mmol, 
5.0 eq.) in CH2Cl2 (75 mL) at 0 °C. The resulting solution was allowed to warm to rt 
and stirred at rt for 16 h. Then, 1 M HCl(aq) (15 mL) was added and the two layers 
were separated.  The aqueous layer was extracted with CH2Cl2 (3 x 30 mL).  The 
combined organic layers were dried (MgSO4) and evaporated under reduce pressure to 
give the crude N-pivaloyl azetidine.  The residue was dissolved in pyridine (150 mL) 
and phosphorous(V) sulfide (14.80 g, 66.6 mmol, 1.25 eq.) was added.  The resulting 
solution was heated to 75 °C for 6 h.  The solution was allowed to cool to rt and then 
poured into 1 M HCl(aq) (150 mL).  1 M HCl(aq) was added until pH 3 was obtained. The 
resulting solution was stirred at rt for 2 h and then extracted with CH2Cl2 (3 × 50 mL).  
The combined organic extracts were washed with 1 M HCl(aq) (50 mL), water (50 mL) 
and brine (50 mL), dried (MgSO4) and evaporated under reduced pressure to give the 
crude product.  Purification by flash column chromatography on silica with 8:2-7:3 
petrol-Et2O as eluent gave thioamide 101 (6.40 g, 78%) as a yellow oil, RF (8:2 petrol-
Et2O) 0.2; 
1
H NMR (400 MHz, CDCl3) δ 4.51 (br t, J = 7.5 Hz, 2H, NCH2), 4.29 (br t, J 
= 7.5 Hz, 2H, NCH2), 2.33-2.25 (m, 2H, CH2), 1.36 (s, 9H, CMe3); 
13
C NMR (100.6 
MHz, CDCl3) δ 209.1 (C=S), 56.6 (NCH2), 56.0 (NCH2) 43.1 (CMe3), 29.8 (CMe3), 
14.6 (CH2). Spectroscopic data consistent with those reported in the literature.
102
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1-[(2R)-2-[(S)-Hydroxy(phenyl)methyl]azetidin-1-yl]-2,2-dimethylpropane-1-thione 
anti-(S,R)-273 and 1-[(2R)-2-[(R)-hydroxy(phenyl)methyl]azetidin-1-yl]-2,2-
dimethylpropane-1-thione syn-(R,R)-273 
N OH
PhH
N OH
PhH
syn-(R,R)-273ant i-(S,R)-273
S S
 
 
Using general procedure L, s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 
1.2 eq.), N-thiopivaloyl azetidine 101 (79 mg, 0.5 mmol, 1.0 eq.) and (−)-sparteine (0.14 
mL, 0.6 mmol, 1.2 eq.) in Et2O (5 mL) and benzaldehyde (76 μL, 0.75 mmol, 1.5 eq.) 
gave the crude product which contained an 86:14 mixture of alcohols syn-(R,R)-273 and 
anti-(S,R)-273 by 
1
H NMR spectroscopy. Purification by flash column chromatography 
on silica with 9:1-8:2 petrol-EtOAc as eluent gave alcohol anti-(S,R)-273 (12 mg, 9%, 
58:42 er by CSP-HPLC) as a white solid, mp 151-153 °C; RF (4:1 petrol-EtOAc) 0.3;
 
IR 
(CHCl3) 3203 (OH), 2921, 1441, 1414, 1341, 1242, 1126, 996, 980, 731 cm
−1
; 
1
H NMR 
(400 MHz, CDCl3) δ 7.44 (d, J = 8.0 Hz, 2H, o-Ph), 7.36 (t, J = 8.0 Hz, 2H, m-Ph), 7.31 
(d, J = 8.0 Hz, 1H, Ph), 5.46 (br d, J = 5.0 Hz 1H, CHO), 5.28-5.24 (m, 1H, NCH), 4.56 
(d, J = 5.0 Hz, 1H, OH), 4.21 (td, J = 10.0, 5.0 Hz, 1H, NCHAHB), 3.92-3.85 (m, 1H 
NCHAHB), 2.35-2.26 (m, 1H, CHAHB), 2.16-2.08 (m, 1H, CHAHB), 1.30 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 211.1 (C=S), 139.6 (ipso-Ph), 128.2 (Ph), 127.7 (Ph), 
126.7 (Ph), 73.7 (OCH or NCH), 73.5 (OCH or NCH), 56.1 (NCH2), 43.4 (CMe3) 29.5 
(CMe3), 17.2 (CH2); MS (ESI) m/z 286 [(M + Na)
+
, 100], 264 [(M + H)
+
, 30], 208 
(100); HRMS m/z calcd for C15H21NO3 (M + Na)
+
 286.1414, found 286.1414 (0.0 ppm 
error); [α]D +40.9 (c 0.65 in CHCl3); CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 
1.0 mL min
-1
) (S,R)-273 7.4 min, (R,S)-273 10.0 min and alcohol syn-(R,R)-273 (99 mg, 
75%, 75:25 er by CSP-HPLC) as a white solid, mp 109-111 °C (lit.,
102
 116-117 °C); RF 
(4:1 petrol-EtOAc) 0.2;
 1
H NMR (400 MHz, CDCl3) δ 7.45-7.43 (m, 2H, Ph), 7.39-7.29 
(m, 3H, Ph), 5.32 (d, J = 7.5 Hz, 1H, CHOH), 5.22 (dddd, J = 9.0, 7.5, 5.0, 1.5 Hz, 1H, 
NCH), 5.17 (br s, 1H, OH), 4.31 (td, J = 10.0, 5.0 Hz, 1H, NCHAHB), 4.20-4.13 (m, 1H, 
NCHAHB), 2.20 (dddd, J = 12.0, 10.0, 9.0, 7.5 Hz, 1H, CHAHB), 1.86 (ddt, J = 12.0, 9.5, 
5.0 Hz, 1H, CHAHB), 1.35 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 212.3 
(C=S), 139.9 (ipso-Ph), 128.3 (Ph), 128.1 (Ph), 127.3 (Ph), 76.3 (OCH or NCH), 73.8 
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(OCH or NCH), 56.0 (NCH2), 43.6 (CMe3), 29.6 (CMe3), 18.3 (CH2); [α]D +74.8 (c 
0.75 in CHCl3); CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-
273 17.8 min, (S,S)-273 20.4 min.  Spectroscopic data for syn-rac-273 is consistent with 
those reported in the literature.
102
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s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq.) was added to a 
stirred solution of N-thiopivaloyl azetidine 101 (79 mg, 0.50 mmol, 1.0 eq.) in Et2O (5 
mL) at −40 °C under Ar.  The resulting solution was stirred at −40 °C for 30 min. Then, 
(−)-sparteine (0.14 mL, 0.60 mmol, 1.2 eq.) was added and the resulting solution was 
stirred for 15 min.  The solution was then cooled to −78 °C and stirred at −78 °C for 30 
min.  Benzaldehyde (38 μL, 0.38 mmol, 1.5 eq.) was added dropwise.  The resulting 
solution was stirred at −78 °C for 10 min and 1 M HCl(aq) was added.  The two layers 
were separated and the aqueous layer was extracted with Et2O (3 x 10 mL). The 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product which contained an 81:19 mixture of alcohols syn-(R,R)-273 and 
anti-(S,R)-273 by 
1
H NMR spectroscopy. Purification by flash column chromatography 
on silica with 9:1-8:2 petrol-EtOAc as eluent gave alcohol anti-(S,R)-273 (9 mg, 7%, 
59:41 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-
iPrOH, 1.0 mL min
-1
) (S,R)-273 7.5 min, (R,S)-273 10.1 min and alcohol syn-(R,R)-273 
(76 mg, 57%, 71:29 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-H 
(95:5 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-273 18.2 min, (S,S)-273 20.2 min. 
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(Table 4.2, Entry 2) 
s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq.) was added to a 
stirred solution of N-thiopivaloyl azetidine 101 (79 mg, 0.5 mmol, 1.0 eq.) and (−)-
sparteine (0.14 mL, 0.6 mmol, 1.2 eq.) in Et2O (5 mL) at −78 °C under Ar.  The 
resulting solution was stirred at −78 °C for 30 min.  Then, the solution was warmed to 
−50 °C and stirred for 1 h.  Benzaldehyde (76 μL, 0.75 mmol, 1.5 eq.) was added 
dropwise and the resulting solution was stirred at −50 °C for 10 min.  Then, 1 M HCl(aq) 
was added.  The two layers were separated and the aqueous layer was extracted with 
Et2O (3 x 10 mL).  The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product which contained a 80:20 mixture of 
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alcohols syn-(R,R)-273 and anti-(S,R)-273 by 
1
H NMR spectroscopy. Purification by 
flash column chromatography on silica with 9:1-8:2 petrol-EtOAc as eluent gave 
alcohol anti-(S,R)-273 (17 mg, 13%, 58:42 er by CSP-HPLC) as a white solid, CSP-
HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
)  (S,R)-273 7.5 min, (R,S)-
273 10.2 min and alcohol syn-(R,R)-273 (108 mg, 82%, 68:32 er by CSP-HPLC) as a 
white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-273 
18.4 min, (S,S)-273 20.9 min.  
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(Table 4.2, Entry 3) 
s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq.) was added to a 
stirred solution of N-thiopivaloyl azetidine 101 (79 mg, 0.5 mmol, 1.0 eq.) and (−)-
sparteine (0.14 mL, 0.6 mmol, 1.2 eq.) in Et2O (5 mL) at −78 °C under Ar.  The 
resulting solution was stirred at −78 °C for 30 min.  Then, the solution was warmed to 
−40 °C and stirred for 1 h.  Benzaldehyde (76 μL, 0.75 mmol, 1.5 eq.) was added 
dropwise and the resulting solution was stirred at −40 °C for 10 min.  Then, 1 M HCl(aq) 
was added.  The two layers were separated and the aqueous layer was extracted with 
Et2O (3 x 10 mL).  The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product which contained a 80:20 mixture of 
alcohols syn-(R,R)-273 and anti-(S,R)-273 by 
1
H NMR spectroscopy. Purification by 
flash column chromatography on silica with 9:1-8:2 petrol-EtOAc as eluent gave 
alcohol anti-(S,R)-273 (19 mg, 14%, 56:44 er by CSP-HPLC) as a white solid, CSP-
HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (S,R)-273 7.5 min, (R,S)-
273 10.1 min and alcohol syn-(R,R)-273 (111 mg, 84%, 62:38 er by CSP-HPLC) as a 
white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-273 
18.2 min, (S,S)-273 20.8 min.  
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(Table 4.2, Entry 4) 
s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq.) was added to a 
stirred solution of N-thiopivaloyl azetidine 101 (79 mg, 0.5 mmol, 1.0 eq.) and (−)-
sparteine (0.14 mL, 0.6 mmol, 1.2 eq.) in Et2O (5 mL) at −78 °C under Ar.  The 
resulting solution was stirred at −78 °C for 30 min.  Then, the solution was warmed to 
−30 °C and stirred for 1 h.  Benzaldehyde (76 μL, 0.75 mmol, 1.5 eq.) was added 
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dropwise and the resulting solution was stirred at −30 °C for 10 min.  Then, 1 M HCl(aq) 
was added.  The two layers were separated and the aqueous layer was extracted with 
Et2O (3 x 10 mL).  The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product which contained a 75:25 mixture of 
alcohols syn-(R,R)-273 and anti-(S,R)-273 by 
1
H NMR spectroscopy. Purification by 
flash column chromatography on silica with 9:1-8:2 petrol-EtOAc as eluent gave 
alcohol anti-(S,R)-273 (15 mg, 11%, 55:45 er by CSP-HPLC) as a white solid, CSP-
HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (S,R)-273 7.5 min, (R,S)-
273 10.2 min and alcohol syn-(R,R)-273 (100 mg, 76%, 59:41 er by CSP-HPLC) as a 
white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-273 
18.5 min, (S,S)-273 20.5 min.  
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(Table 4.2, Entry 5) 
s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq.) was added to a 
stirred solution of N-thiopivaloyl azetidine 101 (79 mg, 0.5 mmol, 1.0 eq.) and (−)-
sparteine (0.14 mL, 0.6 mmol, 1.2 eq.) in Et2O (5 mL) at −78 °C under Ar.  The 
resulting solution was stirred at −78 °C for 30 min.  Then, the solution was warmed to 
−30 °C and stirred for 1 h.  The solution was then cooled to −78 °C and stirred at −78 
°C for 30 min.  Benzaldehyde (76 μL, 0.75 mmol, 1.5 eq.) was added dropwise and the 
resulting solution was stirred at −30 °C for 10 min.  Then, 1 M HCl(aq) was added.  The 
two layers were separated and the aqueous layer was extracted with Et2O (3 x 10 mL).  
The combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product which contained a 86:14 mixture of alcohols syn-
(R,R)-273 and anti-(S,R)-273 by 
1
H NMR spectroscopy. Purification by flash column 
chromatography on silica with 9:1-8:2 petrol-EtOAc as eluent gave alcohol anti-(S,R)-
273 (9 mg, 7%, 59:41 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-H 
(95:5 Hexane-iPrOH, 1.0 mL min
-1
) (S,R)-273 7.4 min, (R,S)-273 10.1 min and alcohol 
syn-(R,R)-273 (95 mg, 72%, 75:25 er by CSP-HPLC) as a white solid, CSP-HPLC: 
Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-273 18.3 min, (S,S)-273 20.5 
min.  
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A solution of stannane (S)-272 (50 mg, 0.16 mmol, 1.0 eq.) in Et2O (3 mL) was added 
dropwise to a stirred solution of n-BuLi (0.07 mL of a 2.5 M solution in hexanes, 0.18 
mmol, 1.1 eq.) and (−)-sparteine (42 μL, 0.18 mmol, 1.1 eq.) in Et2O (2 mL) at −78 °C 
under Ar.  The resulting solution was stirred at −78 °C for 5 min.  Then, benzaldehyde 
(19 μL, 0.19 mmol, 1.2 eq.) was added dropwise.  The resulting solution was stirred at 
−78 °C for 10 min and 1 M HCl(aq) (10 mL) was added.  The two layers were separated 
and the aqueous layer was extracted with Et2O (3 x 10 mL).  The combined organic 
layers were dried (MgSO4) and evaporated under reduced pressure to give the crude 
product which contained an 87:13 mixture of alcohols syn-(R,R)-273 and anti-(S,R)-273 
by 
1
H NMR spectroscopy. Purification by flash column chromatography on silica with 
9:1-8:2 petrol-EtOAc as eluent gave alcohol anti-(S,R)-273 (4 mg, 10%, 62:38 er by 
CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL 
min
-1
) (S,R)-273 7.6 min, (R,S)-273 10.3 min and alcohol syn-(R,R)-273 (37 mg, 88%, 
73:27 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-
iPrOH, 1.0 mL min
-1
) (R,R)-273 18.7 min, (S,S)-273 20.8 min.  
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s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq.) was added to a 
stirred solution of N-thiopivaloyl azetidine 101 (79 mg, 0.5 mmol, 1.0 eq.) and (−)-
sparteine (0.14 mL, 0.6 mmol, 1.2 eq.) in Et2O (5 mL) at −100 °C under Ar.  The 
resulting solution was stirred at −100 °C for 30 min.  Then, benzaldehyde (76 μL, 0.75 
mmol, 1.5 eq.) was added dropwise and the resulting solution was stirred at −100 °C for 
1 h.  Then, 1 M HCl(aq) (10 mL) was added and the two layers were separated.  The 
aqueous layer was extracted with Et2O (3 x 10 mL).  The combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude product which 
contained a 87:13 mixture of alcohols syn-(R,R)-273 and anti-(S,R)-273 by 
1
H NMR 
spectroscopy. Purification by flash column chromatography on silica with 9:1-8:2 
petrol-EtOAc as eluent gave alcohol anti-(S,R)-273 (9 mg, 7%, 57:43 er by CSP-HPLC) 
as a white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (S,R)-
273 7.4 min, (R,S)-273 10.0 min and alcohol syn-(R,R)-273 (87 mg, 66%, 77:23 er by 
CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL 
min
-1
) (R,R)-273 18.4 min, (S,S)-273 20.8 min.  
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1-[(2S)-2-[(R)-Hydroxy(phenyl)methyl]azetidin-1-yl]-2,2-dimethylpropane-1-thione 
anti-(R,S)-273 and 1-[(2S)-2-[(S)-hydroxy(phenyl)methyl]azetidin-1-yl]-2,2-
dimethylpropane-1-thione syn-(S,S)-273 
N OH
PhH
N OH
PhH
syn-(S,S)-273anti-(R,S)-273
S S
 
 
Using general procedure L, s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 
1.2 eq.), N-thiopivaloyl azetidine 101 (79 mg, 0.5 mmol, 1.0 eq.), (+)-sparteine 
surrogate 1 (116 mg, 0.6 mmol, 1.2 eq.) in Et2O (5 mL) and benzaldehyde (76 μL, 0.75 
mmol, 1.5 eq.) gave the crude product which contained an 86:14 mixture of alcohols 
syn-(S,S)-273 and anti-(R,S)-273 by 
1
H NMR spectroscopy. Purification by flash 
column chromatography on silica with 9:1-8:2 petrol-EtOAc as eluent gave alcohol 
anti-(R,S)-273 (9 mg, 7%, 54:46 er by CSP-HPLC) as a white solid, CSP-HPLC: 
Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (S,R)-273 7.5 min, (R,S)-273 10.2 
min and alcohol syn-(R,R)-273 (91 mg, 70%, 54:46 er by CSP-HPLC) as a white solid, 
CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-273 18.2 min, 
(S,S)-273 20.4 min. 
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Using general procedure L, s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 
1.2 eq.),  N-thiopivaloyl azetidine 101 (79 mg, 0.5 mmol, 1.0 eq.), diamine (S,S)-42 
(186 mg, 0.6 mmol, 1.2 eq.) in Et2O (5 mL) and benzaldehyde (76 μL, 0.75 mmol, 1.5 
eq.) gave the crude product which contained a 77:23 mixture of alcohols syn-(S,S)-273 
and anti-(R,S)-273 by 
1
H NMR spectroscopy. Purification by flash column 
chromatography on silica with 9:1-8:2 petrol-EtOAc as eluent gave alcohol anti-(R,S)-
273 (26 mg, 20%, 65:35 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-
H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (S,R)-273 7.5 min, (R,S)-273 10.2 min and 
alcohol syn-(R,R)-273 (96 mg, 73%, 53:47 er by CSP-HPLC) as a white solid, CSP-
HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-273 18.7 min, (S,S)-
273 20.9 min. 
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s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq.) was added dropwise  
to a stirred solution of N-thiopivaloyl azetidine 101 (79 mg, 0.5 mmol, 1.0 eq.), (+)-
sparteine surrogate 1 (116 mg, 0.6 mmol, 1.2 eq.) and benzaldehyde (76 μL, 0.75 mmol, 
1.5 eq.) in Et2O (5 mL) at −78 °C under Ar.  The resulting solution was stirred at −78 
°C for 30 min.  Then, 1 M HCl(aq) (10 mL) was added.  The two layers were separated 
and the aqueous layer was extracted with Et2O (3 x 10 mL).  The combined organic 
layers were dried (MgSO4) and evaporated under reduced pressure to give the crude 
product which contained a 76:24 mixture of alcohols syn-(S,S)-273 and anti-(R,S)-273 
by 
1
H NMR spectroscopy. Purification by flash column chromatography on silica with 
9:1-8:2 petrol-EtOAc as eluent gave alcohol anti-(R,S)-273 (0.5 mg, 0.5%, 56:44 er by 
CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL 
min
-1
) (S,R)-273 7.5 min, (R,S)-273 10.2 min and alcohol syn-(R,R)-273 (2 mg, 1.5%, 
60:40 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-
iPrOH, 1.0 mL min
-1
) (R,R)-273 18.3 min, (S,S)-273 20.3 min and recovered 273 (58 
mg, 73%) as a pale yellow oil. 
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1-[2-[Hydroxy(phenyl)methyl]azetidin-1-yl]-2,2-dimethylpropane-1-thione anti-
rac-273 and 1-[(2-[hydroxy(phenyl)methyl]azetidin-1-yl]-2,2-dimethylpropane-1-
thione syn-rac-273 
N OH
PhH
N OH
PhH
syn-rac-273ant i-rac-273
S S
 
 
s-BuLi (0.23 mL of a 1.3 M solution in hexanes, 0.3 mmol, 1.2 eq.) was added dropwise 
to a stirred solution of N-thiopivaloyl azetidine 101 (40 mg, 0.25 mmol, 1.0 eq.) in Et2O 
(5 mL) at −40 °C under Ar.  The resulting solution was stirred at −40 °C for 30 min.  
Then, benzaldehyde (38 μL, 0.38 mmol, 1.5 eq.) was added dropwise.  The resulting 
solution was stirred at −40 °C for 10 min and 1 M HCl(aq) (10 mL) was added.  The two 
layers were separated and the aqueous layer was extracted with Et2O (3 x 10 mL).  The 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product which contained a 62:38 mixture of alcohols syn-rac-273 and 
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anti-rac-273 by 
1
H NMR spectroscopy. Purification by flash column chromatography 
on silica with 9:1-8:2 petrol-EtOAc gave alcohol anti-rac-273 (14 mg, 21%) as a white 
solid and alcohol syn-rac-273 (27 mg, 42%) as a white solid. 
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s-BuLi (0.23 mL of a 1.3M solution in hexanes, 0.3 mmol, 1.2 eq.) was added to a 
stirred solution of N-thiopivaloyl azetidine 101 (40 mg, 0.25 mmol, 1.0 eq.) in Et2O (5 
mL) at −40 °C under Ar.  The resulting solution was stirred at −40 °C for 30 min and 
then cooled to −78 °C and stirred at −78 °C for 10 min.  Then, (−)-sparteine (68 μL, 
0.30 mmol, 1.2 eq.) was added at the resulting solution was stirred for 30 min. 
Benzaldehyde (38 μL, 0.38 mmol, 1.5 eq.) was added dropwise.  The resulting solution 
was stirred for 10 min at −78 °C and 1 M HCl(aq) was added.  The two layers were 
separated and the aqueous layer was extracted with Et2O (3 x 10 mL).  The combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product which contained a 75:25 mixture of alcohols syn-rac-273 and anti-rac-
273 by 
1
H NMR spectroscopy. Purification by flash column chromatography on silica 
with 9:1-8:2 petrol-EtOAc as eluent gave alcohol anti-rac-273 (12 mg, 19%) as a white 
solid and alcohol syn-rac-273 (28 mg, 43%) as a white solid. 
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n-BuLi (0.06 mL of a 2.5 M solution in hexanes, 0.14 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of stannane (S)-272 (43 mg, 0.13 mmol, 1.0 eq., 68:32 er) 
in THF (5 mL) at −78 °C under Ar.  The resulting solution was stirred at −78 °C for 5 
min.  Then, benzaldehyde (16 μL, 0.16 mmol, 1.2 eq.) was added dropwise.  The 
resulting solution was stirred at −78 °C for 10 min and 1 M HCl(aq) (10 mL) was added.  
The two layers were separated and the aqueous layer was extracted with Et2O (3 x 10 
mL) and the combined layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product which contained a 75:25 mixture of alcohols syn-rac-
273 and anti-rac-273 by 
1
H NMR spectroscopy. Purification by flash column 
chromatography on silica with 9:1-8:2 petrol-EtOAc as eluent gave alcohol anti-rac-
273 (9 mg, 26%, 50:50 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-H 
(95:5 Hexane-iPrOH, 1.0 mL min
-1
) (S,R)-273 7.3 min, (R,S)-273 9.8 min and alcohol 
syn-rac-273 (20 mg, 58%, 50:50 er by CSP-HPLC) as a white solid, CSP-HPLC: 
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Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-273 18.0 min, (S,S)-273 20.3 
min. 
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n-BuLi (0.06 mL of a 2.5 M solution in hexanes, 0.14 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of stannane (S)-272 (43 mg, 0.13 mmol, 1.0 eq., 68:32 er) 
and TMEDA (21 μL, 0.14 mmol, 1.1 eq.) in Et2O (5 mL) at −78 °C under Ar.  The 
resulting solution was stirred at −78 °C for 5 min.  Then, benzaldehyde (16 μL, 0.16 
mmol, 1.2 eq.) was added dropwise.  The resulting solution was stirred at −78 °C for 10 
min and 1 M HCl(aq) (10 mL) was added.  The two layers were separated and the 
aqueous layer was extracted with Et2O (3 x 10 mL).  The combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude product which 
contained a 76:24 mixture of alcohols syn-rac-273 and anti-rac-273 by 
1
H NMR 
spectroscopy. Purification by flash column chromatography on silica with 9:1-8:2 
petrol-EtOAc as eluent gave alcohol anti-rac-273 (8 mg, 24%, 50:50 er by CSP-HPLC) 
as a white solid CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (S,R)-
273 7.4 min, (R,S)-273 10.1 min and alcohol syn-rac-273 (21 mg, 61%, 50:50 er by 
CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL 
min
-1
) (R,R)-273 18.5 min, (S,S)-273 20.4 min. 
 
(S)-1-(tert-Butoxycarbonyl)azetidine-2-carboxylic acid (S)-285
232
 
N
Boc O
OHH
(S)-285  
 
NaOH (420 mg, 10.5 mmol, 1.05 eq.) was added to a stirred solution of (S)-2-azetidine 
carboxylic acid (1.00 g, 10.0 mmol, 1.0 eq.) and di-tert-butyl dicarbonate (2.83 g, 12.5 
mmol, 1.25 eq.) in 2:1 EtOH-water (30 mL) at rt.  The resulting solution was stirred at rt 
for 16 h.  Then, the volatiles were evaporated under reduced pressure and the remaining 
suspension was acidified with 1 M HCl(aq) (20 mL).  The aqueous layer was extracted 
with EtOAc (3 x 50 mL).  The combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give acid (S)-285 (1.96 g, 99%) as a white solid, 
mp 97-99 °C (lit.,
233
 97-98 °C);
 1
H NMR (400 MHz, CDCl3) δ 9.03 (br s, 1H, OH), 4.77 
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(br s, 1H, NCH), 3.96-3.85 (m, 2H, NCH2), 2.46 (br s, 2H, CH2), 1.46 (s, 9H, CMe3);
 
13
C NMR (100.6 MHz, CDCl3) δ 181.5 (C=O, COOH), 156.6 (C=O, Boc), 82.7 (CMe3), 
60.7 (br, NCH), 47.1 (NCH2), 28.2 (CMe3), 19.7 (CH2); [α]D −168.1 (c 0.7 in CHCl3) 
(lit.,
102
 [α]D −116.1 (c 0.75 in CHCl3)). Spectroscopic data consistent with those 
reported in the literature.
232
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tert-Butyl 2S-benzoylazetidine-1-carboxylate (S)-286
234
 
N
Boc O
NH
Me
OMe
N
Boc O
PhH
(S)-286  
 
N-Me morpholine (0.62 mL, 5.6 mmol, 1.2 eq.), HOBt (870 mg, 5.6 mmol, 1.2 eq.) and 
EDC (0.98 mL, 5.6 mmol, 1.2 eq.) were added sequentially to a stirred solution of acid 
(S)-285 (1.00 g, 4.6 mmol, 1.0 eq.) and N,O-dimethylhydroxylamine.HCl (550 mg, 5.6 
mmol, 1.2 eq.) in DMF (10 mL) at 0 °C under Ar.  The resulting solution was stirred at 
0 °C for 2 h and then allowed to warm to rt and stirred at rt for 16 h.  Then, EtOAc (30 
mL) was added and the solution was washed with 1 M HCl(aq) (10 mL), 2 M NaOH(aq) 
(2 x 10 mL) and brine (3 x 10 mL), dried (MgSO4) and evaporated under reduced 
pressure to give the crude Weinreb amide (565 mg, 50%) as a pale yellow solid, 
1
H 
NMR (400 MHz, CDCl3) δ 5.04 (dd, J = 8.5, 5.5 Hz, 1H, NCH), 4.04 (ddd, J = 9.0, 8.0, 
6.0 Hz, 1H, NCHAHB), 3.87 (ddd, J = 9.0, 8.0, 6.0 Hz, 1H, NCHAHB), 3.71 (s, 3H, 
OMe), 3.22 (s, 3H, NMe), 2.51-2.42 (m, 1H, CHAHB), 2.12 (ddt, J = 11.0, 9.0, 5.5 Hz, 
1H, CHAHB), 1.43 (s, 9H, CMe3).  PhMgCl (1.72 mL of a 2.0 M solution in THF, 3.44 
mmol, 1.5 eq.) was added dropwise to a stirred solution of the crude Weinreb amide 
(565 mg, 2.3 mmol, 1.0 eq.) in THF (10 mL) at −78 °C under Ar.  The resulting solution 
was stirred at −78 °C for 2 h.  Then, saturated NH4Cl(aq) (15 mL) was added.  The two 
layers were separated and the aqueous layer was extracted with EtOAc (3 x 15 mL).  
The combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product.  Purification by flash column chromatography on 
silica with 4:1-3:1 petrol-EtOAc as eluent gave ketone (S)-286 (430 mg, 36% over two 
steps) as a white solid, mp 77-79 °C; RF (3:1 petrol-EtOAc) 0.3;
 
IR (CHCl3) 2981, 1720 
(C=O, PhCO), 1675 (C=O, Boc), 1426, 1375, 1210, 1010, 920, 815, 730 cm
−1
; 
1
H NMR 
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(400 MHz, CDCl3) δ 7.85-7.83 (m, 2H, o-Ph), 7.52 (d, J = 7.5 Hz, 1H, p-Ph), 7.41 (t, J 
= 7.5 Hz, 2H, m-Ph), 5.50 (dd, J = 9.5, 5.5 Hz, 1H, NCH), 3.99-3.87 (m, 2H, NCH2), 
2.61 (dddd, J = 11.0, 9.5, 9.0, 6.0 Hz, 1H, CHAHB), 2.06 (ddt, J = 11.0, 9.0, 5.5 Hz, 1H, 
CHAHB), 1.34 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 195.7 (C=O, PhCO), 
155.8 (C=O, Boc), 134.4 (ipso-Ph), 133.6 (Ph), 128.9 (Ph), 128.2 (Ph), 79.8 (CMe3), 
63.6 (br, NCH), 46.9 (br, NCH2), 28.32 (CMe3), 21.3 (CH2); MS (ESI) m/z 284 [(M + 
Na)
+
, 100]; HRMS m/z calcd for C15H19NO3 (M + Na)
+
 284.1257, found 284.1249 (+3.0 
ppm error); [α]D −140.9 (c 0.65 in CHCl3). 
Lab Book Reference 7/524 
 
tert-Butyl (2S)-2-[(S)-hydroxy(phenyl)methyl]azetidine-1-carboxylate syn-(S,S)-284 
and tert-butyl (2S)-2-[(R)-hydroxy(phenyl)methyl]azetidine-1-carboxylate anti-
(R,S)-284 
N
Boc OH
PhH
N
Boc OH
PhH
anti-(R,S)-284syn-(S,S)-284  
 
NaBH4 (73 mg, 1.93 mmol, 1.2 eq.) was added to a stirred solution of ketone (S)-286 
(420 mg, 1.61 mmol, 1.0 eq.) in MeOH (5 mL) at 0 °C.  The resulting solution was 
stirred at rt for 30 min.  Then, the solution was cooled to 0 °C and saturated NH4Cl(aq) (5 
mL) was added dropwise.  The resulting solution was extracted with EtOAc (3 x 10 
mL).  The combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product which contained an 85:15 mixture of alcohols syn-
(S,S)-284 and anti-(R,S)-284 by 
1
H NMR spectroscopy.  Purification by flash column 
chromatography on silica with 9:1-8:2 petrol-EtOAc as eluent gave alcohol syn-(S,S)-
284 (330 mg, 78%, 99:1 er by CSP-HPLC) as a colourless oil, RF (4:1 petrol-EtOAc) 
0.3;
 
IR (CHCl3) 3348 (OH), 2976, 2952, 1687 (C=O), 1445, 1424, 1375, 1246, 1045, 
1025, 915, 800, 730 cm
−1
; 
1
H NMR (400 MHz, CDCl3) δ 7.29-7.36 (m, 2H, o-Ph), 7.34-
7.25 (m, 3H, Ph), 5.75 (br s, 1H, OH), 4.75 (d, J = 8.0 Hz, 1H, OCH), 4.34 (q, J = 8.0 
Hz, 1H, NCH), 3.83-3.72 (m, 2H, NCH2), 1.93-1.80 (m, 2H, CH2), 1.48 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 158.1 (C=O), 139.2 (ipso-Ph), 128.3 (Ph), 127.9 (Ph), 
127.0 (Ph), 80.1 (OCH), 79.1 (CMe3), 67.8 (NCH), 46.1 (NCH2), 28.3 (CMe3), 18.7 
(CH2); MS (ESI) m/z 286 [(M + Na)
+
, 100], 264 [(M + H)
+
, 50], 208 (100), 190 (90); 
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HRMS m/z calcd for C15H21NO3 (M + Na)
+
 286.1414, found 286.1408 (+2.1 ppm 
error); [α]D +1.0 (c 1.3 in CHCl3); CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 
1.0 mL min
-1
) (R,R)-284 11.1 min, (S,S)-284 24.0 min and alcohol anti-(R,S)-284 (65 
mg, 15%, 99:1 er by CSP-HPLC) as a colourless oil, RF (4:1 petrol-EtOAc) 0.2;
 
IR 
(film) 3421 (OH), 2970, 1692 (C=O), 1446, 1420, 1378, 1186, 1050, 1040, 910, 730 
cm
−1
; 
1
H NMR (400 MHz, CDCl3) δ 7.29-7.36 (m, 2H, o-Ph), 7.34-7.25 (m, 3H, Ph), 
5.75 (br s, 1H, OH), 4.94 (d, J = 2.5 Hz, 1H, OCH), 4.57 (td, J = 7.5, 2.5 Hz, 1H, NCH), 
3.73 (dt, J = 8.5, 1.5 Hz, 1H, NCHAHB), 3.48-3.43 (m, 1H, NCHAHB), 2.16-2.04 (m, 
1H, CHAHB), 1.93 (dddd, J = 11.5, 8.5, 7.5 5.0 Hz, 1H, CHAHB),  1.48 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 157.4 (C=O), 139.6 (ipso-Ph), 128.3 (Ph), 127.6 (Ph), 
126.7 (Ph), 80.4 (CMe3), 75.3 (OCH), 66.8 (NCH), 46.7 (NCH2), 28.5 (CMe3), 16.2 
(CH2); MS (ESI) m/z 286 [(M + Na)
+
, 100]; HRMS m/z calcd for C15H21NO3 (M + Na)
+
 
286.1414, found 286.1398 (+5.3 ppm error); [α]D −88.5 (c 1.05 in CHCl3); CSP-HPLC: 
Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-284 11.3 min, (S,S)-284 25.7 
min. 
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tert-Butyl (2R)-2-[(S)-hydroxy(phenyl)methyl]azetidine-1-carboxylate anti-(S,R)-
284 
N
Boc OH
PhH
ant i-(S,R)-284  
 
MeLi (0.38 mL of a 1.6 M solution in Et2O, 0.60 mmol, 6.0 eq.) was added dropwise to 
a stirred solution of alcohol anti-(S,R)-273 (26 mg, 0.25 mmol, 1.0 eq., 58:42 er) in 
THF (5 mL) at 0 °C under Ar.  The resulting solution was stirred at 0 °C for 5 h.  Then, 
1 M HCl(aq) (5 mL) was added dropwise.  The resulting solution was extracted with 
Et2O (10 mL).  The aqueous layer was adjusted to pH 12 by dropwise addition of 1 M 
NaOH(aq) and extracted with Et2O (3 x 10 mL).  The combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude amino alcohol. 
The residue was dissolved in CH2Cl2 (5 mL) and di-tert-butyl dicarbonate (60 mg, 0.28 
mmol, 1.1 eq.) was added at rt under Ar.  The resulting solution was stirred at rt for 16 
h.  Then, 1 M HCl(aq) (10 mL) was added and the two layers were separated.  The 
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aqueous layer was extracted with CH2Cl2 (3 x 10 mL).  The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 9:1-8:2 petrol-EtOAc as 
eluent gave alcohol anti-(S,R)-284 (20 mg, 76%, 57:43 er by CSP HPLC) as a 
colourless oil, [α]D +14.2 (c 0.60 in CHCl3); CSP-HPLC: Chiracel AD-H (95:5 Hexane-
iPrOH, 0.5 mL min
-1
) (S,R)-284 14.9 min, (R,S)-284 15.8 min. 
Lab Book Reference 8/684 
 
tert-Butyl (2R)-2-[(R)-hydroxy(phenyl)methyl]azetidine-1-carboxylate syn-(R,R)-
284 
N
Boc OH
PhH
syn-(R,R)-284  
 
MeLi (0.94 mL of a 1.6 M solution in Et2O, 1.50 mmol, 6.0 eq.) was added dropwise to 
a stirred solution of alcohol syn-(R,R)-273 (65 mg, 0.25 mmol, 1.0 eq., 75:25 er.) in 
THF (5 mL) at 0 °C under Ar.  The resulting solution was stirred at 0 °C for 5 h.  Then, 
1 M HCl(aq) (5 mL) was added dropwise.  The resulting solution was extracted with 
Et2O (10 mL).  The aqueous layer was adjusted to pH 12 by dropwise addition of 1 M 
NaOH(aq) and extracted with Et2O (3 x 10 mL).  The combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude amino alcohol. 
The residue was dissolved in CH2Cl2 (5 mL) and di-tert-butyl dicarbonate (60 mg, 0.28 
mmol, 1.1 eq.) was added at rt under Ar.  The resulting solution was stirred at rt for 16 
h.  Then, 1 M HCl(aq) (10 mL) was added and the two layers were separated.  The 
aqueous layer was extracted with CH2Cl2 (3 x 10 mL).  The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product.  
Purification by flash column chromatography on silica with 9:1-8:2 petrol-EtOAc as 
eluent gave alcohol syn-(R,R)-284 (47 mg, 71%, 75:25 er by CSP HPLC) as a colourless 
oil, [α]D −1.56 (c 1.1 in CHCl3); CSP-HPLC: Chiracel AD-H (95:5 Hexane-iPrOH, 1.0 
mL min
-1
) (R,R)-284 11.1 min, (S,S)-284 25.5 min. 
Lab Book Reference 7/526 
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(S)-2,2-dimethyl-1-(2-(trimethylstannyl)azetidin1-yl)propane-1-thione (S)-272 
N
SnMe3
H
S
(S)-272  
 
Using general procedure L, s-BuLi (1.38 mL of a 1.3 M solution in hexanes, 1.8 mmol, 
1.2 eq.), N-thiopivaloyl azetidine 101 (236 mg, 1.5 mmol, 1.0 eq.) and (−)-sparteine 
(0.41 mL, 1.8 mmol, 1.2 eq.) in Et2O (8 mL) and Me3SnCl (2.25 mL of a 1.0 M in 
hexane, 2.25 mmol, 1.5 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 95:5-9:1 petrol-Et2O as eluent gave stannane (S)-272 
(263 mg, 55%, 68:32 er by CSP-HPLC) as a colourless oil, RF (9:1 petrol-Et2O) 0.3;
 1
H 
NMR (400 MHz, CDCl3) δ 4.65-4.47 (m, 3H, NCH), 2.57-2.48 (m, 1H, CH), 2.26-2.18 
(m, 1H, CH), 1.33 (s, 9H, CMe3), 0.15 (s, 9H, SnMe3);
 13
C NMR (100.6 MHz, CDCl3) δ 
202.4 (C=S), 61.6 (NCH), 56.8 (NCH2), 42.4 (CMe3), 29.9 (CMe3), 18.3 (CH2), −7.7 
(SnMe3); CSP-HPLC: Chiracel OD-H (99.5:0.5 Hexane-iPrOH, 1.0 mL min
-1
) (S)-272 
5.4 min, (R)-272 8.1 min. Spectroscopic data consistent with those reported in the 
literature.
102
  The absolute configuration of the major enantiomer is assumed by analogy 
with the benzaldehyde trapping. 
Lab Book Reference 8/620 637 629 
 
2,2-Dimethyl-1-(2-(trimethylstannyl)azetidin1-yl)propane-1-thione rac-272 
N
SnMe3
rac-272
S
 
 
Using general procedure L, s-BuLi (1.38 mL of a 1.3 M solution in hexanes, 1.8 mmol, 
1.2 eq.), N-thiopivaloyl azetidine 101 (236 mg, 1.5 mmol, 1.0 eq.) and TMEDA (0.27 
mL, 1.8 mmol, 1.2 eq.) in Et2O (8 mL) and Me3SnCl (2.25 mL of a 1.0 M in hexane, 
2.25 mmol, 1.5 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 95:5-9:1 petrol-Et2O as eluent gave stannane rac-272 
(284 mg, 60%) as a colourless oil. 
Lab Book Reference 8/680 
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 (S)-2,2-Dimethyl-1-(2-methylazetidin-1-yl)propane-1-thione (S)-102 
N
Me
H
S
(S)-102  
 
Using general procedure L, s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.60 mmol, 
1.2 eq.), N-thiopivaloyl azetidine 101 (79 mg, 0.50 mmol, 1.0 eq.) and (−)-sparteine 
(0.14 mL, 0.60 mmol, 1.2 eq.) in Et2O (5 mL) and methyl iodide (47 μL, 0.75 mmol, 1.5 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
9:1-8:2 petrol-Et2O as eluent gave methylated azetidine (S)-102 (79 mg, 91%, 59:41 er 
by CSP-HPLC) as a colourless oil, RF (8:2 petrol-Et2O) 0.3;
 1
H NMR (400 MHz, 
CDCl3) δ 4.91-4.82 (m, 1H, NCH), 4.57 (dddd, J = 10.5, 9.0, 7.0, 1.5 Hz, 1H, 
NCHAHB), 4.43 (dddd, J = 10.5, 10.0, 5.0, Hz, 1H, NCHAHB), 2.54 (dddd, J = 11.0, 
10.0, 9.0, 7.0 Hz, 1H, CHAHB), 1.85 (ddt, J = 11.0, 9.5, 5.0 Hz, 1H, NCHAHB), 1.62 (d, 
J = 6.0 Hz, 3H, Me), 1.34 (s, 9H, CMe3);
 13
C NMR (100.6 MHz, CDCl3) rotamers δ 
209.6 (C=S), 65.7 (NCH), 64.8 (NCH), 55.6 (NCH2), 53.7 (NCH2), 43.2 (CMe3), 30.85 
(CMe3), 29.6 (CMe3), 23.1 (CH2), 18.5 (Me); [α]D +0.2 (c 1.0 in CHCl3) (lit.,
102
 [α]D 
−21.3 (c 1.15 in CHCl3 for (R)-102 of 99:1 er)); CSP-HPLC: Chiracel OD-H (99.9:0.1 
Hexane-iPrOH, 1.0 mL min
-1
) (R)-102 11.1 min, (S)-102 11.9 min. Spectroscopic data 
consistent with those reported in the literature.
102
  
Lab Book Reference 8/649 
 
s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq.) was added dropwise 
to a stirred solution of N-thiopivaloyl azetidine 101 (79 mg, 0.5 mmol, 1.0 eq.) and (−)-
sparteine (0.14 mL, 0.6 mmol, 1.2 eq.) in Et2O (5 mL) at −78 °C under Ar.  The 
resulting solution was stirred at −78 °C for 30 min.  Methyl iodide (47 μL, 0.75 mmol, 
1.5 eq.) was added dropwise and the resulting solution was stirred at −78 °C for 2 h.  
Then, benzaldehyde (76 μL, 0.75 mmol, 1.5 eq.) was added.  The resulting solution was 
stirred at −78 °C for 1 h and 1 M HCl(aq) was added.  The two layers were separated and 
the aqueous layer was extracted with Et2O (3 x 10 mL).  The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 9:1-8:2 petrol-Et2O as 
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eluent gave methylated azetidine (S)-102 (67 mg, 78%, 58:42 er by CSP-HPLC) as a 
colourless oil, CSP-HPLC: Chiracel OD-H (99.9:0.1 Hexane-iPrOH, 1.0 mL min
-1
) (R)-
102 11.0 min, (S)-102 12.0 min. 
Lab Book Reference 8/659 
 
 (R)-2,2-Dimethyl-1-(2-methylazetidin-1-yl)propane-1-thione (R)-102 
N
Me
H
S
(R)-102  
 
Using general procedure L, s-BuLi (0.46 mL of a 1.3M solution in hexanes, 0.60 mmol, 
1.2 eq.), N-thiopivaloyl azetidine 101 (79 mg, 0.50 mmol, 1.0 eq.) and diamine (S,S)-42 
(186 mg, 0.60 mmol, 1.2 eq.) in Et2O (5 mL) and methyl iodide (47 μL, 0.75 mmol, 1.5 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
9:1-8:2 petrol-Et2O gave methylated azetidine (R)-102 (76 mg, 88%, 69:31 er by CSP-
HPLC) as a colourless oil, [α]D −2.0 (c 0.95 in CHCl3) (lit.,
102
 [α]D −21.3 (c 1.15 in 
CHCl3 for (R)-102 of 99:1 er)); CSP-HPLC: Chiracel OD-H (99.9:0.1 Hexane-iPrOH, 
1.0 mL min
-1
) (R)-102 14.0 min, (S)-102 15.4 min.  
Lab Book Reference 8/668 
 
s-BuLi (0.46 mL of a 1.3M solution in hexanes, 0.60 mmol, 1.2 eq.) was added 
dropwise to a stirred solution of N-thiopivaloyl azetidine 101 (79 mg, 0.50 mmol, 1.0 
eq.) and diamine (S,S)-42 (186 mg, 0.60 mmol, 1.2 eq.) in Et2O (5 mL) at −78 °C under 
Ar.  The resulting solution was stirred at −78 °C for 30 min.  Then, a solution of methyl 
iodide (31 μL, 0.50 mmol, 1.0 eq.) in Et2O (5 mL) was added dropwise via syringe 
pump over 2 h.  The resulting solution was stirred for 10 min at −78 °C and 1 M HCl(aq) 
(10 mL) was added.  The two layers were separated and the aqueous layer was extracted 
with Et2O (3 x 10 mL). The combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 9:1-8:2 petrol-Et2O as eluent gave methylated 
azetidine (R)-102 (78 mg, 91%, 68:32 er by CSP-HPLC) as a colourless oil, CSP-
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HPLC: Chiracel OD-H (99.9:0.1 Hexane-iPrOH, 1.0 mL min
-1
) (R)-102 13.9 min, (S)-
102 15.4 min.  
Lab Book Reference 8/669 
  
(S)-tert-Butyl 2-(hydroxymethyl)azetidine-1-carboxylate (S)-293 
N
Boc
H
(S)-293
OH
 
 
Borane dimethyl sulfide complex (0.51 mL, 5.42 mmol, 1.3 eq.) was added dropwise to 
a stirred solution of N-Boc acid (S)-285 (840 mg, 4.17 mmol, 1.0 eq.) in THF (10 mL) 
at 0 °C under Ar.  After gas evolution ceased, the resulting solution was stirred and 
heated at 66 °C for 1 h.  Then, the solution was cooled to rt and MeOH (5 mL) was 
added dropwise. The solvent was evaporated under reduced pressure to give the crude 
product.  Purification by flash column chromatography on silica with 6:4-1:1 petrol-
EtOAc as eluent gave alcohol (S)-293 (725 mg, 93%) as a colourless oil, RF (1:1 petrol-
EtOAc) 0.2; 
1
H NMR (400 MHz, CDCl3) δ  4.42 (br s, 1H, NCH), 4.25 (br s, 1H, OH), 
3.88-3.82 (m, 1H, NCHAHB), 3.79-3.68 (m, 3H, NCHAHB + OCH2), 2.16 (tdd, J = 11.5, 
9.0, 5.0 Hz, 1H, CHAHB), 1.91 (br s, 1H, CHAHB), 1.43 (s, 9H, CMe3);  
13
C NMR 
(100.6 MHz, CDCl3) δ 157.5 (C=O), 80.3 (CMe3), 67.0 (OCH2), 63.7 (NCH), 46.7 
(NCH2), 28.3 (CMe3), 17.9 (CH2); [α]D −19.8 (c 0.45 in CHCl3) (lit.,
102
 [α]D −21.5 (c 
0.83 in CHCl3)).  Spectroscopic data consistent with those reported in the literature.
102
 
Lab Book Reference 8/686 
 
(S)-tert-Butyl 2-(iodomethyl)azetidine-1-carboxylate (S)-294
235
 
N
Boc
H
(S)-294
I
 
 
Iodine (1.28 g, 5.06 mmol, 1.5 eq.) was added in three portions to a stirred solution of 
imidazole (459 mg, 6.74 mmol, 2.0 eq.) and triphenylphosphine (1.33 g, 5.06 mmol, 1.5 
eq.) in CH2Cl2 (15 mL) at 0 °C over 30 min.  The resulting solution was allowed to 
warm to rt and then stirred at rt for 10 min.  Then, a solution of alcohol (S)-293 (630 
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mg, 4.17 mmol, 1.0 eq.) in CH2Cl2 (5 mL) was added dropwise and the resulting 
solution was stirred at rt for 16 h.  The solids were removed by filtration and the filtrate 
was evaporated under reduced pressure.  The residue was dissolved in Et2O (25 mL) 
and the solids were removed by filtration.  The organic layer was washed with sat. 
Na2S2O3(aq) (15 mL), dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 9:1 petrol-
EtOAc as eluent gave iodide (S)-294 (851 mg, 85%) as a colourless oil, RF (9:1 petrol-
EtOAc) 0.4; IR (CHCl3) 2975, 2968, 1695 (C=O), 1510, 1446, 1420, 1278, 1190, 1035, 
915, 815, 731 cm
−1
; 
1
H NMR (400 MHz, CDCl3) δ 4.21-4.15 (m, 1H, NCH), 3.81-3.69 
(m, 2H, NCH), 3.51 (br d, J = 9.0 Hz, 1H, CHAHBI), 3.37 (t, 9.0 Hz,  CHAHBI), 2.29 
(dddd, J = 11.5, 9.0, 8.0, 5.5 Hz, 1H, CHAHB), 1.89 (dddd, J = 11.5, 9.0, 6.5, 6.0 Hz, 
1H, CHAHB), 1.43 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 155.6 (C=O), 79.7 
(CMe3), 61.1 (NCH), 44.9 (NCH2), 28.3 (CMe3), 23.4 (CH2), 11.6 (CH2I); MS (ESI) 
m/z 320 [(M + Na)
+
, 60], 241 (100); HRMS m/z calcd for C9H16INO2 (M + Na)
+
 
320.0118, found 320.0108 (+3.0 ppm error); [α]D −88.7 (c 0.95 in CHCl3). 
Lab Book Reference 8/687 
 
(R)-tert-Butyl-2-methylazetidine-1-carboxylate (R)-292
236
 
N
Boc
H
(R)-292  
 
5% Pd/C (65 mg, 10 wt% of (S)-294) was added to a stirred solution of iodide (S)-294 
(650 mg, 2.18 mmol, 1.0 eq.) and Et3N (0.30 mL, 2.18 mmol, 1.0 eq.) in MeOH (10 
mL) at rt.  Then, the reaction flask evacuated under reduced pressure and back-filled 
with Ar three times.  After a final evacuation, a balloon of H2 was attached and the 
reaction mixture was stirred vigorously at rt under H2 for 16 h.  The solids were 
removed by filtration through Celite
®
 and washed with CH2Cl2 (15 mL).  Then, the 
filtrate was evaporated under reduced pressure and the residue was dissolved in CH2Cl2 
(15 mL) and washed with 1 M HCl(aq) (10 mL), dried (MgSO4) and evaporated under 
reduced pressure to give the crude product.  Purification by flash column 
chromatography on silica with 4:1 petrol-Et2O as eluent gave methyl azetidine (R)-292 
(280 mg, 75%) as a colourless oil, RF (4:1 petrol-Et2O) 0.3;
 1
H NMR (400 MHz, CDCl3) 
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δ 4.26 (pent, J = 6.5 Hz 1H, NCH), 3.81-3.77 (m, 2H, NCH2), 2.30-2.21 (m, 1H, 
CHAHB), 1.74 (dtd, J = 11.0, 8.0, 6.0 Hz, 1H, CHAHB), 1.42 (s, 9H, CMe3), 1.35 (d, J = 
6.5 Hz, Me); 
13
C NMR (100.6 MHz, CDCl3) δ 156.4 (C=O), 78.9 (CMe3), 57.9 (br, 
NCH), 45.7 (br, NCH2), 28.4 (CMe3), 23.6 (CH2), 21.5 (Me); [α]D −38.1 (c 1.0 in 
CHCl3) (lit.,
102
 [α]D −40.5 (c 0.80 in CHCl3)). Spectroscopic data consistent with those 
reported in the literature.
102
 
Lab Book Reference: PJR 8/688A 
 
2,2-Dimethyl-1-pyrrolidin-1-ylpropan-1-thione 210
102
 
N
210
S
 
 
Phosphorous(V) sulfide (17.78 g, 80.0 mmol, 1.25 eq.) was added to a stirred solution 
amide 209 (10.0 g, 64 mmol, 1.0 eq.) in pyridine (100 mL) at rt under Ar. The resulting 
solution was heated at 75 °C for 6 h. The solution was allowed to cool to rt and then 
poured into 1 M HCl(aq) (150 mL).  1 M HCl(aq) was added until pH 3 was obtained. The 
resulting solution was stirred at rt for 2 h and then extracted with CH2Cl2 (3 × 100 mL).  
The combined organic extracts were washed with 1 M HCl(aq) (100 mL), water (100 
mL) and brine (100 mL), dried (Na2SO4) and evaporated under reduced pressure to give 
the crude product.  Purification by flash column chromatography on silica with 7:3 
petrol-EtOAc as eluent gave thioamide 210 (5.09 g, 100%) as pale yellow needles, mp 
32-35 °C (lit.,
237
 33-35 °C); RF (7:3 petrol-EtOAc) 0.5; 
1
H NMR (400 MHz, CDCl3) δ 
3.83 (t, J = 7.0 Hz, 2H, NCH2), 3.74 (t, J = 7.0 Hz, 2H, NCH2), 1.95 (quintet, J = 7.0 
Hz, 2H, CH2), 1.81 (quintet, J = 7.0 Hz, 2H, CH2), 1.29 (s, 9H, CMe3); 
13
C NMR (100.6 
MHz, CDCl3) rotamers δ 208.4 (C=S), 57.5 (NCH2), 52.7 (NCH2) 43.4 (CMe3), 30.1 
(CMe3), 27.2 (CH2), 22.8 (CH2). Spectroscopic data consistent with those reported in 
the literature.
237
 
 
Lab Book Reference: PJR 2/110A 
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1-((R)-2-((S)-Hydroxy(phenyl)methyl)pyrrolidin-1-yl)-2,2-dimethylpropane-1-
thione anti-(S,R)-211 and 1-((R)-2-((R)-hydroxy(phenyl)methyl)pyrrolidin-1-yl)-
2,2-dimethylpropane-1-thione syn-(R,R)-211 
N
S
Ph
OH
H
N
S
Ph
OH
H
ant i-(S,R)-211 syn-(R,R)-211  
 
Using general procedure M, s-BuLi (0.50 mL of a 1.3 M solution in hexanes, 0.65 
mmol, 1.3 eq.), (−)-sparteine (145 μL, 0.65 mmol, 1.3 eq.) and N-thiopivaloyl 
pyrrolidine 210 (86 mg, 0.50 mmol, 1.0 eq.) in Et2O (5 mL) and benzaldehyde (76 μL, 
0.75 mmol, 1.5 eq.) gave the crude product which contained a 58:42 mixture of 
diastereomeric alcohols anti-(S,R)-211 and syn-(R,R)-211 by 
1
H NMR spectroscopy.  
Purification by flash column chromatography on silica with 8:2-7:3 petrol-Et2O as 
eluent gave alcohol anti-(S,R)-211 (55 mg, 40%, 86:14 er by CSP-HPLC) as a white 
solid, mp 169-174 °C; RF (7:3 petrol-Et2O) 0.2; IR (CHCl3) 3386 (OH), 2972, 2876, 
1604, 1478, 1411, 1383, 1365, 1160, 732 cm
-1
; 
 1
H NMR (400 MHz, CDCl3) δ 7.53 (d, 
J = 7.0 Hz, 2H, o-Ph), 7.34 (t, J = 7.0 Hz, 2H, m-Ph), 7.26 (t, J = 7.0 Hz, 1H, p-Ph), 
5.90 (br s, 1H, OCH), 5.36-5.32 (m, 1H, NCH), 4.27-4.22 (m, 1H, NCHAHB), 3.52  (td, 
, J = 11.0, 6.0 Hz, 1H, NCHAHB), 2.28 (br s, 1H, OH), 2.12-1.97 (m, 2H, CH), 1.75-
1.64 (m, 2H, CH), 1.44 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 210.1 (C=S), 
141.9 (ipso-Ph), 128.1 (Ph), 127.2 (Ph), 125.5 (Ph), 71.4 (OCH or NCH), 70.4 (OCH or 
NCH), 54.7 (NCH2), 44.2 (CMe3), 30.7 (CMe3), 25.0 (CH2), 22.4 (CH2); MS (ESI) m/z 
300 [(M + Na)
+
, 20], 278 [(M + H)
+
, 100], 260 (30), 125 (40); HRMS m/z calcd for 
C16H23NOS (M + H)
+
 278.1573, found 278.1579 (−2.0 ppm error); [α]D −7.0 (c 1.0 in 
CHCl3); CSP-HPLC: Chiracel AD (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (S,R)-211 11.3 
min, (R,S)-211 14.7 min and alcohol syn-(R,R)-211 (50 mg, 37%, 82:18 er by CSP-
HPLC) as a colourless oil, RF (7:3 petrol-Et2O) 0.1; IR (film) 3387 (OH), 2973, 2876, 
1605, 1452, 1411, 1383, 1365, 1162, 732 cm
-1
;
 1
H NMR (400 MHz, CDCl3) δ 7.41-7.29 
(m, 5H, Ph), 5.68 (td, J = 8.0, 3.5 Hz, 1H, NCH), 5.29-5.26 (m, 1H, OCH), 4.11 (dt, J = 
11.5, 5.5 Hz, 1H, NCHAHB), 3.97 (br d, J = 5.0 Hz, 1H, OH), 3.25-3.18 (m, 1H, 
NCHAHB), 1.90-1.73 (m, 4H, CH), 1.45 (s, 9H, CMe3); 
13
C NMR rotamers (100.6 MHz, 
CDCl3) δ 212.6 (C=S), 141.8 (ipso-Ph), 128.3 (Ph), 128.5 (Ph), 128.3 (Ph), 127.8 (Ph), 
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127.6 (Ph), 127.1 (Ph), 127.0 (Ph), 74.4 (br, OCH), 69.8 (NCH), 65.3 (NCH2), 52.7 
(NCH2), 44.3 (CMe3), 30.7 (CMe3), 24.3 (CH2), 24.1 (CH2); MS (ESI) m/z 300 [(M + 
Na)
+
, 20], 278 [(M + H)
+
, 100], 260 (20), 125 (20); HRMS m/z calcd for C16H23NOS (M 
+ H)
+
 278.1573, found 278.1570 (1.1 ppm error); [α]D +94.2 (c 0.8 in CHCl3); CSP-
HPLC: Chiracel AD (90:10 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-211 10.6 min, (S,S)-
211 22.4 min. 
Lab Book Reference PJR 8/636 6/501 
 
A solution of stannane rac-297 (100 mg, 0.30 mmol, 1.0 eq.) in Et2O (3 mL) was added 
to a stirred solution of n-BuLi (0.13 mL of a 2.5 M solution in hexane, 0.33 mmol, 1.1 
eq.) and (−)-sparteine (77 μL, 0.33 mmol, 1.1 eq.) in Et2O (2 mL) at −78 °C under Ar.  
The resulting solution was stirred at −78 °C for 5 min.  Then, benzaldehyde (46 μL, 
0.45 mmol, 1.5 eq.) was added dropwise.  The resulting solution was stirred at −78 °C 
for 1 h and 1 M HCl(aq) (10 mL) was added.  The two layers were separated and the 
aqueous layer was extracted with Et2O (3 x 10 mL).  The combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude product which 
contained a 55:45 mixture of diastereomeric alcohols anti-(S,R)-211 and syn-(R,R)-211 
by 
1
H NMR spectroscopy.  Purification by flash column chromatography on silica with 
8:2-7:3 petrol-Et2O as eluent gave alcohol anti-(S,R)-211 (32 mg, 39%, 88:12 er by 
CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD (95:5 Hexane-iPrOH, 1.0 mL 
min
-1
) (S,R)-211 11.7 min, (R,S)-211 15.2 min and alcohol syn-(R,R)-211 (29 mg, 35%, 
82:18 er by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiracel AD (90:10 Hexane-
iPrOH, 1.0 mL min
-1
) (R,R)-211 9.8 min, (S,S)-211 18.8 min. 
Lab Book Reference PJR 8/700 
 
 
1-((S)-2-((R)-Hydroxy(phenyl)methyl)pyrrolidin-1-yl)-2,2-dimethylpropane-1-
thione anti-(R,S)-211 and 1-((S)-2-((S)-hydroxy(phenyl)methyl)pyrrolidin-1-yl)-2,2-
dimethylpropane-1-thione syn-(S,S)-211 
N
S
Ph
OH
H
N
S
Ph
OH
H
ant i-(R,S)-211 syn-(S,S)-211  
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Using general procedure M, s-BuLi (0.50 mL of a 1.3 M solution in hexanes, 0.65 
mmol, 1.3 eq.), (+)-sparteine surrogate 1 (120 mg, 0.65 mmol, 1.3 eq.) and N-
thiopivaloyl pyrrolidine 210 (86 mg, 0.50 mmol, 1.0 eq.) in Et2O (5 mL) and 
benzaldehyde (76 μL, 0.75 mmol, 1.5 eq.) gave the crude product which contained a 
78:22 mixture of diastereomeric alcohols anti-(R,S)-211 and syn-(S,S)-211 by 
1
H NMR 
spectroscopy.  Purification by flash column chromatography on silica with 8:2-7:3 
petrol-Et2O as eluent gave alcohol anti-(R,S)-211 (86 mg, 62%, 85:15 er by CSP-
HPLC) as a white solid, CSP-HPLC: Chiracel AD (95:5 Hexane-iPrOH, 1.0 mL min
-1
) 
(S,R)-211 11.2 min, (R,S)-211 14.6 min and alcohol syn-(S,S)-211 (33 mg, 24%, 92:8 er 
by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiracel AD (90:10 Hexane-iPrOH, 1.0 
mL min
-1
) (R,R)-211 10.8 min, (S,S)-211 19.8 min. 
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1-(2-(Hydroxy(phenyl)methyl)pyrrolidin-1-yl)-2,2-dimethylpropane-1-thione anti-
rac-211 and 1-(2-(hydroxy(phenyl)methyl)pyrrolidin-1-yl)-2,2-dimethylpropane-1-
thione syn-rac-211 
N
S
Ph
OH
H
N
S
Ph
OH
H
ant i-rac-211 syn-rac-211  
 
n-BuLi (26 μL of a 2.5M solution in hexanes, 0.066 mmol, 1.1 eq.) was added to a 
stirred solution of stannane (S)-297 (20 mg, 0.06 mmol, 1.0 eq., 78:22 er) in THF (5 
mL) at −78 °C under Ar.  The resulting solution was stirred at −78 °C for 5 min.  Then, 
benzaldehyde (7 μL, 0.07 mmol, 1.2 eq.) was added dropwise.  The resulting solution 
was stirred at −78 °C for 10 min and 1 M HCl(aq) (10 mL) was added.  The two layers 
were separated and the aqueous layer was extracted with Et2O (3 x 10 mL).  The 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product which contained a 60:40 mixture of alcohols syn-rac-211 and 
anti-rac-211 by 
1
H NMR spectroscopy. Purification by flash column chromatography 
on silica with 9:1-8:2 petrol-EtOAc as eluent gave alcohol anti-rac-211 (7 mg, 42%, 
51:49 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD (95:5 Hexane-
iPrOH, 1.0 mL min
-1
) (S,R)-211 11.2 min, (R,S)-211 14.6 min and alcohol syn-rac-211 
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(9 mg, 52%, 51:49 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiracel AD (90:10 
Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-211 10.6 min, (S,S)-211 23.1 min. 
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n-BuLi (26 μL of a 2.5M solution in hexanes, 0.066 mmol, 1.1 eq.) was added to a 
stirred solution of stannane (S)-297 (20 mg, 0.06 mmol, 1.0 eq., 78:22 er) and TMEDA 
(10 μL, 0.066 mmol, 1.1 eq.) in Et2O (5 mL) at −78 °C under Ar.  The resulting solution 
was stirred at −78 °C for 5 min.  Then, benzaldehyde (7 μL, 0.07 mmol, 1.2 eq.) was 
added dropwise.  The resulting solution was stirred at −78 °C for 10 min and 1 M 
HCl(aq) (10 mL) was added.  The two layers were separated and the aqueous layer was 
extracted with Et2O (3 x 10 mL). The combined layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product which contained a 76:24 
mixture of alcohols syn-rac-211 and anti-rac-211 by 
1
H NMR spectroscopy. 
Purification by flash column chromatography on silica with 9:1-8:2 petrol-EtOAc as 
eluent gave alcohol anti-rac-211 (8 mg, 24%, 50:50 er by CSP-HPLC) as a white solid, 
CSP-HPLC: Chiracel AD (95:5 Hexane-iPrOH, 1.0 mL min
-1
) (S,R)-211 11.3 min, 
(R,S)-211 14.7 min and alcohol syn-rac-211 (21 mg, 61%, 50:50 er by CSP-HPLC) as a 
white solid, CSP-HPLC: Chiracel AD (90:10 Hexane-iPrOH, 1.0 mL min
-1
) (R,R)-211 
10.6 min, (S,S)-211 23.0 min. 
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tert-Butyl (2R)-2-[(R)-hydroxy(phenyl)methyl]pyrrolidine-1-carboxylate syn-(R,R)-
73 
syn-(R,R)-73
N
Boc
H
Ph
OH
 
 
MeLi (0.58 mL of a 1.6 M solution in Et2O, 0.93 mmol, 6.0 eq.) was added dropwise to 
a stirred solution of alcohol syn-(R,R)-211 (43 mg, 0.16 mmol, 1.0 eq., 82:18 er) in THF 
(5 mL) at 0 °C under Ar.  The resulting solution was stirred at 0°C for 5 h.  Then, 1 M 
HCl(aq) (5 mL) was added dropwise.  The resulting solution was extracted with Et2O 
(10 mL).  The aqueous layer was adjusted to pH 12 by dropwise addition of 1 M 
NaOH(aq) and extracted with Et2O (3 x 10 mL).  The combined organic layers were 
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dried (MgSO4) and evaporated under reduced pressure to give the crude amino alcohol. 
The residue was dissolved in CH2Cl2 (5 mL) and di-tert-butyl dicarbonate (37 mg, 0.17 
mmol, 1.1 eq.) was added at rt under Ar.  The resulting solution was stirred at rt for 16 
h.  Then, 1 M HCl(aq) (10 mL) was added and the two layers separated.  The aqueous 
layer was extracted with CH2Cl2 (3 x 10 mL).  The combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product.  Purification 
by flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave 
alcohol syn-(R,R)-73 (30 mg, 70%, 82:18 er by CSP HPLC) as a colourless oil, [α]D 
−0.6 (c 0.75 in CHCl3) (lit.,
74
 [α]D −1.6 (c 1.0 in CHCl3 for (R,R)-73 of 97:3 er)); CSP-
HPLC: Chiracel OD (98:2 Hexane-iPrOH, 0.5 mL min
-1
) (R,R)-73 28.6 min, (S,S)-73 
35.7 min. Spectroscopic data consistent with those reported in the literature.
74
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tert-Butyl (2R)-2-[(S)-hydroxy(phenyl)methyl]pyrrolidine-1-carboxylate anti-(S,R)-
73 
syn-(S,R)-73
N
Boc
H
Ph
OH
 
 
MeLi (0.45 mL of a 1.6 M solution in Et2O, 0.72 mmol, 6.0 eq.) was added dropwise to 
a stirred solution of alcohol anti-(S,R)-211 (33 mg of 86:14 er, 0.12 mmol, 1.0 eq.) in 
THF (5 mL) at 0 °C under Ar.  The resulting solution was stirred at 0°C for 5 h.  Then, 
1 M HCl(aq) (5 mL) was added dropwise.  The resulting solution was extracted with 
Et2O (10 mL).  The aqueous layer was adjusted to pH 12 by dropwise addition of 1 M 
NaOH(aq) and extracted with Et2O (3 x 10 mL).  The combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude amino alcohol. 
The residue was dissolved in CH2Cl2 (5 mL) and di-tert-butyl dicarbonate (28 mg, 0.13 
mmol, 1.1 eq.) was added at rt under Ar.  The resulting solution was stirred at rt for 16 
h.  Then, 1 M HCl(aq) (10 mL) was added and the two layers separated.  The aqueous 
layer was extracted with CH2Cl2 (3 x 10 mL).  The combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product.  Purification 
by flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave 
alcohol anti-(S,R)-73 (17 mg, 50%, 86:14 er by CSP HPLC) as a colourless oil, [α]D 
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+79.4 (c 1.0 in CHCl3) (lit.,
74
 [α]D +112.7 (c 1.5 in CHCl3 for (S,R)-73 of 96:4 er)); 
CSP-HPLC: Chiracel OD (99:1 Hexane-iPrOH, 0.5 mL min
-1
) (S,R)-73 25.7 min, (R,S)-
73 28.3 min. Spectroscopic data consistent with those reported in the literature.
74
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 (S)-2,2-Dimethyl-1-(2-(trimethylstannyl)pyrrolidin-1-yl)propane-1-thione (S)-297 
N
S
SnMe3
H
(S)-297  
 
Using general procedure M, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.30 mmol, 
1.3 eq.), N-thiopivaloyl pyrrolidine 210 (171 mg, 1.00 mmol, 1.0 eq.) and (−)-sparteine 
(296 μL, 1.30 mmol, 1.3 eq.) in Et2O (7 mL) and trimethyltin chloride (1.50 mL of a 1.0 
M solution in hexanes, 1.5 mmol, 1.5 eq.) gave the crude product.  Purification by flash 
column chromatography on silica with 95:5 petrol-EtOAc  as eluent gave stannane (S)-
297 (228 mg, 68%, 78:22 er by CSP-HPLC) as a colourless oil, RF (95:5 petrol-EtOAc) 
0.3;
 
IR (film) 2978, 1500, 1482, 1448, 1390, 1370, 1246, 1074, 1036, 912, 809, 730 
cm
−1
; 
1
H NMR (400 MHz, CDCl3) δ 4.37-4.28 (m, 1H, NCH), 3.91-3.78 (m, 2H, 
NCH2), 2.20-2.09 (m, 2H, CH2), 2.07-2.01 (m, 1H, CH), 1.98-1.88 (m, 1H, CH), 1.40 
(s, 9H, CMe3), 0.07 (s, 9H, SnMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 201.0 (C=S), 63.7 
(NCH), 53.1 (NCH2), 43.1 (CMe3), 30.7 (CMe3), 28.2 (CH2), 27.6 (CH2), −6.7 (SnMe3); 
MS (ESI) m/z 336 [(M(
120
Sn) + H)
+
, 100], 334 [(M(
118
Sn) + H)
+
, 70], 332 [(M(
116
Sn) + 
H)
+
, 30]; HRMS m/z calcd for C12H25NS
120
Sn (M + Na)
+
 336.0803 (−1.0 ppm error), 
found 336.0806; [α]D +290.89 (c 0.70 in CHCl3);  CSP-HPLC: Chiracel OD-H (99.5:0.5 
Hexane-iPrOH, 1.0 mL min
-1
) (S)-297 4.9 min, (R)-297 6.4 min.  The absolute 
configuration of the major enantiomer is assumed by analogy to benzaldehyde- 
trappings. 
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(S)-2,2-Dimethyl-1-(2-(trimethylstannyl)pyrrolidin-1-yl)propane-1-thione rac-297 
N
S
SnMe3
rac-297  
 
Using general procedure M, s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.30 mmol, 
1.3 eq.), N-thiopivaloyl pyrrolidine 210 (171 mg, 1.00 mmol, 1.0 eq.) and TMEDA (194 
μL, 1.30 mmol, 1.3 eq.) in Et2O (7 mL) and trimethyltin chloride (1.50 mL of a 1.0 M 
solution in hexanes, 1.5 mmol, 1.5 eq.) gave the crude product.  Purification by flash 
column chromatography on silica with 95:5 petrol-EtOAc as eluent gave stannane rac-
297 (254 mg, 76%) as a colourless oil. 
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 (S)-2,2-dimethyl-1-(2-methylpyrrolidin-1-yl)propane-1-thione (S)-298 
N
S
Me
(S)-298
H
 
 
Using general procedure M, s-BuLi (0.50 mL of a 1.3 M solution in hexanes, 0.65 
mmol, 1.3 eq.), N-thiopivaloyl pyrrolidine 210 (86 mg, 0.50 mmol, 1.0 eq.) and (−)-
sparteine (0.15 mL, 0.65 mmol, 1.3 eq.) in Et2O (5 mL) and methyl iodide (47 μL, 0.75 
mmol, 1.5 eq.) gave the crude product.  Purification by flash column chromatography 
on silica with 9:1-8:2 petrol-Et2O as eluent gave methylated pyrrolidine (S)-298 (78 mg, 
84%, 58:42 er by CSP-HPLC) as a colourless oil. RF (8:2 petrol-Et2O) 0.3; IR (film) 
2975, 2876, 1530, 1458, 1410, 1325, 1116, 730 cm
-1
; 
1
H NMR (400 MHz, CDCl3) 
85:15 mixture of rotamers δ 5.15-5.07 (m, 0.85H, NCH), 4.84-4.78 (m, 0.15H, NCH), 
4.21 (dt, J = 14.5, 8.5 Hz, 0.15H, NCHAHB), 4.00 (ddd, J = 13.5, 12.0, 7.0 Hz, 0.85H, 
NCHAHB), 3.83-3.76 (m, 0.15H, NCHAHB), 3.67 (dt, J = 13.5, 6.5 Hz, 0.85H, 
NCHAHB), 2.13-1.86 (m, 3H, CH), 1.66-1.59 (m, 1H, CH), 1.43 (s, 1.35H, CMe3), 1.39 
(s, 7.65H, CMe3), 1.33 (d, J = 6.5 Hz, 2.55H, Me), 1.24 (d, J = 6.0 Hz, 0.45H, Me); 
13
C 
NMR (100.6 MHz, CDCl3) δ 208.8 (C=S), 61.8 (NCH), 52.0 (NCH2), 44.0 (CMe3), 
30.6 (CMe3), 30.4 (CH2), 24.9 (CH2), 17.7 (Me); MS (ESI) m/z 208 [(M + Na)
+
, 100], 
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186 [(M + H)
+
, 20]; HRMS m/z calcd for C10H19NS (M + Na)
+
 208.1136, found 
208.1131 (−0.5 ppm error); [α]D −10.1 (c 0.95 in CHCl3);  CSP-HPLC: Chiracel OD-H 
(99.5:0.5 Hexane-iPrOH, 1.0 mL min
-1
) (S)-298 8.0 min, (R)-298 9.0 min.  The absolute 
configuration of the major enantiomer was assigned by comparison to unpublished 
results within our group (conversion of (S)-298 into known compound).
212
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Chapter Six: Abbreviations 
Ac  Acetyl 
aq.  Aqueous 
 
Bn  Benzyl 
Boc  t-butoxycarbonyl 
bp  Boiling Point 
br  Broad 
Bu  Butyl 
 
Cb  N,N-Diisoproylcarbamoyl 
CIPE  Complex induced proximity effect 
cm
-1
  Wavenumber 
CSP-HPLC Chiral Stationary Phase High Performance Liquid Chromatography 
 
δ  Chemical shift  
d  Doublet 
DET  Diethyl tartrate  
DMAP  4-Dimethylaminopyridine 
DMF  Dimethylformamide 
dr  Diastereomeric ratio 
 
E
+  
Electrophile 
EDC  1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
ESI  Electrospray ionisation 
eq.  Equivalent(s) 
er  Enantiomeric ratio 
 
g  Gram(s) 
GC  Gas chromatography 
 
h  Hour(s) 
HFIP  Hexafluoroisopropanol 
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HOBt  Hydroxybenzotriazole 
HRMS  High resolution mass spectrometry 
Hz  Hertz 
i-Pr  Isopropyl 
IR  Infra-red 
 
J  Coupling constant in Hz 
 
KHMDS Potassium hexamethyldisilazide 
 
LHMDS Lithium hexamethyldisilazide 
 
M  Molar 
M
+
  Molecular ion 
m  Multiplet 
mCPBA meta-Chloroperoxybenzoic acid 
Me  Methyl 
mg  Milligrams 
min  Minutes 
mL  Millilitre 
mmol  Millimole 
mol  Mole 
MOM  Methoxymethyl ether 
mp.  Melting Point 
MS  Mass Spectrometry 
MTBE  Methyl tert-butyl ether 
m/z  Mass to charge ratio 
 
NCS  N-Chlorosuccinimide  
NMR  Nuclear Magnetic Resonance 
Ns  4-Nitrobenzenesulfonyl 
 
Petrol  Petroleum ether (Fraction which boils at 40-60 °C) 
Ph  Phenyl 
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PMP  para-Methoxyphenyl 
ppm  Parts per million 
PPTS  Pyridinium p-toluenesulfonate 
 
q  Quartet 
 
R  Alkyl group 
RSM  Recovered starting material 
RF  Retention factor 
rt  Room temperature 
 
s  Singlet 
SEM  [2-(Trimethysilyl)ethoxy]methyl 
sp.  Sparteine  
(+)-sp. surr. (+)-Sparteine surrogate 
s-Bu  s-Butyl 
 
t  Triplet 
TBDMS tert-Butyldimethylsilyl 
t-Bu  t-Butyl 
TFA  Trifluoroacetic acid 
TFAA  Trifluoroacetic anhydride 
THF  Tetrahydrofuran 
TLC  Think layer chromatography 
TMEDA N,N,N’,N’-tetramethylethylenediamine 
Ts  p-Toluenesulfonyl 
 
UV  Ultraviolet 
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